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Summary
Cystic fibrosis (CF) patients are predisposed to a number of bacterial infections, including 
Pseudomonas aeruginosa and the Burkholderia cepacia complex (Bcc). Both groups of 
bacteria have been associated with contamination of products containing biocides, leading 
to concerns that the over use of biocide products could select for multi drug resistant 
organisms.
This investigation examined the susceptibility profile of panels of P. aeruginosa and Bcc 
strains to a range of biocides including chlorhexidine and cetylpyridinium chloride (CPC). It 
was found that certain epidemic strains that had spread among individuals with CF, such 
as the B. cenocepacia J2315 strain lineage and the P. aeruginosa Liverpool strain were 
less susceptible to chlorhexidine than other strains representative of the same species. 
Although minimum inhibitory concentration (MIC) screens gave an overall view of biocide 
susceptibility, minimum bactericidal concentrations (MBC) for these bacteria were higher. 
For CPC 27 out of 40 strains required more than 20 fold more biocide than the MIC to 
achieve a bactericidal effect. Suspension tests were performed on two commercial biocide 
formulations, a chlorhexidine-based wash, Hibiscrub™ and a triclosan-based hand gel 
Cuticura™. The epidemic B. cenocepacia strain J2315 was capable of surviving in both 
these products after 20 minutes of exposure and viable bacteria were isolated after 60 
minutes of exposure in Hibiscrub™. The results from this investigation suggest that certain 
commercial biocides are not effective against the Bcc. Therefore to assist in the future 
development of biocides, three highly resistant Bcc strains were proposed as suitable 
reference strains to use in challenge testing for biocide efficacy.
The molecular basis of biocide resistance was determined using a microarray approach to 
profile global gene expression of B. cenocepacia in response to chlorhexidine. B. 
cenocepacia J2315 was exposed to sub-inhibitory levels of chlorhexidine (5 pg/ml) and 
expression compared to cells not exposed to biocide. The microarray analysis 
demonstrated significant alterations in expression at P < 0.05, with a > 1.5 fold change; 
with 98 up-regulated and 76 down-regulated genes. Two chlorhexidine up-regulated genes 
were selected for further analysis, a response regulator (BCAM 0924) potentially involved 
with efflux and a novel transport related gene (BCAL 2553). Site directed mutagenesis of 
these genes was carried out in B. cenocepacia strain K56-2 and a reduction in 
chlorhexidine MIC was observed for each respective mutant compared to the wildtype. 66 
out of 76 (87%) of the down-regulated genes were involved with motility related functions. 
This led to the hypothesis that sub-inhibitory levels of chlorhexidine inhibited swarming 
motility and induced biofilm production. This question was tested for Bcc strains using soft- 
agar swarming tests and 96-well plate biofilm assays. A total of 6 of 10 strains screened 
exhibited both biofilm induction and swarming inhibition in response to chlorhexidine. A 
potential conserved regulatory binding motif was observed upstream of all gene sets down- 
regulated chlorhexidine in the microarray analysis. This suggested that swarming inhibition 
and biofilm induction in B. cenocepacia may be controlled by a coordinated regulatory 
pathway controlled by a two component system sensor-regulator system. A transposon 
mutagenesis approach was used to identify B. cenocepacia mutants that lacked the 
inhibitory response. The screen identified several mutations involved in the phenomenon 
including cheY-like receiver genes and a glycosyl transferase encoding gene. In 
conclusion, the molecular analysis of biocide resistance in Bcc bacteria demonstrated it 
was multifactoral, involving efflux pumps, transport related genes, membrane proteins and 
regulatory genes. The ability of chlorhexidine to inhibit swarming and switch Bcc to a non 
motile biofilm lifestyle was identified as a novel biocide survival response. With further 
research this regulatory pathway may be a potential target for the development of a novel 
biocides and therapeutics which overcome the antimicrobial resistance of these bacteria 
pathogens.
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Chapter 1 Introduction
1.1 Cystic Fibrosis
Cystic Fibrosis (CF) is the most common autosomally inherited recessive disease in 
Caucasian populations. It occurs in approximately 1 in 2500 births and has a 
carrier frequency of 1 in 25 (Tummler and Kiewitz, 1999). Patients diagnosed with 
cystic fibrosis face a life of hospital visits, bacterial infections and clinical treatment 
cycles. They also face the prospect of a much shortened life span and the 
consequences that arise from having a genetically inherited disease. Thankfully 
due to advances in treatment, patients now have a life expectancy of 40 years and 
can lead fulfilling lives. A major advance in the understanding of cystic fibrosis was 
the identification of the gene that caused the disease. CF sufferers have a mutation 
in a cAMP regulated chloride channel called the cystic fibrosis transmembrane 
conductance regulator (CFTR) (Chmiel and Davis, 2003). These mutations cause 
the CFTR to not function properly leading to the symptoms of CF. CFTR is 
expressed at the apical surface of epithelial cells and therefore although 
predominantly associated with lung disease, cystic fibrosis effects many other 
epithelial cells in the body (Chmiel and Davis, 2003). These include sweat glands, 
airways, vas deferens in males, bile ducts, pancreas and intestines. This leads to 
many other CF associated problems such as diabetes, malnutrition and infertility 
(Chmiel and Davis, 2003). However, it is the progressive lung disease that causes 
increased morbidity and mortality in CF patients (Tummler and Kiewitz, 1999).
1.11 The Cystic fibrosis transmembrane conductance regulator
Cystic Fibrosis is caused by mutations in the CFTR gene, which is encoded on 
chromosome 7. Approximately 900 disease causing mutations have been 
identified, but the most common, occurring in 70% of patients is an in frame 3 bp 
deletion of a phe codon (phenylalanine encoding), known as the delta F508 
mutation (Vankeerberghen et a/., 2002). CF has a variable phenotype, with severity 
of disease depending on the mutations carried. A patient carrying two delta F508 
mutations would be classed has having a severe disease and would usually be
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pancreatic deficient, whereas a patient carrying two mild mutations (e.g. R117HH or 
R334W) or one mild and one severe mutation may have a less severe phenotype, 
retaining some pancreatic function (Sheppard and Ostedgaard, 1996).
CFTR belongs to the ATP binding cassette (ABC) transporter family and contains 
two sets of membrane spanning segments, two nucleotide binding domains and a 
regulatory cellular domain. This regulatory domain contains sensor kinases, which 
phosphorylate the regulator domain in a cAMP dependent manor leading to the 
channel opening (Tummler and Puchelle, 1997). The CFTR is predominately a 
chloride ion channel, thus CF patients with defective CFTR have a lack of secretion 
of chloride ions across epithelial cells and a lack of reabsorption of chloride ions 
leading to the characteristic salty sweat that CF patients produce. The sweat test is 
commonly used by clinicians as a diagnostic tool for CF. In addition to its role as a 
chloride channel, the CFTR also acts as a conductance regulator by affecting the 
function of other channels in the epithelium, particularly the amiloride sensitive 
epithelial sodium channel (ENaC) (Chmiel and Davis, 2003). This channel 
transports salt and water and is involved with the reabsortion of sodium from airway 
surface liquid, with water then following. Balanced CFTR and ENaC mediated ion 
transport is required to maintain a constant airway surface fluid depth. Functional 
CFTR down regulates the ENaC channel, so consequently in CF patients lacking 
CFTR function sodium reabsorption is increased (Chmiel and Davis, 2003). The 
excess reabsorption of sodium and thus water from the airway fluid and the 
decreased secretion of chloride ions across the airway leads to a reduced airway 
fluid depth and the production of a sticky mucus (Chmiel and Davis, 2003, Tummler 
and Puchelle, 1997) (Figure 1.1).
The dehydrated mucus produced by CF patients leaves them susceptible to 
bacterial infections. The sticky mucus leads to an impaired mucillary clearance, 
meaning bacterial infections are more likely to persist in the CF lung (Tummler and 
Kiewitz, 1999). An additional factor for the acquisition of bacterial infections is that 
CFTR may be a receptor for bacterial infections such as Pseudomonas aeruginosa, 
so patients with defective CFTR may have impaired endocytosis (Pier et a/., 1997). 
However, this is a controversial study with little follow up work in the last ten years.
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Figure 1.1 The effect of abnormal CFTR on the airways of CF patients
Defective CFTR leads to decreased chloride secretion across the epithelial cells into the CF airway. 
In CF patients CFTR channels are no longer able to open to allow secretion due to the lack of 
phosphorylation of the CFTR regulator domain. As well as effecting the chloride secretion, sodium 
reabsorption is increased by pleiotrophic effects on a sodium transporter channel, ENaC. The 
combination of reduced chloride secretion and increased sodium reabsortion leads to less water in 
the CF airway, causing a lower surface airway fluid depth and consequently and abnormal, sticky 
mucus. (Figure adapted from Chmiel and Davis, 2003).
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Other factors include the adaptation of the bacteria to survive in the CF lung, by the 
formation of biofilms and the production of virulence factors such as endotoxins and 
antimicrobial resistance (Chmiel and Davis, 2003). Infection leads to a constant 
stimulation of the host’s immune system without the clearance of the invading 
bacteria; this in itself can cause problems as persistent inflammation of the lungs 
leads to damage. Stimulation of the immune system causes the migration of 
polymorphonuclear leukocytes and the release of cytokines in the lungs, which do 
not result in the clearance of the infection (Tummler and Kiewitz, 1999). The 
repetitive cycle of obstruction, infection and inflammation lead to bronchiectasis, 
emphysema and fibrosis of pulmonary tissue, eventually leading to respiratory 
failure (Tummler and Kiewitz, 1999).
CF patients acquire a number of bacterial pathogens from an early age. In early 
childhood most patients become infected with Haemophilus influenzae and 
Staphylococcus aureus, then as the patient gets older they frequently become 
infected with P. aeruginosa and to a lesser extent the Burkholderia cepacia 
complex (Bcc) (Pilewski and Frizzell, 1999). Recurrent bacterial infections are a 
major cause of respiratory problems and are the main cause of increased morbidity 
and mortality in CF patients. Not only do bacterial infections have a detrimental 
effect on the patients health, they are also responsible for increased hospital stays, 
treatment with a combination of potent antibiotics and the stigma of having 
infections such as the Bcc which may result in segregation. This investigation 
focuses on two of the most common pathogens infecting CF patients, P. aeruginosa 
and the Bcc.
1.2 Multidruq resistant infections in CF patients 
1.21 Pseudomonas aeruginosa
P. aeruginosa is a Gram negative rod that has polar flagella. Pseudomonads 
usually have very simple nutritional requirements and grow 
chemoorganotrophically. It can utilise a wide range of organic compounds which 
are then used as carbon sources, which allows Pseudomonas species to grow in a
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variety of environments, that other bacteria may not be able to grow in due to the 
limited nutrients (Madigan et a/., 2001b). P. aeruginosa can make use of many 
different sugars, fatty acids, dicarboxylic acids, tricarboxylic acids, alcohols and 
polyalcohols as well as many others. P. aeruginosa is an important organism in the 
soil environment as it may be responsible for the degradation of many soluble 
compounds from plant and animal materials (Madigan et a/., 2001b). It is also 
involved in the nitrogen cycle as a denitrifyer (Tummler and Kiewitz, 1999).
Although this organism is important in environmental situations it is also an 
opportunistic pathogen, infecting the urinary tract and respiratory tract in humans. 
P. aeruginosa is also associated with patients who have severe burns and skin 
damage. P. aeruginosa is often associated with nosocomial infections and is 
difficult to treat due to its innate resistance to many antibiotics, such as R-lactams, 
some quinolones, chloramphenicol, tetracycline, macrolides, trimethoprim / 
sulfamethoxazole and rifampin (Rossolini and Mantengoli, 2005) This leaves 
limited treatment options for patients infected with P. aeruginosa and often results 
in potent, toxic antibiotics being used (Tummler and Kiewitz, 1999). The most 
important anti-pseudomonal agents include some modified R-lactams (ticarcillin, 
ureidopenicillins, piperacillin, cefoperazone, ceftazidime, aztreonam, imipenem and 
meropenem), aminoglycosides (gentamicin, tobramycin, netilmicin and amikacin) 
and fluoroquinolones (ciprofloxacins) (Rossolini and Mantengoli, 2005).
Polymyxins, such as polymyxin B and colistin have high activity against 
Pseudomonads, but have a higher toxicity so are reserved to treat multidrug 
resistant strains (Rossolini and Mantengoli, 2005). Multi drug resistance is often 
conferred by a resistance transfer plasmid (R plasmid), which carries genes coding 
for detoxification of many of the antibiotics in day to day use (Tummler and Kiewitz, 
1999). These plasmids may also encode enzymes called extended spectrum Q>- 
lactamases (ESBL). These enzymes hydrolyse and cause resistance to oxyimino- 
cephalosporins and aztreonam. The majority of ESBLs are derived from mutations 
of other broad spectrum fc-lactamases such as TEM-1 and contributes to the innate 
resistance of P. aeruginosa to many antimicrobial agents (Bradford, 2001).
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P. aeruginosa is the most common infection found in CF suffers, with up to 70% of 
patients becoming chronically infected with it by adulthood (Speert et al., 2002). P. 
aeruginosa causes infections involved in the later stages of a CF patients life and 
the mechanisms of it’s colonisation of the respiratory tract have been well 
documented. The CF lung is already prone to bacterial infections due to 
dehydrated mucus and abnormal pulmonary clearance (Chmiel and Davis, 2003). 
It may become more susceptible to P. aeruginosa infections due to previous 
colonisation with other infections such as S. aureus and H. influenzae. Infection 
with these bacteria will increase lung damage and may aid the colonisation of P. 
aeruginosa (Govan and Deretic, 1996). The P. aeruginosa phenotype is quite 
distinctive when colonizing the CF respiratory tract. Initially when P. aeruginosa 
colonises the respiratory tract, pilli, non pilus adhesions and motility are involved. 
However as it moves into chronic infection, P. aeruginosa appears to adapt to the 
CF host environment by switching to a mucoid form. This is where the bacteria 
secrete exopolysaccharides, exotoxins, proteases, and siderophores, which allow it 
to form biofilms and to effectively evade the hosts defence system (Govan and 
Deretic, 1996). (Figure 1.2). Other adaptations that allow P. aeruginosa to maintain 
infection is the conversion of lipopolysaccharides to rough from smooth and the loss 
of motility (Mahenthiralingam et al., 1994). These changes in the phenotype of P. 
aeruginosa appear to be due to adaptations by the bacteria to chronic colonisation 
and not the replacement of one strain with another (Govan and Deretic, 1996).
The epidemiology of P. aeruginosa is a significant factor for research as it allows 
correct infection control procedures to be put into place. Nearly all CF patients 
become colonised with P. aeruginosa and this infection is usually chronic and 
difficult to eradicate. To see if patient to patient spread was a problem typing 
systems such as a random amplified polymorphic DNA (RAPD) typing and pulsed 
field gel electrophoresis were developed (Mahenthiralingam et al., 1996a). The 
RAPD typing method uses PCR primers of arbitrary DNA sequences, which 
produce different band patterns when separated by gel electrophoresis. Those with 
the same patterns can be said to be the same strain. The RAPD analysis indicated 
that patient to patient transmission was not a problem as most patients were 
colonised with a single strain that they never lost (Mahenthiralingam et al., 1996a). 
The only exceptions were in CF siblings, where prolonged contact led to cross
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Figure 1.2 P. aeruginosa infection in CF patients decreased lung function
The progression of P. aeruginosa infection from acute to chronic. Initially cells adhere to the 
epithelial cells by binding to mucin. The CF airways impaired pulmonary clearance leads to 
aggregation of cells and the stimulation of the host immune system. The ineffective immune system 
causes inflammation and the production of virulence factors by P. aeruginosa. As the infection 
progresses to a chronic state P. aeruginosa loses motility and becomes mucoid and sessile.
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infection. A study in British Columbia found 123 unique P. aeruginosa strains and 
only 34 types shared, 10 of which were between CF siblings (Speert et al., 2002), 
indicating that the risk of transmission was low.
However further examination of CF populations, particularly in the UK demonstrated 
the presence of rogue transmissible strains, such as the strains found in Liverpool 
and Manchester. The Liverpool epidemic strain was found to colonise a high 
proportion of children attending this clinic (Cheng et al., 1996). This strain was 
resistant to ceftazidime and molecular fingerprinting techniques indicated 55 out of 
65 children harboured the same epidemic strain (Cheng et al., 1996). An outbreak 
in a Manchester clinic with an epidemic P. aeruginosa strain had similar results. 
Patients attending this clinic that had no other social contact outside the clinic 
contracted the same strain of P. aeruginosa (Jones et al., 2001b). When this strain 
was examined in detail, it was seen to have some unusual phenotypic differences, 
including a lack of pigment production, lack of motility and was resistant to a 
number of anti-pseudomonal antibiotics (Jones et al., 2001b).
These studies indicate that it is possible for outbreaks of epidemic P. aeruginosa 
strains to occur in CF clinics. Follow up of national surveillance of the UK CF 
population has now shown that certain epidemic strains, such as the Liverpool 
Epidemic strain are widespread across the nation and infect approximately 1 in 4 of 
the adult CF population (Scott and Pitt, 2004). However, in other CF populations, 
such as those in Western Canada it has been shown that patient to patient spread 
is not a significant cause of P. aeruginosa acquisition and thus draconian 
segregation policies may not be necessary in all cases (Speert et al., 2002). RAPD 
analysis also demonstrated that the phenotypic changes in P. aeruginosa are due 
to adaptation to chronic colonisation and not due to replacement of other strains 
(Mahenthiralingam et al., 1996a). There is also some concern that P. aeruginosa 
may be acquired from the environment. This hypothesis is feasible because it is 
found in many habitats including environmental, such as soil and clinical such as 
hospitals (Govan, 2000).
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1.22 The Burkholderia cepacia complex (Bcc)
The genus Burkholderia is a group of Gram negative, aerobic rods from the beta 
proteobacteria group (Madigan et al., 2001b). These species can occupy diverse 
ecological niches ranging from bacteria that inhabit the soil to those that colonize 
the respiratory tract of humans (Coenye et al., 2001). They can also have varied 
host ranges. Some Burkholderia species are restricted to occupying only one type 
of host; for example B. mallei, which causes glanders in horses, where as other 
species can occupy a range of hosts. These interactions can be pathogenic or 
symbiotic or may even be both (Coenye et al., 2001). The Burkholderia genus can 
occupy many niches and are particularly associated with the environment. 
Burkholderia cepacia was originally described as a plant pathogen that caused sour 
skin of onion (Burkholder, 1950), but it was soon discovered that Burkholderia did 
not only form pathogenic interactions with plants but also beneficial associations. 
Many species of Burkholderia can be isolated from the rhizosphere of plants, such 
as rice, peas, tomatoes and maize, where they are involved in nitrogen fixation. 
There is evidence that Burkholderia can form endosymbiotic relationships with 
plants and these may also have beneficial properties to the plant (Coenye et al.,
2001).
Burkholderia are also found in the soil where they have commercial and ecological 
importance as they can be used in agriculture as bio-pesticides and plant growth 
promoters (Govan and Vandamme, 1998). The ability of members of the Bcc to 
metabolize a wide range of substrates means that they could also be used as a 
bioremediation agent to break down pollutants such as trichloroethylene (O'Sullivan 
and Mahenthiralingam, 2005). Therefore these desirable properties of the 
Burkholderia species mean that it is an important group for the agricultural industry. 
However, there has been restrictions placed on the use of Burkholderia species in 
agriculture because many species can also form pathogenic interactions in humans 
(Govan and Vandamme, 1998), especially the Bcc complex, which is a group of at 
least nine closely related species that all have the ability to infect immuno­
compromised patients, especially patients with cystic fibrosis (Mahenthiralingam 
and Vandamme, 2005). As a result there is concern that the environment may be a 
source of infection for cystic fibrosis patients and consequently accurate tests are
10
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Figure 1.3 Interaction of the Bcc with plants and humans
The Bcc was originally designated as a pathogen of onions; however it is now recognised as having 
beneficial interactions with plants as well. They produce secondary metabolites that can protect the 
plant and also aid plant growth. In addition, the Bcc are capable of degrading a number of 
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required to distinguish between clinical and environmental samples (Govan and 
Vandamme, 1998) (Figure 1.3).
The Bcc are a challenging group of bacteria to identify, as it is difficult to distinguish 
between species using conventional biochemical and phenotypic tests 
(Mahenthiralingam and Vandamme, 2005). Therefore a polyphasic taxonomic 
approach is constantly being revised as new and more accurate tests are devised 
(Mahenthiralingam and Vandamme, 2005). The species Burkholderia cepacia was 
originally classified as Pseudomonas cepacia, but in 1992 it was reclassified as 
Burkholderia cepacia by Yabuuchi et al. (Yabuuchi et al., 1992) and designated as 
the type species for the genus Burkholderia. Many other species were added to 
this genus as more accurate taxonomic tests were developed. Originally a 
combination of phenotypic tests was used to distinguish B. cepacia from other 
species. These tests included selective media, conventional biochemical analysis 
and commercial bio - typing systems (Coenye et al., 2001). However these tests 
were not always accurate for the Bcc. The B. cepacia selective media (BCSA) also 
enriched closely related species such as Ralstonia and conventional tests also 
showed discrepancies due to the complex and diverse biochemical nature of B. 
cepacia (Coenye et al., 2001). Therefore a polyphasic approach was devised 
combining a series of tests such as whole cell protein analysis (SDS-PAGE) and 
whole fatty acid analysis (Vandamme et al., 1997). However, these tests could not 
distinguish between the entire Bcc, which lead to the development of genetic 
assays based on the polymerase chain reaction (PCR), which allowed the quick 
and accurate identification of the Bcc (Mahenthiralingam et al., 2000a).
The first assay developed was the 16S rRNA based assay. The 16S rRNA gene 
has been used for the identification of species of other bacteria, so a PCR based 
assay was developed (Coenye et al., 2001). LiPuma et al. (1999) investigated 
species-specific signature sequences in the 16S rRNA gene. However it was 
discovered, using restriction fragment length polymorphism (RFLP) analysis of the 
amplified 16S rRNA gene, that there was a high degree of similarity between 
sequences, thus species -  specific primers could not be designed for most of the 
five members of the complex that were known at this time (LiPuma et al., 1999). 
RFLP analysis involves the use of restriction enzymes, which recognize specific
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short sequences of double stranded DNA and cleave the DNA at these sites. The 
number of recognition sites and their position varies, so the gene may be cut into a 
number of fragments of varying sizes. The variation in the 16S rRNA gene 
sequence between different species often allows RFLP analysis to be used as a 
rapid speciation approach. The 16S rRNA gene was capable of identifying B. 
multivorans and, B. vietnamiensis, but it could not discriminate between B. cepacia, 
B. cenocepacia and B. stabilis (LiPuma et al., 1999). Therefore, although the 16S 
rRNA gene improved the diagnosis of infection with Bcc, a more accurate method 
was required to identify all the species of the Bcc.
RecA a conserved bacterial protein is involved with DNA repair and is encoded on 
the largest chromosome within the Burkholderia genome. RecA is essential to 
three biological processes. The first is general genetic recombination, which allows 
the re-assortment of the genome. RecA also mediates DNA strand exchange 
between two homologous strands of DNA. The second process it is involved with is 
the error prone replicative bypass of DNA lesions. This allows DNA to keep 
functioning even when the damage is too great to repair. The most important 
function of RecA is its role in the SOS response. Here RecA regulates genes that 
are involved with cleavage of proteins required to repair DNA in response to 
damage. Since the recA gene is found in all proteobacteria it has been used as a 
systematic marker and provides taxonomical resolution compared to 16S rRNA.
It was found that there was only a single copy of the recA gene in the B. cepacia 
genome and within the gene there was sufficient nucleotide sequence variation to 
enable the discrimination between all known species of the Bcc (Mahenthiralingam 
et al., 2000a). PCR primers were designed to specifically amplify the recA gene 
and RFLP analysis indicated that these were specific to the Bcc and did not amplify 
other species of Burkholderia or other closely related species of bacteria. Therefore 
it was concluded that recA was a more suitable target for accurate, rapid PCR 
based diagnostic tools (Mahenthiralingam et al., 2000a). The use of the recA gene 
assay allowed the identification of all genomovars of the Bcc, expanding the 
complex from five members to nine (Mahenthiralingam and Vandamme, 2005). A 
recA based assay was developed which was specific for the Burkholderia genus 
(Payne et al., 2005) and subsequently assays were designed that used recA in a
13
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non culture approach. This approach identified a number of novel Burkholderia 
species groups which had not been isolated using a culture dependent approach 
(Payne etal., 2006).
Single gene sequence based identification has now been surpassed by a relatively 
new technique, multi locus sequence typing (MLST). MLST examines nucleotide 
polymorphisms in seven housekeeping genes located on the first and second 
chromosome of Bcc bacteria (Baldwin et al., 2005). This provides an allelic profile 
which is then used to assign a clonal type to each strain (Mahenthiralingam et al., 
2008). MLST provides strain type and species identification that is unequivocal as 
it is based on sequence data. This data can also be placed into a database making 
it easily accessible to the whole scientific community (Mahenthiralingam et al., 
2008). MLST is becoming the gold standard to use for Bcc strain and species 
identification and has resulted in the classification of several novel species groups 
(Vanlaere et al., 2008, Vanlaere et al., 2009).
The development of recA based assays originally distinguished nine closely related 
B. cepacia species that are all associated with the infection of immuno­
compromised patients such as cystic fibrosis patients and patients with chronic 
granulomatous disease. These were formally named as B. cepacia, B. multivorans, 
B. cenocepacia, B. stabilis, B. vietnamiensis, B. dolosa, B. ambifaria, B. anthina 
and B. pyrrocinia (Mahenthiralingam et al., 2000b). All nine species have been 
isolated from patients with CF, but some species are more prevalent than others. 
B. cenocepacia is the most predominant infecting between 50 -  80% of cases. B. 
multivorans is the next most predominant infecting 9 -  37% of cases 
(Mahenthiralingam and Vandamme, 2005). The rest cause less than 10% of CF 
infections. The Bcc complex was expanded to include B. ubonensis as the tenth 
genomovar (Vermis et al., 2002). Two recent studies have expanded the complex 
to 17 members by the addition of B. latens sp. nov, B. diffusa sp. nov., B. arboris 
sp. nov., B. seminalis sp. nov., and B. metallica sp. nov (Vanlaere et al., 2008) and 
B. lata and B. contaminans (Vanlaere et al., 2009).
Members of the Bcc were important CF pathogens in the 1980’s when Isles et al. 
described high levels of mortality with patients infected with members of the Bcc in
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an outbreak in a CF clinic (Isles et al., 1984). They noted that some patients 
appeared to be infected chronically and may have asymptomatic carriage, whilst 
other patients rapidly deteriorated with a necrotizing pneumonia which was 
characterised by high fever, severe progressive respiratory failure, leukocytosis and 
elevated erythrocyte sedimentation (Mahenthiralingam and Vandamme, 2005). 
This became known as “cepacia” syndrome and little is known about why some 
patients develop this whilst others carry Bcc infections chronically, although it is 
thought that both host and strain factors contribute (Mahenthiralingam and 
Vandamme, 2005).
Disease caused by the Bcc is very difficult to manage clinically and this was 
compounded by the emergence of patient to patient spread, first documented in the 
1990’s (Mahenthiralingam et al., 2000a). The most transmissible strain appeared to 
be B. cenocepacia especially lineage ET-12 which has caused the most epidemic 
outbreaks in Canada and the United Kingdom (Mahenthiralingam et al., 1997) 
(Govan et al., 1993). MLST analysis of ET-12 strains found that they fell into four 
very closely related strain types (Baldwin et al., 2005), which only differed at one of 
seven loci (single locus variants). ST 29, 30 and 31 were dominant in Canada, 
where as ST 28 was specific to UK CF patients (Mahenthiralingam et al., 2008). 
Worryingly, B. cenocepacia also appeared to be able to replace other species such 
as B. multivorans (Mahenthiralingam etal., 2001), which lead to the incorporation of 
stringent segregation polices in CF centres and CF camps. This can leave CF 
patients feeling isolated and discriminated against and can be very difficult to 
uphold within or outside the clinical setting.
Members of the Bcc have large genomes, which contain at least three replicons. 
This extensive genomic composition accounts for its versatility that sets it apart 
from other CF pathogens, such as its high transmissibility and inherent resistance 
to antimicrobial compounds (Mahenthiralingam et al., 2005). There are several 
mechanisms that some species of the Bcc employs to allow it to infect CF patients. 
Many of these traits are poorly understood and much research is being carried out 
on these virulence factors in the hope of uncovering novel therapeutic targets. 
These virulence factors include lipopolysaccharides, biofilm formation, quorum 
sensing, the presence of genomic islands, the cable pillus, flagella and intrinsic
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resistance to antibiotics and disinfectants (Govan and Deretic, 1996, 
Mahenthiralingam et al., 2005). Antibiotic and disinfectant resistance is an 
important factor as some members of the Bcc are difficult to treat due to intrinsic 
and acquired resistance. Much research has been carried out into the mechanisms 
of antibiotic resistance, but little is known about disinfectant (biocide) resistance. 
Biocide resistance is becoming more and more common due to the increasing 
domestic and clinical use of biocides and thus this study will attempt to investigate 
the mechanisms of biocide resistance.
1.3 Biocides
Biocides are inorganic or synthetic organic molecules that are used to disinfect, 
sanitize or sterilize objects and surfaces. They can also be used to preserve 
materials from microbiological deterioration (Chapman, 2003a). Biocides are 
usually broad spectrum chemical agents that inactivate microorganisms. Biocides 
can be spilt into different groups, such as antiseptics which destroy and inhibit the 
growth of microorganisms on living tissues, and disinfectants which are used on 
inanimate objects or surfaces (Russell, 2002c). Antiseptics and disinfectants are 
used extensively in hospitals, for topical and hard surface applications. The 
domestic use of biocides as disinfectants has rapidly increased as concerns of 
bacterial contamination have been made more widely known by the media and 
press. These products contain a variety of biocides and are used in things such as 
antibacterial sprays, e.g. kitchen and bathroom cleaners, antiseptic wipes, 
mouthwashes and antiseptic creams to apply to skin wounds (McDonnell and 
Russell, 1999).
Biocides have an important role in hospitals where they are used as an essential 
component of infection control procedures and are used to aid prevention of 
nosocomial infections (Russell, 2002b). Although many biocides have been in use 
for hundreds of years, relatively little is known about their modes of action 
compared to antibiotics, which have been studied intensively. It is known that
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Table 1.1 Biocide classes and the ir uses
Biocide Class Name Uses
Alcohols Ethanol
Isopropanol
Antisepsis
Disinfection
Preservation
Anilides Triclocarbon Antisepsis
Biguanides Chlorhexidine Antisepsis 
Antiplaque agents 
Preservation 
Disinfection
Bisphenols Triclosan Antisepsis 
Antiplaque agents 
Deodorants 
Preservation
Phenols Phenol Disinfection
Preservation
Quaternary
Ammonium
Compounds
Cetrimide
Benzalkonium
chloride
Cetylpyridinium
chloride
Disinfection
Preservation
Antisepsis
Cleaning
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Table 1.2 Biocide “In use” concentrations
Name Concentration (w/v) Use
Chlorhexidine
0.5% -4% Disinfection
0.02% - 4% Antisepsis
0.0025% -0.01% Preservation
Benzalkonium chloride
0.1 -0 .2 % Disinfection of skin
0.1%
Application on mucus 
membrane
0.005% Bladder irrigation
0.001 -0.01%
Throat lozenges, contact 
lens solutions, eye drop
Cetrimide 1 - 3% Shampoo
Cetylpyridinium chloride
0.1 -0 .5 % Skin disinfection and 
antiseptic treatment of 
wounds
0.05% -0.1%
Cosmetics -  deodorants 
and face lotions
Povidone - iodine > 10% Wound disinfection
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biocides tend to have multiple targets in the cells, where as antibiotics tend to have 
one specific intracellular target (McDonnell and Russell, 1999). The major classes 
of biocides used are: alcohols, anilides, biguanides, bisphenols, phenols and 
quaternary ammonium compounds. Table 1.1 summarizes the clinical use of these 
classes of biocides and Table 1.2 provides “In use” concentrations for common 
biocides (McDonnell and Russell, 1999). There is increasing concern that the over 
use of biocides may lead to an increase in bacterial resistance, which raises the 
question of whether biocides used in hospitals could become a source of an 
outbreak themselves? Thus it is important to study the mechanisms of action and 
resistance of biocides, which will aid the development of novel therapeutic targets.
1.31 Biguanides -  Chlorhexidine
Chlorhexidine is a 1, 6 -  di-chlorophenyl-biguanide hexane cationic bisbiguanide 
(Figure 1.4a). It was first synthesized in the 1950’s and is now one of the most 
widely used biocides. Chlorhexidine has a high level of antibacterial activity and 
low mammalian toxicity. It has a strong binding affinity to the skin and mucus 
membranes and has a low rate of irritation, although there are some cases of 
irritation documented (McDonnell and Russell, 1999). It is therefore widely used in 
antiseptic products such as hand washing solutions and oral products, and is an 
important chemical used to prevent nosocomial infections (McDonnell and Russell, 
1999). Chlorhexidine is an odourless, white crystalline powder that can be 
obtained as dihydrochloride, diacetate or gluconate salts. The activity of 
chlorhexidine is dependant on the pH, with its optimum pH being 5-7 and 
concentration. Solutions that are made up using diacetate salts have an odour of 
acetic acid and all solutions using chlorhexidine have a bitter taste, which has to be 
masked for oral use (McDonnell and Russell, 1999). Chlorhexidine is compatible 
with cationic materials and quaternary ammonium compounds, but its activity is 
significantly reduced in the presence of organic substances such as serum, blood 
and pus. It is often formulated as a solution with ethanol and in conjunction with 
detergents, which are used as surgical scrubs. It is also used in eye drops, 
antiseptic creams, mouthwashes, dental gels, catheter sterilisation, disinfectant
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solutions for contact lenses, medical dressings and in cleaning sprays for hard 
surfaces (McDonnell and Russell, 1999).
Chlorhexidine targets cell components such as the outer envelope layers, although 
this is not sufficient to cause complete cell lysis. The chlorhexidine may then pass 
into the cell and attacks the cytoplasmic membranes and causes cell leakage 
(McDonnell and Russell, 1999). A high concentration of chlorhexidine causes 
coagulation of intracellular constituents. It is also thought that chlorhexidine targets 
the enzyme ATPase, although it appears not to be a primary target, with membrane 
disruption causing the most extensive damage (McDonnell and Russell, 1999). 
Chlorhexidine is active against both Gram positive and Gram negative bacteria, but 
is not sporicidal (McDonnell and Russell, 1999). Organisms, such as P. aeruginosa 
and 8. cepacia have high innate resistance to chlorhexidine.
1.32 Alcohols
Alcohols are widely used for disinfection purposes, such as hard surface 
disinfection and antiseptic creams. There are many classes of alcohols that show 
antimicrobial activity. However, ethyl alcohol, isopropyl alcohols and n-propanal are 
the most widely used (McDonnell and Russell, 1999). Alcohols have a rapid broad 
spectrum effect on microbes and are active against most bacteria, viruses and 
fungi, but are not sporicidal (McDonnell and Russell, 1999). They are often used in 
conjunction with other biocides especially chlorhexidine to potentiate their activity. 
Antimicrobial activity is significantly lower at alcohol concentrations of 50% and 
optimal concentrations are in the range of 60-90% (McDonnell and Russell, 1999). 
The mode of action of alcohols is poorly understood, although it is thought that they 
cause membrane disruption and rapid denaturation of proteins which leads to 
interference with metabolism and cell lysis (McDonnell and Russell, 1999).
1.33 Quaternary Ammonium Compounds (QACs)
The quaternary ammonium compounds are a large class of biocides that include 
cetylpyridinium chloride (CPC) (Figure 1.4b), benzalkonium chloride (BZK) (Figure 
1.4c) and cetrimide (Figure 1.4d). They are cationic agents and are used mainly for
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antiseptics and disinfectants (McDonnell and Russell, 1999). The positive charge 
of these biocides allows a strong binding affinity to the bacterial cell membrane 
which has an overall negative charge, and causes displacement of divalent cations. 
This results in cellular leakage and the loss of osmoregulatory and physiological 
functions (Gilbert and Moore, 2005). QACs are used for a variety of clinical 
purposes such as preoperative disinfection of skin, application to mucus 
membranes and disinfection of non critical surfaces. As well as their antimicrobial 
properties, QACs have hard surface cleaning and deodorizing properties 
(McDonnell and Russell, 1999).
QACs have been postulated to target the cytoplasmic membrane of bacteria in the 
following manner (Salton, 1968): (1) adsorption and penetration of the agents into 
the cell wall; (2) reaction with the cytoplasmic membrane, followed by membrane 
disorganization; (3) leakage of intracellular low molecular weight material; (4) 
degradation of proteins and nucleic acids and (5) wall lysis. It is also thought that 
QACs damage the outer membrane of Gram negative bacteria, enhancing their 
own uptake into the periplasmic space, inner membrane and cell (Salton, 1968, 
McDonnell and Russell, 1999).
1.34 Phenols and Anilides
Phenols are used for their antiseptic, disinfectant and preservative properties. They 
are known as general “protoplasmic” poisons, but they also have membrane active 
properties. Phenols induce leakage of intracellular constituents, including K+. 
There is also evidence that high concentrations of phenols causes cytoplasmic 
coagulation which subsequently leads to irreversible cellular damage (McDonnell 
and Russell, 1999).
Triclosan (2, 4, 4 -  trichlor-2-hydroxydiphenylether, also known as Irgasan) (Figure 
1.4e) is classed as a bis phenol. It is only sparingly soluble in water thus is diluted 
in alkalis and organic solvents in most applications (Moore and Payne, 2004). Its 
activity is not affected by the presence of most soaps, surfactants and organic 
solvents, but is affected by ethoxylated surfactants such as polysorbate 80 (Moore
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and Payne, 2004). Triclosan is generally bacteriostatic against Gram positive 
organisms, but has varying effects on Gram negatives, although its activity against 
these bacteria can be enhanced by adding a chelating agent such as EDTA 
(McDonnell and Russell, 1999). Some Gram negatives such as P. aeruginosa 
exhibit extremely low susceptibility to triclosan requiring over 1000 pg/ml for 
inhibition (Moore and Payne, 2004).
Triclosan is found in many personal care products such as toothpaste, 
handwashes, deodorants and has recently been incorporated into other household 
products such as in plastics and fabrics. Triclosan is suited to these applications as 
it is non toxic and can be applied to the skin (Moore and Payne, 2004). However, 
the increased use of triclosan, and the association between triclosan resistant 
bacteria and antibiotic resistance has lead to concerns about the use of this biocide 
(McMurry et al., 1998a).
Triclosan was found to act on a specific target in the bacterial cell. This target was 
fatty acid synthesis and was particularly associated with the fabl gene. This gene 
encodes an enoyl reductase which was essential for fatty acid synthesis (McMurry 
et al., 1998b). McMurry et al. found that triclosan blocks this gene by mimicking its 
substrate, thus preventing fatty acid synthesis. When mutants in this gene were 
created they were no longer inhibited by triclosan (McMurry et al., 1998b). This 
specific mode of action is unusual for biocides, which usually have a broad 
spectrum of cellular targets. More recently, evidence has suggested that as well as 
targeting the fatty acid synthesis pathways triclosan may also have additional 
effects. At high concentrations, triclosan killing of the bacterial cells was rapid and 
fast acting, where as at low concentrations bacterial growth was effected. It has 
been suggested that at lower concentrations fatty acid synthesis is effected but at 
higher concentrations a more general damaging effect may be taking place, such 
as membrane disruption (Gomez Escalada et al., 2005). Although, there may be 
other modes of action of triclosan the specific Fabl gene target may be a key factor 
in the emergence of resistance to this biocide as mutations to change this target 
site may lead to a less susceptible strain.
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Figure 1.4 Chemical structure of common biocides
The chemical structures of five common biocides including A: chlorhexidine, biguanide, B: 
Cetylpyridinium chloride, a QAC, C: benzalkonium chloride, a QAC and D: cetrimide, a QAC, E: 
Triclosan, bis phenol.
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Anilides are generally used for their antiseptic properties and the most widely used 
anilide is triclocarbon. Triclocarban is used in commercial soaps and deodorants. 
It is most active against Gram positive organisms, but it shows significantly less 
activity against Gram negative bacteria and fungi (McDonnell and Russell, 1999). It 
is also not very effective when used on the skin and for these reasons is rarely used 
in clinical environments. Anilides appear to target the cytoplasmic membrane by 
adsorbing and destroying the semi-permeable character of the cytoplasmic 
membrane which leads to cell death (McDonnell and Russell, 1999).
1.35 lodophors
lodophors are surface active agents that can solubilize iodine, such as povidone- 
iodine. These are more desirable than free iodine as they retain bactericidal 
properties but eliminate the undesirable properties such as staining and toxicity. 
Different concentrations of iodophors are used depending on their application, 
either for antiseptic or disinfection purposes (Table 1.2). The concentration of free 
iodine is the active component of the disinfectant and is released when the 
iodophor is diluted. They have an activity over a wide range of pHs and the 
presence of a surface active carrier increases the wetting capacity, lodophors are 
used in a wide range of applications such as in industry for sterilisation of farm 
equipment and for clinical uses such as pre surgical hand sanitisation and skin and 
wound disinfection (Moore and Payne, 2004). The mode of action of iodophors is 
poorly understood, however bactericidal action is rapid even at low levels, 
lodophors penetrates the bacterial cell rapidly and attacks key proteins such as the 
free sulphur amino acids cysteine and methionine, nucleotides and fatty acids, 
which rapidly results in cell death (McDonnell and Russell, 1999). Although iodine 
containing solutions have been useful for wound disinfection, there have been a 
number of cases where solutions of povidone -  iodine have been contaminated 
causing outbreaks. Berkelman et al. (Berkelman et al., 1981) attributed the Bcc to 
an outbreak caused by contamination of a povidone-iodine solution.
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1.4 Biocide resistance mechanisms
Biocides are increasingly being used in domestic and clinical situations. They play 
a large role in clinical situations, where they are often used in disinfection 
procedures of patient’s rooms, equipment and for antiseptic purposes, including 
hand hygiene, cleansing of wounds and in surgical scrubs (McDonnell and Russell, 
1999). Biocides now make up the primary ingredients of many domestic products, 
which are used to disinfectant household surfaces. In a community which is 
becoming increasingly concerned with bacterial infection these antibacterial 
products are being used more frequently and in larger quantities. This increased 
usage of biocides in both clinical and domestic environments has raised concerns 
that incidence of biocide resistance may be rising. This can cause many problems 
with bacteria which have multiple antibiotic resistance and possible biocide 
resistance, therefore making it very difficult to treat and eradicate these infections.
The minimum inhibitory concentration (MIC), which is the lowest dosage of the 
antibacterial that is inhibitory to growth for an organism, is used to determine how 
resistant an organism is (Russell, 2003). Members of the Bcc are examples of multi 
drug resistant bacteria, which have been found to contaminate benzalkonium 
chloride and other QACs as well as chlorhexidine. This is a worrying discovery as 
these biocides are frequently used in hospitals as disinfectants (McDonnell and 
Russell, 1999). Much research has been carried out into antibiotic resistance and 
ways to reduce its emergence. However, little is known about the mechanisms of 
biocide action and therefore the mechanisms of biocide resistance are also poorly 
understood. Biocides in general lack target specificity but different organisms vary 
in their susceptibility to each biocide, suggesting that biocides exert different effects 
on different target cells (Russell, 2001). Generally bacterial spores are the most 
resistant, then mycobacteria, followed by Gram negatives, with Gram positive 
bacteria the most susceptible (Russell, 2001). The mechanisms of resistance can 
be put into two classes, intrinsic resistance, which is resistance that the bacteria 
already posses or acquired resistance which the organism can gain by plasmid 
acquisition or mutation (McDonnell and Russell, 1999). Table 1.3 shows some 
examples of intrinsic and acquired resistance.
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Table 1.3 Bacterial mechanisms of biocide resistance
Type of 
resistance
Possible mechanism Example
Intrinsic
Impermeability Gram negatives 
several biocides
Efflux Gram negatives 
several biocides
Inactivation Triclosan, chlorhexidine
Acquired
Inactivation / modification Formaldehyde
Insensitive target site Triclosan
Decreased accumulation (plasmid 
mediated)
Several biocides
Overproduction of target Triclosan
Absence of enzyme metabolic pathway Isoniazid
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1.41 Acquired Resistance
1.41.1 Non plasmid mediated resistance
Acquired non-plasmid mediated resistance can occur when bacteria are “trained” to 
become resistant to a certain substance. This can occur when a particular 
antimicrobial is continuously present in the environment. The organism adapts to 
grow in gradually increasing concentrations of the biocide, although this resistance 
may not always be stable and can be lost if the antibacterial agent is removed from 
the environment (Russell, 2001). For example P. stutzeri can develop stable 
resistance to increasing concentrations of chlorhexidine and QACs resulting in 
changes to the outer membrane profile (Tattawasart et al., 2000). Although 
temporary resistance by phenotypic adaptation has been shown it is not thought to 
play an important role in resistance to biocides (Russell, 2001).
1.41.2 Plasmid mediated acquired resistance
There has been much debate about the role of plasmid mediated resistance and its 
role in biocide resistance. There have been many documented cases of plasmids 
encoding resistance to antibiotics such as (3 lactams, tetracyclines, macrolides and 
chloramphenicol (Russell, 1997). However, there is little evidence of plasmid 
mediated biocide resistance (Russell, 1997). The RP1 plasmid in P. aeruginosa 
was examined and was found not to alter the resistance to QACs, chlorhexidine 
iodine, or phenols (McDonnell and Russell, 1999). Many studies demonstrated that 
it was difficult to transfer chlorhexidine or QAC resistance by plasmid mediated 
transfer and that the increase in resistance to these biocides was a result of 
mutation (McDonnell and Russell, 1999)
Nonetheless, in methicillin resistant Staphylococcus aureus (MRSA) plasmid pSAJ1 
was found to be involved in biocide resistance. Plasmid pSAJ1 conferred 
resistance to kanamycin, gentamicin, tobramycin, amikacin, benzalkonium chloride, 
acriflavin, ethidium chloride and chlorhexidine. In addition when this plasmid was 
transferred to an E. coli host all of these resistance phenotypes were conserved, 
and resistance to acriflavine was also observed (Yamamoto et al., 1988). MRSA
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also have plasmids that encode qac genes which are found on pSK1 plasmid. The 
qac genes encode export proteins and confer resistance to a number of biocides 
including QACs (McDonnell and Russell, 1999).
1.41.3 Target Alterations
Target alteration is a well known adaptation technique by bacterial cells to resist the 
action of antibiotics. Biocides usually have multiple targets, hence target site 
mutations are not often seen (McDonnell and Russell, 1999). Triclosan however is 
the exception. As mentioned above, triclosan has a specific target, the fabl gene, 
which encodes an enoyl reductase involved in fatty acid synthesis (McMurry et al., 
1998b). Mutations in this gene in some bacterial species such as P. aeruginosa are 
no longer inhibited by triclosan, thus supporting evidence that this gene is an 
important target of triclosan (Poole, 2004).
1.42 Intrinsic resistance
Intrinsic resistance is a natural property of the bacterial cell that renders the biocide 
inactive. Unlike for antibiotics where acquired resistance is more prevalent, biocide 
resistance is frequently due to intrinsic resistance (White and McDermott, 2001). 
Intrinsic resistance is usually associated with cellular impermeability due to the 
composition of the cell wall, but can also be due to chromosomally encoded efflux 
pumps and biocide inactivation. Physiological adaptation is another type of intrinsic 
resistance and is observed when the organism is under a certain growth condition 
(White and McDermott, 2001) (Table 1.3)
1.42.1 Cellular impermeability and the Gram negative outer membrane
One of the main causes of biocide resistance is the reduction in biocide uptake by 
the bacterial cell. In general, Gram negative organisms are more resistant to 
biocides than Gram positive organisms due to the presence of an outer membrane. 
The outer membrane acts as a barrier that limits the entry of many chemically 
unrelated compounds (McDonnell and Russell, 1999). The structure of the Gram 
negative outer membrane is a lipid bilayer and consists of an outer membrane, a
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thin layer of peptidoglycan and a periplasmic space between the outer membrane 
and the cytoplasmic membrane (Denyer and Maillard, 2002). The outer envelope 
bilayer consists of lipopolysaccharides and phospholipids which contain porins 
embedded within them (Figure 1.5) (Denyer and Maillard, 2002) (Hancock, 1997). 
There are a number of contributions the outer membrane makes to resistance 
which are indicated on Figure 1.5 and described below.
1.42.2 Lipopolysaccharides (LPS)
The LPS is a hydrophobic high molecular weight, strongly negative charged 
molecule, which can be divided into three sections, the lipid A portion inserted into 
the membrane, the core region (which the lipid A is attached to), containing a region 
of 8 -  12 variable sugars, that include negatively charged 2 -  keto -  3 -  
deoxyoctanate and 3 - 8  phosphate residues. This region is covalently linked to 
the O antigen which consists of 3 -  5 sugar units that are repeated a variable 
number of times (Hancock, 1997). Some bacterial strains have the O antigen 
missing and these are designated as rough strains (for a diagram of the LPS 
structure see Figure 5.1). Cationic biocides bind to the negatively charged 
membrane to penetrate the cell. To reduce the uptake of the biocide, modifications 
of the LPS can occur. The Bcc modify the composition of the LPS to produce a 
less negatively charged membrane thus reducing the binding affinity of cationic 
compounds (Cox and Wilkinson, 1991). This includes increased Mg2+ content 
which neutralises the negative charge and causes strong LPS-LPS links making 
diffusion into the cell difficult (Hancock, 1997) (McDonnell and Russell, 1999). The 
modifications of the LPS is discussed in more detail in Chapter 5.1.
1.42.3 Porins
The Gram negative outer membrane serves as a molecular “sieve” which allows the 
entry of small hydrophilic molecules via porins (Hancock, 1987). Porins are 
hydrophilic channels that can be classed as either non specific diffusion porins or 
specific porins that mediate the entry of a particular solute (Denyer and Maillard,
2002). Resistance to a number of biocide agents can be enhanced by the loss of
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Figure 1.5 The Gram negative cell wall and resistance mechanisms
1: Porin pathway for small hydrophilic molecules, 2: Three component efflux system, 3: Self promoted uptake pathway for small polycations and 4 
periplasmic p lactamases. Figure adapted from (Hancock, 1997).
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porin proteins or alteration of porin size (Denyer and Maillard, 2002). In the Bcc, 
some strains were found to have a small porin size which contributed to the 
reduced susceptibility to the p lactam nitrocefin (Parr et al., 1987). In P. aeruginosa 
porins do not accommodate the passage of most anti pseudomonal antibiotics 
except carbapenems (Yoneyama et al., 1995). Although porins contribute to 
resistance to antibiotics and most likely biocides, their role may only be a minor 
one. Other mechanisms such as production of inactivating enzymes and efflux 
systems play a more significant role, with porin modification supporting 
antimicrobial resistance (Denyer and Maillard, 2002).
To overcome problems with membrane impermeability, a combination of biocide 
agents may be used. Ethylenediaminetetraacetic acid (EDTA) is a permeabilizing 
agent that disrupts the outer membrane by destabilising LPS bonds, thus increasing 
the permeability of cell. Therefore EDTA can potentate the activity of many 
biocides, combating the problem of reduced uptake (Stickler, 2004) (Moore and 
Payne, 2004).
1.42.4 Efflux pumps
Efflux pumps are an important mechanism of resistance and are involved in the 
active efflux of unrelated compounds. They are broad spectrum, thus there is 
concern that a biocide agent or an antibiotic compound may induce the up 
regulation of an efflux pump which also confers resistance to other antibiotic 
compounds. Consequently this may lead to the emergence of multi drug resistant 
strains. Efflux was first described as a mechanism of resistance in E. coli, which 
contained a plasmid encoding a tet protein exporter conferring tetracycline 
resistance (Poole, 2005b). Efflux has now been described as both plasmid and 
chromosome encoded in numerous organisms. The most well described efflux 
system is the mexAB system in P. aeruginosa. This system can accommodate 
both antibiotics and biocides thus causing many related clinical issues (Poole, 
2004). There are five classes of efflux pumps, with the resistance nodulation 
division occurring most frequently (Poole, 2004). The structure and function of 
efflux pumps are discussed more thoroughly in Chapter 5 and Figure 5.9.
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1.42.5 Inactivation / modification
Another method of preventing killing by antimicrobials is inactivation. This can 
occur by a number of methods. The periplasmic space contains systems that 
inactivate toxic compounds. The periplasm contains a number of enzymes which 
can inactivate compounds, such as p lactamases (Denyer and Maillard, 2002) 
(Figure 1.5). This is most well known for antibiotics, with the inactivation of p 
lactamases and the modification of aminoglycosides by phosphotransferases.
1.42.6 Production of a biofilm
Many bacteria will actually grow in biofilms rather than planktonically. A biofilm is a 
cohort of bacterial cells, which may or may not be a mixed population that has 
adhered to a surface. They usually produce an exopolysaccharide matrix which 
surrounds the bacterial cells (Stickler, 2004). Cells growing in biofilms are 
notoriously more difficult to eradicate and cause problems not only in clinical 
situations, but in industrial settings as well (Stickler, 2004). The biofilm growth state 
renders the antimicrobial ineffective due to reduce permeation of the biofilm, thus 
many cells are protected from contact with the substance. A slower metabolic 
growth rate may be observed and hence a reduced uptake by the cells of the 
biocide follows (Stickler, 1999). Biofilms result in many problems for clinicians and 
can result in treatment failure.
Resistance to ciprofloxacin and ceftazidime, two agents used in the treatment of CF 
infection was enhanced in B. cepacia biofilms up to 15 times more than 
planktonically growing cells (Desai et al., 1998) and evidence that 0.2% 
chlorhexidine was not sufficient to kill a mixed biofilm population after an hours 
exposure has been described (Wilson et al., 1998). Biofilms cause particular 
problems for patients with indwelling catheters and indeed any implanted device. 
Strains of P. aeruginosa and Proteus mirabilis can encrust catheters and cause 
blockages. Once biofilms have formed it appears that even previous sensitive 
strains can become resistant to biocides and that there may be a cross over with 
antibiotic resistance (Stickler, 2002). Stickler found that chlorhexidine was 
ineffective at eliminating biofilms; Williams et al. found similar results with triclosan 
(Williams and Stickler, 2008). Consequently, disinfection routines may not be
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adequate to prevent infections when bacteria are growing as a biofilm and may in 
fact promote resistance to a number of antimicrobials. Biofilms are also discussed 
in Chapter 5.
1.5 Biocide rotation policy
In light of the evidence presented above, disinfection policy, particularly in clinical 
settings should be carefully examined and implemented. Biocide rotation involves 
the alternative use of two active chemical agents with different modes of action. 
This should reduce the possibility of selecting for multi drug resistant organisms and 
to increase the possibility of killing all organisms (Murtough et al., 2001). There are 
many factors involved when implementing rotation, including frequency of rotation 
and period of contact (Murtough et al., 2001). There has been much debate over 
whether biocide rotation is a good idea or not, with arguments for including the 
evidence that adaptive resistance can be trained to low levels of biocides present in 
the environment (Tattawasart et al., 1999). These adapted strains also exhibited 
cross resistance to antibiotics causing concern that multi drug resistant strains may 
emerge (Tattawasart et al., 1999). However, the reverse argument states that this 
resistance is usually unstable and that microbial contamination may be due to poor 
hygiene by personnel, thus it may be more prudent to improve cleanliness and 
personal hygiene rather than rotating biocides (Murtough eta!., 2001).
There has been little evidence that biocides, when used appropriately are causing 
resistant organisms to occur. There is also concern that the over use of biocides 
and residuals in the environment may lead to cross resistance to some antibiotics 
(Chapman, 2003b). The potential cross resistance of biocide and antibiotic 
resistance mechanisms are discussed in Chapter 3.13. However, it may still be 
beneficial to rotate biocides in certain situations where particularly problematic 
organisms such as the Bcc and P. aeruginosa may be present (Murtough et al., 
2001). To prevent contamination of biocides infection control policies should be in 
place and cleanliness, incorporating biocide disinfection should be stringent.
1.6 Infection control in cystic fibrosis clinics
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With the emergence of multi drug resistant organisms, infection control has played 
a vital role in reducing the occurrence of nosocomial infections in patients. In CF 
patients it is particularly important as their disease leaves them vulnerable to many, 
difficult to treat infections. Some members of the Bcc cause infection control 
problems as they are transmissible between patients (Jones et al., 2001a), hence 
clinics often implement draconian segregation polices, which can lead to CF 
patients feeling isolated and discriminated against. Epidemic strains of P. 
aeruginosa, such as the Liverpool (Cheng et al., 1996) and Manchester epidemic 
strains (Jones et al., 2001b) also require attention to prevent other CF patients from 
acquiring these infections The increasing incidence of MRSA in hospitals is also 
causing problems in CF clinics and stringent guidelines must be put into practice to 
reduce the acquisition of these infections.
The Cystic Fibrosis Trust have released guidelines for preventing Bcc infections, 
which contains information on segregation policies and disinfection practices: “The 
Burkholderia cepacia complex: suggestions for Prevention and Control”
(www.cftrust.orq.uk). There are many ways that infections such as B. cenocepacia 
can be spread from patient to patient or health care worker to patient (Table 1.4). 
The standard precautions to prevent infections are as follows: hand washing, 
barrier precautions, e.g. wearing gloves, gown and mask and sterilization of 
respiratory equipment (Saiman and Siegel, 2004).
Those patients that carry highly transmissible infections have further transmission 
based precautions implemented. These are categorised as contact, droplet, 
airborne infection and protective environment (Saiman and Siegel, 2004). Hand 
washing is implemented before and after all patient contact and alcohol based hand 
rubs are used to reduce bacterial contamination. Respiratory equipment such as 
nebulizers, bronchoscopes, spirometers and lung function test machines can be 
reservoirs of infection; therefore careful attention must be paid when disinfecting 
this equipment. Ideally all equipment should be single use only, but this is rarely 
feasible in a hospital environment, so equipment needs to be sterilised 
appropriately (Saiman and Siegel, 2004). To prevent infections being spread in 
hospitals, including out patient clinics, those infected with the Bcc complex and 
other infectious organisms should attend separate clinics on different days to
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Table 1.4 Factors associated with acquisition of infections in CF patients
Risk factors in Non Health 
Care settings Social Contact
Risk Factors in health 
care settings
Attendance at CF summer Kissing
Inpatient exposure 
Recent hospitalization
camps Use of specific shower
Sleeping in the same cabin
Intimate contact
Sharing a hospital room
Sharing a personal item Prolonged car rides with another infected
Dancing or hugging a camper Fitness classes
patient
infected with Bcc Use of respiratory
Sharing drinking equipment
Attendance at summer utensils
educational groups Sharing equipment
Participation in a support
Handshaking
Hospital nebulizers
group Sibling with infection
Spirometer 
Mouthpiece filters
(Adapted from Saiman and Siegel, 2004)
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uninfected patients. Also those patients infected with B. cenocepacia should attend 
clinics on different days to those patients infected with other Bcc strains to avoid 
replacement of less virulent strains with more virulent strains (Saiman and Siegel, 
2004). Acquisition of B. cepacia infections has been associated with 
hospitalization, poor adherence to hand washing, contaminated respiratory 
equipment and contaminated hospital showers; therefore regular disinfection of 
sinks and showers also needs to take place (Saiman and Siegel, 2004). Table 1.5 
highlights some of the methods used to help reduce the acquisition of infections, 
nevertheless to truly prevent patients from acquiring these life threatening 
infections, the cooperation of the patient is vital and regrettably this is often difficult 
to implement and maintain. Therefore it is important to reduce these factors, which 
unfortunately usually means keeping CF patients with Bcc infections away from 
other CF patients
1.7 Aims
The aims of this project were three fold:
1) To characterise the biocide susceptibility for a number of biocides, 
particularly focusing on chlorhexidine and cetylpyridinium chloride for a panel 
of representative strains that encompasses all species of the Bcc.
2) To determine the genetic basis of biocide resistance mechanisms to 
chlorhexidine using a whole genome expression approach.
3) To further characterise genes that may be involved in resistance to 
chlorhexidine.
An overall summary of the aims and the experimental approach taken is shown
in Figure 1.6
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Table 1.5 Measures to prevent the acquisition of infections in CF patients
Prevention method Intervention
Emphasis on hand hygiene
Education
Educate patients families and health care workers about 
risk factors for transmission
Use single patient rooms with separate showers
Eliminate socialising between CF patients infected with Bcc 
and other CF patients in hospital
Place hospitalized patients with infections on contact
precautions
Intervention in 
health care settings
Inpatients and outpatients should wear masks 
Inpatients should wear gloves
Segregate outpatient clinics e.g. B. cepecia clinics attend 
on different days
Ban patients with B. cepecia infection from attending CF
conferences
Environmental
Decontaminate environment including respiratory 
equipment
decontamination Monitor environmental decontamination i.e. drains, 
showers, physiotherapy equipment
Laboratory
practices Improve microbiological detection
Intervention in non 
health settings
Reduce social contact between patients infected with the B. 
cepacia complex and patients in non health care facilities
Provide separate summer camps for CF patients with 
virulent infections
(Adapted from Saiman and Siegel, 2004)
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Figure 1.6 Experimental method used for each aim
Experimental methods used to determine aims of this investigation. The aims were three fold and were used to achieve the main objective; to determine 
biocide resistance mechanisms and possible targets for novel therapeutics.
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Chapter 2.0 Materials and Methods
2.1 Chemicals
The chemicals used in this study, unless otherwise stated were obtained from 
Sigma-Aldrich, Poole, UK, ICN Biomedicals Ltd, Oxon, UK and Fisher Scientific Ltd, 
Loughborough, UK. All aqueous solutions were made in double deionised water.
2.2 Preparation of antimicrobial agents
2.21 Biocides
The composition of the biocides used in this study are presented in Table 2.1 All 
aqueous biocide stock solutions were heated to 50°C to aid the dissolving process 
and left on a rocker platform until a clear solution was obtained and were filter 
sterilised using a 0.2 pm mini filter (Sartorius AG, Goettingen, Germany). These 
stock solutions were subsequently used to create further biocide concentrations 
when needed.
2.22 Antibiotics
The antibiotics used in this study were ampicillin (Ap), kanamycin (Km), 
meropenem (Mp), polymyxin (Pmx) tetracycline (Tc), tobramycin (Tm) and 
trimethoprim (Tp). All antibiotics were made up to a 100 mg/ml stock except 
polymyxin (120,000 units/ml). Antibiotics were dissolved in sterile polished water, 
apart from meropenem, tetracycline and trimethoprim which were dissolved in 
dimethyl sulfoxide (DMSO) due to insolubility in water.
2.3 Bacterial Strains and Plasmids
Bcc organisms, P. aeruginosa organisms and non Bcc species such as 
Staphylococcus aureus, Burkholderia gladioli, Stenotrophomonas maltophilia, 
Ralstonia mannitolilytica, Pseudomonas stutzeri, Ralstonia pickettii, Pseudomonas 
putida, Achromobacter xylosoxidans and Escherichia coli were drawn from the
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Table 2.1 Biocide stock solution compositions
Biocide Class Stock Solution Solvent
Chlorhexidine Biguanide 10 mg/ml Water
Cetylpyridinium
chloride
Quaternary
Ammonium
Compound
10 mg/ml Water
Triclosan Phenol 10 mg/ml DMSO
Benzalkonium
Chloride
Quaternary
Ammonium
Compounds
10 mg/ml Water
Povidone
Iodine releasing 
agent
20 % (w/v) Water
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Mahenthrialingam lab collection, unless otherwise stated. Species and strain 
designations for all bacterial isolates are shown within specific tables in each 
chapter. Plasmids, strains and genetic constructs used for cloning are shown in 
Table 2.2.
2.31 Bacterial Growth conditions
All bacterial strains used were revived from frozen stocks by plating on either 
Tryptone Soya Agar (TSA) or Luria Bertani agar (LBA) at 37°C overnight; 
environmental isolates often required a lower temperature of 30°C. Overnight 
cultures were made by taking a single colony from the revival plates and inoculating 
3 ml of tryptone soya broth (TSB) or Luria Bertani broth (LB), and grown with 
shaking in an incubator (200 rpm) at 37°C for 18 hours.
2.32 Storage of bacterial strains
All strains used in this study were held in an ultra low temperature freezer. Fresh 
colony material from a pure culture plate was inoculated into TSB containing 8% 
DMSO and mixed to produce a bacterial suspension. These stocks were then 
maintained in a -80°C freezer.
2.33 Enumeration of bacteria
To enumerate bacterial suspensions viable drop counts were used. A serial dilution 
of the bacterial suspension was made in TSB and 10 pi drops were placed in 
triplicate onto TSA plates and incubated at 37°C overnight. Individual colonies 
were then counted, the number of bacteria calculated and expressed as colony 
forming units per ml (cfu/ml).
2.4 Preparation of DNA from bacterial cells
2.41 Bead beater method
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Table 2.2 Strains, plasmids and genetic constructs used in this investigation
Strain / Plasmid Features
Reference / 
source
Strains
8. cenocepacia K56-2
ET-12 CF strain used for allelic exchange 
mutagenesis
(Mahenthiralingam 
et al., 2000b)
8. cenocepacia 
AU1054
Environmental 8. cenocepacia III B strain used for 
random transposon mutagenesis
(Mahenthiralingam 
et al., 2000b)
E. c o l i - HB101
Contains plasmid pRK2013 -  helper strain for tri 
parental mating, self transmissible strain with 
mobilisation genes
(Figurski and 
Helinski, 1979)
E. c o li-  JM109
Contains plasmid pTnMod-OTp -  trimethoprim 
resistant plasposon used for random mutagenesis
(Dennis and 
Zylstra, 1998)
E .co li- omnimax cells Standard cloning strain Invitrogen co
Plasmids
pGEM -  T easy PCR product cloning vector
Promega 
corporation inc
pEGM105Tc
pJQ200SK with tetracycline resistant cassette, 
suicide vector used for allelic exchange 
mutagenesis
(Quandt and 
Hynes, 1993)
pUC-Tp 1.1 Kb trimethoprim resistant cassette (Sokol et al., 1999)
p0924-T p
pEGM105Tc carrying 0924 response regulator gene 
interrupted with Tp resistant cassette
This study
p2353-Tp
pEGM105Tc carrying 2353 transport gene 
interrupted with Tp resistant cassette
This study
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Overnight cultures (TSB) of the bacterial strains to be harvested were centrifuged at 
900 x g for 10 minutes. The supernatant was decanted and the bacterial pellet was 
re-suspended in 100 pi of TE buffer (10mM Tris-CI pH8, 1mM EDTA pH8).
The re-suspension was then added to 500 pi of lysis buffer (50 mM Tris-CI pH8, 70 
mM EDTA pH8, 1% SDS) containing 0.5 mg/ml of pronase (Boehringer/Roche) in a 
screw cap tube containing approximately 500 pi of 0.1 mm diameter Zirconium 
glass beads (Biospec Products Inc). The bacterial cells were then placed in a bead 
beater machine (Biospec Products Inc) at the lowest speed setting (25) for 5 to 10 
seconds and then incubated at 37°C for one hour. After incubation, cells are briefly 
centrifuged and 200 pi of saturated ammonium acetate added to the lysate. The 
lysate was pulsed on the bead beater for 5 seconds and 600 pi of chloroform 
added. This was then centrifuged for 5 minutes at maximum speed to separate 
phases and 400 pi of the clear aqueous phase was removed and placed into a tube 
containing 1 ml of 100% ethanol. The tubes were inverted to clot DNA and 
centrifuged for 5 minutes to form a pellet. The ethanol was removed and the DNA 
pellet washed with 70% ethanol. Once removed, the pellet was dried under a 
vacuum for 10 minutes. The DNA was dissolved in low EDTA TE buffer (10 mM 
Tris-CI, pH8, 0.1 mM EDTA) with 0.5 pg/ml RNase A and incubated for one hour at 
37°C to remove any RNA.
2.42 Chelex DNA preparation
Bacterial strains were streaked to single colony; one colony was picked with a 
pipette tip and placed into sterile 5% chelex 100 solution (Sigma -  Aldrich). This 
was then placed in a thermal cycler and heated to 98°C for 5 minutes. After 
incubation, it was then placed on ice for a further 5 minutes. This cycle was 
repeated and then the tube was centrifuged for 5 minutes at 700 x g. DNA within 
the cleared supernatant could then be used in further applications.
2.43 Plasmid preparation for bacterial cells
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To isolate plasmids from bacterial cells the Wizard Plus SV mini prep kit (Promega 
corporation) was used. Overnight cultures were harvested by centrifugation at 900 
x g for 10 minutes. A cleared lysate was produced by adding 250 pi of cell re­
suspension solution to the cell suspension. The cell re-suspension was mixed with 
250 pi of cell lysis solution and incubated until the cell suspension cleared 
(approximately 1 -5  minutes). 10 pi of alkaline protease solution was then added, 
mixed and incubated for 5 minutes. The alkaline protease digested endonucleases 
and other proteins released during the lysis of the bacterial cells, therefore 
improving the quality of the eluted plasmid. After incubation, 350 pi of Wizard plus 
neutralisation solution was added and immediately mixed by inversion. The 
suspension was then centrifuged for 10 minutes at maximum speed.
A series of centrifugations were carried out to remove unwanted products and to 
obtain the plasmid. The cleared lysate was decanted into a prepared spin column 
and centrifuged for 1 minute. The flow through from the collection tube was 
discarded. Then 750 pi of column wash solution was added to the spin column and 
centrifugation was carried out for 1 minute and again the flow through was 
discarded. This wash procedure was repeated with 250 pi of column wash solution 
and was then centrifuged for 2 minutes. The spin columns were transferred to a 
low DNA binding tube and the plasmid eluted by adding 100 pi of nuclease free 
water. This was centrifuged for 1 minute and the spin column discarded. All 
plasmid solutions were stored at -20°C
2.44 Visualisation and quantification of DNA
To visualise DNA and plasmid preps gel electrophoresis was used. Agarose gels 
were made to a percentage depending on the size of the product; 1% for general 
use (1 -  12 Kb), 1.8% or 2.5% for fragments below 3 Kb. A DNA stain, SafeView 
(NBS Biologicals) was added to both the gel and the buffer so no post staining was 
required. Loading dye was added to the samples and the gel ran at 80 volts for 
approximately an hour. A 1 Kb molecular weight ladder was also run to determine 
the size of the products. Once the gel had run, pictures were taken using a UV 
GelDoc machine (Syngene)
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To determine the amount of DNA or plasmid in a sample, 1.2 pi of the sample was 
placed on a Nanodrop (Thermo Scientific), which was calibrated to the buffer used 
to dissolve the sample in. The Nanodrop measured the amount of DNA in the 
sample in ng/pl (using UV absorbance at 260 nm / 280 nm) and provided a graph to 
indicating the quality of the sample.
2.5 Restriction digestion of DNA
Restriction enzyme digests of DNA were required for several cloning steps. All 
enzymes were obtained from Promega and can be seen in Table 2.3. The digest 
protocol used the following: 0.2 -  1.5 pg of substrate DNA, with a two to ten fold 
excess of enzyme. A typical reaction was set up with: sterile deionised water, 16.3 
pi, RE 10 x buffer 2 pi, acetylated BSA (10 pg/pl), 0.2 pi, DNA (1 pg/pl), 1 pi and 
restriction enzyme (10 units/pl), 0.5 pi, to give a final reaction total of 20 pi. Digests 
were incubated at the appropriate temperature (Table 2.3) for approximately 4 
hours. Once incubation was complete termination of the reaction was required. 
Many of the enzymes were susceptible to heat inactivation (Table 2.3), where the 
reactions were heated to 65°C for 20 minutes. However, several enzymes could 
not be heat inactivated so to terminate the reaction chloroform extraction was 
carried out.
2.53 Chloroform extraction
DNA volume was made up to 200 pi and then one third of saturated ammonium 
acetate was added. To extract the DNA, 200 pi of chloroform was added to the 
tube and shaken vigorously. The extract was centrifuged for 1 minute at maximum 
speed and the upper aqueous phase was collected. Three volumes of 100% 
ethanol was added, mixed by inversion and then placed at -80°C for one hour. 
After freezing, the DNA was collected by centrifugation for 20 minutes at maximum 
speed, the supernatant removed and the pellet washed with 100 pi of 70% ethanol. 
This was then dried in a vacuum for 10 minutes and dissolved in approximately 10 
pi of water. Restriction digests can then be visualised by gel electrophoresis.
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2.6 DNA extraction from gels
DNA extraction from agarose gels was carried out using a QIAquick spin kit 
(Qiagen). DNA bands were excised under a UV lamp and weighed in a 1.5 ml tube. 
Three volumes of Buffer QG was added to one volume of gel (e.g. 100 mg of gel 
assumed to be 100 pi) and incubated at 50°C for 10 minutes until the gel had 
dissolved completely. During the incubation period the tube was mixed every 2-3 
minutes. One volume of isopropanol was then added to the sample and mixed, to 
increase the yield of DNA. DNA was bound by applying the sample to a QIAquick 
spin column and centrifuged at maximum speed for 1 minute. Flow through was 
discarded and 500 pi of Buffer QG was added to column and centrifuged for 1 
minute. To wash 750 pi of Buffer PE was added to QIAquick column and 
centrifuged for 1 minute. Flow through was discarded and tube centrifuged for an 
additional 1 minute. Column was placed into a clean tube and DNA eluted by 
adding 50 pi of Buffer EB (10mM Tris-CI, pH 8.5) to the centre of the QIAquick 
membrane and centrifuging for 1 minute.
2.7 Preparation of RNA from bacterial cells
To extract RNA for microarray analysis, a Qiagen kit was used and the 
manufactures protocol followed as stated. Bacterial cells were harvested as 
described in section 2.13. The bacterial pellet was loosened by flicking the tube and 
then re-suspended in 100 pi of TE buffer containing lysozyme by vortexing. This 
was then incubated at room temperature for 10 minutes. An additional sonication 
step was carried out to aid lysis of bacterial cells and increase RNA yield. Samples 
were sonicated at 5 Hz for 10 seconds on, then 10 seconds off 10 times using a 
Sanyo Soniprep 150 Watt sonicator. 350 pi of buffer RLT containing p- 
mercaptoethanol was added to the sample and mixed by vortexing. 
Homogenization was then carried out using the QIAshredder homogeniser. The 
lysate was transferred into the QIAshredder spin columns, which were held within a 
2 ml collection tube. This was then centrifuged for 2 minutes at maximum speed 
and the homogenized lysate collected. 250 pi of 100% ethanol was added and 
mixed by pipetting. The sample was then applied to an RNeasy mini column held in
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a 2 ml collection tube. This was centrifuged for 30 seconds at 7000 x g and the 
flow through discarded.
An optional RNase free DNase step was used to remove residual traces of DNA. 
350 pi of buffer RW1 was added to the RNase mini column and centrifuged at 7000 
x g for 30 seconds and the flow through discarded. Then 10 pi of the DNase 1 
stock solution was added to 70 pi of buffer RDD and mixed by inversion. This was 
pipetted directly onto the RNeasy silica gel membrane and left at room temperature 
for 15 minutes. Buffer RW1 (350 pi) was added to the RNeasy column and 
centrifuged for 30 seconds at 7000 x g and the flow through discarded.
The RNeasy column was transferred to a new 2 ml collection tube and 500 pi of 
buffer RPE was added. The sample was centrifuged at 7000 x g for 30 seconds 
and the flow through discarded. The previous step was repeated and centrifuged 
for 2 minutes to dry the silica membrane. The column was placed into a new tube 
and centrifuged for 1 minute to eliminate carry over. The RNA was eluted by 
transferring the column to a 1.5 ml collection tube and pipetting 30 -  50 pi of RNase 
free water directly onto the silica gel membrane. The sample was centrifuged for 1 
minute at 7000 x g and the eluted RNA collected in the tube. The RNA 
concentration was determined using the Nanodrop as previously described.
After RNA extraction was completed, the RNA was concentrated using precipitation 
with 2.5M of lithium chloride. Lithium chloride (100 pi) was added for every 200 pi 
of RNA and then chilled at -20°C for 30 minutes; the precipitated RNA was then 
collected by centrifugation at 700 x g for 15 minutes. The supernatant was 
discarded and the pellet washed with ice cold 70% ethanol. The pellet was 
dissolved in nuclease free water. The concentration of RNA was determined using 
the Nanodrop and 4.5 -  15 pg were used to synthesise and form labelled cDNA 
(section 2.14).
2.8 Preparation of protein from bacterial cells
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Table 2.3 Restriction enzymes used in this investigation
Restriction
enzyme
Recognition
site
Buffer
Temperature
(°C)
Termination
EcoRI GAATCC H 37
Heat inactivation 
(65°Cfor 20 
minutes)
BamH\ GGATCC E 37 Heat inactivation
Xho\ CTCGAG D 37 Heat inactivation
SsaMl GAATGCN D 65
Chloroform
extraction
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2.81 Whole cell protein lysis
Overnight cultures of bacterial cells (10 ml) were grown and harvested by 
centrifugation at 900 x g for 10 minutes. The supernatant was decanted and the 
pellets re-suspended in 1 ml of PBS. From this point onwards, everything was kept 
on ice. The re-suspension was centrifuged for 2 minutes at 7000 x g and the pellet 
re-suspended in 1 ml of PBS containing a protease inhibitor (1 pi per 100 pi). The 
tubes were placed on ice for 5 minutes and transferred to 2 ml screw cap top tubes 
containing 500 pi of zirconium beads. The tubes were placed in a bead beater for 
approximately 1 minute at lowest setting (25) and placed back on ice. The tubes 
were centrifuged for 3 minutes at maximum speed to produce a thick, clear 
supernatant. The protein sample was aliquoted into clean tubes. For visualisation 
by protein polyacrylamide gel electrophoresis, a 1:1 ratio of sample buffer was 
added to the tubes. The tubes were boiled for 5 minutes and centrifuged for 3 
minutes to remove cellular debris. The supernatant was removed to a fresh tube 
and 15 pi was loaded on the gel. Protein concentration was determined before 
visualisation by SDS PAGE (see below).
2.82 Determination of protein concentration
The Bio-Rad Quick Start Bradford protein assay was used to determine protein 
concentration. The kit was supplied with bovine serum album pre diluted standards 
ranging from 0.125, 0.25, 0.5, 0.75, 1, 1.5 and 2 mg/ml. For determination of 
protein concentration, 20 pi of protein sample and the seven standard 
concentrations were added to clean disposable cuvettes. Then 1 ml of dye reagent 
was added to each sample (containing Coomassie blue). The tubes were 
incubated at room temperature for 5 minutes and the samples read at 595 nm. A 
standard curve was produced from the standard OD readings and protein 
concentrations read off this graph. To determine an exact protein concentration the 
linear regression formula was used. A linear regression = y = a + bx. In this case 
the appropriate values can be entered to give: OD = a + bconc- The values of a and 
b can be determined from the graph using the Minitab version 15 software. To find 
the concentration the equation was rearranged and the values of a and b 
substituted in to give:
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cone = OD -  a (0.1039) / b (0.635).
Approximately 20 pg was required for each sample and thus proteins were diluted 
to the appropriate concentration.
2.83 Membrane protein extraction from bacterial cells
To extract membrane proteins a Bio-Rad ReadyPrep protein extraction kit 
(membrane 1) was used. The kit is based on the separation of membrane proteins 
by temperature dependent phase partitioning using a detergent. Overnight cultures 
were harvested by spinning for 10 minutes at 900 x g. Buffers M1 and M2 were pre 
chilled for at least 15 minutes before use. 0.5 ml of buffer M1 was added per 50 pi 
of bacterial cell pellet. A protease inhibitor was also added at 1 pi per 100 pi to 
prevent protein lysis. The cell suspension was placed in a tube containing 
approximately 500 pi of Zircomium beads and placed in a bead beater for 1 minute. 
This was repeated at least 5 times and tubes were placed on ice between bead 
beatings. The suspension was spun for 3 minutes at maximum speed to produce a 
clear supernatant. An equal volume of chilled buffer M2 was added to the cell 
extract and mixed on a vortex for 60 seconds, 4 - 5  times, taking care to keep 
tubes chilled between mixes. At the end of this mixing the tube was placed on ice 
for 10 minutes. The tube was transferred to a 37°C water bath and incubated for 
30 minutes. The suspension was then mixed for 30 seconds periodically ( 3 - 4  
times) and the tube centrifuged at maximum speed for 5 minutes at room 
temperature.
After centrifugation two layers were present and the top layer removed to a clean 
tube and labelled hydrophilic proteins. 500 pi of buffer M2 was added to the tube 
containing the bottom phase and the mixing steps and chilling steps repeated as 
described above. The tubes were incubated at 37°C and centrifugation steps 
repeated so that two layers were produced. Again the top layer was removed as 
previously described and pooled with the hydrophilic proteins collected earlier. The 
bottom phase was collected and transferred to a clean tube. This was labelled the
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hydrophobic protein fraction. An insoluble pellet was also present and this was 
frozen and stored as the hydrophilic and hydrophobic fractions.
An RC DC protein assay (Bio-Rad) was used to determine protein concentration. 
This assay was compatible with both reducing agents and detergents. 5 pi of DC 
reagent S was added to each 250 pi of DC reagent A that will be required for the 
run. This reagent is referred to reagent A’ and each sample requires 127 pi of 
reagent A’. Dilutions of the BSA standard were made ranging from 0.2, 0.5, 1 and 
1.5 mg/ml. 25 pi of each standard and protein samples were placed into clean 
centrifuge tubes and 125 pi of RC reagent 1 was added to them and incubated at 
room temperature for 1 minute. Then 125 pi of reagent 2 was added to each tube, 
mixed and centrifuged for 3 -  5 minutes at maximum speed. The supernatant was 
discarded and 127 pi of reagent A’ was added, mixed and incubated for 5 minutes 
at room temperature, until the precipitate had completely dissolved. Before 
proceeding the tubes were vortexed and then 1 ml of DC reagent B was added to 
the sample and mixed. This was incubated at room temperature for 15 minutes. 
After the incubation step absorbance was read at 750 nm and a standard curve 
produced. Protein concentrations can then be determined from the graph as 
described in section 2.82.
2.84 Membrane protein clean up
Before proteins could be visualised, samples were cleaned using the Bio-Rad 
ReadyPrep 2D cleanup, to remove detergents that may interfere with SDS -  PAGE. 
The clean up procedure was carried out as described by the manufacture. First, 1 
-  500 pg of protein in a final volume of 100 pi was transferred to a clean tube and 
300 pi of precipitating agent 1 was added and mixed well. This was then incubated 
on ice for 15 minutes and then 300 pi of precipitating agent 2 was added and mixed 
well. The samples were centrifuged for 5 minutes at maximum speed to form a 
pellet and without disturbing the pellet, the supernatant removed. The tubes were 
then centrifuged for a further 15 to 30 seconds and any residual liquid removed. 40 
pi of wash reagent 1 was added to the pellet and centrifuged for 5 minutes at 
maximum speed. The wash was removed and discarded and 25 pi of ultrapure 
water was added and mixed. 1 ml of wash reagent 2 (prechilled at -20°C for at
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least an hour) and 5 pi of wash 2 additive was added to the pellet and vortexed for 
1 minute. The samples were incubated at -20°C for 30 minutes, with mixing every 
10 minutes during the incubation period. After incubation, the sample was 
centrifuged for 5 minutes and the supernatant removed. A brief centrifugation was 
repeated to collect and remove any residual liquid and the pellet was then air dried 
at room temperature for no longer than 5 minutes. Pellets were re-suspended in 
Laemmli buffer.
Before samples were run on the gel, sample buffer was added to the proteins. A 
reducing agent p mercaptoethanol was added to the sample buffer (50 pi to 950 pi 
of buffer). The sample buffer was then added to the sample at a 1:1 ratio and 
mixed until the sample had completely dissolved. The sample was then heated for 
5 minutes at 9 5 -1 0 0  °C and was then ready for SDS-PAGE.
2.9 Visualisation of proteins bv SDS-PAGE
To visualise proteins, SDS -  PAGE was performed using a Bio-Rad Criterion Cell. 
For whole cell protein analysis and initially for membrane protein analysis, a 4 -  
20%, Tris-HCI gradient gel (Bio-Rad) was used. For outer membrane proteins to 
look for changes at a particular protein size, a 12.5% Tris-HCI gel was used 
instead. Proteins were prepared as described above. The gel was placed into the 
tank and 10 X Tris/Glycine/SDS (Bio-Rad) buffer, diluted to a 1 X working solution 
was added. The gel was loaded with the protein samples (20 pg) and run at 80 
volts for approximately one hour.
To stain the gels, Bio-safe Coomassie blue (Bio-Rad) was used. First the gel was 
washed three times in 200 ml of deionised water for 5 minutes. The water was 
removed and 50 ml of Coomassie stain was added and left with rocking for 1 hour. 
The stain was removed and gels washed with 200 ml of deionised water for 30 
minutes. Gels were then photographed. However, due to the lack of sensitivity 
with the Coomassie stain, silver staining was also evaluated.
2.91 Silver staining of protein gels
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Silver staining of gels was carried out using Bio-Rad silver stain kit (Bio-Rad). First 
the gel was fixed in 400 ml fixative (40% methanol, 10% acetic acid v/v) for 30 
minutes with rocking. It was then placed in a second fixative solution (400 ml; 10% 
ethanol, 5% acetic acid v/v) for 15 minutes. The fixative was removed and the gel 
was placed in the second fixative again for 15 minutes. The gel was then placed in 
200 ml of an oxidizer, for 5 minutes and washed in a series of deionised water 
steps of 400 ml for 5 minutes, repeated until all the yellow colour has been removed 
from the gel. 200 ml of silver reagent was then added for 20 minutes. This was 
removed by washing with 400 ml of deionised water for 1 minute. Developer 
solution (200 ml) was then added until the solution turned yellow. The developer 
was removed and fresh developer (200 ml) was added for approximately 5 minutes. 
Developing was stopped when bands were clearly visible by the addition of 400 ml 
5% acetic acid (v/v) for 5 minutes.
2.10 Polymerase chain reaction (PCR)
PCR reactions were used extensively in this investigation for a number of 
applications, including strain identification, cloning and mutagenesis. Promega 
PCR reagents were mainly used (Promega Corporation). For a 1x PCR mix the 
following Promega reagents were used: PCR buffer (5x), 2.5 pi, Mg2+ (25 mM) 2 pi 
(final concentration 2mM), dNTPs (10 mM), 0.5 pi (final 0.2 mM), 1:1 primer mix (20 
pM), 0.6 pi, Taq (5 units/pl), 0.18 pi. 1 pi of template DNA was added to give a final 
reaction volume of 25 pi.
2.10.1 Reverse transcriptase PCR (RT)
RT PCR was used to investigate the expression of genes in the presence of 
chlorhexidine. RNA was harvested from cells in the presence of 5 pg/ml 
chlorhexidine and from cells grown in LB broth as previously described (Chapter 2, 
section 2.7 and 2.13). RNA was then converted to cDNA using the ImProm-ll 
Reverse transcription system (Promega). RNA was first treated with RQ1, RNase 
free DNase (Promega), to remove any DNA present in the sample. The RNA 
sample (5 pi) was added to 1 pi RQ1 RNase free 10 x buffer (400 mM Tris-HCI, 
pH8, 100 mM MgS04 and 10 mM CaCI2) and 1pl RQ1 RNase free DNase
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(containing 10 mM MgCI2, 10 mM HEPES, 50% glycerol and 10 mM CaCI2). The 
reaction was incubated at 37°C for 30 minutes, and then 1 pi of RQ1 DNase stop 
solution was added to terminate reaction. After incubation at 65°C for 10 minutes 
to inactivate DNase, the RNA was used in the reverse transcriptase reaction.
The ImProm -  II reverse transcriptase kit, required several controls, including a 
negative control, no RNA and a positive control, with template and control PCR 
primers which were included in the kit. A no RT control was also included to check 
that no DNA activity was present as this may affect results. DNase treated RNA (2 
pi) was added to 1 pi of random primers for the experimental samples and 1 pi of 
control primers for the positive control. This was made up to 5 pi with sterile 
deionised water. The negative control contained no RNA. Tubes were placed into 
a preheated thermal cycler at 70°C for 5 minutes, and then chilled on ice for 5 
minutes and each tube spun in a bench top centrifuge for 10 seconds. The 
seconds part of the reaction was prepared as follows: for experimental, negative 
and positive control, 4 pi of buffer, 4 pi of 25 mM MgCI2, 1 pi of 10 mM dNTPs, 0.5 
pi of RNasin inhibitor, 4.5 pi of nuclease free water and 1 pi of ImProm reverse 
transcriptase was added to give a final volume of 15 pi. The no RT control was 
made as above with the exception of no reverse transcriptase being added and 
water making up the final 20 pi. This reverse transcription reaction was added to 
the 5 pi RNA and primer reaction tubes and place in a thermal cycler. The following 
programme was used to synthesise cDNA: annealing at 25°C for 5 minutes, 
extension at 42°C for 1 hour, and inactivation of RT at 70°C for 15 minutes.
cDNA was then analysed via PCR. PCR primers used are shown in Table 2.4. A 
control housekeeping gene (phaC) was included which had a constant level of 
expression across both conditions. The programme used was: 94°C for 5 minutes, 
initial denaturation, 94°C for 30 seconds, annealing at specific primer temperature 
(Table 2.4), extension, 72°C for 1 minute, for 40 cycles. MgCI2 concentration was 
adjusted to compensate for carryover from the reverse transcription reaction (6mM) 
to give a final volume of 2 mM. To determine when the PCR product appeared in 
both the control and experimental condition, a 40 cycle PCR reaction was set up. 
After the initial 10 cycles, a PCR tube was removed every 5 cycles, allowing the
56
Chapter 2 -  Materials and Methods
determination of product appearance. PCR products were analysed via gel 
electrophoresis to look for up regulation of genes in the experimental condition.
2.10.2 Real time PCR (QPCR)
Real time PCR was used to validate the microarray results. Real time PCR is a 
quantitative method compared to RT PCR which is only semi quantitative. Q PCR 
incorporates a fluorescent dye called SYBR green (Thermo scientific), which only 
fluoresces when bound to double stranded DNA. As DNA is synthesised the dye is 
incorporated and fluorescence recorded. In this manor, DNA synthesis can be 
recorded in “real time”, thus those genes that may be up-regulated in the 
experimental condition would start to appear at earlier cycles than those in the 
control condition and vice versa.
cDNA was made from RNA as mentioned previously and 0.5 pi of cDNA template 
was added to: 10 pi Absolute SYBR green mix, 0.5 pi of primer mix (20 pM) and 
sterile deionised water to make a final volume of 20 pi. To prepare a standard 
curve, dilutions of the cDNA was made ranging from 1, 1 in 5, 1 in 25 and 1 in 125. 
Before adding cDNA to the sample it was essential to determine the concentration 
of cDNA and adjust it so that the same amount of cDNA was added to each 
reaction. The controls included were a negative control with no cDNA and a no RT 
control, containing no reverse transcriptase. Also included in every reaction was 
the housekeeping gene phaC, to check that the real time PCR had worked as 
expected. Once the reactions were prepared, the tubes were placed in a real time 
thermal cycler (Opticon 2, MJ Research). The programme used was as follows: 
95°C for 15 minutes, 95°C for 15 seconds, and specific annealing temperature for 
primer (64°C) for 30 seconds, 72°C for 15 seconds for 50 cycles. To check that the 
correct product was formed and that controls were negative, a melting curve was 
performed after the 50 cycles, this ranged from 50 -  95°C with a reading taken at 
every 0.5°C for 1 second. This determines the melting point for the product. All 
PCR products for each primer pair should have a similar melting temperature, 
hence the same peak should be observed. The negative controls should have a 
lower melting point indicating no contamination or DNA activity in the no RT control.
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Table 2.4 Primers used fo r RT and Q PCR
Primer
Name
Primer (Forward and Reverse)
5’ - 3 ’
Annealing
temperature
°C
Size bp
Control 
gene BCAL 
1861(phaC)
AGACGGCTT C AAGGT GGT
66 470
ACACGGTGTTGACCGTCA
BCAL 0114 
RT
GCACAGCAGAACCTCAAC 64 519
GTT GTT GT CGAGCG ACA
BCAL 0126 
RT
CAAGGAAGGCACGCTGAC 64 366
CCGTACGACAGCAGGATG
BCAL0143 
RT
GAGCGACTT CAT CG ACGG 64 404
GCCAGTACAACAGGTCGG
BCAL 2353 
RT
GCAACTCGGCAGCTTCTC 65 457
GAAT GCGGT GAACGAT CC
BCAL 2370 
RT
GCAT CAT CCAGCAC AT GC 64 518
CACCAGTGTGCAGACGAG
BCAM 0924 
RT
CACCTGAAACCCGACCTG 65 473
CT GCAG AT GT GGCT GT CG
BCAM 0925 
RT
CGACACGCAGT CGAATCC 64 540
GCGACGAGGTT CT GTT CG
BCAM 0927 
RT
GGCT GTT CGAAC AAGGC AC 64 394
CACGTCCACGTAGACCTG
BCAS 0081 
RT
GCACT GCACACGATGGTC 65 323
AGACGCGGCACGAAATAC
BCAS 0083 
RT
GCTT CC AT GCG ACGT CCAC
64 358
CTT CAGGCTCCCGTCGAT C
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Once the programme was completed the Opticon monitor analysis software was 
used to produce a graphical representation of the reaction as well as the melting 
curve. The threshold value (ct) is the point at which the fluorescence crosses the 
horizontal line set by the user. The ct value can be used to calculate fold change 
by two separate methods. The Delta -  delta method does not take into account the 
efficiency of the reaction and assumed 100% efficiency. The reactions were carried 
out in triplicate and an average taken. The ct value of the control gene was 
subtracted from the ct value of the control housekeeping gene and the ct value of 
the experimental gene was subtracted from the ct value of the experimental 
housekeeping gene. Then the experimental gene delta ct value was subtracted 
from the control gene delta ct value and the fold change calculated using the 
equation: Power (2delta delta ct value).
A more accurate method, which took into account the reaction efficiency, was the 
Pffaffl method (Pfaffl, 2001). Standard curves were produced using the dilutions of 
the cDNA for each gene and the reference gene. The efficiency of the reaction was 
calculated by determining the slope of the curve and by then using the efficiency 
calculator provided by Stratagene.
(http://www.stratagene.com/techtoolbox/calc/qpcr slope eff.aspx). The ratio was 
calculated using the Pfaffl equation: (Pfaffl, 2001)
r a t io  =  (E target )ACt target (control-treated)
(Eref )ACt ref (control-treated)
where E target = the efficiency of the target gene transcript, E ref = the efficiency of the 
reference gene, e.g. phaC, DCt target, which is the Ct value for the target gene 
experimental condition subtracted from the Ct value of the target gene in the control 
condition and DCt ref is the Ct value for the reference gene in the experimental 
condition subtracted from the Ct value of the reference gene in the control 
condition.
2.11 PCR purification
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For some applications, such as cloning and sequencing, DNA within PCR reactions 
was purified to remove excess primers, enzymes and dNTPs that interfered with 
downstream processes. The QIAquick PCR purification protocol was used to 
achieve this (Qiagen). Five volumes of buffer PB1 was added to one volume of 
PCR sample and mixed. A QIAquick spin column was placed into a collection tube 
and the DNA bound to the column by applying the sample and centrifuging for 30 -  
60 seconds. The flow through was discarded and the samples washed with 750 pi 
of buffer PE. This was centrifuged at maximum speed for 30 -  60 seconds and flow 
through was discarded. The column was centrifuged for an additional 1 minute and 
the QIAquick column was placed in a clean tube. DNA was eluted by adding 
between 30 pi and 50 pi of buffer EB (10 mM Tris-CI, pH 8.5) to the membrane and 
centrifuging for 1 minute. Eluted DNA was then quantitated or visualized by gel 
electrophoresis.
2.12 Random amplified polymorphic DNA analysis (RAPP)
To determine if mutants were the same strain as the wildtype, a PCR band DNA 
fingerprinting method was used. Random amplified polymorphic DNA analysis 
uses arbitrary primers that anneal randomly to the genome, creating a unique 
phenotype for that particular strain. Chelex DNA preparations were performed to 
obtain DNA (Chapter 2, section 2.42). Primers used were designed as previously 
described (Mahenthiralingam et al., 1996a) and are as follows: Primer 270, 5’ -TGC 
GCG CGG G- 3’ (MWG Biotech, Covent Garden, London) and Primer 272, 5’ -  
AGCGGGCCAA-3’ (MWG Biotech, Covent Garden, London). A PCR mix was set 
up using Qiagen reagents (Qiagen) as follows: 2.5 pi of 10 x coralload buffer, 5 pi of 
Q solution, 1.5 pi of MgCh (25 mM), 0.5 pi of dNTP (200 pM final concentration), 4 
pi primer (10 pmol/pl working solution), 10.3 pi of sterile water and 0.2 pi of Taq 
polymerase. 2 pi (approximately 50 -  100 ng) of template DNA was added to 23 pi 
of mix to give a final volume of 25 pi. The PCR thermal cycles were carried out on 
a Flexigene Thermal Cycler (Techne Ltd., Newcastle, United Kingdom) as follows 
(ramping time between temperatures): (i) 4 cycles of 94°C for 5 minutes, 36°C for 5 
minutes (70 seconds cooling time), and 72°C for 5 minutes. (70 seconds heating 
time), (ii) 30 cycles of 94°C for 1 minute (55 seconds to heat from 72°), 36°C for 1
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minute (60 seconds to cool), 72°C for 2 minutes. (70 seconds, to heat); and (iii) a 
final extension of 72°C for 6 minutes
Once the reaction had completed, the products were separated on a 1.5% high 
resolution gel (Sigma) with TBE buffer. 12 pi of product was placed on to the gel 
and run at 80 V for approximately 3 hours or until it has run to 8 cm. SafeView DNA 
stain was added to both the gel and the buffer so no post staining was required. 
Once the run was complete, a picture was taken using the UV Gel Documentation 
machine.
2.13 B. cenoceoacia growth curve analysis
To prepare bacteria for RNA extraction and use in microarray experiments, growth 
curve experiments were performed. The bacteria needed to be harvested at mid 
log phase for consistent RNA profiling. LB broth (Sigma) was made with polished 
water and autoclaved. B. cenocepacia J2315 was revived on TSA agar and an 
overnight culture was set up in 3 ml of TSB. This was left for 18 hours. 25 ml of LB 
broth was added to a sterile 250 ml flask. One flask contained normal LB, the 
second flask contained LB and chlorhexidine at a concentration of 5 pg/ml. 500 pi 
of bacterial suspension was added to the flasks and placed into a 37°C incubator 
with shaking at 150 rpm. An OD reading was taken at 600 nm every 90 minutes, 
until exponential growth was observed and then a reading was taken every 60 
minutes. Once both bacterial cultures have reached an OD of 0.5 the bacteria were 
harvested.
To harvest bacteria, 5 ml was placed into a snap top tube and rapidly cooled for 10 
seconds in liquid nitrogen. The tube was then placed in a centrifuge cooled to 2°C 
and spun for 5 minutes at 3000 x g. The supernatant was discarded and the pellet 
frozen in liquid nitrogen. The pellet was stored at -80°C until RNA extraction was 
performed.
2.14 Microarrav experiments
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A two colour microarray of B. cenocepacia J2315 was used to determine the global 
gene expression in response to chlorhexidine. The 2 x 11 K microarray was 
provided by Agilent (Agilent technologies, Santa Clara, California) and was a 60 
mer probe design containing 7251 genes, 1489 intergenic regions from strain J2315 
and genes from 610 control strains. An overview of the microarray experiment is 
shown in Figure 2.1.
2.14.1 Cy3/Cy5 labelling design
Once the RNA was concentrated (section 2.7) it was converted to cDNA and 
labelled with fluorescent dyes. The design used in the microarray experiment was 
a direct comparison with 4 replicates; therefore a dye swap method was used to 
counter for any dye effects. Spike-in controls were also used according to the 
manufactures instructions and this was taken into account when using the dye 
swap method. Microarray labelling was carried out as follows; tube A contained 
control J2315, spike A and dye Cy3, tube B contained experimental J2315, spike B 
and Cy5, tube C contained control J2315, spike B and Cy5 and tube 4 contained 
experimental J2315, spike A and Cy3. This process was repeated for the other 2 
replicates.
2.14.2 Labelling first strand cDNA with amino allyl-dUTP
Labelled cDNA was made using the CyScribe post labelling kit (an indirect amino 
allyl procedure) following the manufactures instructions (Amersham). Amino allyl 
dUTP (AA-dUTP) aliquots were first centrifuged for 15 seconds and 30 pi of 
nuclease free water added. The following reagents were added to PCR tubes: 
Spike controls (A or B), 2 pi, mRNA (500ng), 6pl, random nonamers, 2 pi, anchored 
oligo dt, to give a total volume of 11 pi. These were mixed by gentle pipetting and 
then incubated at 70°C for 5 minutes. The reactions were then cooled for 10 
minutes at room temperature, so that primers and mRNA can anneal. The 
reactions were then centrifuged for 15 seconds. For the extension reaction, the 
tubes were placed on ice and the following was added, leaving the enzyme until 
last: 5 x Cyscript buffer, 4pl, 0.1 M DTT, 2 pi, nucleotide mix, 1 pi, AA-dUTP, 1 pi
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and Cyscript reverse transcriptase to give a total reaction volume of 20 pi. These 
were mixed by pipetting and centrifuged for 15 seconds. The reactions were then 
incubated at 42 °C for 1.5 hours and then placed on ice.
2.14.3 Purification of amino allyl modified cDNA
To degrade the mRNA, 2 pi of 2.5M NaOH was added to each reaction; these were 
mixed by vortexing and spun in a centrifuge for 15 seconds. The reactions were 
then incubated in a water bath at 37°C for 15 minutes. 10pl of 2M HEPES free acid 
was added and mixed by vortexing. The reaction was then centrifuged for 15 
seconds. The cDNA was then ready for purification by ethanol precipitation. 3 pi of 
3 M sodium acetate was added to each reaction and then 105 pi of absolute 
ethanol was added. This was mixed and centrifuged for 15 seconds. The reactions 
were then incubated in -80°C freezer for 1 hour. The reaction was then centrifuged 
at 13,000 x g for 15 minutes and the supernatant was removed with a pipette. The 
pellet was then air dried for approximately 30 minutes and fully re-suspended in 40 
pi of 0.1 M sodium bicarbonate buffer.
2.14.4 Labelling of amino-allyl modified cDNA with CyDye
The purified amino allyl cDNA was added directly to one aliquot of CyDye NHS (N- 
hydroxy-succinimidyl) ester in a 1.5 ml tube. The NHS ester was completely re­
suspended by pipetting several times and then centrifuged at 13 000 x g for 1 
minute to collect the liquid at the bottom of the tube. The reactions were incubated 
at room temperature in the dark for 90 minutes. 15 pi of 4 M hydroxylamine was 
added to each reaction tube and mixed by pipetting. This was then incubated in the 
dark at room temperature for 15 minutes.
2.14.5 Purification of labelled cDNA with autoseq G-50 columns
Two autoseq columns should be used to purify one labelling reaction as the final 
volume of the reaction before purification should be approximately 45 pi. The
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Agilent designed probes using the annotated gene sequence and printed probes onto glass slides. B. cenocepacia J2315 was grown with and without the 
presence of chlorhexidine; RNA was extracted, converted to cDNA and labelled with fluorescent dyes, Cy3 and Cy5. cDNA was printed onto slides and 
unbound probes washed off. The slide was scanned using an Agilent scanner and data put into the computer software Genespring for analysis.
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columns were prepared by vortexing gently, to re-suspend the resin. The caps 
were loosened and the bottom closures were snapped off. The columns were 
placed in 2 ml screw cap microcentrifuge tubes and spun for 1 minute at 1500 x g. 
The columns were placed into a new 1.5ml tube, without a cap and 23 pi of the 
labelling reaction was slowly added to the centre of each column. The sample was 
applied to the angled surface of the resin bed taking care not to disturb the resin. 
The columns were spun for 1 minute at 1500 x g and the purified samples were 
collected at the bottom of the microcentrifuge tube. The recovered material from the 
same labelling reactions was pooled and the total volume measured. The DNA 
content was measured using Gene Quant with the ideal concentration ranging 
between 20 -  50 pg/ml.
2.14.6 Measuring Fluorescence.
The fluorescent signal of each labelled sample was checked by electrophoresis on 
a mini gel. A 1.5% agarose gel containing 50 x TAE was made and 3 ml was 
poured into the gel mould. This was overlaid with a glass slide, taking care to 
prevent bubbles from forming. The labelled samples were prepared by adding 1 pi 
of 50% glycerol to 1 pi of sample. Once the gel had set it was carefully removed 
from the mould and placed into an electrophoresis tank. The samples were loaded 
and the gel was run at 100 V for 20 minutes. Once the electrophoresis was 
complete the slide was removed and scanned (GeneTAC GTLS IV Scanner, 
Genomic Solutions Inc). Cy3 was scanned at 560 nm and Cy 5 was scanned at 
675 nm.
2.14.7 Hybridisation
The amount of sample used for each microarray was adjusted according to the 
fluorescence and concentration in respect to one another. The total amount of 
sample that could be analysed on a microarray slide was 500 ng. Cy3 and Cy5 
labelled samples were combined to give a concentration of approximately 500 ng 
and was re-suspended in 80 pi of nuclease free water. The samples were heat 
denatured at 98°C for 3 minutes and then allowed to cool at room temperature.
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The cDNA target hybridization solution was prepared by adding the following 
reagents: 80 pi of combined cDNA targets, 25 pi of 10 x control targets and 105 pi 
of 2 x hybridisation buffer. This was mixed by pipetting taking care not to introduce 
bubbles. The sample was then centrifuged briefly. The hybridization chambers 
were then prepared by loading a clean gasket slide into the hybridization chamber 
base. The entire sample was then drawn up into a pipette and the solution was 
dispensed slowly into the centre of the gasket well. The Agilent microarray was 
then placed onto the top of the gasket slide making sure that the number labelled 
side was facing upwards. The chamber cover was placed onto the sandwiched 
slides and clamped together using the clamp assembly. To check that the samples 
would hybridize evenly, the chamber assembly was held vertical and rotated 
clockwise. Once a large mixing bubble had formed that could move freely when 
rotated the chamber assembly could be loaded into the hybridisation oven. The 
hybridisation oven was set to rotate at 4 rpm at 65°C and was left to hybridise for 
17 hours.
2.14.8 Washing slides
Before the incubation period was finished four staining dishes were set up, the first 
contained 250 ml of wash solution 1, the seconds contained 250 ml of wash 
solution 2, and the third contained 250 ml of acetonitrile and the fourth contained 
250 ml of wash solution 3. The staining dishes containing wash solution 1, 2 and 3 
were placed onto magnetic stirrers that contained a stirring bar. Once the 
hybridisation was complete, the chamber assembly was removed from the oven 
and the clamp assembly loosened and removed. The sandwiched slides were 
removed and transferred to the rack in the first staining dish. The gasket slide was 
then removed from the microarray slide using tweezers to gently prise it away. The 
magnetic stirrers were then switched on and washing could begin. Slides were 
washed in washing solution one for 1 minute the rack was then removed and 
placed into wash solution 2 for 1 minute. The timing of this step was critical to 
success. The rack was then removed from wash solution two and excess liquid 
poured off. It was then transferred to the acetonitrile for a couple of seconds and 
then transferred to wash solution 3 for 30 seconds. The slide rack was removed
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from wash solution three at a slow and constant rate to minimise the chance of 
precipitates forming on the slide.
2.15 Scanning Microarrav
The microarray was scanned using an Agilent scanner and data extracted using the 
Feature Extractor V.8.1 software. Quality control data was observed to check that 
the microarrays were sufficient for analysis. These consisted of: checking the 
microarray by eye for even spread of fluorescence and hybridisation, background 
check controls, checking that control spots were present in all 4 corners of the 
array, outliers evenly distributed, Mvs plots close to 1, even distribution of up 
regulated and down-regulated features and linear spike-in controls. The microarray 
data was then saved to disk and analysed further using the GeneSpring software.
2.16 Microarrav data analysis -  Genespring
The computer program Genespring was used to analyse the microarray data. All 4 
replicates were uploaded into GeneSpring. The data were checked to make sure 
that all arrays were sufficient to use in analysis. This was assessed visually by the 
graph produced by Genespring, by the production of a condition tree and a principal 
component analysis. Control genes were then filtered out to produce a sub set of 
genes used for analysis. These genes could then be filtered on confidence level at 
P = 0.05 and P = 0.01, allowing genes that were significantly up-regulated or 
significantly down-regulated to be determined.
2.17 Biofilm assays
To asses the production of biofilms by members of the Bcc, a 96 well plate assay 
was used. The assay was adapted from that of Stepanovic et al. (Stepanovic et a/., 
2000). First, 96 well polypropylene plates (Sterlin Ltd, Fisher Scientific) were 
coated with 1 mg per well of mucin (Porcine mucin -  Sigma) (200 pi of a 5 mg/ml 
stock solution). The coating of wells with mucin was to aid adherence of bacterial 
cells. This was left at 37°C overnight and then washed with 250 pi of PBS -  Tween
66
Chapter 2.0 -  Materials and Methods
(0.1% v/v). Each well is washed three times and then left to dry at room 
temperature for 10 minutes. Plates were stored at 4°C until use.
Bacterial suspensions were made by inoculating a 3 ml nutrient broth culture and
leaving to grow at 37°C overnight. Bacterial suspensions were then adjusted to OD 
1 at 630 nm and diluted to approximately 106 cfu/ml. 200 pi of this suspension was 
added to the wells and left to grow for 72 hours statically at 37°C. Planktonic
growth was removed and plates washed three times with PBS buffer.
Bacteria were fixed by adding 200 pi of 99% methanol for 15 minutes. This was 
then removed and wells left to dry at room temperature for 10 minutes. The 
bacteria were stained for 5 minutes with 1% crystal violet solution. Excess stain 
was removed and plates washed with tap water until the wash water ran clear. The 
wells were left to dry at room temperature for 10 minutes and then biofilms were re - 
solubilised by adding 160 pi of 33% glacial acetic acid. To quantify the biofilm 
material, an OD reading was taken at 570 nm. Each assay was carried out in 
triplicate.
To see if biocides induced the formation of biofilms, a similar plate assay was 
performed, but 10 pi of the 106 cfu/ml bacterial suspension was added to 990 pi of 
nutrient broth containing the biocide at a range of concentrations (chlorhexidine and 
CPC, ranging from 0 - 5  pg/ml). The exact same staining method as described 
above was then carried out after 72 hours of growth at 37°C.
2.18 Swarming assays
To asses the ability of the Bcc to swarm over a surface, a swarming screen was 
developed. Semisolid agar plates were made using 0.3% nutrient agar with the 
addition of 0.5% glucose. Bacteria were grown in overnight cultures and OD to 1. 
The suspension was diluted to approximately 106 cfu/ml and a 1 pi spot of this 
suspension was spotted onto the agar and left to dry. Plates were incubated at 
37°C and swarming zones measured at 24 and 48 hours.
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To determine if chlorhexidine inhibited swarming, semisolid swarm plates were 
made as described, with the addition of chlorhexidine at concentrations, 0, 0.1, 0.3, 
0.6, 1.25, 2.5 and 5 pg/ml.
2.19 Mutagenesis
2.19.1 Sub - cloning into pGEM - T easy vector
PCR primers were designed for the target genes, with the appropriate restriction 
enzymes tails (Table 2.5). These gene products were amplified and then sub 
cloned into pGEM -  T easy vector (Promega) before carrying out site directed 
mutagenesis. pGEM -  T easy vector contains multiple restriction cloning sites and 
are prepared with T overhangs for easy cloning (Figure 2.2).
Once PCR products were amplified they were ligated into pGEM-T easy vector. 
The vector and control insert were centrifuged briefly and the reaction set up as 
follows: 5 pi of 2 x rapid ligation buffer, 1 pi of vector (50 ng), PCR product X pi and 
1 pi of T4 DNA ligase. The amount of PCR product added was determined using 
the equation (ng vector X Kb size of insert / Kb size of vector) x insert: vector ratio 
(3:1). The final volume of 10 pi was made up using sterile deionised water. The 
reactions were mixed by pipetting and then incubated at 4°C overnight.
Transformation into E. coli was then performed. High efficiency competent cells 
(Invitrogen) were used for transformation. LB plates with 100 pg/ml of ampicillin, 
0.5 mM IPTG and 80 pg/ml of X-gal were made as the selection agar. 2 pi of the 
ligation was added to 50 pi of competent cells. The tubes were gently flicked to mix 
and the incubated on ice for 20 minutes. After incubation the cells were heat 
shocked for 45 -  50 seconds at 42°C and then immediately placed on ice for 2 
minutes. 950 pi of SOC medium was added and the tubes incubated at 37°C with 
shaking (150 rpm) for 1 hour. After incubation, a 1 in 10 dilution of the original 
transformation suspension was made. 100 pi of both neat and diluted suspension 
was spread onto selection plates and left to dry. Plates were then incubated at 
37°C for 24 -  48 hours and white colonies were picked and placed into 96 - well
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Table 2.5 PCR primers used for Mutagenesis
Name Primer (5’ -  3’)
Annealing
temperature
Size
(bp)
Function
BCAM0924
(EcoRI)
TT ACGAATT CCCT G ATACT GATT G
65 622
pGPQTp
mutagenesis
T AT AG AATT CGAGCTT CTT GCGC AGCCT G
BCAL 2353 
(EcoRI)
T AT AG AATT CCGTT CGCCTT CGGC ATT G
65 1028
pGPQTp
mutagenesis
AATT G AATT CGAGCACGT CGT GAT CGAT G
BCAM
0924
Mutant
GACAT CGCACGGCACACT CC
68 657
Checking
pGPQTp
mutantsCAT C ACCT CGGGCAT GCCCG
BCAL 2353 
Mutant
CCT GCT GCT GAT CGT GAAGC
57 1051
Checking
pGPQTp
mutantsGCGACGAACGCATCGAGCAG
POM -  Tp
GT CT GACGCT CAGT GGAACG
62°C 650
Specific 
primer for 
Tp cassette 
pGPQTp
CGCTT AGGCC AC ACGTT C AAG
BCAM
0924
(BamHl)
T ATAGG AT CCG AT GGTT CG AC AT CGC
65 896
pEGM105Tc
mutagenesis
AAT GGAT CCAGGTAAGGGGACGCAC
BCAL 2353 
(BamHI)
TATAGGATCCCGACGACGACAATTCC
58 2500
pEGM105Tc
mutagenesis
AAT GGAT CCGAGGAGT CGGCGCT CGC
pUCTp
(BsaMl)
AAG AAT GCCGCTT GGTT CGATT GT GAG
60 529
Amplifying 
Tp cassette 
for cloning 
into 2353
AAGAATGCCTCGGGCATCCAAGCAGCAAG
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pUCTp
(Xho\)
T AT ACT CG AGG AATT CCCAC AGC AG
60 509
Amplifying 
Tp cassette 
for cloning 
into 0924AAT CT CGAGC AGCAACG AT GTT AC
BCAM 
0924 check
G ACG ACT AC AT CGT C AAG
65 300
Checking
pEGM105Tc
mutantsCAT GCACGCAT CGAGCAAC
BCAL 2353 
check
CGTT GCT GGT GGCAT GGG
60 340
Checking
pEGM105Tc
mutantsCGCTT CGAGGCT CAGCAG
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Figure 2.2 pGEM- T easy vector map (Promega inc).
Vector map of pGEM -T easy plasmid, showing size of plasmid, resistance genes carried out the 
multi cloning restriction site.
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plates and grown overnight. Plasmid extractions were carried out on clones 
(Section 2.43) and checked for the correct insert by PCR (primers shown in Table 
2.2). If the correct insert was present, the site directed mutagenesis was carried 
out.
2.19.2 Mutagenesis - pGPQTp
Once the PCR products had been sub - cloned into pGEM-T easy vector, the 
products were then cloned into the suicide vector provided by Valvano et al 
(Flannagan et at., 2007). The suicide vector contains a Tp resistant cassette, 
flanked by omega fragments (Table 2.2), which terminates the transcription of 
genes either side of the plasmid. The PCR products were digested from the pGEM 
easy vector and the pGPQTp was linearized using the EcoRI restriction enzyme as 
described in 2.5. The excised fragments were removed from the gel using the 
QIAquick spin column as described previously (section 2.6).
Ligation was carried out using T4 DNA ligase (Promega). The amount of PCR 
product added was determined using the equation as described in section 2.18.1 
and the reaction was set up as follows: 100 ng vector DNA, PCR product adjusted 
to correct volume as determined by equation (Section 2.19.1), 1 pi of ligase 10 x 
buffer, 1 pi of T4 DNA ligase and sterile water to make a final volume of 10 pi. The 
reactions were then incubated at 4°C overnight.
Transformation was then performed. The pGPQTp plasmid does not contain 
Lambda Pir, which was required for replication, JM109 and Omnimax E.coli 
competent cells also do not contain these genes. Therefore, E. coli strain S. 17 was 
made competent, using a calcium chloride extraction method (Section 2.19.3). 
Transformation was carried out as described in section 2.19.1 and transformants 
plated out onto Tp 100 pg/ml selective agar and left for 24 -  48 hours.
Transformants were picked and left to grow overnight. PCR checks were carried 
out using primers as shown in Table 2.5 to check that the gene was correctly 
disrupted. Once correctly inserted transformants were selected, tri parental mating 
was carried out to insert the mutation into B. cenocepacia K56-2 (Section 2.21).
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2.19.3 Making cells competent using calcium chloride
Overnight cultures of E.coli S. 17 cells were grown at 37°C with shaking overnight in 
5 ml of LB broth. 100 pi of this overnight culture was placed in 10 ml of LB broth 
and left to grow at 36 °C for 2- 3 hours until OD 0.5 at 600 nm was reached. The 
cells were harvested by centrifugation at 700 x g for 10 minutes and the 
supernatant was discarded. The pellet was re-suspended in 1 ml of CaCI2 that had 
been prechilled at -20°C and aliquoted into 1.5 ml tubes. This was then centrifuged 
for 1 minute at 13 000 x g. The supernatant was discarded and the pellet washed 
with 1 ml of CaCI2. This wash step was repeated 2 - 3  times. Finally the pellet was 
re-suspended in 200 pi of CaCI2 and left on ice for 30 minutes.
2.19.4 Mutagenesis using pEGM105Tc
The second mutagenesis method used a suicide vector pEGM105Tc, as described 
by Quandt et al (Quandt and Hynes, 1993). First unique restriction sites were 
identified in the two genes of interest (Table 2.5) and primers designed with BamHl 
restriction tails. A trimethoprim resistant cassette was amplified from plasmid pUC, 
with primers with the restriction tails that correspond to the restriction site within the 
gene of interest (Table 2.5). Both, the gene targets and the Tp resistant cassette 
were sub - cloned into pGEM-T easy vector as described in section 2.19.1; an 
overview of the method can be seen in Figure 2.3. Once the transformants had 
been selected, plasmids were extracted (Section 2.43) and checked using PCR 
(Table 2.5).
When the correct inserts had been isolated, restriction digests were performed 
using the unique restriction enzyme for the target genes to remove the Tp resistant 
cassette from the pGEM-T easy vector and to lineralize pGEM-T easy vectors with 
the gene insert. The Tp cassette was extracted from the gel (section 2.6) and 
ligated into the pGEM-T easy vector as described previously (section 2.19.2).
After ligation, the plasmid was transformed into E.coli Omnimax competent cells as 
described previously (section 2.19.1) and transformants selected on Tp 100 pg/ml 
plates. Transformants were picked and grown up and plasmids extracted. To
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check that the transformants were correct, PCR using primers specific for the Tp 
resistant cassette was carried out (Table 2.5). A restriction digest was also 
performed to check for the presence of Tp resistant cassette.
bamHl digests were performed on the pGEM plasmid containing the target genes 
interrupted with the Tp cassette (Table 2.2) and on the pEGM105Tc plasmid. The 
digest was visualised on a gel and the disrupted gene was excised using the 
QIAquick spin kit (section 2.6). The disrupted gene was then ligated into the 
linearized pEGM105Tc plasmid and transformed into E. coli Omnimax competent 
cells. Transformants were selected on Tp 100 pg/ml plates, picked, regrown and 
frozen down at -80°C. Plasmid extraction was carried out and PCR checks 
performed to check that the Tp cassette had inserted correctly. Once transformants 
with the correct insert were isolated, triparental mating with B. cenocepacia K56-2 
was carried out (section 2.21).
2.20 Random transposon mutagenesis
Random transposon mutagenesis was carried out on B. cenocepacia AU1054, to 
examine the chlorhexidine swarming phenotype. Preliminary experiments were 
carried out to determine the antibiotic selection marker required. 8. cenocepacia 
overnight suspensions were spread onto plates containing various concentrations 
of kanamycin, tetracycline and trimethoprim. The plasposon containing a 
trimethoprim resistant cassette (Dennis and Zylstra, 1998) was selected to use and 
tri parental mutagenesis was carried out to transfer the plasposon into 8. 
cenocepacia AU1054.
2.21 Conjugal mating into Bcc strains
Conjugal mating was carried out to transfer: (i) mutant constructs into 8. 
cenocepacia K56-2 via site directed mutagenesis, and (ii) transposons into 8. 
cenocepacia AU1054. J2315 was not used as a mutagenesis strain as it is
notoriously difficult to do genetic work on and K56-2 is a closely related single locus 
variant of this strain, so can be used instead. All matings required the helper 
plasmid pRK2013. The strains required were grown in 3 ml overnight culture.
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Figure 2.3 Mutagenesis of the B. cenocepacia BCAM 0924 gene
A -  BCAM 0924 with Xhol site and Tp resistant cassette with Xhol tails B cloned into pGEM vector. BCAM 0924 and Tp cassette digested with Xhol. B -  Tp 
cassette cloned into BCAM 0924. BCAM 0924 disrupted with Tp cassette digested with BamHI and suicide vector pEGM105Tc also digested with BamHl. C 
-disrupted gene cloned into suicide vector pEGM105Tc and tri parental mating then carried out with B. cenocepacia K56-2
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These strains included the B. cenocepacia strain to be mutated, E. coli strains 
containing plasmid/plasposon and E. coli strain carrying helper plasmid (Km 50 
selection) (Table 2.2). The cells were harvested by centrifugation at 1200 x g for 10 
minutes and the pellet was washed in 5 ml LB 10 mM MgS04. The spin was then 
repeated to harvest bacteria. The E. coli strains were then re-suspended in 4 ml LB 
10 mM MgS04 and the Burkholderia strains in 3 ml LB 10 mM MgS04. 50 pi of 
each strain was then mixed together and 100 pi of the mixture placed onto 
nitrocellulose membranes (25 mm), which had been laid on dry LB MgS04 plates. 
These membranes were then left at 37°C for 4 -  6 hours to allow mating to 
proceed.
After the incubation period, filters were removed from the plate using sterile 
tweezers and placed into 1 ml of LB broth within a 14 ml tube. The tubes were 
vortexed to remove bacteria from the filter. Dilutions of the mating mix were made 
and then 100 pi of each spread onto selection plates, containing either 100 pg/ml 
Tp (for site directed mutagenesis) or 300 pg/ml Tp (for transposon mutagenesis) 
and 120 units / ml of polymyxin (to kill E.coli donor strains). The three strains used 
in the matings were also plated out onto selection plate to check that the plates 
would only select for the correct transconjugants. Plates were then incubated at 
37°C for 24 -  48 hours and potential mutants picked into 96 well plates containing 
TSB with the appropriate antibiotic selection and grown overnight. After addition of 
DMSO, plates were frozen down at -80°C and then used for further analysis.
To isolate mutants capable of swarming in the presence of chlorhexidine, a screen 
was devised. Once mutants had grown on the selective agar they were pooled 
together (approximately 100 colonies in pool) in TSB broth by swabbing the plate 
and inoculating the broth (Figure 2.4). The suspension was mixed thoroughly and a 
10 pi spot was then inoculated into the middle of swarm plates (0.3% nutrient agar, 
0.5% glucose) containing 5 pg/ml of chlorhexidine (Figure 2.4). The plates were left 
to grow for 24 -  48 hours at 37°C. Those mutants that could swarm were picked by 
stabbing the agar at the edge of the swarm zone and re-plating onto standard TSA 
with Tp 300 pg/ml (Figure 2.4). Once the mutants had grown freezer stocks were 
made and the genes involved determined.
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2.22 Determining genes involved in swarming regulation
2.22.1 Two step PCR to amplify flanking DNA
To determine the genes knocked out by the random transposon mutagenesis 
screen a two step nested PCR was performed. The two step PCR used four sets of 
primers (Table 2.6). The first round of PCR used a primer specific for the 
plasposon and a primer that randomly annealed to the Bcc genome. This primer 
also has a conserved tail added for subsequent PCR reactions. After the first round 
of PCR a second reaction is set up using two new primers, one specific for the 
plasposon, which annealed just inside of the first primer (Figure 2.5 and Table 2.6) 
and a primer that is specific for the conserved tail on the second primer (Figure 
2.5). A chelex preparation of DNA from the mutants was performed as described in 
section 2. 42. A 1X PCR reaction was set up as follows using Promega reagents: 2 
pi 10 x buffer, 1.2 pi of MgCI2, 0.4 pi of dNTPs, 1 pi primer 1 (20 pmol/pl stock), 1 pi 
of primer 2b, 0.2 pi Taq polymerase, 13.2 pi sterile water and 1 pi of template DNA 
to make a final volume of 20 pi. These reactions were placed in a thermal cycler 
and the programme used is shown in Figure 2.6. After this reaction, a second PCR 
mix was made as follows: 5 pi of 10 x buffer, 2 pi of MgCh, 1 pi of dNTPs, 2.5 pi 
primer2.5 pi primer 4, 0.5 pi Taq polymerase, 33 pi of sterile water and 2.5 pi of 
PCR product from first reaction to make a final volume of 50 pi. This was placed 
into a thermal cycler and the programme used is shown in Figure 2.6.
Once the reaction was complete the reactions were cleaned up using a QiaQuick 
spin kit (section 2.11) and then 2 pi of loading dye was added to 8 pi of sample and 
analysed on a 2% gel at 80 volts.
2.22.2 Sequencing mutant PCR products
Once the nested PCR had been carried out, the products were sent for sequencing 
to determine the site of transposon insertion. The DNA quantity was measured and 
recorded. Primer 3 was used for sequencing as this was specific for the plasposon 
(1.6 pmol/pl stock). The sequencing reaction was carried out by Applied
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10 pi spot of 
pooled mutants
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containing 5 pg/ml 
chlorhexidine
Mutants pooled
After 24 -  48 hours 
some mutants may 
swarm
Swarming mutants 
picked at edge of 
swarm zone
Figure 2.4 Mutagenesis screen to isolate swarming mutants
Mutants were swabbed from the selective plate and pooled in broth. Then 10 pi of the pooled 
mixture was spotted onto swarming agar plates containing 5 pg/ml of chlorhexidine and left for 24 -  
48 hours. After this time non chlorhexidine responding mutants may swarm. To isolate these 
mutants a pick was made at the edge of the swarm zone, so as to avoid any non swarming mutants.
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Biosystems Big Dye Terminator ready reaction mix version 3.1, with subsequent 
analysis on an Applied Biosystems ABI-Prism 3100 automated sequencer.
2.23 Bioinformatics
Bioinformatic analysis was performed using a range of software. To visualise and 
annotate Burkholderia genomes, Artemis software was used (Rutherford et a/., 
2000). Sequence homology to the Bcc genome was searched using the basic local 
alignment search tool (BLAST) database, found at the National centre of 
Biotechnology Information (http://www.ncbi.nlm.nih.gov/index.htm). DNA sequence 
data obtained from the transposon mutagenesis screen was correlated to the Bcc 
genome using two methods. The first method used a BLAST search within the B. 
cenocepacia AU1054 genome found at the Joint Genome Institute 
(http://genome.iai-psf.org/finished microbes/burca/burca.home.html). This was 
then uploaded into Artemis to look for the position of the gene and its surrounding 
genes. Recently, a new database specifically for Burkholderia has been produced 
(Winsor et a/., 2008). BLAST searches of the sequence data was also performed 
using this database, which gave information on the genes function and surrounding 
genes (http://burkholderia.com/). This database also gave details on partially and 
fully sequenced B. cepacia genomes, the institute that sequenced them, whether 
they are complete or not and when it was last updated. 
http://burkholderia.com/viewAIIGenomes.do. The B. cenocepacia J2315 sequence 
however, is not available on this database and can be found at the Sanger centre 
website (http://www.sanger.ac.uk/proiects/microbes)
To further analyse the sequence data, derivatives of BLAST were used. PSI 
BLAST (position specific Iterated) (Altschul et a/., 1997) and BLAST P were used to 
identify protein domains. Protein family information was obtained from the protein 
family database (PFAM http://pfam.sanaer.ac.uk/) and from the Clusters of 
Orthologous Groups database (COG http://www.ncbi.nlm.nih.gov/COG/). To 
predict transmembrane helices within the sequence data, the Transmembrane 
Hidden Markov Model database was used. (TMHMM
http://www.cbs.dtu.dk/services/TMHMM-2.0/). Homology to transport related
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---------------------------
Chrom osom e
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Figure 2.5 Schematic drawing of how the two step plasposon PCR works.
Primer 1 was specific for the plasposon and primer 2 randomly anneals to the Burkholderia 
chromosome. Primer 2 also has a conserved tail added to the end. After the first round of PCR, a 
second reaction was performed using primer 3 (which was specific for the plasposon) and (primer 4, 
which was specific for the conserved tail on primer 2). Once the reactions were complete the 
products were sent for sequencing using Primer 3.
Plasposon
Table 2.6 PCR primers for Random transposon mutagenesis
Name 5’ - 3 ’
Primer 1 AGGCT CAGT GCAAATTTAT CC
Primer 2 GGCCACGCGTCGACTAGTACN1 0ACGCC
Primer 3 TTGAACGTGTGGCCTAAGCGAGC
Primer 4 CGT CACCATTT GGGAGCACAT GC
79
Chapter 2.0 -  Materials and Methods
PCR 1
95°C -  5 minutes
PCR 2
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*
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Figure 2.6 PCR programmes for nested PCR
PCR 1 was carried out on 2 pi of template DNA from mutants. Once reaction was completed 2 .5  pi 
of PCR product was added to the reaction and PCR 2 was carried out. Once the reactions were  
complete, products were visualised on a gel and sent for sequencing.
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proteins was determined using the Transport Classification database (TCB 
http://www.tcdb.org/).
2.24 Minimum inhibitory concentrations (MIC)
2.24.1 Broth dilution method
A broth dilution assay adapted to examine biocide susceptibility of Bcc bacteria was 
carried out as follows. Filtered sterilised aqueous solutions of chlorhexidine (10 
mg/ml) and cetylpyridinium chloride (5 mg/ml) were used to make up stock 
concentrations of 100 pg/ml and 1000 pg/ml biocide. These solutions were then 
added to TSB to make up biocide concentrations ranging from: 0-100 pg/ml for 
chlorhexidine and 0-200 pg/ml for cetylpyridinium chloride. We found that growth in 
liquid medium as opposed to growing bacteria on slopes of solid agar produced 
consistent numbers of viable cells for the Bcc strains studied. Therefore, each Bcc 
strain was grown overnight (18 hours) in 3 ml TSB at 37°C (within a 14 ml tube, 
shaken horizontally at 200 rpm); the culture was diluted to an optical density of 1 
(630 nm) corresponding to a viable count of approximately 1 x 108 cfu/ml. 
Approximately 1 x 105 cfu of each test Bcc strain was then added to 1 ml of each 
biocide concentration and 200 pi of this was added to 3 replicate wells within a 96 
well plate. The microplates were incubated with shaking (200 rpm) at 37°C for 24 
hours and the OD was read using a Dynex technologies MRX® microplate 
absorbance reader with Revelation application. An endpoint reading at 630 nm was 
taken with ten seconds of shaking beforehand.
B. multivorans LMG 13010 was included in all assays as a control strain as 
preliminary experiments with this strain exhibited a reproducible effect. Addition of 
biocides to the growth media resulted in changes to optical density. Therefore, the 
MIC value was designated as the concentration of biocide that resulted in an 80% 
knockdown of culture OD in comparison the control wildtype growth with no added 
biocide. Viable counts performed on the control strain after running the broth 
dilution MIC assay demonstrated the presence of 9.7 x 105 cfu/ml at a chlorhexidine 
concentration of 20 pg/ml, while no viable cells were detected above this 
concentration. Using the 80% knockdown in culture OD, the MIC of the control
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strain was found to be 30 -  40 pg/ml, which corresponded well to the absence of 
viable cells in concentrations of chlorhexidine above 20 pg/ml. The results were 
subjected to statistical analysis to determine levels of susceptibility.
2.24.2 Agar dilution method
To screen the subset of 38 strains against the three additional biocides, povidone, 
benzalkonium chloride and triclosan, an agar dilution method was used. The 
method allowed for higher concentrations of biocides to be examined where the 
broth dilution assay was prevented due to the biocides altering the OD reading. 
Stock solutions of the three biocides were made up as follows: Triclosan, 10 mg/ml 
in DMSO (this solvent did not inhibit the growth of Bcc bacteria at the 
concentrations used); povidone, 20 % in water, and benzalkonium chloride, 10 
mg/ml in water. After autoclaving, Tryptone soya agar was cooled to 50°C and the 
appropriate amount of each biocide was added to 40 ml of agar for concentration 
ranges of 0 -  500 pg/ml for triclosan, 0 -  400 pg/ml for benzalkonium chloride and 0 
-  5 % for povidone. The bacterial strains were cultured and diluted to 1 x 108 cfu 
per ml as described above; 200 pi of this suspension was then added to a 96-wells 
plate to create a master plate containing eight replicates of each test strain. The 
strain suspensions from the master plate were then replicated onto the biocide 
containing agar plates using a 96-well replicator and left to grow for 48 h at 37°C. 
The MIC was designated as the concentration of biocide where no visible growth 
was apparent.
2.25 MIC determination using the Bioscreen C
Chlorhexidine susceptibility of the site directed mutants was determined using an 
automated microbiology growth analysis system, the Bioscreen C (Thermo Fisher 
scientific). MIC experiments were set up as described in section 2.24.1 and placed 
into 100 - well honeycomb plates (Thermo Fisher Scientific). Two replicates of 
each mutant and wildtype strain, and a control containing only broth were included 
in each experiment. Incubation conditions were set up using the EZExperiment 
software supplied with the Bioscreen C. The Bioscreen C was set to take an OD
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reading every 5 minutes, with 10 seconds of shaking beforehand for 48 hours, 
using the wideband filter with a range of 420 -  580 nm. After the experiment was 
completed, data was exported into Excel, the control blank checked and subtracted 
and growth curves produced.
2.26 Minimum bactericidal concentrations (MBC)
2.26.1 Neutraliser efficiency tests
Before minimum bactericidal concentrations could be performed a neutraliser which 
was effective at terminating biocide activity but which was non toxic to the bacterial 
cells was required. The neutraliser chosen was 5% Tween 80 and 0.75% azolectin, 
which was filter sterilised. The neutraliser was selected on the basis of previous 
studies which had successfully employed this neutraliser (Lear et al., 2002).
The strain tested was B. cenocepacia K56-2. A cell suspension of this strain was 
made by diluting an overnight culture to approximately 106 cfu/ml. Firstly, to check 
the neutraliser was not toxic to bacterial cells, 100 pi of bacterial suspension was 
added to 900 pi of neutraliser and left in contact for 5 minutes. Viable cells were 
enumerated by viable counts and compared to a control where the neutraliser was 
replaced with water.
To ensure the neutraliser was effective at terminating the activity of the biocide, 100 
pi of biocide at a lethal concentration was added to 800 pi of neutraliser solution. 
Immediately, 100 pi of bacterial suspension was added and left in contact for 5 
minutes. Bacterial counts were enumerated by viable counts and compared to a 
control, whereby both the biocide and the neutraliser was replaced with water. If 
the neutraliser was efficient at terminating activity no reduction in viable cell count 
was observed.
2.26.2 MBC assays
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Bacterial suspensions were made as described previously (section 2.24) and 
diluted to approximately 106 cfu/ml. Biocide solutions were made ranging from 0 -  
1000 pg/ml for chlorhexidine and 0 -  5000 pg/ml for CPC. 10 pi of the bacterial 
suspension was added to 990 pi of the biocide solution and 200 pi placed into the 
well of a 96-well plate in triplicate. The plates were incubated at 37°C with shaking 
for 24 hours and then 20 pi of the bacterial suspension was placed into 180 pi of 
neutraliser solution. This was left in contact for 5 minutes and then replicated onto 
TSA agar plates. The plates were incubated at 37°C for 24 -  48 hours and the 
MBC recorded when growth ceased.
2.27 Antibiotic MICs -  E - test®.
To determine the antibiotic MIC values for the Bcc, commercial E-test® strips were 
used (AB biodisk). These strips contain a gradient of the antibiotic and an MIC can 
be read directly from the strip. Eleven antibiotics were screened, that 
encompassed a range of classes of antibiotics, including some that are important 
for treatment of CF infections, e.g. meropenem, ciprofloxacin and tobramycin. The 
bacterial strains were revived on TSA and colonies placed into iso -  sensitest broth 
(Oxoid) and diluted to an OD of 0.5 at 630 nm. The cultures were then swabbed 
onto iso sensitest agar to cover the whole plate and left to dry for 15 minutes. The 
E-test® strip was then placed onto the lawn of bacteria using sterile tweezers and 
the plates incubated at 37°C for 24 hours. The MIC was read off the strip as a zone 
of clearing on the lawn of bacteria (Figure 2.7). To determine if the bacteria was 
classed as resistant, sensitive or intermediate, the MIC was compared to a chart of 
MIC breakpoints, provided by the manufacturer (Table 2.7).
2.28 Suspension tests
Suspension tests were carried out on two commercial biocides, the chlorhexidine 
based Hibiscrub™ and triclosan based Cuticura™. Suspension tests were carried 
out as described by Lear et a i (Lear et al., 2002). Bacterial cultures were prepared 
as previously described (section 2.24). Cells were harvested by centrifugation at 
700 x g and supernatant removed. The cells were re suspended in PBS and
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MIC Value
Increasing 
concentration of 
antibiotic
Figure 2.7 Antibiotic E-test® strip
The strip was placed onto a lawn of bacterial cells and left to grow for up to 48 hours. A zone of 
inhibition may be present and the MIC value read from the strip, where the zone of clearing 
intersects the strip.
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Table 2.7 E- test® MIC breakpoints
Antibiotic Class MIC (pg/ml)
Amikacin aminoglycoside 16 (S) -  32 ( I ) - 6 4  (R)
Azithromycin macrolide 2 (S) -  4 (I) — 8 (R)
Ceftazidime cephalosporin 8 ( S ) - 16 ( I ) - 3 2  (R)
Chloramphenicol
Protein synthesis 
inhibitor
8 (S) — 16 (I) — 32 (R)
Ciprofloxacin fluoroquinolone 1 (S) -  2 (I) -  4 (R)
Imipenem p lactam 4 (S) -  8 (1) - 1 6  (R)
Meropenem P lactam 4 ( S ) - 8 ( I ) - 1 6 ( R )
Piperacillin P lactam 16 ( S ) - 3 2 - 6 4  ( I ) - 1 2 8  (R)
Temocillin P lactam N/A
Tobramycin aminoglycoside 4 (S) -  8 (I) -  16 (R)
Trimethoprim / 
sulfamethoxazole
Dihydrofolate 
reductase inhibitors
2 (S) -  4 (R)
S = sensitive 
I = intermediate 
R = resistant
8 6
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diluted to approximately 106 cfu/ml. 1 ml of the cell suspension was added to 9 ml 
of commercial biocide and left in contact for 5, 10, 20 and 60 minutes. At every 
time point 100 pi of suspension was removed and placed into a neutraliser solution 
(5 % Tween 80 and 0.75% azolectin). The neutraliser was checked as previously 
described (section 2.26.1). After 5 minutes of neutralisation, serial dilutions were 
made in PBS. Viable cells were enumerated by drop counts onto TSA and 
compared to a control where the biocide was replaced with water.
2.29 Efflux inhibitor assays
To examine the potential role of a mutant in efflux, an inhibitor assay was employed 
(Guglierame et a/., 2006). Bacterial suspensions of the mutant and the B. 
cenocepacia K56-2 wildtype were grown in an 18 hour overnight culture and diluted 
to an OD of 0.5. The bacteria were harvested and washed twice with PBS. The 
suspension was added to glass cuvettes and ethidium bromide added to a final 
concentration of 20 pM. The fluorescence was recorded over a period of 10 
minutes, with a reading taken at 2 minute intervals using a Cary Eclipse fluorimeter. 
After 10 minutes the energy uncoupler carbonyl cyanide 3 chlorophenylhydrazone 
(CCCP) was added to a final concentration of 30 pM and fluorescence recorded for 
a further 16 minutes at 2 minutes intervals. Two replicates of each strain were 
performed and graphs were produced.
2.3 Statistical analysis
Due to the multifactorial mechanisms of biocide action, the MIC values obtained in 
replicate experiments spanned a range; therefore the results were split into a mean 
minimum value and a mean maximum value. All the results were analysed using 
the statistical software Minitab V.14. Kruskal-Wallis and Mann-Whitney statistical 
tests were carried out on the data sets and significant differences were determined 
(p < 0.05 for Kruskal-Wallis and P < 0.05 for Mann-Whitney). An antibiotic profile 
score was also calculated as a measure of overall antibiotic resistance within a Bcc 
species as follows: (i) for a given antibiotic, the mean MIC of all the strains in
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species tested was calculated; (ii) the mean for all ten of the antibiotics tested was 
then calculated to produce an overall score value for the Bcc species. Mann- 
Whitney tests were applied to determine the significance of the species mean 
antibiotic profile score (P < 0.05); however, the significance of the score was not 
determined for Bcc species represented by less than two strains. The antibiotic 
profile score did not correlate to clinically defined break points for resistance; it just 
served as a measure of the overall multiple drug resistance observed in each Bcc 
species.
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3.0 Characterising antimicrobial susceptibility in the 
Burkholderia cepacia complex
Published in part; in the Journal of Antimicrobial Chemotherapy -  Biocide 
Susceptibility of the Burkholderia cepacia complex. (See appendix 1)
3.1 Introduction
3.11 Antibiotic resistance in the Bcc
Since the first cases of B. cepacia infections in cystic fibrosis patients were 
identified, incidences of antimicrobial resistance, often multidrug resistance, have 
been observed (Mahenthiralingam and Vandamme, 2005). Some members of the 
Bcc are particularly problematic due to innate resistance to multiple antibiotics, such 
as aminoglycosides, polymyxins and beta lactams (Chernish and Aaron, 2003). 
Clinically, this innate resistance is a problem as isolates are resistant to 
combinations used for treatment (Mahenthiralingam et a/., 2005). Often this results 
in an aggressive treatment regime for the patient, using double or triple antibiotic 
combinations before eradication can occur (Chernish and Aaron, 2003). Chernish 
et al. found that 50% of B. cepacia isolates were resistant to all single antibiotics, 
which included meropenem, tobramycin, chloramphenicol and ceftazidime. When 
double combinations such as meropenem plus either amikacin, ceftazidime, 
chloramphenicol or tobramycin were tested 8% of isolates were resistant to these. 
This leaves only triple drug combination therapy as an option, such as meropenem 
plus tobramycin and either ceftazidime, trimethoprim / sulfamethoxazole, 
chloramphenicol or aztreonam (Chernish and Aaron, 2003).
Members of the Bcc are also intrinsically resistant to trimethoprim via a 
trimethoprim resistant dihydrofolate reductase. As mentioned previously (Chapter 
1) efflux pumps can have broad specificity and lead to resistance to a wide range of 
antimicrobials, in the Bcc group this includes trimethoprim, chloramphenicol and 
quinolones (Burns eta!., 1996). The ceo operon in B. cenocepacia encodes a RND 
efflux pump that confers resistance to chloramphenicol, trimethoprim and 
ciprofloxacin, therein is a vital mechanism of multidrug resistance (Nair et al., 2004).
90
Chapter 3 -  Characterising antimicrobial susceptibility in the Burkholderia cepacia complex
The outer membrane of the Bcc enhances the resistance phenotype due to its lack 
of permeability and the structure of the LPS confers resistance to p lactams and 
cationic peptides. Consequently infection with the Bcc, particularly multidrug 
epidemic strains can be difficult to treat, leaving clinicians and patients with little 
options. Therefore much research has been carried out into understanding 
resistance to antimicrobials and to find an effective treatment to prevent and 
eradicate Bcc infections.
3.12 Biocide resistance and the Bcc
In contrast, the molecular basis of biocide resistance in the Bcc bacteria has been 
poorly studied despite these organisms being linked to many cases of 
contamination in disinfectants and preservative solutions (Jimenez, 2007). Such 
contamination is problematic and may act as a reservoir for infection in CF patients 
and in vulnerable non-CF patients. Infection with Bcc outside of CF is not well 
characterised, however cases of specific Bcc infections have been isolated. Reik et 
al. found that in 90 non-CF patients 25.6% were infected with B. cenocepacia, 
18.9% with B. cepacia and 15.6% with B. multivorans (Reik et al., 2005). A study 
by Garcia-Erce et al. reported an outbreak of B. cepacia in blood transfusion 
patients was due to contamination of a 0.5% chlorhexidine solution that was used to 
disinfect the skin (Garcia-Erce et al., 2002). These patients suffered from septic 
shock and were seriously ill. Pharmaceutical formulations containing benzalkonium 
chloride (Frank and Schaffner, 1976), cetylpyridinium chloride (Kutty et al., 2007) 
and povidone-iodine (Panlilio et al., 1992) have also been contaminated by Bcc 
bacteria. CF patients often use nebulizers to deliver aerosols of antibiotics and 
other drugs. These can become contaminated if disinfection is not carried out 
adequately and may be a primary route of infection. Bcc isolates frequently 
contaminate home use nebulizers and DNA fingerprinting indicated that the 
contaminating isolate was indistinguishable from the patients sputum isolate 
(Hutchinson et al., 1996). Thus, disinfection of nebulizers should be carried out 
frequently to prevent patients from acquiring infections.
The potential contamination of disinfectant solutions may have serious 
consequences for patients, especially those with cystic fibrosis. A patient who has
91
Chapter 3 -  Characterising antimicrobial susceptibility in the Burkholderia cepacia complex
been hospitalised can acquire a serious infection from these contaminated solutions 
and this may lead to increased hospital stays, increased antibiotic use and an 
increase in morbidity and mortality. This not only impacts the patient but also has 
economical outcomes. Hospital acquired infections can put an enormous strain on 
clinics due to increased hospital costs from replacing contaminated solutions to the 
cost of keeping a patient in hospital for a longer period of time. Therefore 
preventing the contamination of antinfectives is an important area of research. 
However, the only reported Bcc outbreak in CF patients due to contaminated 
products was in a Portuguese CF clinic and this outbreak was attributed to the 
contamination of non sterile saline solutions used in inhalant therapy, not 
contamination of a disinfectant solution (Cunha et al., 2007). Therefore there 
appears to be a low risk of infection outbreaks in CF clinics from contaminated 
biocide products. Nonetheless, care should be taken as members of the Bcc are 
capable of surviving in biocide solutions and could potentially be a hazard for 
vulnerable patients.
The Bcc are a group of closely related bacteria that can be isolated from many 
sources including the environment. Preventing patients from acquiring these 
infections can be difficult due their abundance in nature, thus disinfection 
procedures are important in both clinical and domestic situations. Although there 
are guidelines to hospital disinfection, there are no standardised polices that are 
implemented by all hospitals (Maillard, 2005). There may also be a lack of 
compliance to outlined procedures, which leads to ineffective disinfection and 
sterilization (Rutala and Weber, 2004). This can be particularly problematic with 
surgical implants and equipment such as endoscopes, which can lead to the spread 
of infection (Rutala and Weber, 2004). There have also been conflicting opinions 
on the indiscriminate use of biocides and the use of biocides in preservative 
formulations at lower concentrations (Russell, 2002a). There is a disagreement 
whether disinfection of non-critical surfaces, such as walls and floors should be 
carried out as over use of biocides may pave the way for resistance to occur. 
Generally it is agreed that disinfection should occur in areas where hospital 
acquired infection is a high risk, such as showers, baths and toilets, where as other 
lower risk areas may only require cleaning (Maillard, 2005).
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3.13 Biocide resistance and antibiotic resistance
The increased usage of biocides not only in clinical situations but also in domestic 
situations has raised the issue of whether residues of biocides in the environment 
selects for antibiotic resistance (Russell, 2000). Although biocides and antibiotics 
have different modes of actions, because of the broad specificity of biocides due to 
their action on multiple targets these mechanisms may overlap (Fraise, 2002) 
(Figure 3.1). Efflux pumps are a good example of an overlapping mechanism of 
resistance. Efflux pumps are often broad spectrum and can pump out a number of 
unrelated compounds from the cell conferring resistance. The use of triclosan has 
been seen to select for low level resistance to some antibiotics in E. coli due to 
efflux pumps (McMurry et al., 1998a). The MexAB-OprM efflux system in P. 
aeruginosa can also pump out triclosan. Exposure to triclosan selected for 
multidrug resistant strains, which included resistance to antipseudomonal drugs 
such as ciprofloxacin. This resistance was due to the over expression of the 
MexAB-OprM efflux pump due to exposure to triclosan (Chuanchuen et al., 2001).
The latter mechanisms of resistance are all intrinsic. Although acquired resistance 
is a major cause of antibiotic resistance in the Bcc, rendering some strains 
untreatable, in biocide resistance acquired mechanisms are less important. 
However, acquired mechanisms may lead to cross resistance with biocides and 
antibiotics. Yammamato et al. found a plasmid from a methicillin and gentamicin 
resistant strain of Staphylococcus aureus conferred resistance to kanamycin, 
gentamicin, tobramycin, amikacin, benzalkonium chloride, acriflavin, ethidium 
bromide and chlorhexidine (Yamamoto et al., 1988). In addition this plasmid could 
be transferred to other bacterial species (Yamamoto et al., 1988). This is a cause 
for concern as broad spectrum resistance plasmids could be spread and selected 
for in clinical situations. However, although there is much debate on whether the 
indiscriminate use of biocides does select for multidrug resistant bacteria, there is 
also another side to the argument. Many of these studies use low levels of the 
biocide. In reality the in use concentration (Table 1.2) is often used at much higher 
levels that are bactericidal and therefore selection of resistance mechanisms will 
not occur' (Russell, 2000), although persistence of residuals of disinfectants may 
be a cause
93
Chapter 3 -  Characterising antimicrobial susceptibility in the Burkholderia cepacia complex
B io c id e
Multiple targets
Overproduction of 
target
Modification of a 
target
A n tib io tic
Specific target
Overproduction of 
specific target
Mutation at target site
Figure 3.1 Biocide and antibiotic mechanisms of resistance.
Biocide resistance mechanisms include overproduction of the target, modification of target site, 
active efflux of the compound, enzyme degradation and low permeability. Antibiotic resistance 
mechanisms include overproduction of the target, mutations of targets, active efflux, enzyme 
degradation and low permeability. The potential for cross resistance between antibiotics and 
biocides is clearly a possibility, with some mechanisms overlapping, such as low permeability and 
efflux. Adapted from (Russell, 2003)
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for concern.
3.14 Measuring biocide susceptibility
Routine antibiotic susceptibility screening is carried out in laboratories. However for 
biocides, routine susceptibility testing is more difficult and are often not carried out 
as the in use concentration of disinfectants are at such a high level they should be 
bactericidal. Due to increasing incidences of biocide contamination, susceptibility 
testing of biocides should be performed regularly. A major problem with biocide 
susceptibility testing is the lack of a standardized reproducible test. This means 
that a disinfectant that passes in one country may not pass in another (Lambert, 
2004). The British testing standards BS EN 1276 consist of 3 stages of testing. 
Stage 1, where suspension tests are carried out to look for surviving bacteria, with 
two reference species, Staphylococcus aureus and Pseudomonas aeruginosa, after 
exposure to the disinfectant. Stage 2, involves testing possible in use scenarios 
using capacity tests, where the in use dilution is inoculated for a certain amount of 
time and sampled for surviving bacteria, then a fresh inoculum was added to the 
biocide. Finally in stage 3, the disinfectant is tested in the field e.g. surface testing 
(Lambert, 2004). Although these tests are recognised as the gold standard to use, 
they come with problems. Many of these tests have poor reproducibility and a 
study by Taylor et al. found that 7 out of 18 commercial disinfectants failed the 
suspension test (Taylor et al., 1999). This indicates that more rigorous, 
standardized tests are required.
Minimum inhibitory concentration (MIC) screens are often used to gauge the 
susceptibility of a bacterial strain to an antimicrobial. The minimum inhibitory 
concentration is the lowest concentration where growth is inhibited (Lambert, 2004), 
but is only a measure of bacteriostatic activity. Although it would appear that MIC’s 
are unrelated to the much higher in use concentrations, these screens provide 
important preliminary information and can aid our understanding of the action of 
biocides as well as the effect lower concentrations have on bacterial strains 
(Russell, 2001). Minimum bactericidal concentration (MBC) screens are used to 
determine the killing action of a biocide in support of MIC data.
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The aim of this study was to provide an up to date survey of the biocide 
susceptibility profiles of a representative panel of Bcc species which accounted for 
both taxonomic and genetic diversity. To ensure that a wide genetic diversity of 
Bcc was sampled isolates were selected on the basis of their MLST type (Baldwin 
et al., 2005). Susceptibility data also related to the clinical use of disinfectants by 
looking at minimum bactericidal concentrations for the most resistant and 
susceptible strains and investigating the efficacy of commercial biocides against 
members of the Bcc.
3.2 Results
3.21 Chlorhexidine and Cetylpyridinium chloride susceptibility
Minimum inhibitory concentrations for two biocides, the bisbiguanide chlorhexidine 
and the quaternary ammonium compound cetylpyridinium chloride were initially 
determined for 101 strains of the Bcc via a broth dilution assay (Chapter 2, section 
2.24.1). These two biocides were chosen as they are widely used in clinical 
situations and are also soluble and easily incorporated into the MIC screens. 
However, limitations with the broth dilution method meant a maximum value of 100 
pg/ml of chlorhexidine and 500 pg/ml of CPC was used as at higher concentrations 
these biocides precipitated out of solution, skewing OD readings. After replicate 
analysis the mean minimum and the mean maximum MIC values for each species 
was calculated (Table 3.1). Despite rigorous standardization of the MIC assay an 
absolute end point for the biocides MIC were not obtained, due to the fluctuations 
observed between the replicates of the assay. An internal B. multivorans control 
strain, LMG 13010 was included in every assay. Although this strain exhibited the 
desired effect, slight differences were observed between experiments and the 
standard error of the mean was quite large in some cases (Figure 3.2). Therefore a 
range was used as the MIC value to compensate for these differences.
The species screened included the recently classified species, B. lata, B. 
contaminans and novel Bcc group K isolates, which have been associated with 
contamination of preservative products (Vanlaere et al., 2008). Preservatives are
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used to prevent the spoilage of commercial products and are incorporated into 
personal care products which can be directly applied to the surface of the body or 
used internally, like shampoos, conditioners, toothpaste and mouthwashes and to 
home use products such as washing powders (Russell, 2006). Biocides may be 
incorporated into products as a preservative agent at lower concentrations, hence 
issues with bacterial resistance are abundant with Bcc group K being particularly 
problematic (Vanlaere et al., 2009). For chlorhexidine, a variable range of growth 
inhibition was observed around the Bcc mean of 33 to 42 pg/ml. This ranged from 
15 pg/ml for B. lata to 57 pg/ml for B. cepacia (Table 3.1). Although there were no 
significant differences observed between the MIC’s for chlorhexidine, strains of B. 
cepacia, B. vietnamensis and B. cencepacia possessed the highest MIC values. 
For CPC, the susceptibility of the Bcc was much less, with approximately 3 fold 
larger amounts of CPC required for inhibition (mean MIC range 129 pg/ml to 144 
pg/ml); Table 3.1). Species differences were also observed; with B. cepacia, B. 
cenocepacia, B. lata, B. contaminans and novel Bcc group K being significantly less 
susceptible to CPC than other members of the Bcc (Table 3.1).
The collection of isolates examined contained nine examples of Bcc strains that 
were involved in outbreaks in multiple CF patients. The B. cenocepacia ET-12 
epidemic strain J2315 and two additional single locus variants strains (K56-2 and 
LMG 18827) had high chlorhexidine MIC values (>100 pg/ml). In comparison, only 
one other recA group lll-A outbreak strains (Mu1) and a recA lll-B group isolated 
from an urinary tract infection (LMG 18832) possessed a chlorhexidine MIC value 
greater than 100 pg/ml. Other epidemic strains within B. cenocepacia lll-B, such as 
the PHDC and Mid Western strains were prevented from growing at < 60 pg/ml of 
chlorhexidine.
Interestingly, B. multivorans isolate, LMG 16660 was observed to have a high 
chlorhexidine MIC value (90-100 pg/ml) compared to other B. multivorans strains 
(Table 3.2). This strain was part of an outbreak in CF patients in Glasgow. To 
determine if this was a feature of the outbreak strains, 19 additional Glasgow
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Figure 3.2 Mean MIC range for control B. multivorans strain, LMG 13010 over 
ten experiments in chlorhexidine.
The MIC was taken as an 80% knockdown from growth at zero concentration of chlorhexidine (blue 
line). Mean data obtained from ten separate experiments and standard error of mean was 
calculated (error bars). MIC value = 30 -  40 pg/ml. Fluctuations were observed over the ten 
experiments, with the MIC ranging from 20 -  50 pg/ml.
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strains (from 17 CF patients) were screened using the broth dilution method 
previously described. The chlorhexidine MIC of all Glasgow strain isolates ranged 
from 44 pg/ml to 100 pg/ml (Table 3.2). This was significantly higher than MIC 
values for other B. multivorans strains. In fact when the mean MIC values were 
examined, the MIC values for Glasgow outbreak strains were twice as high other B. 
multivorans strains (44 to 53 pg/ml compared to 22 to 33 pg/ml, Table 3.2). 
However, in contrast to the elevated chlorhexidine MIC, the Glasgow outbreak 
strains were significantly more susceptible to cetylpyridinium chloride (76.6 - 89.5 
pg/ml) than other B. multivorans strains (105 -  126 pg/ml).
The Bcc strains were also compared to a control group of non-Bcc species that are 
commonly encountered in CF infections, such as S. aureus, P. aeruginosa and 
Ralstonia pickettii. For chlorhexidine there were no significant differences between 
the MIC values for the Bcc compared to the non Bcc species, although 6 of the 10 
species tested were inhibited by < 20 pg/ml of chlorhexidine (Table 3.3). 
Cetylpyridinium chloride resistance was elevated in several Bcc species when the 
means were compared (Table 3.1 and 3.3). B. cepacia, B. cenocepacia and Bcc 
novel group K were significantly less susceptible (p<0.05) than the non-Bcc species 
total. P. aeruginosa was the only CF pathogen that was comparable to Bcc 
bacteria for susceptibility profiles to both biocides (see chapter 4.0 for more details 
on P. aeruginosa biocide susceptibility).
In addition to screening non -  Bcc strains, three control reference strains that are 
often used in clinical laboratories for antibiotic susceptibility tests were also 
screened for comparison. These strains were from the NCTC (National collection 
of Type Cultures) collection and consisted of an E. coli NCTC 12241, P. aeruginosa 
NCTC 12903 and a S. aureus NCTC 12981. All three strains were very 
susceptible to chlorhexidine with MIC values of 10 -  20 pg/ml (Figure 3.3a), 
however CPC MIC susceptibilities were more comparable with Bcc MIC’s with all 
three strains having an MIC of >200 pg/ml (Figure 3.3b).
3.22 Minimum Bactericidal Concentrations
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Table 3.1 Susceptibility of Bcc and other species to chlorhexidine and CPC
Species 
(No. of Strains 
tested)
Chlorhexidine  
Mean Min. MIC 
(Mg/ml)
C hlorhexidine  
Mean M ax. MIC  
(pg/m l)
CPC Mean Min. 
MIC (pg/ml)
CPC Mean Max. 
MIC (pg/m l)
B. cepacia (10) 57 65 170a 175b
B. multivorans 
(30) 36.6 46 77.7 101.3
8. cenocepacia 
(31)
47.4 54.8 175.5C 184.5°
8. stabilis (3) 40 46.7 146.7 166.7
8. vietnamiensis 
(5)
52 58 90 106
8. dolosa (3) 26.7 36.7 66.7 86.7
8. ambifaria (6) 33.3 41.7 98.3 116.7
8. anthina (2) 10 20 95 125
8. pyrrocinia (2) 15 25 50 70
8. lata (4) 15 25 183.3d 200d
8. contaminans 
(3) 13.3 23.3
200e 200f
Novel Bcc Group 
K (2) 50 60 2009
2009
Mean Bcc (101) 33.03 41.9 129.4 144.3
a At the mean minimum CPC MIC, 8. cepacia was significantly more resistant than 8. multivorans, B. dolosa, 8. 
ambifaria and 8. pyrrocinia (p < 0.05).
b At the mean maximum CPC MIC, 8. cepacia was significantly more resistant than 8. multivorans, 8. dolosa 
and 8. pyrrocinia (p < 0.05).
c At the mean minimum and mean maximum CPC MIC, 8. cenocepacia was significantly more resistant than 8. 
multivorans, 8. vietnamensis, 8. dolosa, 8. ambifaria, 8. anthina and 8. pyrrocinia (p < 0.05).
d At the mean minimum and mean maximum CPC MIC, 8. lata was significantly more resistant that 8. 
multivorans (p < 0.05).
e At the mean minimum CPC MIC, 8. contaminans was significantly more resistant than 8. multivorans and 8. 
ambifaria (p < 0.05).
1 At the mean maximum CPC MIC, 8. contaminans was significantly more resistant than 8. multivorans (p < 
0.05).
9 At the mean minimum and mean maximum CPC MIC, Bcc novel group K significantly more resistant than 8. 
multivorans (p < 0.05).
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Table 3.2 Susceptibility of B. multivorans Glasgow outbreak strains and B. 
multivorans strains to chlorhexidine and CPC
Species
Chlorhexidine 
Mean Min. 
MIC (pg/ml)
Chlorhexidine 
Mean Max. 
MIC (pg/ml)
CPC Mean 
Min. MIC 
(pg/ml)
CPC Mean 
Max. MIC 
(pg/ml)
8.
multivorans
(10)
22 33 105* 127.3*
Glasgow 
Outbreak 
strains (20)
44* 53* 76.5 89.5
* Denotes those species that are significantly different as determined by Kruskal-Wallis and Mann- 
Whitney tests ( P < 0.05).
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In addition to MIC screening, the chlorhexidine and CPC MBC of 38 strains from the 
original panel of 101 strains was determined. Twenty two strains were selected 
with high MIC’s to chlorhexidine and CPC, while 16 were selected with low MICs to 
both biocides. The MBC screen was carried out as previously described (Chapter 
2, section 2.26.1). To terminate the action of the biocides after the given exposure 
period a neutraliser was used (0.75% azolectin and 5% Tween 80). Before MBC 
experiments could be performed, control experiments to check that the neutraliser 
was efficient at terminating activity and not toxic to bacterial cells were carried out 
as described in chapter 2.
To check that the neutraliser was efficient at terminating activity viable counts for 
bacteria in a control (biocide and neutraliser replaced with water) were compared to 
viable counts of bacteria exposed to chlorhexidine and CPC which had been 
exposed to the neutraliser for five minutes. There were no log differences between 
the number of viable bacteria in the control and the two neutralised biocide 
solutions, thus indicating that the neutraliser solution was capable of terminating 
activity of the biocide (Table 3.4). To check that the neutraliser was non toxic to 
bacterial cells it was inoculated directly with bacterial suspension and viable counts 
indicated that the neutraliser was not lethal to the bacteria (Table 3.4). Therefore 
this neutraliser solution was used for both chlorhexidine and CPC screens.
The mean Bcc chlorhexidine MBC was 229 pg/ml (Table 3.5) which was 
approximately six fold greater than the MIC value for this biocide. The majority of 
strains tested (35/38) required no more than 300 pg/ml for a bactericidal outcome. 
A B. multivorans strain, C1607 and two B. cenocepacia strains, DN and X100 had 
MBC values of 500 pg/ml and only two B. cenocepacia strains, LMG 18832 and 
Mu1 needed at least 1000 pg/ml chlorhexidine to achieve killing, a value ten fold 
above their MIC. In CPC, 27 out of the 38 strains tested required over 20 fold more 
CPC than the MIC for a bactericidal effect to be seen, with a mean CPC MBC of 
2998 pg/ml (Table 3.5). In addition 13 Bcc strains were still viable after 24 hours of 
exposure to 5000 pg/ml of CPC.
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Table 3.3 Chlorhexidine and cetylpyridinium chloride susceptibilities of non 
Bcc bacterial species.
Species Isolate Chlorhexidine MIC (pg/ml) CPC MIC (pg/ml)
Staphylococcus
aureus
MRSA - 224005 10-20 150-180
M R S A -223021 90-100 150-180
LMG 22203 90-100 10-30
MRSA 223054 90-100 10-30
MSSA 90-100 10-30
NCTC 12981 90-100 10-30
Burkholderia gladioli LMG 2216 10-20 150-180
Stenotrophomonas
maltophilia LMG 958 10-20 100-120
Pseudomonas
aeruginosa PA01 20 -3 0 >200
Ralstonia
mannitolilytica LMG 6866 80 -90 150-180
Pseudomonas
stutzeri LMG 11199 10-20 120-150
Burkholderia dolosa AU1069 2 0-30 50-70
Ralstonia pickettii LMG 5942 4 0 -5 0 120-150
Pseudomonas putida LMG 2257 10-20 150-180
Achromobacter
xylosoxidans LMG 1863 10-20 100-120
Escherichia coli NCTC 12241 10-20 10-30
Mean Non -  Bcc (16) 42.5-52.5 93.1 -1 1 6 .3
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Figure 3.3 E. coli NCTC 12241 (± SE) MIC values to a. chlorhexidine and b. 
CPC.
E. coli antibiotic reference strain NCTC 12241 has a MIC of 10 -  20 pg/ml in chlorhexidine and >200 
pg/ml in CPC. MIC values are taken as an 80% knockdown from growth at zero concentration, as 
indicated by the blue line.
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3.23 Triclosan, povidone and benzalkonium chloride susceptibility
The same sub group of 38 Bcc strains that were screened for MBC analysis were 
also screened against an additional three biocides, triclosan, povidone and 
benzalkonium chloride (Table 3.5). In povidone all strains tested possessed 
povidone MIC’s in excess of 50000 pg /ml (data not shown), with the exception of 
one B. pyrrocinia strain (MIC 20000 pg/ml). The maximum mean MIC observed for 
triclosan was 374 pg/ml, with 11 Bcc strains having MIC’s greater than 500 pg/ml.
Benzalkonium chloride had MIC values comparable to the other quaternary 
ammonium compound tested CPC, with a mean MIC of 164 pg/ml. Notably both 
strains from the ET-12 lineage, J2315 and K56-2 had high MIC’s to triclosan (> 500 
pg/ml), povidone (> 5000 pg/ml) and benzalkonium chloride (350 pg/ml) as well as 
possessing high chlorhexidine and CPC MIC’s.
3.24 Antibiotic susceptibilities
Antibiotic susceptibilities to ten antibiotics commonly used in CF clinics were 
determined for 60 strains of the Bcc complex. The MIC’s were determined using 
commercial E-tests® and classification of sensitivity or resistance was determined 
using the manufacture’s break points (Chapter 2, section 2.27). The mean MIC for 
each species was also determined and analysed (Table 3.6). Clinically defined 
resistance and sensitivity to individual antibiotics varied widely, not only between 
species groups but also within species. However, when a total antibiotic profile 
score (mean of individual antibiotic MIC’s for a species) was determined (Chapter 2, 
section 2.10), differences were observed. B. cepacia, B. multivorans, B. 
cenocepacia, B. stabilis and B. dolosa possessed the highest levels of multiple 
antibiotic resistances (Table 3.6).
This did not always correlate with biocide resistance. For example a B. dolosa 
strain involved in an outbreak in a hospital in Boston (Kalish et a/., 2006) had low 
MIC’s to chlorhexidine and CPC (20 -  30 pg/ml and 50 -  70 pg/ml respectively), but 
was defined as clinically resistant to all ten of the antibiotics. Generally, all species 
tested appeared to show high levels of resistance to azithromycin and tobramycin,
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Table 3.4 Neutraliser efficiency tests for minimum bactericidal concentrations
Condition Viable counts of K56-2 ( cfu/ml to 107 ± SE )
Control* 3.53 ( ± 6.6 )
Chlorhexidine exposed 3.75 (±22 .5  )
CPC exposed 7.6 ( ± 0 . 3 )
Neutraliser control* 13.3 ( ± 3 . 3 )
* = biocide and neutraliser replaced with water
# = neutraliser inoculated with bacterial suspension 
SE = standard error of the mean
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Table 3.5 Biocide susceptibility and minimal bactericidal concentrations for 
Bcc
Species Strainname
Chlorhexidine CPC Triclosan
MIC
(pg/ml)
Benzalkonium 
chloride MIC 
(pg/ml)
MIC
(pg/ml)
MBC
(jicj/m ! ] _
MIC
(p g /m l)
MBC
(p g /m l)
B. cepacia (7)
LMG 17997 100 100 7 0 -1 0 0 2000 400 200
ATCC 49709 100 100 >200 500 300 50
IST431 9 0 -1 0 0 - >200 3000 400 - 450 200
LMG18821 9 0 -1 0 0 300 >200 2000 >500 100
AVC1717 7 0 - 8 0 300 >200 >5000 500 200
ATCC 17759 2 0 - 3 0 100 >200 3000 >500 100
Bcc0176 1 0 -2 0 50 3 0 -4 0 50 500 100
B. multivorans (5)
LMG 16660 90-100 300 > 200 >5000 >500 200-250
ATCC 17616 10-20 300 5 0 -1 5 0 1000 50 150
C1582 100 300 > 2 00 1000 450-500 150
C1607 100 500 200 >5000 500 250
LMG 18825 20-30 100 50-100 50 50 100
B. cenocepacia 
(12)
J2315 >100 100 >200 >5000 >500 350
X100 9 0 -1 0 0 500 7 0 -1 0 0 >5000 >500 350
LMG18827 >100 - >200 - 500 150
MU1 >100 1000 >200 >5000 10 350
WH1 1 0 -2 0 100 1 5 0 -1 8 0 4000 450-500 200
LMG 16654 80-90 300 >200 >5000 >500 50
DN 100 500 >200 2000 450 - 500 50
K56-2 90-100 300 >200 >5000 >500 150
PC002 100 300 >200 >5000 >500 >400
ATCC 25609 5 0 -6 0 300 >200 >5000 400 350
LMG 18832 >100 1000 >200 >5000 >500 350
PC523 1 0 -2 0 100 150 - 190 3000 500 200
8. stabilis (2) ATCC 35254 1 0 -2 0 100 200 >5000 500
200
LMG 14294 100 100 1 8 0 -2 0 0 >5000 400 200
8. vietnamiensis 
(4)
LMG 16232 100 100 1 8 0 -2 0 0 4000 450-500 100
G4 1 0 -2 0 300 3 0 -5 0 500 50 50
J1738 2 0 - 3 0 100 1 0 -3 0 50 50 50
LMG 10929 100 100 3 0 -5 0 300 100 50
8. dolosa (2) LMG 18943 20-30 300 5 0 -7 0 2000 450-500
200
AU0090 4 0 - 5 0 100 1 0 0 -1 2 0 5000 450-500 100
8. ambifaria (3)
MC40-6 2 0 - 3 0 50 1 0 0 -1 2 0 2000 50 50
ATCC 53267 100 - 1 8 0 -2 0 0 5000 >500 50
LMG 19467 2 0 - 3 0 50 7 0 -1 0 0 1000 >500 150
8. anthina (2) LMG 16670 1 0 -2 0 50 7 0 -1 0 0 500
150-200 50
LMG 20980 1 0 -2 0 50 1 2 0 -1 5 0 2000 150 50-100
8. pyrrocinia (1) LMG 14191 1 0 -2 0 50 5 0 -7 0 2000 50 50
Mean 
maximum 
value (Mg/ml)
74 229 155 2998 374 164
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Table 3.6 Mean MIC values (|jg/ml) for Bcc species to ten antibiotics
Organism 
(No. of strains 
tested)
AK AZ TZ CL Cl IP MP PP TM TS
Antib io tic
Profile
Score
8. cepacia (5) 109.6 125.3 5.98 13.3 5.2 17.6 0.9 13.1 88.23 0.5 37.9 a
B.
multivorans
(24) 81.6 110.4 52.9 101.6 1.976 25.8 2.2 21.4 30 0.4 42.8 b
B.
cenocepacia
(14) 111.5 81.2 2.6 12.2 1 35.6 3.1 23.4 37.5 9.1 31.7 c
B. stabilis (2) 8 32.7 1.6 22 16.3 3 1.5 3 4.5 2 9.5 d
B.
vietnamiensis
(4) 6.3 13.5 2.5
8 0.2 0.4 0.5 1.25 4.6 0.3 3.8
B. dolosa (4) 224 256 66.7 192.7 10.3 26.2 17.5 82.3 118 12 100.6 e
B. ambifaria
(4) 9.8 23.6 1.2 3.25 0.1 1.1 0.2 1.1 6.6 0.1 4.7
B. anthina (1) 16 32 1.5 4 0.19 2 0.38 1 8 0.19 6.5
B. pyrrocinia
d) 0.094 24 0.75 1.5 0.003 0.19 0.002 0.25 2 0.002 2.9
B.
contaminans
(V
1 16 1.5 8 0.25 24 0.75 1 0.38 0.125 5.3
3 B. cepacia significantly more resistant than B. vietnamensis, B. ambifaria, B. anthina, B. pyrrocinia 
and B. contaminans.
b8. multivorans significantly more resistant than B. ambifaria, B. anthina, B. pyrrocinia and 8. 
contaminans.
c 8. cenocepacia significantly more resistant than 8. vietnamensis, B. ambifaria, B. anthina and 8. 
contaminans.
d 8. stabilis significantly more resistant than 8. pyrrocinia and 8. contaminans 
e B. dolosa significantly more resistant than B. stabilis, B. vietnamensis, B. ambifaria, B. 
anthina, B. pyrrocinia  and B. contaminans.
Key: AK = amikacin, AZ = azithromycin, TZ = ceftazidime, CL = chloramphenicol, Cl = ciprofloxacin, IP = 
imipenem, MP = meropenem, PP = piperacillin, TM = tobramycin and TS -  trimethoprim / sulfamethoxazole
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but were overall more susceptible to the p lactams, such as meropenem, 
piperacillin and imipenem. The Bcc were also susceptible to the trimethoprim/ 
sulfamethoxazole combination, although the epidemic ET-12 B. cenocepacia strain 
J2315 was resistant to this combination.
The 20 B. multivorans Glasgow outbreak strains were also screened against the ten 
antibiotics and compared statistically to the four other B. multivorans strains (Table 
3.7). The Glasgow outbreak strains were significantly less susceptible to amikacin, 
azthromycin, ceftazidime, ciprofloxacin, meropenem, piperacillin and tobramycin 
than other B. multivorans strains. The B. multivorans strains were only significantly 
less susceptible than Glasgow outbreak strains to the p lactam, imipenem. There 
is a lack of correlation between biocide and antibiotic resistance as B. multivorans 
Glasgow outbreak strains with both low and high resistance to chlorhexidine, having 
multidrug antibiotic resistance. For example, B. multivorans Glasgow outbreak 
strain C1579 has a chlorhexidine MIC of 80 -  90 pg/ml and is resistant to amikacin, 
azithromycin, ceftazidime, chloramphenicol, ciprofloxacin, meropenem and 
tobramycin. In comparison, C1636 has a lower chlorhexidine MIC of 20 -  30 pg/ml, 
but was resistant to the same antibiotics as the strain with a higher chlorhexidine 
MIC.
As well as screening ten antibiotics commonly used in CF treatment, temocillin a p 
lactam antibiotic derived from ticarcillin (Lekkas et a/., 2006) was also screened 
against 20 representative strains of the Bcc (Table 3.8). Although there are 
currently no breakpoint values for temocillin, it can clearly be seen that most strains 
had low MIC values, apart from J2315, which has a higher MIC of 48 pg/ml (Table
3.9). When comparing J2315 and the Tp mutant, this was the only antibiotic where 
the MIC decreased in the mutant (Table 3.8).
The production of spontaneous resistant colonies was observed within the zone of 
inhibition after 48 hours for several antibiotics, assessed by E-strips® (Figure 3.4). 
The species that produced the most spontaneous resistant colonies were B. 
cenocepacia and B. multivorans strains (Figure 3.5) compared to strains such as B. 
cepacia which produced them less often, p lactam antibiotics induced the most 
spontaneous resistant colonies (Figure 3.5), with B. multivorans (41%) and B.
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cenocepacia (33%) strains generating the greatest proportion of these resistant 
colonies (Figure 3.6). All other Bcc species demonstrated low rates of this 
phenomenon with B. vietnamensis (at 11% of strains tested) being the next highest 
observed.
3.25 Training resistance to trimethoprim
Resistance to the dihydrofolate reductase inhibitor trimethoprim was induced in B. 
cenocepacia J2315 by successive culture passage onto increasing concentrations 
of trimethoprim in TSA plates. Resistance could be induced up to 1100 pg/ml of 
trimethoprim, approximately five fold higher than the normal MIC of between 150 -  
200 pg/ml. To see if this resistance was stable, the resistant mutant was plated out 
onto normal TSA plates and passaged three times before re plating onto Tp 1100 
pg/ml plates. The Tp mutant grew after re-plating in 48 hours, thus suggesting that 
the acquired resistance was stable. The adapted resistant mutant was also 
screened for antibiotic susceptibilities using E tests®. Interestingly, as well as the 
increased resistance to trimethoprim, the mutant also had increased resistance to 
azithromycin, ceftazidime, ciprofloxacin, chloramphenicol, and meropenem making 
the J2315 Tp mutant clinically resistant to nine out of ten antibiotics (Table 3.9)
Previous studies have suggested that TP resistance may be due to changes in the 
outer membrane, with the loss of major protein bands (Rajyaguru and Muszynski, 
1997). This was investigated for our mutants by SDS-page. From whole protein 
extracts no differences could be observed between the wild type J2315 and the 
resistant mutant (Figure 3.7). When outer membrane protein extraction was 
performed, again no obvious differences were observed (data not shown).
3.26 Susceptibility to commercial biocide formulations
To determine if commercial biocide formulations were bactericidal for Bcc strains, 
four strains with high MIC and MBC values to specific biocides were selected and 
suspension tests were performed. Two commercial biocide products were 
evaluated. Hibiscrub™, a chlorhexidine based disinfectant used in clinical settings
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Table 3.7 Mean MIC values (pg/ml) for Glasgow outbreak strains and B. 
multivorans strains to ten antibiotics
Mean Antibiotic MIC (pg/ml)
Name AK AZ TZ CL Cl IP MP PP TM TS
B.
multivorans
38 74 2.1 95 0.97 32* 1.7 4.8 21.5 0.3
Glasgow
outbreak
strains
225.2* 197.1* 216.2* 98.1 11.7* 7.4 18.1* 73.2* 75.6* 0.4
* - denotes significantly difference (P<0.05)
Spontaneous 
resistant 
mutant _
Figure 3.4 Production of spontaneous resistant colonies to piperacillin
B. cenocepacia, ATCC 17765, spontaneous resistant colonies produced in response to piperacillin, 
after 48 hours of growth.
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Table 3.8 Temocillin susceptibility of selected Bcc strains
Species Name MIC (pg/ml)
B. cepacia K LMG 23255 3
B. cepacia IST431 4
B. cepacia AVC1717 6
B. multivorans LMG 16660 16
B. multivorans ATCC 17616 8
B. multivorans C1607 12
B. cenocepacia J2315 48
B. cenocepacia LMG 18832 2
B. cenocepacia LMG 18829 0.75/1.5
B. cenocepacia AU1054 4
B. cenocepacia K56-2 16
B. stabilis ATCC 35254 6
B. vietnamiensis G4 3
B. vietnamiensis J1738 4
B. dolosa AU 1069 12
B. dolosa LMG 18943 12
B. ambifaria LMG 19467 0.38
B. ambifaria MC40-6 3
B. anthina LMG 20980 6
B. pyrrocinia LMG 141 1.5
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Figure 3.5 Proportion of strains producing spontaneous resistant colonies to 
ten antibiotics
Spontaneous resistant colonies were defined as those that appeared within the zone of inhibition 
after 48 hours. Not all species produced spontaneous resistant colonies. B. cenocepacia and B. 
multivorans strains produced the most spontaneous resistant colonies compared to other species 
such as B. anthina. The p lactam antibiotics imipenem, meropenem and piperacillin induced 
adaptive resistance most often.
Key
AK = amikacin, AZ = azithromycin, TZ = ceftazidime, CL = chloramphenicol, Cl = ciprofloxacin, IP = imipenem, 
MP = meropenem, PP = piperacillin, TM = tobramycin and TS -  trimethoprim / sulfamethoxazole
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□  B. cepacia
■  B. multivorans
■  B. cenocepacia
□  B. vietnamensis 
m B. ambifaria
H B. anthina
Figure 3.6 Proportion of Bcc strains producing spontaneous resistant 
colonies to the p lactam antibiotics, meropenem, imipenem and piperacillin
B. multivorans strains and B. cenocepacia strains produced the largest proportion of spontaneous 
resistant colonies to the three (3 lactam antibiotics, compared to other species. 41% of B. 
multivorans strains produced spontaneous resistant colonies compared to 7% of B. ambifaria 
strains.
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for pre operative hand disinfection and skin antisepsis and Cuticura™, a triclosan 
based hand gel sold for both home and clinical use. Both formulations contained 
alcohol and Hibiscrub™ contained 4% w/v chlorhexidine gluconate. The four 
strains selected had high chlorhexidine resistance (90 -  100 pg/ml) and were: 
B.cepacia LMG 18821, B. multivorans LMG 16660, B. cenocepacia J2315 and Bcc 
novel group K strain 24. B. multivorans ATCC 17616 was used as a susceptible 
control strain.
After exposure to the biocide the suspension must be neutralised. A neutraliser 
previously described (0.75% azolectin and 5% Tween 80) had already been seen to 
be non toxic to Bcc bacteria. To check that this neutraliser was efficient at 
terminating activity of commercial biocides, neutraliser efficiency tests were carried 
out (Chapter 2, section 2.26.1). In Hibiscrub™ a small knockdown from the control 
where the biocide and neutraliser was replaced with water was observed (Table
3.10). However, using the equation: LogNc - LogNb, where Nc is the neutraliser 
control and Nb is the biocide suspension, the log difference was only 0.11 which 
was sufficient to allow use of this neutraliser. In Cuticura™ there were no 
differences observed between the control and the biocide suspension (Table 3.10). 
As expected the sensitive control strain was killed after 5 minutes of exposure to 
both biocides. Five minutes of exposure to both biocides was also sufficient to 
produce a bactericidal effect for B. multivorans LMG 16660 and B. cepacia novel 
group K strain 24. In contrast B. cenocepacia J2315 were able to survive after an 
hour exposure with only a 1 log knockdown from the control observed (Table 3.11). 
J2315 was more susceptible to Cuticura™ with complete killing observed after 20 
minutes exposure (Table 3.11). B. cepacia LMG 18821 was killed after five minutes 
of exposure to Hibiscrub™, but was viable after an hour exposure to Cuticura™ 
with a one log knockdown observed (Table 3.11 and Figure 3.8). According to the 
British Standard: BS EN 13727, chemical disinfectants and antiseptics, quantitative 
suspension test for evaluation of bactericidal activity of chemical disinfectants, a 
disinfectant product will only pass the standard if it demonstrates at least a five log 
reduction of viable bacteria within 60 minutes or less (13727, 2003). Two of the 
strains tested, J2315 in Hibiscrub™ and LMG 18821 in Cuticura™ would not pass 
this criteria.
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Table 3.9 Comparison of antibiotic susceptibilities between B. cenocepacia 
J2315 and the J2315 Tp mutant
Name AK AZ TZ Cl CL IP MP PP TM TS TMO
J2315 >256(r) 96 (r) 8(3) 3 (I) 12 (s)
>32
(r) 1 (s)
>256
(r)
128
(r)
>32
(r) 48
Tp
1100 -
>256
(r)
12
(s)
>32
(r)
>256
(0
>32
(r) 24 (r)
>256
(r)
128
(r)
>32
(r) 32
J2315 Tp1100
75 KDa
 ►
50 KDa
 ►
25 KDa
 ►
Figure 3.7 Whole cell protein extraction of J2315 and the resistant mutant 
Tp1100
First lane -  J2315 control protein extract
1 = Tp1100 grown in TSB
2 = Tp1100 grown in TSB and Tp 100
3 = Tp1100 grown on Tp 100 agar
4 = Tp1100 grown on TSA
Tp1100 mutant was grown in trimethoprim to select for mutations. Approximately 20 pg of protein 
was loaded onto the gel.
LJ.
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3.26 Biofilm production
Bacteria within biofilms are less susceptible to killing by antimicrobial agents than 
those grown planktonically (Stickler, 1999). To determine if there was a correlation 
between biofilm formation and biocide resistance in a planktonic state, 11 Bcc 
strains were screened for their ability to form biofilms. Six strains were selected 
with low susceptibilities to chlorhexidine (>80 pg/ml) and five with high susceptibility 
(< 30 pg/ml). No correlation between innate ability to form biofilms and 
chlorhexidine resistance was observed (Figure 3.9). The strain that produced the 
best biofilm was B. multivorans ATCC 17616 one of the most sensitive to 
chlorhexidine (MIC 1 0 - 2 0  pg/ml) (Figure 3.9). In contrast, the highly transmissible 
epidemic strains, associated with clinical infections, with a high chlorhexidine MIC 
(> 100 pg/ml) were poor biofilm producers in the assay used (Figure 3.9).
3.3 Discussion
3.31 MIC broth dilution screen
The minimum inhibitory screen used in this investigation was an adapted broth 
dilution method to examine biocide susceptibility. This method was modelled 
closely on previous reported methods including the British Standard, BS EN 
13721:2003 (13727, 2003). This method used Muller Hinton broth as the medium. 
However previous experiments with this media have found that the Bcc grow 
poorly, so it was decided not to use this for our MIC screens. Iso-sensitest medium 
was also evaluated, but a starch precipitate was often produced that could interfere 
with optical density readings. Thus it was decided to use TSB as the medium for 
this screen as the Bcc can grow well and consistently in this medium.
An 80% reduction in OD from the control with no biocide was designated as the 
MIC value. This value was chosen for a number of reasons. The addition of 
chlorhexidine and CPC alters the optical density in a variable manner depending on 
the concentration of the biocide. This meant that a direct comparison to the control 
culture with no biocide could not be made. Therefore an optical density cut-off that 
was above the baseline noise produced by the biocides needed to be adopted.
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Furthermore, the variability of the Bcc growth made it difficult to determine an exact 
endpoint. For example, the internal control strain LMG 13010 was chosen as it 
represented a good biocide inhibition effect. The MIC was determined at 30 -  40 
pg/ml using the 80% endpoint (Figure 3.12). However above this biocide 
concentration the optical density remained higher than the media blank which was 
used to subtract all reading in the plate reader. This variation made it difficult to 
determine an exact MIC value. When viable counts were performed (data not 
shown), no viable bacteria were isolated after 30 pg/ml, which correlates well with 
the MIC determined by the 80% endpoint, therefore this endpoint was used to 
designate an MIC range for all strains screened.
3.32 Biocide resistance and the Bcc
Biocides are used to sterilise a range of surfaces and have an integral role in 
infection control procedures. Disinfection procedures have greatly aided the 
reduction of nosocomial infections, however the over use of biocides have raised 
concerns that bacteria will adapt and become resistant to multiple antinfectives 
including widely used biocides (McDonnell and Russell, 1999). This concern 
extends to bacteria that infect cystic fibrosis patients, as it is known that many of 
these bacteria, such as P. aeruginosa and members of the Bcc are innately 
resistant to many antimicrobials (Govan and Deretic, 1996). Biocides have been 
used for many years in clinical situations for hand washes, surgical scrubs, 
antiseptic creams and surface disinfection, however in recent years there has been 
an increasing demand for the inclusion of biocides in everyday domestic products to 
satisfy consumers fears of bacterial contamination (Bloomfield, 2002). Many 
biocides are incorporated into daily life, such as surface decontamination of food 
preparation areas, for cleaning toilets, sinks and drains and for general cleanliness 
of the home (Bloomfield, 1978). Some biocides have now been incorporated into 
household products, for example the inclusion of biocides such as triclosan in 
chopping boards, knife handles, paint and socks (Gilbert and McBain, 2001). There 
is concern that the publics over zealous use of biocides may lead to residues of 
biocides in the environment, which in turn may select for resistant organisms 
(Fraise, 2002).
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Table 3.10 Neutraliser efficiency tests for Hibiscrub™ and Cuticura™
Condition Viable counts cfu/m l ( ± SD)
Control* 1.03x10® (0.7)
Hibiscrub™* 8 x 107 (1.0)
Cuticura™* 1.5 x 10® (0.9)
Neutraliser control* 1.2 x 10® (1.5)
* = control -  biocide and neutraliser replaced with water
# = neutralised biocide test suspensions
+ = neutraliser control -  bacterial suspension inoculated in neutraliser
Table 3.11 Log Reduction in viable cell count for B. cepacia LMG 18821 and B. 
cenocepacia J2315 after exposure to Hibiscrub™ and Cuticura™
Log Reduction B. cepacia LMG 
18821
Log Reduction B cenocepacia 
J2315
Time (min) Cuticura™ Hibiscrub™ Cuticura™ Hibiscrub™
0 * * ♦ ★
5 0.5 1 1.2
10 0.9 1.7 1.2
20 1 4.7- 1.1
60 1.1 ~ 4.7- 1
* - No inhibition 
-  - No growth
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Figure 3.8 Log Reduction of B. cepacia LMG 18821 cells in Cuticura
Cuticura™ a triclosan based hand gel, caused a one log reduction in viable B. cepacia LMG 18821 
cells after 20 minutes of exposure. After one hour viable bacteria were still present and the criteria 
of a five log reduction was not fulfilled.
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Members of the Bcc are known to have resistance to multiple antibiotics. However 
an up to date survey of their biocide resistance, which is related to recent 
taxonomic changes has not been carried out. The aim of this study was to analyse 
the susceptibilities of the Bcc to a range of biocides. This analysis revealed that 
resistance levels varied widely within and between species to chlorhexidine, 
cetylpyridinium chloride, triclosan and benzalkonium chloride. Species dependent 
differences were only observed for CPC where B. cenocepacia, B. cepacia, B. lata, 
B. contaminans and Bcc novel group K were significantly more resistant (P<0.05, 
Table 3.1) than other Bcc species. This is interesting as B. cenocepacia strains are 
often associated with serious clinical infections that are often transmissible and are 
the most prevalent infections in CF patients (Reik et a/., 2005).
In chlorhexidine, B. cepacia, B. cenocepacia and B. vietnamensis species had 
elevated MICs compared to other species. This is not surprising for B. cepacia and 
B. cenocepacia strains as these are relatively common pathogens in both CF and 
non-CF patients (Mahenthiralingam et a/., 2008). However, B. vietnamensis is a 
less common Bcc member found to infect CF patients and is more commonly 
encountered in the environment. B. vietnamensis can colonise the rhizosphere of 
plants and has the potential for use in bioremediation (O'Sullivan et a i, 2007). 
Nevertheless, B. vietnamensis can infect CF patients, albeit with a lower frequency 
than B, cenocepacia and B. multivorans strains. For example from a survey of 606 
US patients, 50% were infected with B. cenocepacia, 38% with B. multivorans and 
5% with B. vietnamensis (Parke and Gurian-Sherman, 2001). There has been 
much debate about whether clinical strains are more resistant than environmental 
strains, with some studies indicating that clinical isolates are more antibiotic 
resistant than environmental isolates (Butler et ai, 1995, Wigley and Burton, 1999). 
However these studies were performed before Bcc species epidemiology was 
characterised and other more recent studies indicate that environment and clinical 
isolates may be similar. For example Bevivino et a i found that some of the 
candidates for transmissibility and virulence were also present in environmental 
isolates (Bevivino et ai, 2002). Baldwin et ai found that > 20% of 381 clinical 
isolates were indistinguishable from environmental isolates via MLST (Baldwin et 
ai, 2007). Another investigation found a B. cenocepacia isolate in agricultural soil 
identical to that found in CF clinics, signifying that there may be a risk to CF
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patients from environmental sources (LiPuma et al., 2002). In this study clinical 
isolates, including CF and non CF isolates were significantly less susceptible 
(P<0.05, Mann-Whitney)) to chlorhexidine than environmental strains (clinical mean 
= 485 -  58.6 pg/ml compared to environmental mean = 31.4 -  40 pg/ml). In 
contrast no differences were found in CPC susceptibilities (P>0.05, Mann-Whitney) 
between environmental and clinical isolates (clinical mean = 130.3 -  143.4 pg/ml 
compared to environmental strains 145 -  160.6 pg/ml). Thus this indicates that the 
environment could be a reservoir for infection. Hence, there needs to be careful 
consideration of the risks before Bcc species can be used as bioremediation. This 
may be an example of residuals of biocides in the environment leading to 
mutational resistance. Recently, new species of the Bcc have been classified 
(Vanlaere et al., 2008). In particular, B. lata and B. contaminans, as well as a novel 
Bcc group K strains have been associated with the contamination of various 
commercial products. Therefore, it is interesting to note that these strains have 
higher MIC values to CPC than other Bcc bacteria (approx 200 pg/ml, Table 3.1).
Maintaining product sterility is a problem faced by manufacturing industries on a 
daily basis. A recent survey of the pharmaceutical industry has shown that B. 
cepacia are one of the leading causes of product recalls (Jimenez, 2007). Jimenez 
et al. analysed FDA recall data and found that B. cepacia was the most frequently 
isolated contaminant in both non sterile and sterile products (22% and 2.5% 
respectively). These included mouth washes, antiseptic creams, body sprays, 
shampoo, hand disinfection detergents and soaps and ophthalmic solutions 
(Jimenez, 2007). The MBC data obtained in this study indicates that some Bcc 
bacteria may need more than 25 times more biocide than the MIC value to achieve 
killing. The concentration of the biocide is an important factor in it’s efficacy against 
bacteria and varies for different applications. For example chlorhexidine is used for 
surface disinfection at 0.5 -  4% (w/v), for antisepsis at 0.02 -  4% (w/v) and for 
preservation at 0.0025% - 0.01% (w/v) (Maillard, 2005). At the lowest 
concentrations this is not sufficient to kill some of the more resistant strains. B. 
cenocepacia strains, LMG 18832 and Mu1, both CF infection isolates, required 
more than 1000 pg/ml before a bactericidal effect was seen.
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Figure 3.9 Biofilm production by selected Bcc strains
Six strains with high (black bars) and low (open bars) chlorhexidine were tested for biofilm formation. 
The biofilm biomass readout is shown on the vertical axis. Strains are as follows: 1 - 8 .  cepacia 
LMG 18821, 2- 8. multivorans LMG 16660, 3 -  8. cenocepacia LMG 18832, 4 -  8. cenocepacia 
J2315, 5 - 8 .  cenocepacia C4455, 6 - 8 .  cepacia novel group K, 24, 7 -  8. multivorans LMG 13010, 
8 - 8 .  multivorans ATCC 17616, 9 -  B. dolosa LMG 18943, 10 8. ambifaria AM M D, 1 1 - 8 .  
vietnamensis G4.
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The data from this investigation suggests that MIC data can be misleading and 
irrelevant in real life situations where the in use concentrations of biocides are often 
much higher compared to MIC levels (Maillard, 2007). Nonetheless, it is useful to 
investigate MIC values as it may indicate a trend towards emerging resistance 
(Maillard, 2007). Formulations such as preservatives are used to prevent a 
product from spoiling, so contain lower concentrations of biocides, as they do not 
need to be bactericidal. At this level MIC data can be valuable, as at lower 
concentration bacterial contamination is likely to be more frequent (Russell, 2004).
3.33 Contamination of commercial biocides by the Bcc
Considering that in use concentrations of biocides are often quite high, it would be 
expected that the incidences of bacterial contamination would be fairly low. 
Nevertheless, there have been many recorded instances of contamination of 
antimicrobial formulations, many of which resulted in outbreaks in patients. 
Chlorhexidine has been widely used in hospitals as a major disinfectant, however 
dilute solutions appear to be particularly prone to contamination. Sobel et al (Sobel 
et al., 1982) carried out a retrospective study due to the increase in B. cepacia 
isolates recovered from patients in the hospital. Most of these isolates were from 
urinary origin, especially catheterised patients, although the outbreak was 
widespread in the hospital with B. cepacia being recovered from wound, vaginal 
and oral samples. The outbreak was traced to a mouthwash solution that contained 
0.2% (v/v) chlorhexidine as well as a 0.05% (v/v), and a 0.1% (v/v) chlorhexidine 
solutions used for swabbing the perineum and genitalia before catheters were 
inserted. The chlorhexidine was provided at a 5% (w/v) solution and diluted with 
non sterile water and it was determined that the chlorhexidine was contaminated 
during the dilution process (Sobel et al., 1982). This corroborates data from our 
study, where in lower concentrations of chlorhexidine many strains of the Bcc could 
easily survive (B. cenocepacia LMG 18832, Chlorhexidine MBC > 1000 pg/ml, 
Table 3.5).
Incidences of bacteraemia linked to the contamination of biocide solutions include 
bloodstream infections caused by the use of contaminated water to dilute alcohol
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skin antisepsis solutions (Nasser et al., 2004), contamination of a 0.5% (v/v) 
chlorhexidine solution used for skin cleansing (Garcia-Erce et al., 2002), 
contamination of 0.02% (v/v) benzalkonium chloride and 0.02% (v/v) and 0.05% 
(v/V) of chlorhexidine gluconate (Oie and Kamiya, 1996). Both Berkelman et al. 
(Berkelman et al., 1981) and Panlilio et al. (Panlilio et al., 1992) reported an 
outbreak of Burkholderia cepacia in their hospitals due to contamination of a 10% 
(v/v) povidone-iodine solution that was used to disinfect the skin before veno 
puncture. Similarly 37 out of 38 strains screened in this investigation were able to 
survive in 5% (v/v) povidone. These studies indicate that biocides can harbour 
resistant organisms and may be a source of infection themselves. Worryingly, 
there are increasing reports of products not necessarily just used in clinical settings 
that are becoming contaminated with problematic pathogens. Kutty et al. (Kutty et 
al., 2007) reported a multi-state outbreak of B. cepacia which was associated with a 
contaminated alcohol free mouthwash. This mouthwash contained an unknown 
amount of CPC and was contaminated during the manufacturing process. The 
outbreak involved 22 hospitals across nine states and two patients died as a direct 
result of the outbreak (Kutty et al., 2007). Similarly, moisturizing body milk used in 
hospitals was found to be contaminated with B. cepacia causing infection in an 
intensive care unit (Alvarez-Lerma et al., 2008). These are obviously serious 
issues that need to be addressed as contamination of these products are causing 
infection in already vulnerable people. There is also concern that contaminated 
products, such as moisturisers and cosmetics that contain preservatives and low 
levels of disinfectants may cause infections in people such as CF sufferers if they 
use them in their homes.
Data obtained in this study supports the observation that Bcc bacteria are adept at 
contaminating commercial products. Two biocides were tested to see if strains with 
high MIC values to chlorhexidine could survive. The two biocides were Hibiscrub™, 
a chlorhexidine based disinfectant and Cuticura™, a triclosan based hand gel. 
Both are used for skin antisepsis. Five strains were tested including a sensitive B. 
multivorans strain as a control. It was observed that two strains, B. cepacia LMG 
18821 and B. cenocepacia J2315 were capable of surviving at these in use 
concentrations. Although B. cepacia, LMG 18821 was killed by Hibiscrub™, only a 
one log reduction was seen after an hour of exposure to Cuticura™. B.
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cenocepacia J2315 was equally capable of surviving in Hibiscrub™ after an hour of 
exposure, although was killed after 20 minutes exposure to the triclosan based 
hand gel (Table 3.11). The lack of rapid killing may still be problematic as in day to 
day situations hand gels may not be left on the skin for this length of time. This 
data also indicates that more than one mechanism of resistance is employed as 
survival in one disinfectant does not necessarily confer survival in a different 
disinfectant. These results are concerning as 8. cenocepacia and 8. cepacia 
strains are prevalent in clinical infections and 8. cenocepacia J2315 is 
representative of a transmissible strain, that appears to be able to survive in high 
concentrations of chlorhexidine (Hibiscrub™ 4% v/v). Hibiscrub™ may not be used 
at the concentration provided as it is often diluted to use as a pre operative body 
wash or scrub, thus lending itself to further contamination by strains that may be 
inhibited at the higher concentration. Although this data leans towards the 
conclusion that problematic, epidemic Bcc strains are capable of contaminating 
commercial biocide formulations, it is worth noting that the 8. multivorans Glasgow 
outbreak strain, LMG 16660 was killed after five minutes exposure to both biocides.
3.34 Antibiotic susceptibility of the Bcc
As well as characterising the susceptibility of the Bcc to biocides, 60 strains were 
also screened for resistance to ten antibiotics commonly used to treat CF infections 
(Table 3.6). Generally the antibiotic resistance varied widely within and between 
species, however when an antibiotic profile score was calculated for each species 
8. cepacia, 8. multivorans, 8. cenocepacia, 8. stabilis and 8. dolosa were 
significantly more resistant (Table 3.6). In contrast Nzula et al. (Nzula et a i, 2000) 
found that there were no significant trends in antimicrobial resistance to strains in 
six of the Bcc species, although this study was carried out eight years ago, when 
the Bcc taxonomy was not completely defined. However, with recent changes in 
the taxonomic status of the Bcc and the larger collection of isolates examined in this 
study, it is perhaps not surprising to find some significant differences.
8. cenocepacia strains possessed high levels of resistance to both biocides and 
antibiotics and interestingly are one of the most common cause of infections in CF
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patients (Mahenthiralingam eta!., 2005), although recently B. multivorans infections 
have become more frequent in the UK (Govan et al., 2007). B. cenocepacia strains 
had high resistance to the trimethoprim / sulfamethoxazole combination, possibly 
due to fact that B. cenocepacia strains are intrinsically resistant to this combination 
by the production of different dihydrofolate reductase inhibitors (Rajyaguru and 
Muszynski, 1997). Almost all strains tested were resistant to azithromycin, a 
macrolide antibiotic. This is concerning as macrolides are increasingly being used 
as a long term treatment in cystic fibrosis patients. Saimen et al. carried out a 
randomized placebo controlled trial in CF patients and found a 6.2% improvement 
in lung function when using azithromycin and that it may also reduce the frequency 
of pulmonary exacerbations (Saiman et al., 2005). Thus it is worrying that the use 
of an antibiotic as an anti inflammatory drug may be selecting for resistant species 
such as the Bcc.
Most strains were more susceptible to p lactam antibiotics, such as meropenem, 
imipenem and piperacillin, however it was these antibiotics that produced the most 
spontaneous resistant colonies. Spontaneous resistant colonies are colonies that 
appear within the zone of inhibition after 48 hours of growth (Figure 3.4). These 
colonies indicate that in the presence of the antibiotic the strain may adapt or 
mutate to become resistant to this substance and thus are able to grow (See 
chapter 1 for more details on bacterial resistance mechanisms). This may involve 
the induction of enzymes such as p-lactamases or the up-regulation of efflux 
pumps. The species that produced the most spontaneous resistant mutants to the 
three p lactam antibiotics were B. multivorans (41%) and B. cenocepacia (33%) 
strains. This is particularly worrying as these strains are most commonly 
associated with clinical infections that are most problematic for CF patients 
(Mahenthiralingam et al., 1996b). The appearance of these apparently resistant 
colonies indicates that even antibiotics that are fairly effective against the Bcc 
complex, can become less potent if the species are exposed to it for a period of 
time. In this case, resistance was observed after only 48 hours of exposure.
The ability of bacteria to be able to adapt to their environment and survive antibiotic 
treatment, is a cause for concern as many patients may not complete their antibiotic 
regime and the inappropriate use of antibiotics has led to drug resistance. For
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example, clinicians often prescribe antibiotics unnecessarily. Data from surveys 
have indicated that treatment with antibiotics is needed 20% of the time, yet are 
often prescribed in 80% of cases (Madigan et al., 2001a). In this study resistance 
to the antibiotic trimethoprim was trained in B. cenocepacia J2315 by successive 
passages onto increasing concentrations of the antibiotic. Resistance was trained 
up to 1100 pg/ml, indicating that in the presence of the antibiotic resistance can be 
induced and that prolonged therapy with a single antibiotic can have serious 
consequences with respect to resistance. This mutant was also resistant to nine 
out of ten antibiotics screened, compared to six in the wildtype, indicating that the 
mutation has a broad spectrum that is not just specific for the dihydrofolate 
reductase, indicating that several changes have occurred.
Consequently this is indicative that the outer membrane may play a role. This is 
supported by a previous study by Rajyaguru et al (Rajyaguru and Muszynski, 
1997). They isolated chloramphenicol and trimethoprim / sulfamethoxazole 
mutants of B. cepacia strains ATCC1394, Per, CAS and D4 by stepwise exposure. 
Resistance to trimethoprim / sulfamethoxazole was attributed to the absence of a 
major outer membrane protein (39 -  47 kDa) and changes to the LPS profile. 
Additional outer membrane proteins were also seen in the mutants. It was 
suggested that the missing outer membrane protein may directly be involved in the 
passage or uptake of these antibacterials (Rajyaguru and Muszynski, 1997). Thus, 
this indicated that a similar mechanism may be occurring in the J2315 trimethoprim 
mutants, especially as resistance to other antibiotics are also seen in the mutant 
(Table 3.9). Whole cell protein extraction and outer membrane protein extraction 
was carried out (Chapter 2, section 2.8) and visualised by SDS-PAGE. However, 
no differences could be clearly observed (Figure 3.7), signifying that changes to the 
outer membrane may not be involved in adaptive resistance, or that the method of 
extracting the protein was not sufficient to visualise changes.
Many of the antibiotics are not effective against the Bcc, epidemic strains being 
particularly problematic with resistance to some of the extended spectrum p 
lactams being observed, for example J2315 resistance to piperacillin (MIC >256 
pg/ml). This poses a problem when trying to treat CF patients with these infections. 
Recently, the antibiotic temocillin, a semi synthetic derivative of the p lactam
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ticarcillin has been suggested as an alternative treatment for patients infected with 
the Bcc. Temocillin fails to induce (3 lactamase production so is generally more 
active than other p lactams. Retrospective studies of the use of treatment with 
temocillin have produced positive results, with one centre reporting a 56.25% 
improvement in patients infected with Bcc (Lekkas et al., 2006). Kent et al. found 
that temocillin given in conjuncture with an aminoglycoside had equivalent activity 
for the Bcc when compared to standard combination therapy for an acute 
exacerbation (Kent et al., 2008). A small representative panel of Bcc strains were 
screened for susceptibility to temocillin in this study. The E-test® strips for 
temocillin have no break points for resistance as of yet, however all of the strains 
screened apart from B. cenocepacia J2315 had low MIC values (Table 3.8) ranging 
from 0.38 -  16 pg/ml. J2315 had a three times greater MIC (48 pg/ml), than the 
previous highest MIC. Interestingly, temocillin was the only antibiotic to show a 
decrease in the MIC value for the trimethoprim mutant (Table 3.9), although it still 
has a higher MIC to temocillin than any other strain tested. Consequently, 
temocillin appears to be more active against the Bcc and may be an appropriate 
alternative when treating patients.
3.35 Biocide and antibiotic resistance
To explain the controversy of cross resistance between antibiotics and biocides we 
correlated MIC’s for both. There were no obvious relationships between biocide or 
antibiotic resistances, although many of the strains tested were less susceptible to 
two or more agents. Certain epidemic strains, such as the ET-12 strains possessed 
among the highest levels of resistance to both classes of antimicrobial agents. For 
example, B. cenocepacia J2315 had high MIC’s to chlorhexidine, CPC, triclosan, 
benzalkonium chloride, povidone and was classed as resistant to six out of ten 
antibiotics. The B. multivorans Glasgow epidemic strain (Whiteford et al., 1995) 
had chlorhexidine MIC values nearly double that of other B. multivorans strains and 
also was significantly more resistant to seven out of ten antibiotics (Table 3.7). This 
indicates that there may be cross resistance in the Bcc.
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Previous investigations have found similar results in other pathogen species. One 
such study found that resistance to ciprofloxacin, imipenem, cefotaxime, 
ceftazidime, gentamicin and aztreonam indicated increased chlorhexidine 
resistance in some Gram negative species, such as E. coli and P. aeruginosa 
(Koljalg et aL, 2002). Akimitsu et al. reported that methicillin resistant 
Staphylococcus aureus mutants resistant to benzalkonium chloride also exhibited 
increased resistance to some p lactam antibiotics (Akimitsu et al., 1999). This was 
corroborated by another study which suggests that methicillin resistant S. aureus 
are also resistant to chlorhexidine and QACs such as CPC and benzalkonium 
chloride compared to methicillin sensitive S. aureus (Suller and Russell, 1999). 
These investigations indicate that there may be some overlapping mechanisms of 
resistance, such as permeability and efflux. There should be concerns over 
residues of biocides, causing a gradient to form, leading to the selection of bacteria 
that have low levels of susceptibility to disinfectants and antibiotics (White and 
McDermott, 2001).
Given the well known phenotypic diversity of the Bcc, it was not surprising that in 
this study there was also contradictory evidence of cross resistance. One epidemic 
strain, B. dolosa LMG 18943, (Kalish et al., 2006) possessed low chlorhexidine and 
CPC MIC’s but were resistant to all ten antibiotics tested. There was also a lack of 
correlation between planktonic biocide resistance and the ability to form biofilms 
(Figure 3.9). Although the ability to form a biofilm is a well know resistance 
mechanism and despite the advantages it confers in terms of survival under 
antimicrobial stress (Parsek and Fuqua, 2004), not all Bcc have adapted this 
phenotype, but instead have other enhanced resistance mechanisms. However, 
two of the strains tested, both B. cenocepacia strains (K56-2 and C4455) have the 
potential to be particularly problematic as they both have the ability to form good 
biofilms and have high intrinsic resistance to biocides.
3.36 European guidelines strain recommendation
The efficacy of disinfectant products and procedures may be tested according to 
Standard European guidelines. A set of reference strains are recommended for
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inclusion in these tests, including E. coli, P. aeruginosa, S. aureus and 
Enterococcus hirae (Marchetti et al., 2003). Considering the potential of 
contamination by the Bcc complex of disinfectants and preservatives, only one 
strain, B. cepacia type strain ATCC 25416 is included in the reference strain panel 
(Lambert, 2004). Although this strain has the maximum CPC MIC (> 200 pg/ml), its 
chlorhexidine MIC was relativity low (20 -  30 pg/ml) and was not among the most 
resistant encountered. Given the major role that Bcc organisms may play in 
contamination of disinfectant products (Jimenez, 2007), future testing should 
include representative strains of the Bcc. Three well defined strains stand out as 
being resistant to multiple biocides (Table 3.5): (i) B. cenocepacia LMG 18832 
(ATCC 17765), a urinary tract infection isolate, (ii) B. cenocepacia J2315 (LMG 
16656), an epidemic CF isolate, and (iii) B. multivorans LMG 16660 (C1576) a CF 
isolate from the Glasgow outbreak. All the latter strains were included in a historical 
reference panel of Bcc strains (Mahenthiralingam et al., 2000b) and are available 
form recognised strain collections.
3.4 Conclusions
In summary, characterisation of the antimicrobial susceptibility of an up to date 
survey of the Bcc, focusing on resistance of two biocides, the cationic bisbiguanide 
chlorhexidine and the quaternary ammonium compound cetylpyridinium chloride, 
revealed that many of the Bcc strains possessed high resistance to biocides and 
commercial formulations of these agents. Some of the clinical epidemic strains that 
have been involved in outbreaks in numerous hospitals are in particular resistant to 
multiple biocides and antibiotics, which may be problematic for vulnerable patients, 
particularly CF sufferers. From this investigation it appears that QAC’s such as 
CPC, triclosan and povidone are ineffective against Bcc bacteria and therefore their 
use should be restricted in situations where these bacteria may be encountered.
There was inconclusive evidence that the over use of biocides leads to cross over 
with antibiotic resistance, but there appears to be the potential for this to occur so 
caution should be exercised when using disinfectants in the home and in clinical 
situations. The ability of the Bcc bacteria to adapt to harsh environments, including
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exposure to antinfectives, means that stricter guidelines should be implemented for 
cleaning and sterilisation in hospitals, particularly those that deal specifically with 
CF and particularly vulnerable patients such as intensive care units. In addition, the 
three Bcc strains recommended in this study should be included as reference 
strains in standard testing methods, in the hope that this will reduce incidences of 
contamination and lead to the production of new antinfectives capable of killing 
these bacteria.
In addition, contrary to belief, we found that biofilm formation is not linked to intrinsic 
antibiotic and biocide resistance, therein other resistance mechanisms, such as 
decreased permeability and efflux are more important for intrinsic resistance than 
biofilm production.
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4.0 Characterising the antimicrobial susceptibility in 
Pseudomonas aeruginosa
4.1 Introduction
4.11 Antimicrobial resistance
Pseudomonas aeruginosa is the most common infection found in CF sufferers, with 
up to 80% of patients becoming infected chronically by the time they reach 
adulthood (Currie et al., 2003). Thus, P. aeruginosa is a problematic pathogen that 
causes significant problems in both the management and treatment of CF patients. 
Like the Bcc P. aeruginosa strains are difficult to treat and eradication is almost 
impossible due to its innate resistance to multiple drugs, such as P-lactams, older 
quinolones, chloramphenicol, tetracycline, macrolides, trimethoprim / 
sulfamethoxazole and rifampicin (Rossolini and Mantengoli, 2005). This leaves 
very few treatment options and possibly the use of more potent drugs that could 
have serious side effects (Tummler and Kiewitz, 1999). The most important anti 
pseudomonal treatments are p-lactams (ticarcillin, piperacillin, cefoperazone, 
ceftazidime, cefepime, aztreonam, imipenem and meropenem), aminoglycosides 
(gentamicin, tobramycin and amikacin) and fluoroquinolones (ciprofloxacin). 
Polymyxins and colistin are also active but are reserved for multidrug resistant 
strains due to increased toxicity (Rossolini and Mantengoli, 2005).
Intrinsic antimicrobial resistance is mediated by a number of well known 
mechanisms. P. aeruginosa strains possess an AmpC chromosomally inherited p 
lactamase that confers resistance to ampicillin and most cephems. This enzyme is 
inducible by the presence of the antibiotics it degrades (Rossolini and Mantengoli, 
2005). A general decrease in permeability due to the outer membrane also 
increases antibiotic resistance and the interplay between this low permeability and 
broadly specific drug efflux pumps leads to the emergence of multiple drug resistant 
strains (Li et al., 2000). One such efflux pump is the well characterised MexA- 
MexB-OprM pump, which can export a number of unrelated compounds such as 
antibiotics, biocides, dyes and detergents (Poole et al., 1993). P. aeruginosa can 
also acquire resistance through the acquisition of multi drug plasmids, such as the
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transferable R plasmid, which carries genes for the detoxification of many 
antibiotics (Tummler and Kiewitz, 1999). Resistance to aminoglycosides, which are 
often used in combination with p lactams as the primary treatment for P. aeruginosa 
infections have also become more common with the advent of modifying enzymes. 
There are many enzymes which modify the structure of aminoglycosides which 
cause the inactivation of that antibiotic. These modifications include 
phosphorylation (aminoglycoside phosphoryltransferase [APH]), acetylation 
(aminoglycoside acetyltransferase [AAC]) or adenylation (aminoglycoside 
nucleotidyltransferase [ANT]). Often P. aeruginosa strains will carry multiple 
modifying enzymes that confer broad aminoglycoside resistance (Poole, 2005a). 
Thus, the acquisition of P. aeruginosa in a CF patient can be devastating for the 
patient and lead to increased hospital stays and the application of multiple 
antibiotics.
A strategy to eradicate early P. aeruginosa infection, before it becomes chronic 
may prevent the rapid decline of lung function. During early infection in the CF 
lungs P. aeruginosa demonstrates a non mucoid, smooth lipopolysaccharide and 
sensitivity to anti-pseudomonal antibiotics. Often chronic infections are established 
with the conversion to a mucoid, alginate producing phenotype that are almost 
impossible to eradicate and that lead to a poor prognosis for the patient (Govan and 
Deretic, 1996). Eradication therapy involves the use of nebulised antibiotics either 
alone or in combination with oral or intravenous anti-pseudomonal antibiotics 
(Jones, 2005). The Cystic Fibrosis Trust produced a booklet on infection control in 
CF patients and suggested the combination of nebulised colistin or tobramycin and 
oral ciprofloxacin, which produced eradication of P. aeruginosa in 80% of newly 
infected individuals (Littlewood, 2002). Therefore understanding the mechanism of 
resistance to antimicrobials is important so that new therapeutic treatments can be 
developed to reduce the emergence of resistant P. aeruginosa and to potentiate 
existing therapies.
4.12 Biocide susceptibility
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P. aeruginosa is a CF pathogen that like the Bcc is multidrug resistant and difficult 
to treat. Similarly, both are associated with contamination of disinfectant products 
that should contain high enough concentrations to be bactericidal. As the threat of 
bacterial infection is highlighted by the media, the use of disinfectants in the home 
environment is becoming more and more widespread. Coupled with the copious 
use of biocides in hospital surroundings, cases of bacterial contamination of these 
products and resistance to them are becoming more and more common.
Triclosan is an example of a biocide where bacterial resistance has developed. It is 
a broad spectrum antimicrobial that is used in products such as soaps and oral 
hygiene products (Gomez Escalada et al., 2005). One of its targets in bacteria is 
the Fabl, an enoyl acyl carrier protein reductase that is involved with fatty acid 
biosynthesis (McMurry et al., 1998b). It acts as a potent inhibitor by mimicking its 
substrate (Gomez Escalada et al., 2005). It is unusual for a biocide to have a 
specific target in the bacterial cell, although at higher concentrations it is thought 
that triclosan has a broader activity by causing membrane damage (Villalain et al.,
2001). This specific target may be a factor in resistance occurring and P. 
aeruginosa isolates are well known to be triclosan resistant, with the presence of 
multiple resistance nodulation division (RND) efflux pumps (Mima et al., 2007) and 
the low permeability of the P. aeruginosa outer membrane for hydrophobic 
compounds (Ellison etal., 2007).
This intrinsic resistance may cause issues in clinical settings as P. aeruginosa is an 
opportunistic pathogen, that as well as being a common infection in CF patients 
also infects many other vulnerable people. For example any patient that has a 
urinary catheter inserted is likely to become infected. Catheters are particularly 
problematic due to the formation of crystalline biofilms that encrust the catheter. P. 
aeruginosa is a common pathogen found to form these encrustations. In a study by 
Williams et al. the use of triclosan to prevent encrustation found that P. aeruginosa 
was not reduced and blockages could still form (Williams and Stickler, 2008). 
Stickler et al. (Stickler, 2002) also found that catheter associated bacteria were 
biocide resistant. The in use concentration was not effective at killing strains of 
Proteus mirabilis and P. aeruginosa and the chlorhexidine resistant strains were 
multidrug resistant. It was determined that chlorhexidine was not an effective agent
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to use in catheter care and that alternatives should be sort (Stickler, 2002). Once 
P. aeruginosa infection is acquired it is often impossible to eradicate and has a 
serious, detrimental impact on the patient’s outcome. Adequate and efficient 
hygiene regimes to prevent the acquisition of infections from the hospital 
environment is particularly important for multi-drug resistant organisms and 
increasing reports of contamination of disinfectant and cosmetic products should be 
addressed to reduce this problem.
The objectives of this chapter were to characterise the susceptibility of a panel of P. 
aeruginosa strains obtained from a range of sources to a number of commonly 
used biocides. Biocide susceptibility was then correlated to their antibiotic 
susceptibilities and recommendations made for disinfection procedures.
4.2 Results
4.21 Chlorhexidine and cetylpyridinium chloride susceptibility
As previously described (section 2.24) a panel of 61 P. aeruginosa strains were 
screened for chlorhexidine and CPC susceptibility (Table 4.1). The panel included 
the following: (i) environmental strains (ii) catheter strains (iii) clinical CF strains (iv) 
Liverpool epidemic strains and (v) other epidemic strains. This gave a broad 
diversity of strains from various sources to give a rounded overview of the 
susceptibility of P. aeruginosa strains. In chlorhexidine, susceptibility was much 
higher, with most strains inhibited at approximately 25 pg/ml. There were no 
significant differences between epidemic, catheter, clinical CF and environmental 
strain groups. However, Liverpool epidemic strains were approximately four times 
less susceptible to chlorhexidine than other strains (Table 4.1) with an approximate 
MIC of 80 pg/ml compared to 25 pg/ml. This was also significantly higher than 
other epidemic strains which included the Manchester epidemic strain and 
Melbourne epidemic strain. There were no significant differences between 
environmental isolates and clinical isolates, with all having comparable MIC values 
to chlorhexidine. In the quaternary ammonium compound, CPC all strains tested 
were capable of growth, with an MIC of > 200 pg/ml, the maximum tested, and 
indicated intrinsic resistance.
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4.22 Susceptibility to other biocides
Twenty four strains from the original panel of 61 were selected for further biocide 
analysis. These strains were representative of chlorhexidine sensitive strains (18) 
and resistant strains (6). MICs were determined for three biocides in conjunction 
with chlorhexidine and CPC. These were triclosan, benzalkonium chloride and 
povidone (Table 4.2). All P. aeruginosa strains screened were resistant at the 
highest level of triclosan (MIC >500 pg/ml) and povidone (>5%) (Table 4.2). 
Benzalkonium chloride susceptibility was more variable, with MIC’s ranging from 
200 pg/ml to 400 pg/ml. The Liverpool epidemic strain LES B40 exhibited low 
levels of susceptibility to chlorhexidine (70 -  80 pg/ml), CPC (200 pg/ml), triclosan 
(>500 pg/ml), povidone (>5%) and benzalkonium chloride (>400 pg/ml), indicating a 
multiple biocide resistant phenotype for this problematic strain.
4.23 Minimum bactericidal concentrations
The panel of 24 strains described above were also screened for biocide bactericidal 
efficacy as described previously (Chapter 2.26). For CPC the MBC’s were 
approximately 15 times higher than the MIC value with all five groups having similar 
MBC’s, with no significant differences seen between them (Table 4.3). 
Chlorhexidine MBC’s were similar to the MIC values with a 1.5 fold change between 
the values. Some strain group differences were seen, with Liverpool epidemic 
strains being significantly less susceptible than other epidemic strains (85 pg/ml 
and 50 pg/ml respectively) or other clinical strains (Table 4.3, Mann Whitney 
P<0.05).
4.24 Antibiotic susceptibilities
The antibiotic susceptibilities of 33 strains from the panel of 61 were tested and 
mean values calculated. In general there were high incidences of resistance to 
azithromycin and chloramphenicol and low levels of resistance to the p-lactams, 
such as meropenem. When the susceptibility of individual antibiotics is examined, 
clinically defined resistance varies across and within the strain groups. As 
described for the Bcc complex, an antibiotic profile score was determined that 
encompasses all ten antibiotics and was analysed statistically (Table 4.4). Unlike
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Table 4.1 Mean P. aeruginosa MIC values in ch lorhexid ine
Strains (61)
Mean min 
Chlorhexid ine 
(Mg/ml)
Mean max 
C hlorhexid ine 
(Mg/ml)
Liverpool epidemic (15) 80* 83.3*
CF Epidemic strains (8) 12.9 22.9
Catheter strains (8) 18.3 28.3
Clinical CF Strains (26) 14.4 24.4
Environmental strains (4) 12.5 22.5
Total Mean 27.6 36.3
* Denotes the species that are significantly different as determined by Kruskall Wallis and Mann 
Whitney Tests (P<0.05)
Table 4.2 Mean MIC values fo r benzalkonium  ch loride
Strains (24) Mean Benzalkonium  
ch loride MIC (pg/m l)
Liverpool epidemic (7) 271.4
CF Epidemic strains (5) 300
Catheter strains (3) 333.3
Clinical CF Strains (7) 328.6
Environmental strains (2) 200
Total mean 286.7
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the Bcc, the antibiotic profile scores were similar for each group. However, 
Liverpool epidemic strains were significantly less susceptible to the antibiotics than 
both the clinical and environmental strains (39.16 pg/ml compared to 37.69 pg/ml 
and 34.1 pg/ml respectively). The antibiotic MIC values also demonstrated no 
significant differences between clinical and environmental strains.
The production of spontaneous resistant colonies within the zone of inhibition was 
also observed for several P. aeruginosa strains. The Liverpool epidemic strains 
produced the most resistant colonies to all antibiotics tested, 49% compared to 24% 
of clinical strains, 15% of epidemic strains, 6% of catheter strains and 6% of 
environmental strains (Figure 4.2). The (3 lactam antibiotics were among the most 
potent against the strains tested, but after 48 hours produced the most 
spontaneous resistant mutants out of all of the antibiotics (Figure 4.1) and again the 
Liverpool epidemic strains produced the largest proportion of spontaneous colonies 
to this class of antibiotic. The combination of trimethoprim / sulfamethoxazole and 
ciprofloxacin also produced numerous resistant mutants.
4.3 Discussion
4.31 Biocide susceptibility
P. aeruginosa infections in patients with CF are often chronic and are difficult to 
eradicate leading to increased morbidity and mortality (Tummler and Kiewitz, 1999). 
P. aeruginosa strains are notoriously difficult to treat due to their intrinsic resistance 
to many antimicrobials. This concern stretches to disinfectant solutions, where 
contamination of these products has been frequently observed. P. aeruginosa 
strains have been isolated from the surface of hospital soap dispensers, containing 
a 2% (v/v) chlorhexidine based hand soap. The P. aeruginosa strains isolated were 
also resistant to 14 antibiotics, raising concerns that the soap was not bactericidal 
and that it was selecting for multidrug resistant organisms (Brooks et al., 2002). 
Similarly, from urinary catheters in spinal cord patients, P. aeruginosa resistant to 
chlorhexidine and other cationic biocides were found. These strains cause
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Table 4.3 Biocide susceptibility and minimum bactericidal concentrations in P. aeruginosa strains
Chlorhexidine (* = s ig n if ic a n t  d if fe re n c e  
a s  d e te rm in e d  by M ann W h itn ey  (P<0.05)
CPC
Name Type (source) MIC(pg/ml)
MBC
(pg/ml)
Mean MBC 
(pg/ml)
MIC
(pg/ml)
MBC
(pg/ml)
Mean MBC 
(pg/ml)
CF Epidemic strains
Epidemic Manchester (CF) 2 0 -3 0 50
50
>200 3000
3400
Clone C epidemic (CF) 1 0 -2 0 50 >200 3000
Midland 1 epidemic (CF) 1 0 -2 0 50 >200 3000
Midland 1 epidemic (CF) 8 0 -9 0 50 >200 3000
Melbourne epidemic (CF) 2 0 -3 0 50 >200 5000
Liverpool Epidemic
Liverpool Epidemic (CF) 1 0 -2 0 50
85.7*
>200 5000
3428.5
Liverpool Epidemic (CF) 7 0 -8 0 100 >200 3000
Liverpool Epidemic (CF) 2 0 - 3 0 100 >200 4000
Liverpool Epidemic (CF) 2 0 - 3 0 50 >200 3000
Liverpool Epidemic (CF) 100 100 >200 4000
Liverpool Epidemic (HV +) (CF) 100 100 >200 4000
Liverpool Epidemic (HV -) (CF) 100 100 >200 1000
Catheter Strains
Catheter (clinical) 1 0 -2 0 50
50
>200 5000
4666.7Catheter (clinical) 2 0 -3 0 50 >200 4000
Catheter (clinical) 2 0 -3 0 50 >200 5000
Clinical Strains
Non - epidemic Manchester CF (CF) 1 0 -2 0 50
50
>200 5000
3857.1
Non - epidemic Manchester CF (CF) 1 0 -2 0 50 >200 5000
Random Unique (clinical) 1 0 -2 0 50 >200 5000
Random Unique (clinical) 1 0 -2 0 50 >200 5000
Random Unique (clinical) 2 0 - 3 0 50 >200 3000
Random Unique (clinical) 1 0 -2 0 50 >200 3000
Random Unique (clinical) 1 0 -2 0 50 >200 1000
Environmental strains
Random Unique (Env) 3 0 -4 0 50
75
>200 100
1050
Random Unique (Env) 8 0 -9 0 100 >200 2000
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particular problems in patients with catheters and can lead to blockages (Stickler et 
al., 1981). P. aeruginosa strains tolerant to chloroxylenol and triclosan have also 
been recovered from industrial sources (Lear et al., 2002). The ubiquitous nature of 
these bacteria in the environment indicates that the environment is a key reservoir 
of infection and leads to infection control issues (Balfour and Elborn, 2007). There 
is considerable debate about the use of biocide rotation in hospitals to combat the 
problem of resistance. Currently there is little evidence to support biocide rotation 
and the need for hygiene and cleanliness should be emphasised. However, as 
some bacteria, such as P. aeruginosa are intrinsically resistant to biocides such as 
chlorhexidine, the precautionary rotation of biocides could be implemented to 
prevent contamination of biocide stock solutions (Murtough et al., 2001). As the 
public become more aware of the possibility of infection, the use of biocides as 
disinfectants in the home has increased dramatically. The over use of biocides 
could lend itself to the possibility of residues of the biocide in the environment which 
may confer a selective advantage for resistant organisms, although there is limited 
evidence that this is a major problem (Russell, 2002a).
This investigation explored the susceptibility of a panel of P. aeruginosa strains to a 
range of biocides. The panel of strains included epidemic, clinical (CF and non CF) 
and environmental strains. All the strains tested were intrinsically resistant to three 
of the biocides screened, povidone, triclosan and CPC, with growth above the 
threshold (> 80% knockdown from zero biocide control) still being observed at the 
maximum concentration tested. Resistance to triclosan is well documented, with 
many instances of triclosan being ineffective for the disinfection of P. aeruginosa 
(Williams and Stickler, 2008, Ellison et al., 2007). CPC is a quaternary ammonium 
compound, which causes membrane damage and coagulation of cell components 
(McDonnell and Russell, 1999). It is concerning that P. aeruginosa strains appear 
to be intrinsically resistant to CPC. QAC’s are common biocides used in many 
disinfectant products such as preoperative skin disinfection (0.1% - 0.2% (v/v)), in 
antiseptic creams (0.01 -  0.5% (v/v)), in throat lozenges (0.01% (v/v)) and in 
contact lens disinfection solutions (0.001 -  0.01% (v/v)) (Moore and Payne, 2004). 
For a more comprehensive list of biocides and their uses see Table 1.2. 
Considering the degree to which P. aeruginosa strains are resistant to this QAC, it 
would raise the issue of cross resistance with other QAC biocides. Loughlin et al.
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Table 4.4 Mean antibiotic susceptibilities of P. aeruginosa
S tra in A K A Z T Z C L Cl IP M P PP TM TS
A n tib io tic
p ro file
s c o re
Liverpool 
epidemic (15)
33.9 188.8 48.6 24.4 1.5 15.7 12.1 58.4 3.4 4.8 39.16*
Epidemic 
Strains (4)
7.5 256 3.3 160 2.1 6.6 0.2 1.6 3.9 32 47.32
Catheter 
strains (3)
2.1 234.6 2 149.3 0.1 0.9 0.4 2.5 0.3 1.8 39.4
Clinical strains 
(7)
3.0 191.1 4.78 141.5 0.7 0.4 0.2 31.0 0.5 3.7 37.69
Environmental 
strains (2)
1.5 256 2.5 76 0.1 0.5 0.3 2.2 0.3 1.5 34.1
* Liverpool epidemic strains significantly less susceptible than clinical and environmental strains 
Key
AK = amikacin, AZ = azithromycin, TZ = ceftazidime, CL = chloramphenicol, Cl = ciprofloxacin, IP = 
imipenem, MP = meropenem, PP = piperacillin, TM = tobramycin and TS -  trimethoprim / 
sulfamethoxazole
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Figure 4.1 Production of spontaneous resistant colonies in P. aeruginosa 
strains.
Not all strain groups produced spontaneous resistant colonies (spontaneous resistant colonies = 
colonies seen within the zone of inhibition after 48 hours of growth). The Liverpool epidemic strains 
consistently produced resistant colonies to all antibiotics, followed by clinical strains. The p lactams, 
imipenem, meropenem and piperacillin induced the most adaptive resistant mutants compared to 
the other antibiotics.
Key
AK = amikacin, AZ = azithromycin, TZ = ceftazidime, CL = chloramphenicol, Cl = ciprofloxacin, IP = imipenem, 
MP = meropenem, PP = piperacillin, TM = tobramycin and TS -  trimethoprim / sulfamethoxazole
S ■  Environmental■  Catheter
■  Clinical 
□  Epidemic
■  Liverpool Epidemic
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Figure 4.2 Percentage of P. aeruginosa strain groups producing spontaneous 
resistant colonies to all ten antibiotics
Liverpool epidemic strains produced the largest proportion of spontaneous resistant colonies after 
48 hours of exposure to all ten antibiotics (49%). This was followed by clinical strains (24%), 
epidemic strains (15%), catheter and environmental strains (6%).
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(Loughlin et al., 2002) found that P. aeruginosa strains that were trained to be 
resistant to benzalkonium chloride were also resistant to other membrane acting 
biocides such as cetrimide and CPC, but not to triclosan or chlorhexidine. Cross 
resistance to clinically relevant antibiotics was also not observed (Loughlin et al.,
2002). The current study found that the mean MICs of all the strains screened for 
benzalkonium chloride were not significantly different from one another, although 
the total mean was 286.7 pg/ml, (Table 4.2) approximately ten times higher than 
the MIC for chlorhexidine. Thus, it appears that the benzalkonium chloride is 
ineffective against P. aeruginosa.
Nevertheless, it should also be taken into account that MIC screens are often 
conducted at levels below the in use concentration, rendering them inappropriate 
for assessing the effectiveness of a biocide, although they do provide valuable 
preliminary information (Maillard, 2005). To counter this problem MBC screens 
were carried out on a sub-set of P. aeruginosa strains to asses whether 
chlorhexidine and CPC were suitable biocides to use in infection control 
procedures. Out of the biocides screened chlorhexidine was the most effective 
growth inhibitor, with fairly low MIC values (Mean 27.6 -  37.3 pg/ml, Table 4.1). 
MBC analysis reveals that for a bactericidal affect approximately three times more 
chlorhexidine is required, thus the MIC and MBC values are concurrent with one 
another. Unfortunately this was not the case for CPC. The MBC values are much 
higher than the MIC, with a 16 fold greater requirement of CPC needed to achieve a 
bactericidal effect, although both screens indicate that CPC is a poor biocide for 
use against P. aeruginosa (Table 4.3). In general it would appear that QACs are 
not suitable for disinfection of places where P. aeruginosa are encountered 
frequently. Similarly, triclosan and povidone are also ineffective. Although the “in 
use” concentration of biocides should be high enough to affect rapid killing of the 
bacteria, there is much speculation on the effect of residues of biocides in the 
environment. In situations where biocides are used to sterilise surfaces or are 
diluted with water for handwashing or equipment sterilisation, bacteria will be 
exposed to sub-inhibitory residues (Gilbert and McBain, 2001). This may induce 
resistance to this biocide and consequently cross resistance between unrelated 
compounds may occur. However, Thomas et al. found that P. aeruginosa strains 
with elevated MIC values to chlorhexidine that were exposed to chlorhexidine
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residues were no less susceptible to chlorhexidine and antibiotics, suggesting that 
biocides residuals are not selecting for multi drug resistant organisms (Thomas et 
al., 2000).
4.32 Antibiotic susceptibilities
The antibiotic susceptibilities were also determined using commercial E-test® 
strips. In general P. aeruginosa strains were sensitive to all of the P-lactams tested 
(imipenem, meropenem and piperacillin) and to ciprofloxacin, amikacin, ceftazidime 
and tobramycin (Table 4.4, for MIC break points see Table 2.7). It is interesting that 
many of the strains tested were sensitive to p-lactams as it has been well 
documented that P. aeruginosa have p-lactamases, which degrade the antibiotic. 
Extended spectrum p-lactamases have also arisen and are spread on plasmids. 
The PER-1 type extended spectrum P-lactamase confers resistance to several 
antibiotics as well as ceftazidime, piperacillin and ticarcillin, which usually retain 
their activity (Vahaboglu et al., 1997). In this investigation approximately 45% of P. 
aeruginosa strains were resistant to the p-lactams (15 out of 33), however after 48 
hours of exposure spontaneously resistant colonies were observed (Figure 4.1). 
Thus, it may be that increased contact with the antimicrobial leads to the selection 
of resistant organisms. There were no significant differences between 
environmental and clinical strains of P. aeruginosa, indicating that there is little 
differentiation between strains found in clinical hospital situations and strains found 
in the environment, thus vulnerable patients should be cautious as the environment 
may pose as a source of infection.
4.33 The Liverpool Epidemic strains
One of the striking observations made from this investigation were the elevated 
chlorhexidine MIC values in the Liverpool epidemic strains compared to all other 
strains. This included other epidemic strains, such as the Manchester and 
Melbourne epidemic strains. Most strains were inhibited at 20 pg/ml of 
chlorhexidine, but the Liverpool epidemic strains required four times this amount to 
achieve the same effect (Table 4.1).
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Historically it was observed that a unique P. aeruginosa strain was acquired by the 
patient and they then progressed to a chronic infection with this strain. Isolates 
from CF patients were phenotypically different from environmental isolates as they 
exhibited loss of motility and mucoidy. It was shown by RAPD profiling that this 
was due to the adaptation of the strain to a chronic state, not replacement with a 
new strain (Mahenthiralingam et al., 1996a). A surveillance study carried out in 
Vancouver found that out of 174 CF patients, 123 carried a unique strain that was 
not seen in any other patient. 34 strains were shared, with ten of these patients 
being siblings (Speert et al., 2002). Therefore it was concluded that P. aeruginosa 
carried a very low risk of transmission and prolonged contact with an infected 
individual such as in the case of siblings was the greatest cause of cross infection 
(Speert et al., 2002), thus consequently segregation of patients was not 
recommended.
However, in the UK a different epidemiology was observed with the emergence of 
epidemic transmissible strains. Cheng et al (Cheng et al., 1996) found that an 
unusually high number of children (70.6%) in a Liverpool clinic were colonised with 
a ceftazidime and P-lactam resistant strain of P. aeruginosa. They recommended 
that this strain may be an antibiotic resistant induced transmissible strain and that 
those patients harbouring it should be segregated from other patients (Cheng et al., 
1996). In a Manchester CF clinic the emergence of a different epidemic strain 
became apparent. Fourteen percent of patients carried an epidemic strain that had 
an unusual phenotype (non-pigmented and non-motile). This strain was genetically 
distinct from the transmissible strain isolated in Liverpool and was called the 
Manchester epidemic strain (Jones et al., 2001b).
A more recent survey of over 31 CF centres in England and Wales, identified the 
Liverpool epidemic strain as the most common with 48% of CF centres harbouring it 
(Scott and Pitt, 2004). This implies that cross infection can occur and that these 
epidemic strains may be more aggressive and able to replace a patient’s original 
strain (Scott and Pitt, 2004). The possibility of cross infection with healthy 
individuals may also be a concern. Although very few cases have been 
documented, McCallum et al. (McCallum et al., 2002) reported a CF patient infected 
with the Liverpool epidemic strain, which consequently infected her parents.
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Although her father had a pre-existing lung condition, he was generally in good 
health and the patient’s mother was healthy with no medical conditions. The 
colonisation of non- CF healthy people is a serious issue, particularly for parents 
with CF children and although cross infection is rare, it is perhaps pertinent to 
screen people who are in close contact with colonised patients for these organisms 
(McCallum etal., 2002).
The emergence of the Liverpool and Manchester epidemic strains is worrying as 
they demonstrate increased antibiotic resistance and are more virulent, causing 
serious health implications for the patients. Due to the transmissibility of these 
strains there are also infection control issues, where patients harbouring a 
transmissible strain may be segregated (Scott and Pitt, 2004).
In this study, the Liverpool epidemic strains were significantly less susceptible than 
other strains to chlorhexidine, including other epidemic strains (Table 4.1). This is 
interesting as in previous studies it has been noted that the LES may have 
enhanced virulence contributing to its transmissibility. It was reported that LES 
strains had multi drug resistance to p-lactams such as ceftazidime and imipenem 
(Cheng et al., 1996). This was probably due to selection by the use of 
monotherapy to treat P. aeruginosa infection. However, it has also been 
determined that multiple drug resistance can be attributed to specific mutations in 
efflux pumps. LES isolates also have up regulation of the AmpC p-lactamase gene 
and in quorum sensing genes (Salunkhe et al., 2005). In particular, strain LES 431, 
was deemed hyper virulent due to it’s high levels of p-lactamase activity, coupled 
with up regulation of quorum sensing, thus LES 431, which also has the ability to 
infect non CF parents of CF patients, is a particularly problematic strain for CF 
patients (Salunkhe et al., 2005). Many of the LES isolates have this unusual 
phenotype, which is thought to contribute to their increased virulence. This includes 
up regulation of quorum sensing genes, such as the over production of pyocyanin, 
a blue green pigment which has many toxic effects and the LasA protease 
(Fothergill et al., 2007). However, not all isolates of the LES strain have this 
phenotype and the LES genotype appears to be unstable with many deletions, 
insertions and rearrangements occurring (Fothergill et al., 2007). The current 
investigation found that not all LES strains had increased chlorhexidine MICs,
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although the majority did show this phenotype (78.6% had a chlorhexidine MIC of 
70 pg/ml or above compared to 21.4% of strains with low chlorhexidine MIC).
The antibiotic susceptibility profiles for individual strains varied, but overall the 
Liverpool epidemic strains had higher MIC’s to the P-lactams, ceftazidime, 
imipenem, meropenem and piperacillin (Table 4.4), than all other strains, including 
other epidemic strains. This could be attributed to the up regulation of the AmpC p 
lactamase gene and also to the up regulation of efflux pumps. It is interesting to 
note that the hypervirulent strain LES 431 was resistant to chlorhexidine and six out 
often antibiotics screened, correlating to previous data that this isolate in particular 
is more virulent than other strains (Salunkhe et al., 2005). All strains tested were 
resistant to CPC, triclosan and povidone and there were no significant differences 
between benzalkonium chloride MIC values, indicating that P. aeruginosa strains 
are less susceptible to these agents. Most strains were very susceptible to 
chlorhexidine, except the LES strains. This may be due to the up regulation of 
efflux pumps, such as the MexAB OprM, which can have broad specificity for many 
unrelated compounds (Li et al., 2000), but as of yet the mechanism of the LES 
increased chlorhexidine resistance has not been determined.
Evidently the Liverpool epidemic strains are a group of strains that have increased 
virulence and multiple antimicrobial resistance which extends to antibiotics and 
disinfectants. Not only does this make it difficult to treat patients infected with these 
strains, but the ability of the LES to super infect patients and its transmissibility 
generates infection control problems that need to be resolved to prevent the spread 
of these epidemic strains. P. aeruginosa strains have high tolerance to a number of 
biocides and this could be a contributory factor to its continued spread across CF 
clinics. Understanding the mechanism of resistance so that new therapies can be 
developed to target these strains is unmistakably an important area of research.
4.34 Biocide resistance mechanisms
The results obtained in this investigation correlate with other literature that suggest 
P. aeruginosa, especially transmissible epidemic strains are multidrug resistant to 
antibiotics. A new finding of this work is that epidemic strains are resistant to many
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classes of biocides, including QACs, phenols and povidone. Due to the action of 
biocides on multiple targets, specific resistance mechanisms are poorly understood, 
but a brief overview is provided here and Table 4.5 provides a summary of the 
antibiotic and biocide resistant mechanisms. The outer membrane of P. aeruginosa 
plays an important part in the resistance to many biocidal agents, particularly 
hydrophobic agents that cannot diffuse across the outer membrane due to LPS 
molecules (McDonnell and Russell, 1999). The high Mg2+ content leads to strong 
LPS -  LPS links, preventing access of the biocide to the cell (McDonnell and 
Russell, 1999).
Efflux is a well known mechanism involved with both antibiotic and biocide 
resistance and is well defined in P. aeruginosa. One of the main efflux pumps, the 
RND MexAB-OprM , is known to induce resistance to a number of antibiotics and 
biocides (Poole, 2004). Recently an efflux pump was described that actively 
effluxes triclosan. This pump was one of five that is known to effectively efflux 
triclosan and indicates that efflux is one of the main resistant mechanisms for 
triclosan (Mima et a/., 2007). The latter mechanisms are all intrinsic to P. 
aeruginosa.
Although not thought to play a central role in resistance in Gram negative bacteria, 
acquired resistance can occur. This includes the adaptation of bacteria to become 
resistant to a certain antimicrobial due to increased exposure to the agent. This 
can lead to up regulation of efflux pumps or enzymes and may also lead to outer 
membrane changes that leave the bacteria less susceptible (Loughlin et a/., 2002). 
The acquisition of plasmids is also known to increase bacterial resistance. The 
acquisition of plasmids conferring antibiotic resistance has not been well described 
in P. aeruginosa and it is not thought to play a central role in resistance to biocides 
(Russell, 1997).
The lifestyle of P. aeruginosa could contribute to resistance to both antibiotics and 
biocides. In the CF lung, P. aeruginosa congregate and forms biofilms, which 
produce an exopolysaccharide glycocalyx. Biofilms are difficult to penetrate with 
antimicrobials as they are protected by the exopolysaccharide and cells within the
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Table 4.5 Antibiotic and biocide resistant mechanisms in P. aeruginosa
Antim icrobial Agent Resistant m echanism s
Reference
Antibiotics
(3-lactams Enzyme inactivation e.g. (3 - 
lactamases
Efflux
(Bradford, 
2001, Russell, 
2000)
Aminoglycosides Enzyme modification 
Reduced uptake 
Efflux
(Russell, 
2000, Poole, 
2005a)
Chloramphenicol Efflux
(Poole et a/., 
1993)
Fluoroquinolones Efflux
(Russell,
2000)
Biocides
QACs Reduced uptake 
Efflux
(Maillard, 
2005) 
(McDonnell 
and Russell, 
1999)
Chlorhexidine Reduced uptake 
Efflux
(Maillard, 
2005, 
McDonnell 
and Russell, 
1999)
Triclosan Reduced uptake 
Efflux
(Maillard, 
2005, 
McDonnell 
and Russell, 
1999, Mima et 
a/., 2007)
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biofilm are often growing more slowly reducing the uptake (Govan and Deretic, 
1996). Biofilm grown isolates were perceived to be less susceptible to single and 
double combinations of antibiotics compared to planktonically grown strains (Hill et 
at., 2005). Stickler (Stickler, 2002) found that patients with catheters often had 
blockages due to the formation of biofilms. These biofilms were made up of 
bacteria from a number of species including Proteus mirabilis and P. aeruginosa. 
Chlorhexidine was used to disinfect the area before the catheter was applied and 
many of the isolates obtained from these biofilms were chlorhexidine resistant 
Other studies have also found that 80% of P. aeruginosa cells in biofilms were not 
killed by in use concentrations of benzalkonium chloride (1% w/v), chlorhexidine 
gluconate (4% w/v) and triclosan (1% w/v) (Smith and Hunter, 2008). P. 
aeruginosa strains adapt to the CF lung and become mucoid producing a sticky 
alginate that contributes to the biofilm production and therefore the antibiotic and 
biocide resistant profile that this species are well known for (Govan and Deretic, 
1996). In this study, mucoidy and biocide resistance was not investigated. 
Mucoidy may have a key role in biocide resistance thus to expand this work, P. 
aeruginosa strains grown as biofilms could be screened for biocide MICs and this 
data compared with planktonically grown cells.
The many and varied mechanisms of resistance that P. aeruginosa employs to 
avoid being killed and promote survival in hostile environments generates a species 
that is particularly difficult to treat once a patient is infected. Infection control and 
the prevention of patients acquiring P. aeruginosa is an important area of research, 
although the abundance of this organism in the environment may make this an 
impossible task. New therapeutics should be developed to target mechanism of 
resistance, such as modification of existing agents to prevent enzyme inactivation 
and the combination of antimicrobials to produce a synergistic effect, such as 
increased permeability.
4.4 Conclusions
In summary, this chapter expands other data that P. aeruginosa strains are 
multidrug resistant and are also intrinsically resistant to many biocides, such as
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triclosan, CPC and benzalkonium chloride. These are agents that are often used in 
clinics for a multitude of purposes and this in itself may select for resistant 
organisms and lead to nosocomially acquired infections. In addition, the Liverpool 
epidemic strains, a transmissible strain, now recognised as one of the most 
common clones in the UK (Scott and Pitt, 2004), was observed to be more 
chlorhexidine resistant compared to all other strains tested. The LES strains are 
known to posses multi-drug resistance and increased virulence factors which may 
contribute to the higher resistance seen in these strains to chlorhexidine. Liverpool 
epidemic strains pose a particular problem due to their transmissibility, therefore it 
is especially important that efficient disinfection practices are employed to prevent 
infection and spread of these organisms. In general, QACs, triclosan and povidone 
should not be used against P. aeruginosa strains as all strains regardless of the 
habitat they came from or whether they were epidemic or not, were intrinsically 
resistant to them. Chlorhexidine should be used with caution, as most strains were 
susceptible to it, but it should be noted that resistance can be trained and the LES 
were more resistant to it. Further investigations should be carried out to determine 
if commercial biocides are bactericidal for P. aeruginosa and additional disinfection 
guidelines can then be recommended. Although in this investigation the genetic 
basis of biocide resistance in P. aeruginosa was not studied, it is still an important 
area for research, as the genetic understanding of biocide resistance may help 
prevent CF patients becoming infected with multidrug resistant P. aeruginosa that 
have a large consequence on their morbidity and mortality.
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Chapter 5.0 -  Gene expression of B. cenoceoacia J2315 in 
response to chlorhexidine
5.1 Introduction
5.11 The Burkholderia cepacia complex -  mechanisms of biocide 
resistance
The Bcc are a group of intrinsically antimicrobial resistant organisms, which are 
capable of contaminating disinfectant and preservative formulations, hence making 
infection control exceedingly difficult. Their ability to contaminate commercial 
products are particularly problematic for cystic fibrosis (CF) and intensive care (ITU) 
patients as they may acquire these serious infections from the contaminated 
product (Frank and Schaffner, 1976, Berkelman et a/., 1981), leading to a poor 
outcome. Evidently it is important to understand the mechanisms by which 
pathogens become resistant to certain antimicrobials so that new therapies may be 
devised to combat these life-threatening infections.
The general mechanisms of biocide and antibiotic resistance were outlined in 
Chapter 1. The outer membrane structure is an important aspect of resistance for 
both classes of antimicrobial. The outer membrane gives limited permeability so 
many antimicrobials cannot penetrate through to the inner cell. It consists of 
lipopolysaccharides, porins that form hydrophilic channels and efflux pumps (Burns, 
2007). The LPS composition of Gram negative bacteria is a major cause of the 
impermeability to many compounds, especially membrane active agents such as 
chlorhexidine (Denyer and Maillard, 2002). Bcc species have a very different LPS 
composition compared to other Gram negative species. The core oligosaccharide 
of the Bcc LPS contains less phosphate and 3-deoxy-D-manno-octo-2-ulosonic acid 
(KDO) than other Gram negative species (Cox and Wilkinson, 1991). The Bcc LPS 
also contains 4 amino-4 deoxyarabinose (Ara4N) residues attached to phosphate 
groups of glucosamine disaccharide in the lipid A backbone (Isshiki et a/., 1998) 
(Figure 5.1). The presence of Ara4N and the fact that the LPS contains less 
phosphate and -deoxy-D-manno-oct-2-ulosonic acid contributes to antimicrobial 
resistance as it reduces the negative charge of the outer membrane, effectively
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Figure 5.1 The structure of LPS in (i) Gram negative bacteria and (ii) Bcc 
bacteria.
Bcc LPS structure contains 4 -  amino-4-deoxyarbinose (highlighted in blue) and substitutes a KDO 
module for a KO (highlighted in red). This reduces the negative charge of the membrane, 
concealing binding sites for cationic compounds. Adapted from (Russell and Chopra, 1996)
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concealing the binding sites for cationic agents (Goldberg, 2007, Burns, 2007).
Porins are also contributing factors to resistance. Porins form channels through the 
outer membrane that allow the free diffusion of hydrophilic compounds which 
include many antibiotics and some biocides. The Bcc notably have a lower 
permeability for many of these compounds, particularly p lactam antibiotics. It has 
been suggested that the low permeability of the outer membrane contributes 
significantly to this intrinsic resistance and that the porins play a major role. The 
porins of the Bcc have been found to have low conductance for hydrophilic 
compounds, due to the small channel size they form (Parr et al., 1987). This 
restricts access across the membrane for many antimicrobials.
Also part of the outer membrane are efflux pumps, an essential component to the 
resistance machinery. Efflux pumps use the proton motive force to expel cytotoxic 
compounds (Borges-Walmsley and Walmsley, 2001). These compounds may be 
unrelated and can include antibiotics, dyes, detergents and biocides (Piddock, 
2006a). There are five classes of efflux pumps: the resistance nodulation division 
(RND), the major facilitator superfamily (MFS), the small multi drug resistance 
(SMR), multidrug and toxic compound extrusion (MATE) family and the ATP binding 
cassette (ABC) transporters. Members of the Bcc have a number of efflux pumps in 
their outer membranes, including RND and MFS drug pumps. Wigfield et al. 
(Wigfield et al., 2002) described an immunodominant drug efflux pump called BcrA, 
which was specific for tetracycline and nalidixic acid. This efflux pump belongs to 
the major facilitator superfamily class of efflux pumps and although did not increase 
resistance to a number of detergents and biocides (e.g. Tween 20, ethidium 
bromide and chlorhexidine, it still pumped out non related classes of antibiotics 
(Wigfield et al., 2002). RND pumps have also been identified, with some showing 
homology to the MexAB-OprM pump described in P. aeruginosa (Guglierame et al.,
2006) and an efflux operon (ceoA) that is induced by the siderophore salicylate and 
confers resistance to ciprofloxacin, chloramphenicol and trimethoprim (Nair et al., 
2004). The presence of these efflux pumps contributes to the multidrug resistance 
of the Bcc and possibly gives rise to cross resistance due to the ability of the pumps 
to remove unrelated classes of compounds.
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Members of the Bcc also have the ability to form biofilms which are thought to be 
associated with increased resistance due to the lack of penetration of the biofilm by 
the antimicrobial. Cells growing in a biofilm have an altered growth rate compared 
to planktonically growing cells, reducing uptake of the antimicrobial. Biofilms are 
formed by the production of exopolysaccharides which surround colonies growing 
within the biofilm. Approximately 80% of the Bcc produce an exopolysaccharide, 
cepacian which contributes to the persistence and colonisation of the Bcc (Cunha et 
al., 2004). There are three stages to the formation of a mature biofilm, adhesion, 
aggregation and formation of mature biofilm (Figure 5.2). The production of a 
mature biofilm is not only associated with increased antimicrobial resistance but 
also other virulence factors, such as ability to withstand the hosts immune system 
and inflammation (Riedel and Eberl, 2007).
Biofilm production is mediated by the cell density dependent quorum sensing 
system, a cell to cell communication system which allows the coordination of many 
regulatory mechanisms in a number of cells at the same time (Riedel and Eberl,
2007). The quorum sensing system uses small signalling molecules, N-acyl- 
homoserine lactones (AHL) to mediate coordination. The Bcc has such a system, 
the Cepl / CepR system, where Cepl makes the autoinducer, which when a 
threshold level is reached binds to the regulator protein (CepR), which then 
activates the required genes (Lewenza et al., 1999). As well as mediating biofilm 
production, the QS system also mediates the expression of extracellular proteases 
chitinases and swarming motility (Riedel and Eberl, 2007), thus in itself it is an 
important virulence factor and may contribute to the biocide resistance displayed by 
many members of the Bcc. In addition some transmissible B. cenocepacia strains 
have genomic islands that contain virulence factors. The cenocepacia island (cci), 
encodes a predicted N-acylhomoserine lactone synthase gene and a response 
regulator, indicating that this may contribute to quorum sensing and therefore 
biofilm production (Malott et al., 2005).
The above mechanisms of resistance all have a role in the Bcc resistance to 
biocides. Although these mechanisms have been determined the underlying 
genetic pathways and their role in resistance have yet to be elucidated. It is 
important to determine these pathways, so that resistance can be fully understood
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Figure 5.2 The development of a mature biofilm in Bcc
Planktonic bacteria swim towards the substratum using flagella and then attach loosely. They then 
migrate over the surface forming micro-colonies. These micro-colonies differentiate into a mature 
biofilm, where cells are embedded in a thick EPS matrix (cepacian). Maturation involves quorum 
sensing, twitching, cell surface proteins and an increase in antimicrobial resistance. Adapted from 
(Riedel and Eberl, 2007).
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and new targets for antimicrobials can be determined or alternate methods for 
targeting bacterial infections can be ascertained.
5.12 Methods of studying the genetics of resistance mechanisms
As outlined above there are many mechanisms that play a role in resistance to 
biocides in the Bcc. However, it has not yet been determined which of these have 
the largest role in biocide resistance and the underlying genetics have not yet been 
fully understood. There are many ways of studying the genetic pathways of 
resistance mechanisms and determining the role certain genes play in virulence 
and pathogenesis. One of the most commonly used methods is mutagenesis. 
There are several different types of mutagenesis with one of the most useful being 
random transposon mutagenesis. Transposons are mobile genetic elements that 
randomly insert into bacterial genomes. They contain a transposase that allows 
them to “jump” and often carry antibiotic resistant genes which allows them to be 
easily selected for (De Lorenzo et al., 1998). Most transposons have been modified 
such as the mini Tn5 and Tn10 transposons, which are specialised transposons 
that are stable and contain antibiotic selection markers for rapid cloning (de 
Lorenzo etal., 1990).
Random transposon mutagenesis works by mating a strain containing the 
transposon on a suicide delivery plasmid with the bacterial strain of interest. The 
transposon will then insert into genes and possibly knockout their function. A 
screen can then be developed to identify a loss of function in a given mutant. For 
example to look for loss of resistance to an antibiotic, mutants would be plated out 
onto agar containing the antibiotic in question. Those that didn’t grow would be 
selected from a master plate and further analysis carried out, e.g. sequencing and 
bioinformatics. Although this approach produces many mutants, it can be time 
consuming to screen for mutants, and the process is greatly facilitated by having a 
genome to determine the location of each mutated gene. The insertion of 
transposons may induce polar effects, terminating the transcription of genes 
downstream of the insertion point (Hensel and Holden, 1996).
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Other mutagenesis techniques include directed mutagenesis, where a known 
identified gene is knocked out to confirm function. This is achieved either by gene 
disruption or gene replacement. Gene replacement involves replacing a gene with 
previously cloned DNA that contains insertions, deletions or base replacements. 
This effectively alters the gene, so that it is no longer functional (Quandt and Hynes, 
1993). Gene disruption inactivates the gene by insertion of a marker, usually an 
antibiotic resistant cassette into the gene. This has the added bonus of allowing the 
mutants to be selected for easily, as long as they are originally susceptible to the 
antibiotic. This technique is useful to confirm gene function however it is not useful 
if the genes involved are not already known.
Gene transfer can also be used to determine gene function. Genes possibly 
involved in resistance can be transferred to a susceptible strain which is then 
screened to see if resistance has been induced by the presence of the new gene. 
This instantly provides information on the importance of that gene in resistance. 
Nevertheless, there are many limitations to this approach. Genes in operons may 
not show a significant effect if only one component is transferred to the susceptible 
host. This technique is generally applied to systems where known genes are 
deleted. There may also be issues if the resistant host and the susceptible host are 
evolutionary different as the recipient may not contain the necessary regulatory 
machinery to express the genes transferred into it (Hensel and Holden, 1996).
Investigating gene expression is another way to determine genes that may have a 
role in resistance. This approach is based on the hypothesis that genes important 
in pathogenesis will be expressed during infection and may only be activated when 
in this state. This technique can also be applied to resistant genes as generally 
they are switched off until placed in a situation where they are required. Often 
maintaining expression of resistant genes can have a large metabolic cost to the 
organism, thus it is beneficial to only switch them on in response to particular 
situations. To study gene expression RNA is extracted from bacteria present in an 
infection state or exposed to the antimicrobial and then converted to cDNA. Those 
genes present in the infection state can then be screened for using subtractive 
hybridization, where labelled probes are synthesised and hybridized to cDNA
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(Hensel and Holden, 1996). Again a major limitation of this method is the need to 
know the gene involved so a suitable probe can be designed.
5.13 Whole genome approach to studying gene expression
Recently the whole genome microarray approach has become more popular for 
studying gene expression. A microarray allows the observation of the 
transcriptional response of the whole genome to an environmental stimulus 
(Ehrenreich, 2006). This produces a large data set that allows the researcher to get 
an overview of the genes that are important in the conditions they have set. A 
microarray is a microscopic slide that contains a series of samples, usually DNA or 
RNA from a particular organism. These are placed or synthesised on the slide in 
an ordered manor so that any data obtained can be traced back to the original gene 
(Pasanen et al., 2003). RNA is extracted and converted to cDNA, labelled with 
fluorescent dye and then hybridised onto the microarray. The ratio of fluorescence 
is then determined and expression changes can be ascertained quantitatively. 
Microarray approaches are becoming more favourable as the whole transcriptomic 
expression can be elucidated in as little as one experiment. This provides a 
massive bank of data that can be further investigated and may also pin point 
important genes that may otherwise not have been seen due to small changes in 
their expression. Not only does a microarray approach provide data on genes that 
are up-regulated in their expression in response to the stimulus, but it also 
highlights genes that are repressed in response to the stimulus. Thus the 
experimenter gets an overall view of the important pathways involved in response 
to certain conditions.
Microarrays have been used to look at gene response to a number of different 
environmental stimuli. For example, oxidative stress is a contributory factor to 
killing of bacterial species. In the lung of CF patients, phagocytic reactive oxidants 
are present, thus protection against these radicals is important. Chang et al. 
investigated the response of P. aeruginosa to oxidative stress by exposing P. 
aeruginosa to hydrogen peroxide. Genes important in the antioxidant defence 
system included DNA repair proteins and catalyses. Interestingly, it was seen that
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pyocin production was up-regulated, indicating that this may be a novel defence 
mechanism against oxidative killing (Chang et al., 2005).
Other studies have also focused on the CF lung as an interesting environment for 
investigation. Drevinek et al. used a B. cenocepacia microarray to look at the gene 
expression in response to cystic fibrosis sputum. Genes involved in iron uptake, 
protection against reactive oxidative stress, secretion and motility and antimicrobial 
resistance were significantly altered (Drevinek et al., 2008). Due to the continuous 
nature of antibiotic treatment in CF patients, it was perhaps not surprising that some 
efflux genes were up-regulated in CF sputum, however not all efflux genes were up- 
regulated and some appeared to be repressed in CF sputum depending on the 
antibiotic treatment each patient received (Drevinek et al., 2008).
Studying expression profiles of genes exposed to antibiotics can aid our 
understanding of resistance mechanisms and expose new targets for 
antimicrobials. Comparison studies of resistant and sensitive strains could 
elucidate genes that play a vital role in resistance (Brazas and Hancock, 2005). 
Biocides have a broad spectrum of activity compared to antibiotics, which generally 
have one target. Thus mechanisms of resistance are more complex and may be 
more difficult to determine due to the involvement of many genes. Consequently 
using a microarray approach may overcome some of these problems, by providing 
a whole genome analysis. A study investigating the effects of triclosan on S. 
aureus, using a microarray found that triclosan affects many components of 
metabolism. These included the down regulation of virulence related genes and 
genes involved in energy metabolism, such as amino acid, carbohydrate and lipid 
transport and metabolism, where as up regulated genes were involved in multi drug 
resistance (Jang et al., 2008). The study implied that triclosan may kill S. aureus by 
interfering with its ability to form cell membranes. Genes involved with fatty acid 
metabolism were also down-regulated which may have consequences, as triclosan 
targets fatty acid synthesis (McMurry et al., 1998b). However, the fabl enoyl 
reductase gene involved in resistance had no change in expression after exposure 
to triclosan (Jang et al., 2008).
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Previous studies have therefore shown a microarray approach to be appropriate for 
the discovery of important genes in response to the biocide triclosan. In this study, 
a microarray was carried out to investigate genes that have a vital role when 
exposed to the biocide chlorhexidine. It was hypothesised that genes involved in 
resistance would have a change in expression and that this may lead to the 
identification of novel antimicrobial targets. B. cenocepacia J2315 was used as 
model organism.
5.14 8. cenocepacia J2315 as a model organism
B. cenocepacia J2315 was used as a model organism for this study as its genome 
has already been sequenced (Pathogen Sequencing Group at the Sanger Institute, 
Hinxton, Cambridge, http://www.sanqer.ac.Uk/proiects/B cenocepacia). Recently 
the genome paper containing detailed annotation has been published (Holden et 
al., 2009). Hence, any genes determined by the microarray could be linked back to 
the sequence and functions determined. J2315 is a pathogenic strain of B. 
cenocepacia, from the ET-12 lineage which is known to be an epidemic 
transmissible strain. Therefore it is interesting to study this strain, as it may display 
traits involved with virulence, transmissibility and antimicrobial resistance. This 
pathogen is already known to be multidrug resistant to a number of antibiotics and 
from preliminary work carried out in this study (Chapter 3.0), able to survive within 
biocides routinely used in clinical situations. Consequently, a microarray looking at 
the change in gene expression in response to chlorhexidine may highlight genes 
involved in resistance to chlorhexidine.
As well as the above reasons, J2315 was used as a model organism in this study 
as a microarray had already been produced for this organism. The microarray was 
a custom 2 x 11 K microarray, developed using Agilent’s two colour 60 mer 
SurePrint™ ink jet synthesis platform and contained all the genes in the J2315 
genome as well as some control strains (see Chapter 2, section 2.14). The array 
and labelling procedures had been validated previously (Leiske et al., 2006). 
Therefore, B. cenocepacia J2315 was a good model to use, due to the extensive
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genome data available and the availability of a validated, commercially produced 
microarray.
5 .1 5 - Aims
The aim of this investigation was to determine genes involved in chlorhexidine 
resistance, by (i) Developing growth conditions to examine the effect of sub MIC 
levels of chlorhexidine on B. cenocepacia J2315 and (ii) performing a microarray 
experiment to look for genes with altered levels of expression under these 
conditions. These genes can then be characterised further and their role in biocide 
resistance determined.
5.2 Results
5.21 J2315 growth curves and RNA extraction
Preliminary experiments were conducted to select the best concentration of 
chlorhexidine to use. Ideally exposure to the in use concentration of chlorhexidine 
would be used, however these concentrations are usually bactericidal thus rapid 
killing would occur and very few interesting genes expressed. Bacteria are often 
exposed to sub lethal concentrations of biocides, particularly in clinical situations 
where disinfectants are employed regularly. Therefore a microarray on sub MIC 
values would show altered expression in genes that may aid bacterial survival in 
chlorhexidine. Originally, J2315 was grown in the presence of 10 pg/ml of 
chlorhexidine. However, with this concentration J2315 took over 10 hours to reach 
mid log phase, thus it was decided to use 5 pg/ml of chlorhexidine. J2315 exposed 
to 5 pg/ml of chlorhexidine took 8 hours to reach mid log phase (Figure 5.3), 
compared to six hours when grown in LB broth. Once mid log phase was reached, 
cells were harvested and RNA was extracted and concentration determined.
5.22 Microarray performance
Four microarray experiments were carried out, four technical replicates and two 
biological replicates. The transcriptomic profiles produced in the four replicates 
were excellent, although the second two arrays had a greater coverage of the slide
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Figure 5.3 Growth curves for J2315 grown in LB broth (blue) and grown in the 
presence of 5 pg/ml chlorhexidine (pink).
S. cenocepacia J2315 reached mid log phase after 6 hours of growth with approximately 3 hour lag 
phase. In the presence of chlorhexidine, although a similar lag phase was seen, mid log phase took 
approximately 2 hours longer to reach mid log phase (8 hours). Once mid log phase was reached 
(designated as an OD reading of 0.5) bacterial cells were harvested for expression analysis.
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with a more even hybridisation than the first two arrays. The array to array 
correlation between all four replicates was 0.898, with a distance of one meaning 
the arrays would be exactly the same (Figure 5.4). Therefore, the close proximity of 
the arrays to one another meant that all four arrays could be used for data mining 
and that the microarray provides consistent data over the microarray experiment. 
Once control genes had been filtered out and the data normalised, 7251 (83%), of 
J2315 specific features were eligible for analysis.
5.23 Microarray data analysis
The data obtained from the microarray was analysed using statistical software 
GeneSpring GX 7.3 (Agilent, Chapter 2, section 2.16). Once normalisation had 
taken place to correct for biases that occur due to differences in RNA concentration 
or differing efficiencies of label incorporation (Ehrenreich, 2006), filtering on 
confidence level and analysis of gene expression fold change were carried out. 
This produced a reduced list of significantly changed genes to work with. Filtering 
on confidence level p < 0.05 reduced the list of significantly altered genes to 339. In 
GeneSpring the data can be represented in various formats, including line graphs 
and block diagrams. One signifies no change in expression in both conditions 
(yellow colour) and anything above one represents genes up-regulated in response 
to chlorhexidine (red colour) and below one indicates genes down-regulated in 
response to chlorhexidine (blue colour) (Figure 5.5).
Fold change differences were looked for by filtering on the p<0.05 gene list. A 
greater than two fold change gave a gene list of 32 up-regulated genes and 41 
down-regulated genes. Although a two fold threshold is fairly low, to further prevent 
missing false negatives, the threshold was lowered even further to a > 1.5 fold 
change. Whilst this may seem an insignificant change, it has been seen for efflux 
proteins, that a change as low as 1.3 fold change in expression has a dramatic 
effect on the activity of the pump (Eaves et al., 2004). Therefore this data was 
included in the original analysis and produced a list of 98 up-regulated and 76 
down-regulated genes (Table 5.1 and 5.2). These genes were spread across the 
genome of J2315 and often clusters of genes were seen to be affected. As
169
Chapter 5.0 Gene expression of B. cenocepacia J2315 in response to chlorhexidine
Distance 0.898
4 arrays (Default Inter.
t t t t
Array 1 Array 2 Array 3 Array 4
Figure 5.4 Condition tree analysis of all four replicates showing an 0.898 array 
to array correlation
Condition tree analysis to compare reproducibility of the four microarray replicates. The array to 
array correlation was 0.898, with a distance of 1 representing arrays that are exactly the same. Due 
to the close proximity of the four microarrays, all of replicates were included in further analysis.
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Figure 5.5 Filtering on confidence level p<0.05 gives 339 genes out of 7251 
J2315 specific genes
Normalisation of data and filtering on confidence level to produce a list of significantly altered genes. 
Red lines indicate genes that are significantly up-regulated at p < 0.05 in exposure to chlorhexidine. 
Blue lines indicate genes that are significantly repressed at p < 0.05 in response to chlorhexidine 
and yellow lines indicate genes with no alteration in gene expression in response to chlorhexidine.
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expected many of the genes up-regulated were involved in efflux, such as 
resistance nodulation division pumps. Genes involved with transport and secretion 
were also up- regulated, which may also be involved in the removal of cytotoxic 
compounds from the cell. Down-regulated genes were mostly involved in motility 
and chemotaxis, with only 10 genes (13%) of the 76 repressed genes involved with 
other processes. Two up-regulated genes were selected for further analysis, 
BCAM 0924, a putative response regulator and BCAL 2353 a transport related 
gene.
5.24 Validating microarray data
To validate the microarray data, semi quantitative reverse transcriptase (RT PCR) 
and quantitative Real Time PCR (QPCR) was carried out on a selection of genes. 
The growth curve experiments and RNA harvesting was repeated on fresh cultures 
before validation was performed. Semi quantitative PCR was performed on three 
up-regulated genes, a response regulator (BCAM 0924), fold change 15.92, a 
secretion protein (BCAM 0927), fold change 13.14 and a transport related protein 
(BCAL 2353), fold change 3.453 (primers Table 2.4). The semi quantitative method 
compares the cycle with which the product appeared in both conditions. In an up - 
regulated gene you would expect a product to appear earlier. For comparison, a 
housekeeping gene, phaC (BCAL 1861) was selected which had a constant level of 
expression in both conditions. In the control experiment, the product appears after 
30 cycles in both conditions (Figure 5.6), indicating that there is a constant level of 
expression and that cDNA concentrations are not affecting the PCR outcome. For 
the three up-regulated genes, it was seen that in each experimental condition 
(Figure 5.6), the product appears earlier compared to the control condition. BCAL 
2353 appears after 25 cycles compared to 30 cycles in the control condition. 
BCAM 0924 and BCAM 0927 have very low intensities in the control condition, but 
it can clearly be seen that the product is appearing at 30 cycles compared to 35 
cycles in BCAM 0924 and 35 cycles compared to 40 cycles in BCAM 0927. This 
indicates that the microarray experiment produced accurate results and that 
transcription of these three genes was genuinely up-regulated in response to 
chlorhexidine.
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Table 5.1 Up-regulated genes in J2315 exposed to Chlorhexidine (P<0.05, >1.5
fold change)
Gene Name Fold change Function
BCAL0010 2.6 phenylalanine-4-hydroxylase
BCAL0042 1.6 bifunctional PutA protein [includes: proline
BCAL0057 1.8 putative membrane protein
BCAL0355 1.7 putative transmembrane protein (fragment)
BCAL0428 1.6 putative tRNA modification GTPase
BCAL0500 1.9 ATP-dependent Hsl protease ATP-binding subunit
BCAL0659 2.3 conserved hypothetical protein
BCAL0660 1.9 biotin carboxylase
BCAL0661 2.3 putative biotin-bindina protein
BCAL0662 1.9 LamB/YcsF family protein
BCAL0874 1.8 putative membrane protein
BCAL0961 1.7 putative lipoprotein
BCAL1664 1.5 conserved hvoothetical protein
BCAL1665 1.7 conserved hvoothetical protein
BCAL1689 1.5 conserved hypothetical protein
BCAL1725 1.55 precorrin-8X methylmutase
BCAL1726 1.7 putative oxidoreductase
BCAL1808 1.7 putative membrane protein
BCAL1853 1.5 putative cystathionine beta-lyase
BCAL1857 11.7 putative membrane protein
BCAL1858 12.7 conserved hvoothetical protein
BCAL1919 1.8 CIpB heat-shock protein
BCAL1938 1.5 family C40 unassigned peptidase
BCAL1952 1.8 conserved hypothetical protein
BCAL2022 1.9 conserved hvoothetical protein
BCAL2023 1.5 putative membrane protein
BCAL2024 1.5 larae-conductance mechanosensitive channel
BCAL2116 1.5 putative acyl-CoA-binding protein
BCAL2352 3.3 putative carbonic anhvdrase
BCAL2353 3.4 putative transport-related membrane protein
BCAL2370 2.6 putative membrane protein
BCAL2420 1.6 putative depolymerase/histone-like protein
BCAL2441 1.8 conserved hvoothetical protein
BCAL2442 1.692 chaperone protein HtpG
BCAL2451 2.7 putative membrane protein
BCAL2462 1.6 putative RNA polymerase sigma factor, sigma-70
BCAL2472 1.7 alpha,alpha-trehalose-phosphate synthase
BCAL2607 1.6 putative exported protein
BCAL2820 1.8 outer membrane efflux protein
BCAL2821 2.1 putative RND family acriflavine resistance
BCAL2822 2.1 putative RND familv acriflavine resistance
BCAL2823 2.0 TetR familv reaulatory protein
BCAL2828 1.9 putative exported protein
BCAL3003 2.2 hypothetical protein
BCAL0010 2.6 phenylalanine-4-hydroxylase
BCAL0042 1.6 bifunctional PutA protein [includes: proline
BCAL0057 1.8 putative membrane protein
BCAL0355 1.7 putative transmembrane protein (fragment)
BCAL0428 1.6 putative tRNA modification GTPase
BCAL0500 1.90 ATP-dependent Hsl protease ATP-binding subunit
BCAL0659 2.3 conserved hvoothetical protein
BCAL0660 1.9 biotin carboxylase
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Table 5.1 cont
Gene Name Fold change Function
BCAL3148 1.9 conserved hypothetical protein
BCAL3152 1.8 putative RNA oolvmerase siama factor
BCAL3153 1.6 putative lipoprotein
BCAL3524 1.6 putative general secretory pathway protein
BCALr2006 1.8 tRNA Leu anticodon TAG, Cove score 75.32
BCAM0025 1.7 putative membrane protein
BCAM0085 3.1 putative regulatory protein - TetR family
BCAM0269 1.7 hypothetical protein
BCAM0301 1.6 putative membrane protein
BCAM0398 1.5 hypothetical protein
BCAM0459 2.2 cysteine desulfurase
BCAM0476a 1.5 hypothetical protein
BCAM0493 1.7 putative membrane protein
BCAM0893 1.6 putative membrane protein
BCAM0924 15.9 putative response reaulator
BCAM0925 8.0 putative outer membrane protein OprM precursor
BCAM0927 13.1 putative secretion protein - HlvD familv
BCAM1010 2.3 putative UTP-glucose-1-phosphate
BCAM1017 J 1 1.7 formate dehydrogenase, major subunit
BCAM 1239 1.7 hypothetical protein
BCAM1411 1.5 putative short-chain dehydrogenase
BCAM 1726 1.8 putative exported protein
BCAM1742 2.9 putative exported protein
BCAM2052 1.7 putative type III secretion system protein
BCAM2053 2.0 putative tvpe III secretion svstem protein
BCAM2073 1.8 conserved hypothetical protein
BCAM2152 1.6 putative transmembrane protein
BCAM2400b 2.3 putative exported protein
BCAM2418 1.5 putative membrane-anchored repetitive
BCAM2444 2.3 putative exported protein
BCAM2487 2.0 conserved hypothetical protein
BCAM2562 1.6 putative succinate-semialdehyde dehydrogenase
BCAM2623 1.8 conserved hypothetical protein
BCAMr0727 1.8 tRNA Pseudo anticodon GAA, Cove score 36.58
BCAS0018 1.5 putative transcriptional regulator, MarR family
BCAS0081 6.8 ABC transporter
BCAS0082 2.1 putative exported protein
BCAS0083 3.5 putative transcriptional reaulator - TetR
BCAS0167 1.7 sgualene-hopene cyclase
BCAS0203 1.6 putative membrane protein
BCAS0219 1.6 putative exported protein
BCAS0221 1.5 putative ABC transporter (pseudogene)
BCAS0223 1.5 possibly involved in production of antifungal
BCAS0235 1.5 putative two-component response regulator
BCAS0246 1.6 conserved hypothetical protein
BCAS0412 1.6 putative membrane protein
Gene name in bold = > 2 fold change 
Underlined = neighbouring genes
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Table 5.2 Down-regulated genes in J2315 exposed to Chlorhexidine (P<0.05,
>1.5 fold change)
Gene Name Fold change Function
BCAL0110 2.8 putative aminotransferase. O-antiaen related
BCAL0111 2.7 putative TPR reoeat protein
BCAL0112 4.8 conserved hvoothetical protein
BCAL0113 7.2 flaaellar hook-associated protein
BCAL0114 7.8 flaqellin
BCAL0124 1.5 flagellar regulon master regulator subunit FlhD
BCAL0126 2.4 chemotaxis protein MotA
BCAL0127 2.3 chemotaxis protein MotB
BCAL0128 3.4 chemotaxis two-component response reaulator
BCAL0129 3.4 chemotaxis two-component sensor kinase CheA
BCAL0130 1.8 chemotaxis protein CheW
BCAL0132 2.3 chemotaxis protein methvltransferase
BCAL0133 3.7 putative chemotaxis protein
BCAL0134 4.5 chemotaxis orotein-qlutamate methvlesterase
BCAL0135 2.7 chemotaxis protein CheY2
BCAL0136 2.7 chemotaxis protein CheZ
BCAL0137 1.9 conserved hvoothetical protein
BCAL0142 2.7 flaqellar biosvnthesis protein FlhF
BCAL0143 2.9 flaaellar biosvnthesis protein FlhG
BCAL0144 2.5 RNA polvmerase siqma factor for flaqellar
BCAL0349 1.5 putative outer membrane protein
BCAL0350 1.6 conserved hypothetical protein
BCAL0520 4.0 putative flaqellar hook-lenqth control protein
BCAL0521 3.1 flaqellar fliJ protein
BCAL0523 2.7 flaqellar assemblv protein
BCAL0524 1.8 flaqellar motor switch protein
BCAL0525 2.2 flaqellar M-rinq protein
BCAL0527 4.2 flaaellar protein
BCAL0528 1.7 conserved hvoothetical protein
BCAL0561 2.0 putative flaqella svnthesis protein
BCAL0562 3.4 putative neqative reaulator of flaqellin
BCAL0564 4.2 putative flaaellar basal-bodv rod protein
BCAL0565 5.9 flaaellar basal-bodv rod protein
BCAL0566 4.7 putative basal-bodv rod modification protein
BCAL0567 5.2 putative flaaellar hook protein
BCAL0568 6.8 flaaellar basal-bodv rod protein
BCAL0569 5.1 flaqellar basal-bodv rod protein
BCAL0570 4.3 flaqellar L-rinq protein precursor
BCAL0571 3.9 flaaellar P-rinq protein precursor
BCAL0572 3.9 putative peotidoalvcan hydrolase
BCAL0575 2.97 conserved hvoothetical protein
BCAL0576 4.9 putative flaaellar hook-associated protein
BCAL0577 6.2 putative flaqellar hook-associated protein
BCAL0910 1.5 putative PhoH-family protein
BCAL1063 1.6 succinylarginine dihydrolase
BCAL1069 1.6 putative cyclic-di-GMP signaling protein
BCAL1213 2.2 2-oxoisovalerate dehydrogenase beta subunit
BCAL1252 1.5 putative proline/betaine transporter
BCAL1262 1.5 carbamoyl-phosphate synthase large chain
BCAL1668 1.7 putative amino acid transport system, exported
BCAL1859 1.6 putative dihydrofolate reductase
BCAL2682 1.7 putative sulfate adenylyltransferase subunit 2
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Table 5.2 cont
Gene Name Fold Change Function
BCAL2905 2.1 hypothetical protein
BCAL3244 1.5 putative glycosyl transferase
BCAL3336 1.6 bifunctional purine biosynthesis protein
BCAL3502 1.5 flagellar biosynthetic protein
BCAL3505 5.3 probable flaaellar motor switch Drotein
BCAL3506 1.5 flaaellar motor switch Drotein FliM
BCALr2994 1.5 tRNA Thr anticodon CGT, Cove score 87.03
BCAM0548 1.8 60 kDa chaperonin (protein cpn60) (groel
BCAM0987 2.0 putative flagellar basal body rod protein
BCAM1503 4.4 putative methyl-accepting chemotaxis protein
BCAM1744 3.3 putative exported peptidase
BCAM2193 1.6 putative 3-hydroxyisobutyrate dehydrogenase
BCAM2342 1.6 putative betaine aldehyde dehydrogenase
BCAM2395 1.6 putative dehydrogenase/oxidoreductase protein
BCAM2564 3.7 putative aerotaxis receptor
BCAM2837 J 0 1.7 putative response regulator, pseudogene
BCAM2837 J 1 2.5 putative response regulator, pseudogene
BCAS0130 1.6 putative ABC transporter substrate-binding
BCAS0520 1.9 hypothetical ohaqe protein
BCAS0521 1.8 hypothetical Dhaae protein
BCAS0523 1.7 hypothetical Dhaae protein
BCAS0524 1.9 hypothetical Dhaae protein
BCAS0717 1.5 hypothetical protein
fliE 3.1 fliE
Bold gene name = > 2 fold change 
Underlined = neighbouring genes
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Figure 5.6 Validation of microarray data by semi quantitative PCR
Results of semi quantitative PCR on cDNA derived from 8. cenocepacia grown in A - control 
conditions (LB broth only) and B experimental conditions (5 pg/ml chlorhexidine). The number of 
cycles at which the product appeared are labelled above the panel.
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To get more accurate levels of gene expression fold change, QPCR was used 
(primers Table 2.4). The method selected used a fluorescent dye called SYBR 
green (AB gene) that binds and fluoresces to double stranded DNA. Thus is this 
manor, the product can be detected as it is synthesised by measuring fluorescence. 
It is called Real Time PCR as the fluorescence is read continuously so as the 
product appears it is recorded by an increase in fluorescence. Fold change can be 
calculated by two methods, delta delta C j or the Pfaffl method, as described in 
Chapter 2, section 2.10.2). QPCR was carried out for ten genes, seven up- 
regulated and three down-regulated. Both calculation methods were used to 
determine fold changes. Control experiments were included. The control gene 
phaC (BCAL 1861) was included in every experiment and a no reverse 
transcriptase control was incorporated to check that there was no contamination 
with DNA which may effect the amplification. The experiments were carried out in 
triplicate so an average could be calculated (Figure 5.7). To check that the right 
product has been amplified and that all replicates were the same a melting curve 
analysis was carried out (Figure 5.8). All products should have the same melting 
point, so a melting curve as observed in Figure 5.8 suggests that the QPCR results 
are correct. The QPCR calculations corroborated the microarray data, with all 
genes showing the correct up or down regulation (Table 5.3).
5.3 Discussion
5.31 Whole genome analysis using microarrays compared to traditional 
methods
In this investigation a microarray experiment was conducted to determine the 
effects of sub inhibitory levels of chlorhexidine on the gene expression in the model 
B. cenocepacia pathogen J2315. Chlorhexidine is a disinfectant often used in 
clinical situations, but is often found to be contaminated by many species of 
bacteria including members of the Bcc (Oie and Kamiya, 1996). Several Bcc 
species in particular cause many problems due to contamination of both clinical and 
domestic products, which may be the source of infection in vulnerable patients 
(Jimenez, 2007). Consequently it is important to understand the underlying 
mechanisms of resistance to help prevent infections occurring and possibly
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Figure 5.7 Real time PCR results for secretion protein BCAM 0927
QPCR screen of the secretion protein BCAM 0927. Red, green and blue lines represent replicates 
of the control condition and orange, turquoise and purple lines represent replicates of the 
experimental condition (exposure to chlorhexidine). Products appeared at approximately 30 cycles 
in the experimental conditions compared to 36 cycles in the control condition, corresponding to an 
up regulation of this gene. The CT value is an arbitrary threshold level set by the experimenter, 
which allows cycle number to be determined.
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Figure 5.8 Melting curve for secretion protein, BCAM 0927
Melting curves are performed after the QPCR run has taken place as a quality control step. 
Products of the same size should have similar melting points as shown in this graph. Lower 
temperature melting points may indicate the formation of primer dimers and suggest the formation of 
an incorrect product.
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elucidate new targets for antimicrobial therapy. In this investigation J2315 was 
grown in the presence of 5 pg/ml of chlorhexidine. This is a level well below the 
MIC (>100 pg/ml), but provided information on genes that are altered in expression 
to sub inhibitory levels. However bacteria are often exposed to sub MIC levels of 
biocides in the environment due to residuals resulting from over use of biocides. It 
is also interesting to study the effects of sub inhibitory levels of biocides as it 
reveals genes that may be significant for resistance and survival as they are 
affected by very low concentrations of the biocide.
Traditionally, random mutagenesis screens have been used to create mutant banks 
that are screened for a loss of a specific phenotype. As well as being time 
consuming (generating enough mutants and picking and screening mutants), there 
are limitations with the screening process as they may miss some genes that play a 
role due to no mutant being generated and it may be difficult to see the interactions 
of certain genes in pathways. The microarray provides data on all genes that are 
altered in expression and can rapidly distinguish the role they play in the 
experimental conditions. As well as providing functional information (for annotated 
genomes), a microarray experiment also provides data on genes that are not only 
switched on due to the environmental stimulus but also repressed. Clusters of 
genes are also revealed, indicating operons which are altered in expression, thus 
giving an in depth view of the bacterium’s response in relation to the stimulus, in 
this case chlorhexidine.
A microarray experiment has the added bonus of allowing the comparison of two 
conditions simultaneously, generating a vast amount of data (Ehrenreich, 2006). 
Expression profiling using microarrays has the capacity to produce a large bank 
of data. However, this is also one of the drawbacks of using a microarray. 
Extensive data mining needs to be carried out, which can be time consuming and 
the sheer volume of data produced can make it difficult to select which genes to 
analyse further. Other issues that arose from the microarray experiment are the 
cost of production and reagents for the experiments. Specialist equipment, such as 
the scanner are also required and extensive technical training is also needed
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Table 5.3 Confirmation of microarray data by real time PCR
Gene
Putative
Function
M icroarray  
fold change
Delta delta  
CT method
Pfaffl
method
U p / Down  
regulated
BCAL 0114 Flagellin -7.8 -238.1 -15873 4
BCAL 0126
Chemotaxis  
proton MotA
-2.4 -3.3 -1.8 4
BCAL 0143
Flagellar 
biosynthesis  
protein FilG
-2.9 -8.9 -5.9 4
BCAL 2353
Transport 
related protein
3.4 11.7 7.4 t
BCAL 2370
Membrane
protein
2.6 2.9 7.7 t
BCAM 0924
Response
regulator
15.9 10.6 8.1 t
BCAM 0925
Outer membrane 
protein OprM
8.0 106.4 62.7 t
BCAM 0927
Secretion 
protein HlyD
13.1 150.5 71.2 t
BCAS 0081
ABC transporter 6.8 10.2 37.9 t
BCAS 0083
Transcriptional 
regulator - TetR
3.5 34.6 7.7 t
Fold change as determined by delta -  delta method and Pfaffl method (Chapter 2, 2.10.2). Delta -  
delta method uses the control gene (phaC) for normalisation. The Pfaffl method also takes into 
account the efficiency of the reaction, determined by a standard calibration graph.
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(Ehrenreich, 2006). Nonetheless, microarray experiments are being used more 
frequently and provide the researcher with a comprehensive whole genome view of 
the expression profile of the bacterium in the experimental conditions. In this 
investigation the microarray produced a list of genes with altered expression in the 
presence of chlorhexidine. These genes were distributed across the genome of B. 
cenocepacia J2315. The largest proportion of altered genes was found on the large 
chromosome which was not surprising as this chromosome contains most genes, 
including essential housekeeping genes. For up-regulated genes, 57 were found 
on the large chromosome, 29 on the second chromosome and 12 on the small 
chromosome. Down-regulated genes were distributed as follows: 59 on the large 
chromosome, 10 on the second chromosome and 6 on the small chromosome.
5.32 Validation of microarray data
The B. cenocepacia J2315 microarray had only been recently designed, therefore 
to fully validate it the data was confirmed by both reverse transcriptase PCR and 
real time PCR (QPCR). Three up-regulated genes were selected for reverse 
transcriptase PCR and ten genes for QPCR. These genes were all compared to a 
housekeeping gene which expressed consistently in both condition (phaC). The 
genes were selected to include: up-regulated and down-regulated genes, those 
from different functional classes and those with a range of fold changes. Reverse 
transcriptase PCR on three up-regulated genes indicated that the microarray data 
was correct (Figure 5.6). All three gene products appeared in the experimental 
condition (5 pg/ml of chlorhexidine), at least five cycles earlier than in the control 
condition. The phaC housekeeping gene appeared at 30 cycles in both conditions 
demonstrating that equal concentrations of cDNA was added in both conditions, so 
that the results were not biased.
Reverse transcriptase PCR is a semi quantitative method of validating the 
microarray results, so to further confirm these results a quantitative method can be 
used. Real time PCR measures the production of double stranded DNA by 
scanning for fluorescence and gives a numerical value that allows fold change to be 
calculated. There are a number of ways to calculate fold change. The delta delta 
CT method is a quick method that assumes 100% efficiency (see Chapter 2 for
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equation). Although this is not the most accurate method it still gives a close 
estimation of fold change. Alternatively the Pffaffl method can be used (Pfaffl,
2001). This takes into account the efficiency of the reaction by creating a standard 
curve and then calculating the efficiency of the reaction from the slope. Both 
methods were used in this investigation and compared to the microarray data 
(Table 5.3). Both methods of calculating fold change in the QPCR experiment gave 
an appropriate answer and correlated well to one another.
Most of the genes had a fairly consistent fold change across the three separate 
methods, although the QPCR method generally produced higher fold changes than 
the microarray experiment. For example a putative ABC transporter had a 6.8 fold 
change in the microarray, but had a 10.2 and 37.9 fold change from the QPCR 
analysis. The flagellin gene (BCAL 0114) was the only gene that demonstrated a 
large discrepancy in fold change between the microarray data and Real time PCR 
data, although it still confirmed the microarray data by indicating this gene was 
down-regulated (Table 5.3). Although absolute values were different they still 
corroborate the microarray data (Table 5.3). Thus the semi quantitative reverse 
transcriptase and Real time PCR have an excellent correlation with the microarray 
data, demonstrating that the J2315 microarray was performing well and that data 
obtained via the microarray could be used for further analysis.
5.33 Up-regulated genes involved with biocide resistance
The microarray experiment produced a list of genes with altered expression in 
response to chlorhexidine. Filtering at p<0.05 with a fold change of > 1.5, gave a 
list of 90 up-regulated genes. These genes can be spilt into three major categories 
that encompass genes involved in biocide resistance: (i) efflux proteins, (ii) 
transport and secretion proteins and (iii) membrane related proteins (Table 5.4).
5.33.1 Efflux pumps
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Table 5.4 Major Gene Groups in B. cenocepacia involved in biocide resistance
Gene Number
Fold
Change
Putative Gene function
Transport / Secretion
Up-regulated
BCAL 2353 3.7 Transport related
BCAL 2821 2.1 RND acriflavine resistance
BCAL 2822 2.1 RND acriflavine resistance
BCAM 0924 16.3 Response regulator (efflux)
BCAM0925 7.9 Outer membrane protein OprM precursor
BCAM 0927 13.2 Secretion protein HlyD
BCAM 2053 2.0 Type III secretion system
BCAS 0081 7.1 ABC transporter
Down-regulated (none)
Regulation and Stress
Up-regulated
BCAL1919 1.8 Heat shock CIpB
BCAL 2823 2.0 TetR regulatory protein
BCAS 0018 1.5 MarR transcriptional regulator
BCAS 0083 3.5 TetR transcriptional regulator
BCAS 0235 1.5 Two component response regulator
Down-regulated (none)
Motility and Chemotaxis
Up-regulated (none)
Down-regulated
BCAL 0110-0114 to Lj I 'sj 00 Flagellin
BCAL 0126-0137# 1 .8 -4 .5 Chemotaxis
BCAL 0142-0144 2 .5 -2 .9 Flagellar biosynthesis
BCAL 0520 -  0528* 1.7 — 4.2 Flagellar assembly
BCAL 0561 -  BCAL 0577* 1.5 — 6.8 Flagellar assembly / proteins
Other
Up-regulated
BCAL 1857 11.7 Membrane associated protein
BCAL 2370 2.6 Membrane associated protein
BCAL 2451 2.7 Membrane associated protein
Down-regulated (none)
# - excluding BCAL 0231, * - excluding BCAL 0522 and 0526, + - excluding BCAL 0563, 0573 and 
0574
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Efflux pumps are well known devices of antimicrobial resistance and are often 
associated with multidrug resistance. The most commonly found efflux pump is the 
RND family, which have a tripartite structure (Piddock, 2006a). The three 
components are a transporter protein embedded in the inner membrane, a 
periplasmic accessory protein which links the inner and outer components and the 
outer membrane protein channel (Figure 5.9) (Poole, 2004). The RND efflux 
pumps work by the proton motive force, using the proton gradient across the 
membrane to exchange one hydrogen ion for one drug molecule (Piddock, 2006a). 
MFS, MATE and SMR pumps also use the proton motive force, where as ABC 
transporters are driven by the hydrolysis of ATP (Figure 5.9).
Efflux pumps work by the transporter or efflux protein in the inner membrane 
binding to the substrate, most likely through hydrogen bonding or electrostatic 
interactions and then transporting them to the external medium via the outer 
membrane protein channel. This interaction between the efflux protein and the 
outer membrane is mediated by the periplasmic accessory protein (Piddock, 2006a, 
Paulsen, 2003). All types of pump apart from MATE pumps have a tripartite 
structure similar to RND pumps.
Efflux pumps can either be chromosomally encoded or may be transferred on 
mobile genetic elements. Most bacteria carry more than one efflux pump, which 
confers resistance to a number of substrates that may be structurally unrelated. An 
efflux pump may have broad specificity, due to a flexible hydrophobic cavity which 
can bind unrelated substrates (Paulsen, 2003). A strain is classed as multidrug 
resistant (MDR) if it is resistant to at least three different classes of antimicrobial 
such as antibiotics, disinfectants, dyes and detergents (Piddock, 2006a). Many 
efflux pumps have been identified in bacterial species, especially those that efflux 
antibiotics, such as the ArcA-ArcB-TolC pump in E. coli and MexA-MexB-OprM 
pump in P. aeruginosa (Poole, 2004). Biocides are also inducers of efflux systems. 
The qac genes efflux quaternary ammonium compounds and can be found in Gram 
positives (usually plasmid encoded) and Gram negatives (chromosomally 
encoded). An efflux gene cepA has been isolated from Klebsiella pneumoniae 
which confers resistance to chlorhexidine (Fang et a/., 2002) and was found to 
have putative homologs in many other bacterial species indicating that an
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Figure 5.9 Classes of Efflux pumps and their mechanism of action
OM = outer membrane, PP = periplasmic space, CM = cytoplasmic membrane, MFP = membrane fusion protein, MFS = multifacilitator superfamily, SMR 
small multidrug resistance, MATE = multidrug and toxic compound extrusion, ABC = ATP binding cassette, RND = resistance nodulation family and QAC 
quaternary ammonium compound. Adapted from (Poole, 2004).
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chlorhexidine efflux pump may be widely distributed amongst Gram negative 
pathogenic bacteria (Poole, 2005b). Triclosan resistance has been widely reported 
and efflux plays a major role (Mima et a/., 2007). Many RND antimicrobial 
resistance pumps can also efflux triclosan. There are also concerns that the use of 
triclosan selects for multidrug resistant mutants due to over expression of efflux 
pumps (Poole, 2005b). Thus biocide efflux mediated resistance is a potential target 
for new antimicrobial therapies as this may not only increase susceptibilities to 
biocides but also unrelated antibiotics.
The Bcc are known to encode a number of efflux pumps, with a recent study 
indicating a possible 14 RND pumps in B. cenocepacia species alone (Guglierame 
et a/., 2006). Comparison of these 14 possible pumps with data from this study 
indicated some overlaps. BCAL 2821 was up-regulated by 2.1 fold in this 
microarray experiment and appears to be part of an RND efflux operon involved in 
acriflavine resistance. In the investigation by Guglierame et a\. BCAL 2821 was 
identified as an efflux transporter acrB domain. This gene appeared to be part of 
an operon that also contained mexA and oprM homologs, thus contained all three 
components of a tripartite efflux pump (Guglierame et a!., 2006). This investigation 
also identified BCAM 0926, a possible multi drug efflux transporter protein. 
Although not significantly up-regulated in this experiment, this efflux transporter 
pore domain, appears to be part of an operon which was up-regulated. BCAM 
0924 -  0927 had homology to components of RND efflux pumps including the outer 
membrane component and a response regulator, hence these two pumps may be 
particularly interesting for investigation.
An immunodominant drug efflux pump, BcrA has previously been described in B. 
cenocepacia J2315. This pump belongs to the major facilitator superfamily and 
gave resistance to nalidixic acid and tetracycline, but not to many other 
antimicrobials such as ciprofloxacin, chlorhexidine, meropenem, gentamicin and 
detergents such as Tween (Wigfield et al., 2002). Arguably the ceo operon (BCAM 
2549-2552, 2554) is the most well characterised efflux pump in B. cenocepacia. 
This is a RND efflux cluster that can remove chloramphenicol, trimethoprim and 
ciprofloxacin and is induced by salicylate, an important siderophore (Nair et al., 
2004). Interestingly, the ceo operon or the BcrA pump was not altered in
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expression in response to chlorhexidine. The microarray indicated that other less 
well understood pumps such as the two RND operons up-regulated in this 
experiment (BCAM0924 -  0927 and BCAL 2820 -  2823) play a larger role in 
disinfectant resistance.
Also up-regulated in the microarray experiment was an ABC transporter, BCAS 
0081. ABC transporters are types of efflux pumps that use ATP to actively efflux 
compounds. ABC transporters are involved with the removal of cytotoxic 
compounds, including antimicrobials. They have a high affinity for binding 
antimicrobials and thus contribute to multidrug resistance (Sheps and Ling, 2007). 
The ABC transporter may be an interesting gene to select for further analysis as to 
our knowledge, an ABC transporter involved with biocide resistance in the Bcc has 
not yet been identified.
5.33.2 Secretion and Membrane proteins
Transport and secretion related genes were seen to be up-regulated in this 
experiment, such as the type three secretion system, BCAM 2052 and BCAM 2053. 
Type three secretion systems (TTS) are well known virulence factors and have a 
variety of functions within the bacterium. They deliver excreted proteins to target 
cells including toxins and other cytotoxic compounds that may aid pathogenesis. 
They do this via ATP hydrolysis, allowing secretion across the inner membrane 
(Winstanley and Hart, 2001) Type three secretion systems are linked with the host 
cell response and are often induced by the host interactions. Type three secretion 
systems can protect the bacterium from the host’s immune system by killing 
macrophages. They also aid invasion of host cells and transport other proteins 
involved in virulence, such as elastase, protease, a haemolysin and exotoxins 
directly into host cells (Glendinning et al., 2004).
Secretion systems have been identified in members of the Bcc, including type three 
secretion systems BCAM 2052 and BCAM 2053 (Table 5.1), which are usually 
found on pathogenicity islands. These two genes are components of a 
characterised type three secretion system which is possibly involved in 
pathogenesis but not necessarily invasion of host cells (Holden et al., 2009).
188
Chapter 5.0 Gene expression of B. cenocepacia J2315 in response to chlorhexidine
Bacterial strains that have mutations in type three secretion systems have 
attenuated virulence and are thus easily killed by the host’s immune response, 
implying that TTS are important for the bacterium’s survival within the host (Tomich 
et al., 2003). After exposure to chlorhexidine, a TTS system (BCAM 2052 -  BCAM 
2053) was up-regulated in B. cenocepacia J2315, suggesting that sub inhibitory 
levels of chlorhexidine are causing an increase in virulence factors that may allow 
the persistence of Bcc species in the host.
Also observed in this experiment was the up regulation of membrane proteins such 
as BCAL 1857 and BCAL 2370 (Table 5.1 and 5.4). The outer membrane is 
associated with antimicrobial resistance due to its limited permeability to many 
antimicrobials, especially cationic compounds. As previously mentioned (Chapter 
5, section 5.1) the Bcc has a membrane composition that lends itself to being 
particularly resistant to a multitude of compounds. Therefore it is not surprising that 
in response to chlorhexidine, many membrane proteins are over expressed. 
Tattawasart et al. conducted a study to investigate outer membrane changes in 
chlorhexidine sensitive and chlorhexidine resistant P. stutzeri. They found that 
chlorhexidine resistant strains had a different outer membrane profile compared to 
the sensitive strains, with the appearance of three dominant bands, signifying that 
these bands are being over expressed (Tattawasart et al., 2000). Thus, in B. 
cenocepacia J2315 a similar effect may be happening, with chlorhexidine inducing 
expression of membrane proteins to prevent chlorhexidine entering the cell. 
Although studies such as Tattawasart et al. have shown changes in the membrane 
structure in resistant bacteria very few specific genes have actually been implicated 
in these changes. This study found three membrane proteins up-regulated (Table
5.4) in response to chlorhexidine and could account for membrane profile changes.
5.33.3 Other genes involved in antimicrobial resistance
When bacterial cells are exposed to environmental stress, such as fluctuations in 
temperature or exposure to antimicrobials they need to adapt rapidly to survive. 
Many of these adaptive responses are controlled by regulatory proteins, which 
respond to the stimulus and then modulate transcription and translation of genes
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that are required for survival (Ramos et al., 2005). Two interesting transcriptional 
regulators were observed as up-regulated in response to chlorhexidine, BCAS 
0018, a MarR transcriptional regulator (1.5 fold change) and BCAS 0083 and 
BCAL2823, TetR transcriptional regulators (3.5 and 2 fold change respectively).
The MarR regulator is part of a regulon found in E. coli that is involved with multiple 
antibiotic resistance (multiple antibiotic resistance). The mar locus alters gene 
expression of multiple genes involved in resistance on the chromosome, thus 
conferring resistance to not only antibiotics, but also organic solvents, oxidative 
stress agents and disinfectants (Alekshun and Levy, 1999). MarA, an activator is 
usually repressed by MarR, however when the bacterial cell is exposed to stress, 
MarR is inactivated and MarA can be over expressed and activate the expression of 
resistance genes. Resistance is induced by the decrease of influx and increase of 
efflux of toxic chemicals, hence the expression of membrane proteins are effected 
and resistance to oxidative stress is achieved by increased expression of enzymes 
that counteract the damage to the cell (Alekshun and Levy, 1999). The mar operon 
is induced by tetracycline, chloramphenicol and confers resistance to a range of 
antibiotics including norfloxacin, ampicillin, nalidixic acid and rifampicin. As well as 
resistance to antibiotics over expression of MarA gives resistance to disinfectants 
including phenols (chloroxylenol), QACs and triclosan (Alekshun and Levy, 1999). 
In this experiment, MarR regulatory protein was over expressed in response to sub 
inhibitory concentrations of chlorhexidine, indicating that it can also be induced by 
biguanides, however the role MarR plays in resistance may be different in B. 
cenocepacia J2315 as it is the repressor that is being over expressed. The over 
expression of efflux pumps, such as the RND acriflavine pump and a heat shock 
protein (BCAL 1919) involved in protection against oxidative stress, suggests that 
the mar locus may be involved in the regulation of these important resistance 
genes. There may also be an indication of cross resistance as the mar locus is 
involved in the regulation of a broad spectrum of resistance mechanisms.
The second transcriptional regulator up-regulated was a homolog of TetR, which is 
part of a family of proteins that control the expression of tet genes whose products 
are involved in tetracycline resistance (Ramos et al., 2005). Like the mar operon, 
the tet locus may regulate efflux pumps. In the chlorhexidine experiment, two of the
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TetR family regulators were adjacent to genes involved with efflux, BCAL 2820 -  
2823, RND efflux and BCAS 0081 — 0083, ABC transporter. Thus this suggests 
that the TetR family of regulators are intricately involved with efflux regulation and 
that chlorhexidine is capable of inducing this regulatory system.
5.34 Down-regulated genes are involved in motility and chemotaxis
An interesting observation from the microarray experiment was that the majority of 
genes repressed after exposure to chlorhexidine were involved with the production 
of flagellar and chemotaxis proteins (Table 5.4). Many of these genes were 
adjacent to one another suggesting that whole operons were being repressed in 
response to chlorhexidine, indicating that chlorhexidine is sensed by the bacterial 
cell and a global regulation mechanism is employed (Figure 5.10). The down 
regulation of genes involved in motility leads to the conclusion that this 
phenomenon must play an important role in bacterial survival to biocides like 
chlorhexidine, raising many interesting questions. Before these questions can be 
addressed, the role of flagella and chemotaxis should be discussed.
Flagella biosynthesis is complicated with the hierarchical transcription of over 40 
genes usually conforming to the order the proteins are assembled. The 
coordination of transcription is controlled by master regulons such as FilD 
(McCarter, 2006). The structure of the flagella comprises of an basal body 
(containing an MS ring, rod and a periplasmic P ring), the flagellar motor, 
regulatory switch which is activated by environmental signals, a flagellar hook, 
flagellar filament, capping proteins and export apparatus (Macnab, 2003) (Figure 
5.11). Flagella are associated with host invasion, adhesion, chemotaxis, swarming, 
biofilm production and interactions with the host defence system. Chemotaxis is 
the coordinated migration of bacterial cells towards a chemical signal. For example 
planktonic cells migrate towards nutrients or other cells attached to a surface (Pratt 
and Kolter, 1998), thus chemotaxis may promote biofilm formation, a lifestyle which 
allows bacteria to persist in unfavourable environments.
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Figure 5.10 Flagellar operon down-regulated in response to chlorhexidine
Artemis view of part of the flagellar operon down-regulated in response to chlorhexidine and their putative functions.
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C Ring Basal body Hook Propeller
EXPORT
Figure 5.11 Structure and organisation of bacteria flagella.
The structure of flagella and its organisation. The flagella plays a role in both motility and export 
containing type three secretion like elements. The bacterial flagellum is powered by the proton 
motive force, leading to rotation of the flagellar motor, which is attached via the MS ring to the basal 
body rod, to the hook and then flagella filament. The type three secretion export apparatus is found 
at the centre of the basal body MS ring and consists of ATPase components that drive export. Nine 
flagellar proteins are solely required for export including FliH, Flil, FliJ, FilA, FilB, FilO, FilP, FilQ and 
FilR (Macnab, 2004). Adapted from (McCarter, 2006)
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Flagellin is the structural protein that forms a major portion of flagellar filaments, 
and has conserved domains. The conserved regions are recognised by the hosts 
cells. The flagella regulon also contains a type three secretion like system which 
exports proteins. The flagella type three secretion system can also facilitate 
pathogen invasion by allowing cells to adhere to the surface and stimulate the 
immune system Toll like receptors (TLR), causing a pro-inflammatory response 
(Ramos et al., 2004). Stimulation of the host immune system may be problematic 
for the infecting bacteria, thus once infection has been established it makes sense 
to repress the flagella machinery to prevent the induction of the immune system 
Although flagellum induces the host immune system it is essential for the invasion 
of host’s tissues. Tomich et al. (Tomich et al., 2002) found that B. cenocepacia 
strains with mutations in filG a motor switch component and fill, a gene involved in 
ATPase protein translocation via the type three secretion system were defective in 
host cell invasion, indicating that the flagellar export system was essential for 
invasiveness (Tomich et al., 2002).
Finally flagella are also involved with swarming motility, the ability of bacteria cells 
to move through viscous surfaces in the presence of extracellular slime (i.e. 
exopolysaccharides) (Daniels et al., 2004). Swarming allows the spreading of 
biofilms across surfaces and non motile strains appear to have attenuated 
virulence. Swarming may be regulated by quorum sensing, which is a population 
dependent response to an environmental stimulus (Daniels et al., 2004). CF 
patients infected chronically with P. aeruginosa tend to have isolates that are non 
motile and resistant to phagocytosis, making eradication difficult (Mahenthiralingam 
et al., 1994). Although this has never been described in Bcc species, it appears 
that a similar, non motile sessile lifestyle is being entered in the presence of 
chlorhexidine. This could lead to the emergence of resistant strains present in a 
biofilm that are difficult to treat, thus the regulation of the expression of motility 
genes after exposure to chlorhexidine should be elucidated to determine novel 
antimicrobial targets.
5.4 Conclusions
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The microarray experiment used in this investigation provided a large bank of data 
which was mined to determine B. cenocepacia genes with altered expression after 
exposure to 5 pg/ml of chlorhexidine. Prior to data analysis, the microarray was 
validated by real time PCR methods. The good correlation between quantitative 
PCR and microarray methods indicated that the microarray was working well and 
the data obtained could be used for further analysis.
The hypothesis that genes involved in antimicrobial resistance such as efflux 
pumps and membrane proteins was fulfilled. Two RND efflux pumps were 
significantly up-regulated (BCAL 2820 -  2823 and BCAM 0924 -  BCAM 0927), as 
well as an ABC transporter (BCAS 0081 -  0083). Other transcriptional regulators 
involved in antimicrobial resistance and stress were up-regulated (MarR and TetR) 
and numerous membrane and transport related proteins were also up-regulated 
(Table 5.1). These genes were the most important in relation to chlorhexidine 
resistance and two genes, BCAM 0924 (efflux response regulator) and BCAL 2353 
(previously un-described transport related gene) were selected for further 
investigation (Chapter 6).
In addition to determining up-regulated genes, genes that were repressed were also 
examined. These genes followed a pattern and were involved in the production of 
flagellar and the process of chemotaxis. Flagella are important virulence factors 
associated with adhesion, invasion, biofilm production and swarming. It is 
interesting to note that whole operons appear to be affected by the presence of 
chlorhexidine, pointing to a global regulation response. To our knowledge this is 
the first time that a motility repression response has been described in the Bcc, 
which may be associated with a non motile, biofilm lifestyle that leads to biocide 
resistance. This phenomenon was investigated further (Chapter 6) as a potential 
target for novel antimicrobial targets.
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Chapter 6.0 Characterising the function of B. cenocepacia 
J2315 genes regulated bv chlorhexidine
6.1 Introduction
As outlined in the previous chapter, there are many complex mechanisms involved, 
in resistance to the biocide chlorhexidine. Gene expression determined using a 
microarray, identified genes which were either up-regulated or down-regulated in 
response to chlorhexidine (Table 5.1, 5.2 and 5.4). These genes involve RND 
efflux pumps, transcriptional regulators, secretion proteins and membrane proteins. 
Less obviously involved with biocide resistance was the repression of genes 
involved with the biogenesis of flagella and chemotaxis. Hence, the microarray 
experiment provided an extensive data bank, from which to select interesting genes 
for further analysis. The microarray also raised a number of questions that were 
explored in more detail in this chapter:
1) What is the role of efflux and transport genes in resistance to chlorhexidine?
2) Do sub-inhibitory levels of chlorhexidine inhibit swarming motility?
3) Do sub-inhibitory levels of chlorhexidine induce biofilm production?
4) Is biocide induced biofilm production a coordinated regulatory phenotype?
5) Are any of these genes potential targets for antimicrobial therapy?
6.11 Investigating efflux and transport genes
Efflux pumps are an important mechanism of antimicrobial resistance and may also 
contribute to cross resistance between unrelated classes of compounds such as 
dyes, detergents, antibiotics and biocides, due to their broad spectrum of activity 
(Chapman, 2003b). For example the acquisition of qac genes, found on a 
transmissible plasmid can mediate cross resistance between quaternary
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ammonium compounds and antibiotics in both Gram negative (P. aeruginosa) and 
Gram positive (S. aureus) organisms (Chapman, 2003b). Bacteria can express 
more than one efflux pump, both within the same family (i.e. RND) or members of 
different families, increasing the amount of substrates an individual strain may be 
resistant to. Efflux attributed resistance is most likely when there is a simultaneous 
increase in MIC’s to three or more compounds compared to a sensitive strain 
(Piddock, 2006b). Efflux pumps are problematic and can render treatment 
ineffective, if they are over expressed. They also contribute to the multidrug 
resistance of a bacterial species.
As well as playing a major role in antimicrobial resistance there has also been 
speculation on the role of efflux in bacterial pathogenesis. Several studies have 
indicated that efflux pumps not only remove antimicrobials but may also export 
virulence factors, such as toxins and also help the bacteria to evade host defences 
by removing secondary metabolites produced by the host which may be toxic to the 
bacterium (Piddock, 2006b). Studies have shown that the lack of expression of 
efflux pumps have a deleterious effect on the invasiveness of some species. P. 
aeruginosa mutants lacking components of the MexAB-OprM could not invade 
epithelial cells, thus exhibited attenuated pathogenesis. The ability to invade 
epithelial cells was restored by complementation with MexAB-OprM (Hirakata et al.,
2002). Therefore there is evidence that efflux pumps may also be important for 
virulence and pathogenesis of clinically relevant bacteria.
Data obtained from the microarray experiment revealed the up regulation of two 
RND efflux pumps in B. cenocepacia J2315 after exposure to chlorhexidine (Table 
5.1 and 5.4). The efflux of triclosan (Mima et al., 2007) has been well described in 
many bacterial species, however efflux pumps that are specific for chlorhexidine 
resistance have not been determined, thus this data suggests that these two pumps 
may be important in chlorhexidine resistance. As well as influencing the MIC of B. 
cenocepacia to chlorhexidine, there is the potential that up-regulated pumps may 
be involved in the B. cenocepacia pathogenesis. Thus exposure to chlorhexidine 
may also contribute to virulence in B. cenocepacia species however this 
speculation can only be tested by the creation of mutants in each efflux pump, 
followed by analysis in models of B. cenocepacia virulence.
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To conclude the investigation into the molecular basis of chlorhexidine resistance in 
B. cenocepacia J2315, an efflux pump gene was chosen for further analysis. 
BCAM 0924 was found on the second chromosome of the B. cenocepacia genome 
and is a response regulator for a MexA like efflux pump. This gene was selected as 
it is involved in the regulation of efflux and thus may be a reasonable target for 
antimicrobial therapy as disrupting its function should have polar effects on the rest 
of the genes in the efflux operon.
As well as a response regulator, a transport related gene was also chosen for 
further investigation. BCAL 2353 was found on the first chromosome in the 
genome and little is known about its specific function. Transport related genes 
could be involved with a number of traits, such as an undefined efflux pump, 
secretion systems, virulence, metabolism and pathogenesis. This gene was 
selected as it was up-regulated in sub inhibitory levels of chlorhexidine and its 
function in biocide resistance has not yet been elucidated. Thus this may be an 
novel mechanism of resistance.
To investigate the role of these two genes, detailed bioinformatic analysis was 
carried out to fully determine the function of the genes. Then site directed 
mutagenesis was used to delete these genes and the phenotypic effect on the 
chlorhexidine susceptibility determined. If these genes are involved in 
chlorhexidine resistance then it would be expected to see a reduction in the MIC of 
B. cenocepacia J2315 to chlorhexidine, which at > 100 pg/ml is representative of 
the highest level of resistance seen within the Bcc.
6.12 Is motility important for survival in chlorhexidine?
An interesting observation from the microarray experiment was that genes down- 
regulated in expression after exposure to chlorhexidine were involved in motility and 
chemotaxis. It appears that the flagella operon is completely repressed in response 
to chlorhexidine (Figure 5.10). This signifies that a coordinated regulation of this 
phenotype is occurring and that chlorhexidine induced a non motile state in B. 
cenocepacia. This non motile lifestyle may be essential for survival in the presence
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of chlorhexidine. The down regulation of motility genes pointed to a decrease in 
swarming motility and the induction of a biofilm lifestyle. Swarming and biofilms are 
implicated in many important processes in the bacterial cell, including invasion of 
host cells, virulence and antimicrobial resistance. Swarming is the coordinated 
movement of bacterial cells across a surface in the presence of an extracellular 
slime (Daniels et al., 2004). This is advantageous if there are nutrient limitations in 
the environment and in addition can spread biofilms across a surface (Daniels et 
al., 2004). Flagella are required for attachment of bacterial cells during the 
formation of biofilms. However, in this investigation it was observed that flagella 
were repressed in response to chlorhexidine, indicating that initial attachment of 
cells may occur by other mechanisms and that repression of flagella leads to 
maturation of the biofilm (Daniels et al., 2004)
The regulation of this non motile phenotype may be an essential component of B. 
cenocepacia’s ability to survive in chlorhexidine, thus understanding this 
mechanism should aid the development of new antimicrobials that can kill this 
organism. A well described swarming regulation system in the Bcc is quorum 
sensing. Quorum sensing is a cell density dependent regulatory mechanism that is 
controlled by the production of sensing molecules, N-acylhomoserine lactones (N- 
acyl-HSLs) which can bind to specific proteins and regulate transcription of genes 
(Lewenza et al., 1999). The quorum sensing system in the Bcc involves two 
proteins, Cepl, which produces the autoinducer N-acyl-HSLs and CepR, which the 
N-acyl-HSLs bind to and activate transcription (Lewenza et al., 1999). Quorum 
sensing is known to regulate virulence factors, such as the production of 
extracellular proteases and chitinase, but also regulates swarming and biofilm 
production (Subsin et al., 2007). Huber et al. found that mutants defective in Cepl 
and CepR were incapable of forming biofilms, due to lack of maturation of the 
biofilm. Swarming was also seen to be QS regulated, through the control of 
biosurfactant (extracellular slime) production (Huber et al., 2001). Consequently 
QS may be intrinsically linked to the regulation of biofilms and motility and may be 
involved in the regulation that has been observed in this investigation.
In prokaryotes, there is an abundance of two component regulatory systems, which 
regulate gene transcription in response to environmental signals. A bacteria’s
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environment is always changing, hence for the bacteria to survive it must be able to 
readily adapt to its environment. Two component regulatory systems regulate 
bacterial adaptation via a signalling system that involves a histidine kinase and a 
response regulator. The histidine kinase is a sensor molecule, which contains a 
signal recognition domain. The environmental signal is recognised and it 
autophosphorylates a histidine residue, by ATP hydrolysis. The response regulator 
then catalyses the transfer of the phosphoryl group to one of its own aspartine 
residues. This activates an effector domain in the response regulator, such as a 
GGDEF domain, which elicits a specific response, such as the switching on of 
transcription of specific genes (West and Stock, 2001, Hoch, 2000) (Figure 6.1). 
Potentially, a two component system could have a role in the regulation of flagella 
and the transition to a non motile, sessile lifestyle in response to chlorhexidine.
The connection between sub inhibitory levels of chlorhexidine and the repression of 
flagella genes was explored further in this chapter. Does chlorhexidine induce 
bacteria to form biofilms and in turn become less susceptible to the biocide? Is B. 
cenocepacia adapting to the environment via a two component regulatory system 
and can this system be targeted by antimicrobial therapy? To investigate this 
phenomenon a swarming screen was performed to determine if chlorhexidine 
inhibits swarming. Biofilm assays were carried out to establish if sub inhibitory 
levels of chlorhexidine induced biofilm production. Finally a mutagenesis screen 
was performed to try and uncouple the swarming down regulation mechanism to 
reveal genes that may be central to the expression of the swarming / biofilm 
phenotype.
6.2 Results
6.21 Bioinformatic analysis on BCAM 0924 and BCAL 2353
Two genes with up-regulated expression in response to chlorhexidine were chosen 
for further bioinformatic analysis. As well as analysing the two selected genes, the
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Figure 6.1 Structure of a two component regulator system: a without an 
environmental stimulus and b, with an environmental stimulus
The environmental stimulus binds to the signal recognition site in the sensor kinase and causes the 
ATP dependent autophosphorylation of a histidine residue (H). The phosphoryl (P) group is then 
transferred to a specific aspartine residue (D) located on the response regulator. Phosphorylation of 
the response regulator activates an effector domain such as the GGDEF domain, which elicits a 
cellular response such as the transcription of genes, i.e. GGDEF synthesis of signal molecule cyclic 
diguanylate monophosphate (ci-diGMP).
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surrounding genes were also investigated to provide information on the potential 
role of the operon in biocide resistance. BCAM 0924 was a response regulator 
homolog possibly involved with efflux and BCAL 2353 was a transport related gene. 
Five bioinformatic programmes were used to determine function, BLAST, to look 
for homologs, Pfam, to look at protein families, COG, to look at protein 
classification, the transport classification database (TCDB: http://www.tcdb.org/) 
and the transmembrane helix prediction database (THMM: 
http://www.cbs.dtu.dk/~kroqh/TMHMM/).
BCAM 0924 had four genes surrounding it that could form a possible operon. 
BCAM 0925 and BCAM 0927 were also up-regulated in the microarray experiment 
suggesting co-regulation as a single transcription unit (Figure 6.2). BCAM 0924 is 
found on the second chromosome of J2315 and was homologous to a two 
component system response regulator with a CheY like receiver domain and other 
motifs homologous to OmpR like, outer membrane proteins (Table 6.1). The genes 
that surround BCAM 0924 are potentially involved in secretion, efflux and were 
homologous to a MexAB like RND efflux pumps. BCAM 0923 had no significant 
Pfam or COG matches but was homologous to a HAMP sensor kinase which would 
link with the response regulator as part of a potential two component system (Table 
6.1). BCAM 0924 was aligned with other Burkholderia genomes via the BLAST 
search tool on the Burkholderia genome database. It was conserved across the 20 
available genomes, indicating that this response regulator is a vital gene required in 
many species.
BCAL 2353 had three genes surrounding it that could be a possible operon (Figure 
6.3). BCAL 2352 was also up-regulated in the microarray experiment. BCAL 2353 
was homologous to a transport related gene predicted to be involved in inorganic 
ion transport such as sulphate and could potentially be involved with a MFS 
superfamily of transporters which are multidrug facilitator efflux pumps (Table 6.2). 
BCAL 2352 was a carbonic anhydrase and BCAL 2351 was a hypothetical protein 
with an unknown function (Table 6.2). Similarly to BCAM 0924, BCAL 2353 was 
conserved across the 20 Bcc species, again indicating an important conserved 
gene.
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6.22 Mutagenesis of BCAM 0924 and BCAL 2353
Mutagenesis was performed to delete the response regulator and transport related 
gene to see if they were phenotypically involved with chlorhexidine resistance. The 
first method attempted was based on an insertional inactivation method using a 
suicide plasmid constructed by Flannigan et al. (Flannagan et a/., 2007). The 
pQGPTp plasmid contains a trimethoprim cassette and omega fragments. The two 
genes of interest were amplified with primers with EcoRI tails (Table 2.5) and 
cloned into the pQGPTp plasmid. The omega fragments cause polar mutations 
effectively knocking out down stream genes as well as the gene of interest. The 
genes were cloned into the suicide vector, transformed into E. co//, and the correct 
plasmid constructs identified by PCR. Once constructs were created, tri-parental 
matings were carried out to insert the plasmid into the gene in 8. cenocepacia K56- 
2. PCR was used to identify the correct gene insertions (Table 2.5, Chapter 2, 
section 2.19.2). When PCR checks were carried out on potential mutants, the 
correct insertion of the pQGPTp constructs had not occurred. Therefore a second 
strategy was employed to generate mutants.
A second insertional inactivation method was used where a trimethoprim cassette 
was inserted into the gene to disrupt expression (Chapter 2, section 2.19.4). Both 
genes and the trimethoprim cassette were successfully cloned into the pGEM easy 
vector. The trimethoprim cassette was then digested and cloned into single 
restriction sites within the BCAM 0924 and BCAL 2353 gene constructs to form 
plasmids pGEM0924Tp and pGEM2353Tp (trimethoprim resistant) (Table 2.2 and
2.5). PCR was performed to check that the insert was correctly inserted. Once the 
construct was complete and stored, the plasmid was extracted and digested with 
bamHI. The suicide vector pEGM105Tc (Quandt and Hynes, 1993), was also 
digested with bamHI and the gene construct ligated into this plasmid to form 
plasmid pHR0924Tp and pHR2353Tp. PCR confirmed that the construct was 
correct and tri-parental mating was then carried out to transfer the deleted gene 
construct into 8. cenocepacia strain K56-2.
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Figure 6.2 BCAM 0924 operon
BCAM 0924 putative operon: BCAM 0923 possible sensor kinase, BCAM 0924, putative response regulator, BCAM 0926, putative efflux pump and BCAM 
0927 putative HlyD secretion protein
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Figure 6.3 BCAL 2353 operon
BCAL 2353 putative operon: BCAL 2351 hypothetical protein, BCAL 2352 carbonic anhydrase and BCAL 2353 putative transport related gene.
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Table 6.1 Bioinformatic analysis of BCAM 0924 and surrounding genes
Gene
Name
Fold Up 
regulation
Pfam function COG THMM TCDB
BCAM
0923
-
No significant Pfam 
match -  closest -  
HAMP domain -  
sensor kinase
No significant 
matches
2 predicted 
transmembrane 
helices
No
transport
related
proteins
BCAM
0924
15.9
Response regulator 
receiver domain -  
two component 
regulatory systems -  
drug resistance - 
efflux
T -  signal 
transduction 
mechanisms 
K - transcription
No predicted 
transmembrane 
helices
No
transport
related
proteins
BCAM
0925
8
Outer membrane 
efflux protein -  OprM 
-  form trimeric 
channels that allow 
export
M -  cell 
wa I l/e n ve lo pe/m em 
brane biogenesis 
N -  cell motility
No predicted 
transmembrane 
helices
Outer 
membrane 
proteins -  
RND efflux 
proteins
BCAM
0926
-
Acrd/AcrB/AcrF -  
integral membrane 
proteins -  part of the 
trimeric structure of 
efflux pumps
Q -  production of 
secondary 
metabolites and 
transport
12 predicted 
transmembrane 
proteins
RND efflux 
transport
BCAM
0927
13.1
HlyD secretion -  
produces proteins 
that are secreted 
across the 
membrane
Q -  production of 
secondary 
metabolites and 
transport
No predicted 
transmembrane 
helices
RND
family
efflux
proteins
206
Chapter 6.0 -  Characterising the function of B. cenocepacia J2315 genes regulated by chlorhexidine
Table 6.2 Bioinformatic analysis of BCAL 2353 and surrounding genes
Gene
Name
Fold Up 
regulation
Pfam
function'
COG THMM TCBD
BCAL
2351
-
No Pfam matches 
-  hypothetical 
protein
No matches
No predicted 
transmembrane 
helices
No transport 
related 
genes
BCAL
2352
3.3
Carbonic 
anhydrase -  
catalyse 
reversible 
hydration of 
carbon dioxide
P -  inorganic ion 
transport and 
metabolism
No predicted 
transmembrane 
helices
No transport 
related 
genes
BCAL
2353
3.4
T ransport of 
sulphate across 
the membrane
P -  inorganic ion 
transport -  
sulphate transport 
and related 
transporters (MFS 
superfamily)
10 predicted 
transmembrane 
helices
Sulphate
transporters
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6.23 Genetic analysis of putative mutants
After 48 hours of growth at 37°C approximately ten colonies were observed. 
However, the control plates which contained wildtype K56-2 also had 5 - 1 0  
colonies growing on it, suggesting that spontaneous resistant mutants rather than 
true mutants may be present. The colonies were picked and left to grow for 18 
hours. A direct PCR was carried out on the mutants to check for the presence of 
the trimethoprim cassette. In all mutants and for both genes, the Tp cassette was 
present (Figure 6.4), suggesting mutagenesis had been successful.
Three mutants were selected for each gene and stored frozen. Further analysis 
was carried out on these six potential mutants. RAPD analysis was performed to 
confirm that all the mutants picked were B. cenocepacia K56-2. All RAPD profiles 
were the same as the wildtype (Figure 6.5), verifying that the mutants were the 
correct species. Two other PCR checks were carried out. First a PCR using the 
forward primer of the Tp cassette and the reverse primer of the gene was used. 
The final product size should include the entire Tp cassette (approximately 500 bp) 
and half of the gene (approximately 400 bp for BCAM 0924 and 1.25 kb for 
BCAL2353). PCR on the mutants were positive for these products (Figure 6.6) 
Secondly, internal primers for each gene were designed, approximately 150 bp 
upstream and downstream of the restriction site where the Tp cassette had been 
inserted. If the Tp cassette has inserted and recombined correctly in the mutants, 
then a larger product would be observed. This PCR also allowed single crossovers 
to be detected, by the presence of both the wildtype and the larger sized band. 
When this PCR was carried out only the wildtype band was present, suggesting that 
the Tp cassette (although present as detected in the first PCR) had not correctly 
inserted. These PCR results suggested that a form of single cross over may have 
occurred at the BCAM 0924 and BCAL 2353 loci, leading to insertion of the 
mutation constructs, but also leaving the wildtype gene intact.
6.24 Phenotypic characterisation of potential mutants
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1650 bp 
1000 bp 
650 bp
Figure 6.4 PCR amplification of the trimethoprim cassette from BCAM 0924 
mutants and BCAL 2353 mutants
PCR amplification of potential mutants to confirm the presence of the Tp cassette. The pUC plasmid 
containing the Tp cassette was included as a positive control. All samples were positive for the Tp 
cassette (509 bp).
BCAM 0924 Tp cassetti BCAL 2353 Tp cassette
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Figure 6.5 RAPD fingerprint profile of potential mutants
Three potential mutants for each gene were selected and RAPD profiling performed. K56-2 was 
included as the wildtype strain. All six potential mutants had the same fingerprint as the wildtype 
indicating that all mutants were K56-2.
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To characterise the mutants, MIC screens for chlorhexidine susceptibility were 
performed to see if there were any phenotypic changes. The MIC screens were 
carried out as previously described. The mutants had a lower MIC value of 
approximately 50 -  80 pg/ml for BCAL 2353 and 50 -  70 pg/ml for BCAM 0924 
(Figure 6.7), compared to 90 -  100 pg/ml for K56-2 wildtype. CPC MICs were 
carried out to see if there were any cross over effects, but there was no knock down 
in MIC observed with all mutants having a MIC value of > 200 pg/ml, the same as 
the wildtype.
To further investigate the phenotypic effect, a growth curve MIC analysis was 
carried out using a microbial growth analyser, Bioscreen C (Chapter 2, section 
2.25). K56-2 was capable of growing in all chlorhexidine concentrations screened, 
up to 100 pg/ml (Figure 6.8 a). BCAM 0924 mutants and BCAL 2353 mutants all 
ceased growth after 40 pg/ml (Figure 6.8 b and c).
Finally, the ability of the mutants to form biofilms was assessed. The mutants had 
attenuated biofilm formation compared to the wildtype (Figure 6.9). K56-2
produced approximately two -  four fold more biofilm than the mutants. The 
phenotypic evidence of increased chlorhexidine susceptibility and reduced biofilm 
formation in the presence of the biocide, suggested that while the wildtype genes 
were still detectable by PCR, the insertion of the knockout constructs may have 
disrupted their expression.
6.25 Biofilm production
Biofilm assays were carried out to see if the presence of sub-inhibitory levels of 
chlorhexidine induced biofilm formation in the Bcc. In addition, CPC was also 
screened for the ability to induce biofilm production. The screen was a modified 
plate assay and biofilms were stained with 1% crystal violet. The first screens 
produced variable results between replicates so the assay was optimised as 
follows: a range of growth media were tested for biofilm production, including TSB, 
nutrient broth, double strength TSB and nutrient broth and basal salts media. One 
test plate was coated with porcine mucin to determine if this also aided biofilm
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Figure 6.6 PCR checks on BCAM 0924 mutants
All but one mutant amplified. The correct product size should be approximately 850 bp. All the 
amplified mutants are this size, indicating they are correct. Some colonies were present on the 
control plate, which should have been negative. No amplification was observed on these colonies 
indicating that they were spontaneous resistant colonies or contamination on the plate.
|  4 Contro1 Plate co|on 'e !BCAM 0924 mutants
212
Chapter 6.0 -  Characterising the function of 8. cenocepacia J2315 genes regulated by chlorhexidine
K56-2
2353 1
0924 2
0924 3
Figure 6.7 Chlorhexidine MIC’s o f K56-2, BCAL 2353 mutants and BCAM 0924 
mutants
MIC experiments carried out as previously described (broth dilution method). After 24 hours of 
growth, mutants were spotted onto TSA plates using a 96 point replicator and left to grow for 48 
hours MICs were determined by visually looking for growth inhibition. K56-2 was capable of growth 
at 100 pg/ml, compared to 70 -  80 pg/ml for BCAL 2353 mutant 1 and 50 -  60 pg/ml for BCAM 0924 
mutants 2 and 3.
Blank
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Figure 6.8 Bioscreen C analysis of BCAM 0924, BCAL 2353 mutants and the 
wildtype K56-2 in chlorhexidine
MIC determination was carried out in a Bioscreen microbial growth analyser. Each mutant and the 
wildtype were grown in TSB containing a series of concentrations of chlorhexidine. An OD reading 
was taken by the Bioscreen every 5 minutes for 48 hours. Each growth curve was replicated and 
the curves shown represent the mean analysis of this data.
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Figure 6.9 Biofilm production (± SE) of K56-2 and BCAM 0924 and BCAL 2353 
mutants
Mutants were grown in nutrient broth and placed in 96 well plates. The strains were left for 72 hours 
to allow biofilm development. To visualise biofilms, strains were stained with 1% crystal violet and 
then resolubilised with 33% acetic acid. OD readings were taken at 570 nm. All experiments were 
carried out in triplicate and a mean OD calculated. Mutants have attenuated biofilm production 
compared to the wildtype. K56-2 produces 2 - 4  fold more biofilm than the mutants.
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adherence. 8. cenocepacia J2315 and C4455 were used as model strains and 
chlorhexidine concentrations 0, 0.6, 1.25, 2.5 and 5 |jg/ml were tested. These 
concentrations were used to mimic the microarray experiment, where down 
regulation of motility genes were seen at 5 pg/ml. Mucin coated plates with nutrient 
broth gave the most reproducible and clear results so it was decided that these 
conditions would be used in all further biofilm assays.
A panel of 12 Bcc strains were selected for biofilm analysis, four with low 
susceptibility to chlorhexidine and eight with high susceptibility to chlorhexidine. 
After 72 hours of growth biofilm production was enumerated by optical density 
reading. Statistical analysis was carried out on the strains to determine if a 
significant increase in biofilm production had occurred (Figure 6.10). Out of the 12 
strains, 7 strains (58.3%) showed some increase in biofilm production in 
chlorhexidine compared to biofilm production in zero chlorhexidine. For example, 
8. cenocepacia strain C4455, had a 7.5% increase in biofilm production at 5 pg/ml 
chlorhexidine (Figure 6.10). CPC exhibited a greater induction effect, with 10 (83%) 
of the 12 strains tested producing more biofilm in sub inhibitory levels (Figure 6.11). 
8. cenocepacia strain C4455 produced 9% more biofilm at 5 pg/m of CPC (Figure 
6.11). Significant differences (P<0.05) were only observed for 8. cenocepacia 
J2315 in CPC at 1.25, 2.5 and 5 pg/ml, 8. cenocepacia K56-2 in CPC at 1.25 pg/ml 
and 8. cenocepacia LMG 18827 in chlorhexidine at 1.25 pg/ml.
In addition, four strains, 8. cenocepacia AU1054, C4455, J2315 and 8. multivorans 
ATCC 17616, were screened against three other antimicrobial compounds, 
triclosan, benzalkonium chloride and the antibiotic tobramycin. Concentrations 
were adjusted according to the MIC values of the strains. Triclosan exhibited no 
biofilm effect so was not included in further analysis. Only 8. cenocepacia J2315 
had an increase in biofilm production in the presence of benzalkonium chloride, with 
a maximum increase of 8.7% at 2.5 pg/ml. J2315 had a significant increase in 
biofilm production at 1.25 pg/ml (P < 0.0238, Mann Whitney) and at 2.5 pg/ml (P < 
0.0019, Mann Whitney). The other three strains all saw a reduction in biofilm 
production in the presence of BZK. In contrast, all four strains saw an increase in 
biofilm production in tobramycin (Figure 6.12). 8. cenocepacia C4455 had the
largest increase in biofilm production in tobramycin with a 20% increase at 1 pg/ml
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Figure 6.10 Mean biofilm production in sub inhibitory levels chlorhexidine (± SE)
Panel of 12 strains showing production of biofilm in the presence of increasing concentrations of chlorhexidine. B. cepacia LMG 18821 had a 0.3% increase 
at 2.5 pg/ml, B. cenocepacia J2314 had 0.3, 3.3 and 4.2% increase at 1.25, 2.5 and 5 pg/ml, B. cenocepacia AU1054 had a 1.8 and 1.6% increase at 0.6 and 
5 pg/ml, B. cenocepacia LMG 18829 had 1.7% increase at 0.6 pg/ml, B. cenocepacia LMG 18827 had a 1.7 and 5.7% increase at 0.6 and 1.25 pg/ml, B. 
cenocepacia C4455 had a 1.5, 2 and 7.5% increase at 1.25, 2.5 and 5 pg/ml and Bcc novel group K had a 2.8% increase at 0.6 pg/ml. Biofilm production 
(OD) was determined after 72 hours of growth in nutrient broth containing a series of chlorhexidine concentrations, within 96 well plates. The strains were 
stained with 1% crystal violet and resolubilsed in 33% acetic acid. All experiments were carried out in triplicate and a mean OD calculated
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Figure 6.11 Mean biofilm production in sub inhibitory levels of CPC (± SE)
Panel of 12 strains showing production of biofilm in increasing concentrations of CPC. B. cepacia LMG 18821 had 3.7, 0.08 and 3.5% increase at 0.6, 2.5 and 5 pg/ml, B. 
multivorans LMG 16660 had a 1.7% increase at 0.6 pg/ml, B. multivorans ATCC 17616 had a 5.2, 11.4 and 2% increase at 0.6, 1.25 and 2.5 pg/ml, B. cenocepacia J2315 had 
a 1.9, 6.5 and 4% increase at 1.25, 2.5 and 5%, B. cenocepacia K56-2 had a 1.9, 5.8, 2.7 and 5.8% increase at 0.6, 1.25, 2.5 and 5 pg/ml, B. cenocepacia AU1054 had a 0.1, 
2.5, 3.3 and 1.4% increase at 0.6, 1.25, 2.5 and 5 pg/ml, B. cenocepacia LMG 18827 had a 1.4 and 2.5% increase at 2.5 and 5 pg/ml, B. cenocepacia LMG 18832 had a 1.7% 
increase at 5 pg/ml, B. cenocepacia C4455 had a 2.5, 3.9 and 9% increase at 1.25, 2.5 and 5 pg/ml, Bcc novel group K had a 3.2, 5.8, 1.7 and 1.9% increase at 0.6, 1.25, 2.5 
and 5 pg/ml and B. dolosa LMG 18943 had a 0.6 and a 0.8% increase at 0.6 and 1.25 pg/ml. Biofilm production (O D) was determined after 72 hours of growth in 
nutrient broth containing a series of chlorhexidine concentrations, within 96 well plates. The strains were stained with 1% crystal violet and resolubilsed in 33% acetic 
acid. All experiments were carried out in triplicate and a mean OD calculated
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compared to the control with no antibiotic (Figure 6.12). Although all strains had an 
increase in biofilm formation at sub-inhibitory levels of tobramycin only B. 
cenocepacia J2315 had significant differences as determined by Mann Whitney 
tests at 0.3 pg/ml and 0.6 pg/ml (P<0.05).
Three P. aemginosa strains were screened to see if the same effect could be 
observed. P. aemginosa reference strain PA01 did not show enhanced biofilm 
formation in chlorhexidine or CPC. The Liverpool epidemic strain and the Midlands 
epidemic strain did have an effect. The Liverpool epidemic strain had a 5.6% and a 
1.6% increase in biofilm production at 0.6 and 1.25 pg/ml of chlorhexidine 
respectively and in CPC had a 2.65% and 0.7% increase at 0.6 and 1.25 pg/ml. 
The Midlands strain has no effect in CPC but in chlorhexidine exhibited a 2.1% and 
1.1% increase at 0.6 and 1.25 pg/ml of CPC.
6.26 Multiple EM for motif elicitation
Due to the possibility of a coordinated phenotype, regions upstream of the down- 
regulated genes was analysed using the multiple EM for motif elicitation (MEME) 
software (Bailey et a/., 2006). Nine genes were selected to put into MEME: BCAL 
0114, (flagellin); BCAL 0126, (chemotaxis protein MotA); BCAL 0527, (flagellar 
protein); BCAL 0562, (negative regulator of flagellin); BCAL 0576, (flagellar hook 
associated protein); BCAL 2904 (hypothetical protein); BCAM 1503, (chemotaxis 
protein); BCAM 1744, (exported peptidase) and BCAM 2564 (aerotaxis receptor). 
The results from the MEME analysis indicate there may be a conserved regulatory 
motif involved in the coordination of flagella repression in the presence of 
chlorhexidine (Figure 6.13). The possible motifs are positioned between 150 -  250 
bp (Figure 6.13 a) and have regions of similarity (Figure 6.13 b). A consensus 
sequence was generated by the programme which could be a regulatory binding 
motif. This sequence was 5’ CTAAACI ITTCCCATCGCCCGCCGATA 3’.
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Figure 6.12 Biofilm production of four strains in the presence of tobramycin 
(± SE)
Biofilm production (OD) was determined after 72 hours of growth in nutrient broth containing a series 
of chlorhexidine concentrations within 96 well plates. The strains were stained with 1% crystal violet 
and resolubilsed in 33% acetic acid. All experiments were carried out in triplicate and a mean OD 
calculated. All strains had an increase in biofilm production at sub inhibitory levels of tobramycin. B. 
cenocepacia AU1054 had an increase of 1.8% and 3.2% at 0.6 and 1 pg/ml, B. multivorans ATCC 
17616 had an increase of 0.09, 1.1, 8.3 and 14.5% at 0.1, 0.3, 0.6 and 1 pg/ml, B. cenocepacia 
J2315 had an increase of 3.4, 3.9, 3 and 0.9% at 0.1, 0.3, 0.6 and 1 pg/ml and B. cenocepacia 
C4455 had an increase of 5, 10.2 and 20.5% at 0.1, 0.6 and 1 pg/ml.
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BCAL0126 CGGGCGGCCG C AAA
BCAL0562 GCTCGCGATG CT AAA
BCAL0576 GCATTTTTTC C l CAA
BCAM1503 TCACAACGAC CT CAA
BCAL2904 ATCGCGCCCG CT CAA
BCAL0527 CTCCGCGCAC CT AAA
BCAL0114 CCACGTGCCC CT CAA
BCAM2564 CGCAACGGGA TT AA
BCAM 1744 CCGAAACGCA CT CAA
T T T T C C T  CC ACT CC 
TTCGOGCCCACCCC GCC 
T T T T T C  A TC C  G CCGCC  
TAA C C C A T I  CC 
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Figure 6.13 MEME analysis output; A -  Block diagram of motif positions and 
B -  alignment of potential motifis
Output from a MEME analysis: A = Position of motif alignments 150 -  250 bp upstream of genes. B 
= Alignment of potential motifs. Three areas are conserved, indicating a motif.
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6.27 -  Bcc swarming screen
A collection of 251 Bcc strains from all species were screened for the ability to 
swarm on 0.3% nutrient agar plates supplemented with 0.5% glucose. The strains 
were classed into three categories, good swarmer (> 40 mm swarm diameter), poor 
swarmer (< 40 mm swarm diameter) and no evidence of swarming (< 20 mm 
swarm diameter). Of the 251 Bcc strains 67.7% were good swarmers, 19.2% were 
poor swarmers and 13.1% showed no evidence of swarming. All species except B. 
vietnamensis strains had a greater proportion of good swarmers than either poor or 
non swarmers (Table 6.3). B. ambifaria, B. contaminans, B. multivorans and B. lata 
strains contained the best swarmers, exhibiting significantly greater mean swarm 
diameters than other species (Table 6.3). The B. diffusa strain also produced a 
large swarm diameter of 85 mm. However, as only one strain was available for 
screening, it was not included in the statistical comparison. Surprisingly, B. 
cenocepacia 111 -A and 111 -B strains were poor swarmers with mean swarm 
diameters of 38.6 and 43.4 mm, comparable with B. vietnamensis, 35.5 mm, B. 
stabilis 35.3 mm and B. anthina 49.1 mm strains (Table 6.3).
6.28 Chlorhexidine swarming screen
The down regulation of motility genes such as flagella related proteins, suggested 
that swarming may be inhibited in the presence of sub inhibitory levels of the 
biocide. A chlorhexidine swarming screen was devised to assess this across the 
Bcc. Twenty one strains representative of each Bcc species were examined. The 
concentration of chlorhexidine used in the screen spanned the following range: 0, 
0.1, 0.3, 0.6, 1.25, 2.5 and 5 pg/ml. The maximum concentration was chosen as 5 
as no strains screened had a MIC lower than 10 pg/ml, thus 5 pg/ml would indicate 
if motility was being inhibited without the results being biased by bacterial growth 
inhibition by the biocide. Twelve of he eighteen strains selected were also 
representative of chlorhexidine sensitive and resistant strains (Table 6.4). A total of 
67% of strains exhibited reduced swarming in the presence of chlorhexidine. There 
was little difference between resistant and sensitive strains, with five out of seven 
resistant strains and five out of six sensitive strains showing the effect. B. 
multivorans ATCC 17616 had the most pronounced effect and clearly had a
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Table 6.3 Bcc swarming screen
% of species
Species Good (> 40 mm) Poor (< 40 mm)
No evidence (< 
20 mm)
Mean swarm 
diameter (mm)
B. cepacia (30) 76.7 6.7 16.7 63.3a
B. multivorans 
(24)
87.5 4.2 8.3 75.1b
B. cenocepacia A 
(27)
48.1 33.3 18.5 38.6
B. cenocepacia B 
(27)
44.4 33.3 22.2 43.3
B. stabilis (16) 37.5 37.5 25 35.3
B. vietnamensis 
(16)
37.5 43.8 18.8 35.5
B. dolosa (7) 57.1 28.6 14.3 51
B. ambifaria (35) 85.7 14.3 0 71.3C
B. anthina (14) 57.1 28.6 14.3 49.1
B. pyrrocinia (16) 62.5 12.5 25 48.6
B. contaminans 
(5)
100 0 0 83.8d
B. lata (10) 100 0 0 76.5e
Bcc (20) 55 45 0 49.6r
B. arboris (3) 66.7 0 33.3 51.7
S.. diffusa (1) 100 0 0 85
Mean (251) 67.7 19.2 13.1
a = B. cepacia significantly different to B. cenocepacia A, B. cenocepacia B, B. stabilis and B. 
vietnamensis
b = B. multivorans significantly different to B. cenocepacia A, B. cenocepacia B, B. stabilis, B. 
vietnamensis, B. dolosa, B. anthina, B. pyrrocinia and Bcc strains
c = B. ambifaria significantly different to all strains except B. cepacia, B. multivorans, B. contaminans 
and B. lata strains
d and e = B. contaminans and B. lata strains significantly different to all strains except B. cepacia, B. 
multivorans and B. ambifaria
f = Bcc strains significantly different to B. stabilis and B. vietnamensis strains
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reduction in motility as the chlorhexidine concentration increased (Figure 6.14). 
There was a marked decrease in swarm diameter even at low concentrations, for 
example at 0.1 pg/ml there was a 42% reduction in swarm zone compared to the 
control with no biocide (Figure 6.14).
In addition, three other biocides, triclosan, CPC and benzalkonium chloride and two 
antibiotics meropenem and tobramycin were screened for inhibition of swarming. 
The strains screened were 8. multivorans ATCC 17616, 8. cenocepacia J2315, and 
8. cenocepacia AU1054. 8. multivorans ATCC 17616 was unaffected by triclosan, 
benzalkonium chloride and the two antibiotics. In CPC there was swarming 
inhibition at 2.5 and 5 pg/ml, with a 34% and 84% reduction respectively. However 
at the lower concentrations the results were variable. 8. cenocepacia J2315 had no 
effect in any other antimicrobial agent apart from the original chlorhexidine assay, 
although it is worth noting that this strain was not a particularly good swarmer in the 
first instance. 8. cenocepacia AU1054, also exhibited no reduction in swarming 
with the other antimicrobial agents, apart from triclosan, where a 75% reduction in 
swarming was observed at 5 pg/ml. Thus it appears that this phenomenon is more 
specific for chlorhexidine, but may, in certain Bcc strains and species occur for 
other antimicrobial agents.
6.29 Correlation of chlorhexidine biofilm induction and swarming 
inhibition
Correlation of the biofilm induction and the swarming inhibition phenotypes in 
response to sub-inhibitory levels of chlorhexidine was performed (Table 6.5). 10 
strains were correlated for both biofilm induction and swarming inhibition. Out of 
these strains, 6 had both induction of biofilms and inhibition of swarming. Two 
strains (8. multivorans LMG 16660 and 8. cenocepacia LMG 18832), had neither 
induction nor inhibition of biofilms and swarming. Two strains, 8. dolosa LMG 
18943 and 8. multivorans ATCC 17616, did not show induction of biofilm production 
in chlorhexidine, but did show inhibition of swarming (Table 6.5). Although only a 
small panel was screened, there appears to be a tentative correlation between 
increase in biofilm production and swarming repression in the presence of 
chlorhexidine. However, four strains contradict this evidence, indicating that a
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Table 6.4 Bcc swarming response to chlorhexidine
Chlorhexidine concentration (pg/ml)
Species Name
0 0.1 0.3 0.6 1.25 2.5 5 R/S*
Diameter of swarm zone (mm)
B. cepacia
ATCC 25416 63 67 75 55 65 65 66 S
LMG 18821 60 60 13 10 10 10 10 R
B. multivorans
LMG 13010 85 85 79 20 50 35 22 S
ATCC 17616 85 50 38 24 15 12 10 S
LMG 16660 29 20 29 25 30 25 20 R
B. cenocepacia
AU1054 85 85 69 49 41 20 20 S
LMG 18832 13 15 10 15 14 14 14 R
LMG 18827 42 53 32 32 22 25 12 R
J2315 12 11 11 11 10 5 5 R
C4455 12 12 5 4 4 4 2 R
B. stabilis 17-474 65 40 24 29 17 15 14 -
B. vietnamensis CRE-7 85 45 40 25 20 23 20 -
B. dolosa
AU3556 85 15 13 85 85 85 85 -
LMG 18943 44 42 35 23 15 12 10 S
B. ambifaria
KCO-18 85 85 85 85 85 85 85 -
AMMD 54 49 30 35 29 32 35 s
B. anthina AU3904 85 85 85 85 85 85 85 -
B. pyrrocinia AU2419 80 65 60 45 45 27 25 -
B. contaminans VP1 80 55 17 14 13 18 20 -
BccK 24 70 60 25 20 18 12 7 R
B. lata ATCC 17769 85 85 85 85 85 85 80 -
* R/S = Resistant or sensitive to chlorhexidine as determined by the broth dilution MIC screen.
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Figure 6.14 B. multivorans ATCC 17616 swarming inhibition in sub inhibitory levels of chlorhexidine
Swarming plates were made using 0.3% nutrient agar with the addition of 0.5% glucose. 1 p spots were added to the centre of the plate and left to swarm for 
up to 48 hours.
226 Chapter 6.0 -  Characterising the function of B. cenocepacia J2315 genes regulated by chlorhexidine
Chapter 6.0 -  Characterising the function of B. cenocepacia J2315 genes regulated by chlorhexidine
Table 6.5 Correlation between biofilm production and swarming repression 
phenotypes
Strain Species
Biofilm
induction
Swarming
inhibition
LMG 18821 8. cepacia Yes Yes
LMG 16660 B. multivorans No No
ATCC 17616 B. multivorans No Yes
J2315 B. cenocepacia Yes Yes
C4455 B. cenocepacia Yes Yes
AU1054 B. cenocepacia Yes Yes
LMG 18827 B. cenocepacia Yes Yes
LMG 18832 B. cenocepacia No No
24 Bcc Novel group K Yes Yes
LMG 18943 8. dolosa No Yes
Grey shaded areas = strains that exhibit both induction of biofilm production and inhibition of 
swarming in the presence of chlorhexidine.
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larger panel should be screened before a definitive link can be made (Table 6.5).
6.2.10 -  Transposon mutagenesis screen
The observation that swarming is inhibited at sub-lethal concentrations of 
chlorhexidine was explored further by creating a mutant bank and screening for 
mutants with uncoupled swarming inhibition. It was hoped this strategy could 
identify the genetic basis for sensing chlorhexidine and the repression of motility. 
B. multivorans ATCC 17616 was selected as a model organism for mutagenesis as 
it produced the clearest inhibition in chlorhexidine. B. cenocepacia J2315 would 
have been the ideal genetic model organism as the microarray experiment was 
carried out on this organism. However, although the inhibition effect can clearly be 
seen (Figure 6.15), J2315 is a poor swarmer and would have been difficult to use in 
the mutagenesis screen.
Preliminary experiments were carried out to check the antibiotic susceptibility of 
ATCC 17616 and to make sure insertion of the mini-Tn5 transposon was random. 
Due to the high resistance of this strain to kanamycin, a transposon carrying this 
resistance gene could not be used (it was capable of growth at 600 pg/ml). 
Consequently, a tetracycline resistance transposon was utilised. A preliminary 
mating was carried out, but the sequence analysis of the random mutants nested 
PCR suggested that the transposon had inserted into the same gene. Four 
mutants were sent for sequencing and they all mapped to the same gene, an 
aldehyde dehydrogenase, indicating that the ATCC 17616 genome had an insertion 
hotspot for mini-Tn5 within this gene. Hence, a plasposon with trimethoprim 
resistance was used, however this was also observed to insert into the same gene 
as the mini-Tn5 transposon. Finally, B. cenocepacia AU1054, another genome 
sequenced strain was chosen as a model as this also had a good chlorhexidine 
inhibition effect. AU1054 had high resistance to kanamycin and tetracycline (300 
pg/ml), so the Tp plasposon was used to create a random bank of mutants, which 
were then pooled and spotted onto swarming media (Chapter 2, section 2.20). 
Approximately 3000 mutants were screened for uncoupled swarming, producing 31 
positive mutants (Table 6.6). Mutants that swarmed in the presence of 
chlorhexidine were picked and sequenced.
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Figure 6.15 B. cenocepacia J2315 swarming inhibition in response to chlorhexidine
Swarming plates were made with 0.3% nutrient agar with the addition of 0.5% glucose. 1 pi spots were placed onto the centre of the plate and left to swarm 
for up to 48 hours.
1.25 pg/ml 2.5 pg/ml 5 pg/ml
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Table 6.6 B. cenocepacia AU1054 swarming mutants
M u ta n t N am e F u n ctio n
G e n e  N u m b e r  
(c h ro m o s o m e )
S w a rm in g  a t 5 
Mg/ml 
c h lo rh e x id in e  
(m m )
AU1054 
(control)
B. cenocepacia strain - 30
HR 2 Transcriptional regulator - GntR Been 5579 (3) 30
HR 3 pyroxaimnie 5 phosphate Been 2826 (1) 35
HR 5 response regulator containing a CheY like receiver Been 1049 (1) 40
HR 6 glycosyl transferase Bcen_0291 (1) 50
HR 7 glycosyl transferase Bcen_0291 (1) 30
HR 8 proton-translocating NADH-quinone oxidoreductase Bcen_6005 (3) 35
HR 9 hypothetical signal peptide protein precursor Bcen_5923 (3) 70
HR 10 glycosyl transferase Bcen_0291 (1) 60
HR 11 proton-translocating NADH-quinone oxidoreductase Bcen_6005 (3) 14
HR 12
IcmF, Uncharacterized protein conserved in bacteria 
- hypothetical
bcen_2620 (1) 75
HR 13
4-hydroxyphenylpyruvate dioxygenase and related 
haemolysins
been__2785 (1) 75
HR 14 Phytanoyl-CoA dioxygenase bcen_1544 (1) 45
HR 15 IcmF, Uncharacterized protein conserved in bacteria bcen_2620 (1) 32
HR 16 ankyrin repeat protein bcen_6189 (3) 69
HR 17
Wza, Periplasmic protein involved in polysaccharide 
export
bcen_0287 (1) 80
HR 18 cobalamin (vitamin B12) biosynthesis CbiX protein bcen_1858 (1) 85
HR 19 AcrB, Cation/multidrug efflux pump bcen_1143 (1) 32
HR 23 Cytochrome C Bcen_2058 35
HR 24 MFS protein Bcen_1316 35
HR 25 Phage transcriptional regulator AlpA Bcen_1759 65
HR 26 Ferredoxin reductase Bcen_2439 25
HR 27 3 hydroxyl co A Bcen_3317 60
HR 28 Hypothetical protein Bcen_6297 72
HR 29 Cell division Bcen_0496 39
HR 30 OmpR transcriptional regulator Bcen_6141 (3) 60
HR 31 Hypothetical protein Bcen_1095 (1) 55
HR 33 CoA thioesterase Bcen_0321 (1) 30
HR 34 Hypothetical - phenol degradation Bcen_4081 (2) 55
HR 36 Phage transcriptional regulator, AlpA Bcen_1759 (1) 65
HR 37 OsmC like regulator Bcen_5771 (3) 40
HR 38 Levanase Bcen_4097 65
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6.2.11 Phenotypic characterisation of swarming mutants
Minimum inhibitory concentrations in chlorhexidine were carried out for 16 of the 
swarming mutants to see if they had become more susceptible to chlorhexidine 
(Table 6.7). 13 out of 16 mutants had no difference in their MIC value to the 
AU1054 control. Three of the mutants had an elevated MIC value of > 100 pg/ml. 
None of the mutants appeared to be more susceptible to chlorhexidine.
As well as chlorhexidine MIC values, biofilm assays were performed to determine if 
the ability to swarm in the presence of chlorhexidine leads to attenuated biofilm 
formation. Eleven mutants were screened for biofilm induction on the presence of 
chlorhexidine compared to B. cenocepacia AU1054 wildtype. Out of the eleven 
mutants, 81% had no induction of biofilm production in chlorhexidine compared to 
the wildtype (Figure 6.16). Two mutants, HR5, a CheY like receiver and HR 6; a 
glycosyl transferase did have induction of biofilm production at sub inhibitory levels 
of chlorhexidine. However, the wildtype had a greater proportion of biofilm 
induction compared to HR 5 and HR 6 (Table 6.8).
6.2.12 Bioinformatic analysis of mutants
To further elucidate the role these genes play in the swarming inhibition phenotype 
and the possibility of contribution to biocide resistance, two genes that produced 
good uncoupling mutants and their surrounding genes were analysed. These 
genes were, HR 5, CheY like receiver and HR 6, a glycosyl transferase. The 
bioinformatic analysis carried out for each gene can be seen in Table 6.9 and 6.10 
and included BLAST, PFAM and COG searches. To look for transmembrane 
domains the TMHMM database was used and to look for transport related function 
the transport classification database was employed. The genes surrounding the 
mutated gene were selected on the basis that they may be part of an operon. 
BCEN 1049 was found on chromosome one and had thirteen surrounding genes. 
This gene mapped to a CheY-like receiver, which could be part of a two component 
regulator system. CheY is part of a response regulator involved with chemotaxis. 
The surrounding genes were involved in the synthesis and secretion of protein
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Table 6.7 Chlorhexidine MIC values in B. cenocepacia AU1054 mutants
Mutant Name MIC (Mg/ml)
AU1054 (control) 4 0 - 5 0
HR 2 > 100
HR 3 4 0 -5 0
HR 5 >100
HR 6 >100
HR 7 4 0 -5 0
HR 8 4 0 -5 0
HR 9 3 0 -4 0
HR 10 3 0 -4 0
HR 11 4 0 -5 0
HR 24 4 0 - 5 0
HR 26 4 0 -5 0
HR 29 4 0 - 5 0
HR 33 4 0 - 5 0
HR 34 4 0 - 5 0
HR 37 2 0 - 3 0
HR 38 3 0 - 4 0
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Figure 6.16 B iofilm  production (± SE) in ch lo rhexid ine in: a, B. cenocepacia 
AU1054 w ildtype and b, AU1054 swarm ing m utant HR 2 (transcrip tiona l 
regulator)
In the wildtype strain biofilm production has increased (reading taken at 72 hours after 1% crystal 
violent staining and resolubilisation in acetic acid) as concentration of chlorhexidine increases (Panel 
a). In the mutant, biofilm production decreases as chlorhexidine concentration increases.
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Table 6.8 B iofilm  induction in B. cenocepacia  AU1054, swarm ing m utant HR 5 
and HR 6
B. cenocepacia AU1054 derivative
Cone (HQ/ml)
AU1054 HR 5 HR 6
Percentage increase in biofilm production (%)
0.6 1.325 0.7 3.1
1.25 1.5 0.25 2.15
2.5 1.875 0.35 -0.7
5 1.775 0.125 -1.4
234
Chapter 6.0 -  Characterising the function of B. cenocepacia J2315 genes regulated by chlorhexidine
required for Tad pilin biogenesis. Pili are involved with bacterial adherence, as well 
as biofilm formation and are a well know virulence factor. The Tad genes are found 
on a genomic island and encode the machinery that is required for the assembly of 
the Flp pili. This pili is essential for colonization, adherence, virulence, 
pathogenesis, biofilm formation and possibly twitching motility. Originally the Tad 
loci was identified in the Gram negative pathogen Aggregatibacter 
actinomycetemcomitans, but homologs have also been identified in a number of 
Gram positive and Gram negative species such as Yersinia pestis, Vibrio cholerae, 
Mycobacterium tuberculosis, P. aeruginosa, Bordetella pertussis and Burkholderia 
pseudomallei (Tomich et a/., 2007).
BCEN_ 2091 was a glycosyl transferase. The mutagenesis screen had multiple 
hits within this gene (three), indicating it may be important in swarming. This gene 
was also found on chromosome one and had five possible genes within the operon. 
These genes were involved with the transport and secretion of sugars, cell to cell 
regulation and transport of cytotoxic compounds from the cell (ABC transporters).
The model strain used in transposon mutagenesis screen was B. cenocepacia 
AU1054. As the microarray experiment was carried out on B. cenocepacia J2315, 
the genes knocked out by mutagenesis were compared to the J2315 genome to 
look for homology and then analysed in GeneSpring to determine if any of these 
genes had altered expression in the presence of chlorhexidine. All of the genes 
had homology to the J2315 genome. Nonetheless, when searched for in 
GeneSpring, none of these genes had a significant change in expression in 
response to chlorhexidine, with values close to 1.
6.3 Discussion
6.31 Are genes BCAM 0924 and BCAL 2353 important for chlorhexidine 
resistance?
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Table 6.9 Bioinformatic analysis of AU1054 mutant HR 5 (BCEN_1049), CheY like receiver and surrounding genes
Gene Name BLAST PSI PFAM COG TCDB TransmembranePrediction
BCENJ037 Flp/Fap pilin superfamily Flp_Fap component COG3847 -  N -  Cell motility and secretion
Sodium dependent 
phosphate pump 1
BCENJ038 peptidase A24A, prepilin 
type IV/CpaA
Peptidase_A24- essential for 
correct formation of 
pseudopilli in type 4 secretion 
systems (PFO 1478)
COG4960 -  U - 
Intracellular trafficking 
and vesicular support
Type 4 prepillin type 
proteins 5
BCENJ039 TadE family
TadE (PF07811)- involved 
in pillus assembly - 
adherence
COG4961 -  U - 
Intracellular trafficking 
and vesicular support
Type 4 -  secretory 
pathway 1
BCENJ040 Saf superfamily/ CpaB -  
pilus assembly
SAF (PF08666) -  range of 
proteins including flagellar 
FlgA and pilus CpaB proteins
COG3745 -  N -  Cell 
motility and secretion
Type 4 -  secretory 
pathway 1
BCENJ041 Secretin superfamily -  type 2 and 3 secretion 
system -  PulD - motility
Secretin (PFO0263) -  
involved with transporting 
exoproteins from the 
periplasm -  secretion 
systems
COG4964 -  U - 
Intracellular trafficking 
and vesicular support
Pillin secretion / 
fimbrial assembly 
protein
0
BCEN_1042 ABC_ATPase superfamily -  response regulator 
receiver protein
(PF00072) -  response 
regulator, receives the signal 
from the sensor partner in 
two component systems
COG4963 -  U - 
Intracellular trafficking 
and vesicular support
0 0
BCENJ043
VirB111-like ATpase- 
type 4 secretory protein/ 
type 2
GSP11_E (PF00437) -  
contains type 2 and 4 
secretion proteins
COG4962 -  U - 
Intracellular trafficking 
and vesicular support
0 0
BCENJ044 Type 2 secretion system. Gsp11 F superfamily. 
TadB
Gsp11_F (PF00482) -  type 2 
secretion, type 4 pilus and 
archaeal flagellar
COG4965 -  U - 
Intracellular trafficking 
and vesicular support
Type 4 secretary 
pathway 5
BCENJ045 Gsp11_F superfamily. TadC -  pilus/motility and 
secretion
Gsp11_F (PF00482) -  type 2 
secretion, type 4 pilus and 
archaeal flagellar
COG2064 -  U - 
Intracellular trafficking 
and vesicular support
Adherence (Pilius) 
biogenesis 4
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Name BLAST PSI PFAM: function COG TCDB Transmembraneprediction
BCEN_1046 TadD -  pilus assembly -  secretion. 
Tetratricopeptide TPR 2
Tetratricopeptide repeat 
(PF07719)
COG5010 -  U - 
Intracellular trafficking 
and vesicular support
No hits 0
BCENJ047 Hypothetical protein No matches No hits 0
BCENJ048 COG4655 superfamily -  predicted membrane 
protein
TadE (PF07811)- involved 
in pillus assembly -  
adherence -  possible or 
domain of unknown function 
-  transmembrane?
COG4655 -  S -  predicted 
membrane protein No hits 1
BCEN_1049
Activates expression of 
genes from promoters 
recognised by core RNA 
associated with sigma 
factors -  involved with two 
component regulatory 
system and possess a 
domain that can be 
phosphorylated by a 
sensor-kinase protein in 
their N-terminal section
Sigma 54 interaction domain
COG 2204 -  response 
regulator containing a 
CheY like receiver -  
sigma 54 specific 
transcriptional regulator
Type 6 secretion 
system 0
BCENJ050 Hypothetical protein No matches -  putative lipoprotein
COG4655 -  D 
chromosome segregation 
ATPases
No hits 0
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Table 6.10 Bioinformatic analysis of AU1054 mutant HR 6 (BCEN_0291), glycosyl transferase and surrounding genes
Name BLAST PSI PFAM: function COG TCDB Transmembraneprediction
Bcen_0293
ABC membrane 
superfamily -  type 2 -  
TagG -  Carbohydrate 
metabolism, cell envelope 
biogenesis and outer 
membrane
ABC type 2 transporters -  
consists of a conserved ATP 
binding cassette and a 
transmembrane domain. Bind 
ATP -  hydrolysis -  signature 
motifs. Provides essential 
nutrients and is involved in the 
export of toxic substances
COG 1682 -  M -  cell 
wall / membrane / 
envelope biogenesis
ATP binding cassette 
(ABC superfamily) 6
Bcen_0292
ABC transporter -  
involved in the export of 
polysaccharides. May 
also be involved in drug 
resistance
ABC transporter -  same as 
above -  responsible for the 
translocation of a variety of 
compounds across biological 
membranes
C O G 1 1 3 4 -G - 
carbohydrate transport 
and metabolism
ATP binding cassette 
(ABC superfamily) 0
Bcen_0291
Glycosyl transferase -  
same as below -  but 
contains 3 copies of 
tetratricopeptide repeat 
domain -  consensus 
sequence in many 
functions -  protein -  
protein interactions, 
chaperone and transport
TPR - tetratricopeptide repeat 
-  involved in cell to cell 
regulation and protein folding. 
Also glycosyl transferase type 
1 -  transfers sugars -  involved 
in many process including 
exopolysaccharide 
biosynthesis.
COG0438 -  M -  cell 
wall / membrane/ 
envelope biogenesis
Protein importer 0
Bcen_0290
Superfamily -  Glycosyl 
transferase family 1 -  
transfer activated sugars 
to substrates such as 
lippopolysaccharides -  
cell envelope biogenesis 
and outer membrane -  
multi domain RfaG
Same as above -  no TPR
COG0438 -  M -  cell 
wall / membrane/ 
envelope biogenesis
Respiratory nitrate 
reductase 0
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Name BLAST PSI PFAM: function COG TCDB Transmembraneprediction
Bcen_0289 Sulfotransferase domain -  hypothetical protein
Sulfotransferase -  transfer of 
sulphate groups to compounds
COG1196 -  D -  cell 
cycle control / cell 
division
Oxidase proteins 0
Bcen_0288
Glycosyl transferase 
family 2 -  transfers 
sugars to a range of 
substrates. Maybe cell 
wall biogenesis
Glycosyl transferase family 
type 2 -  transfers sugars to a 
range of substrates including 
cellulose, dolichol phosphate 
and teichoic acids.
COG0463 -  M - cell 
wall / membrane/ 
envelope biogenesis
Glycosyl polymerization 
family 0
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The microarray experiment (Chapter 5) produced a list of genes with significant 
changes in expression when B. cenocepacia J2315 was exposed to chlorhexidine. 
Two of these genes were selected for further analysis, BCAM 0924 a response 
regulator and BCAM 2353 a transport related gene.
BCAM 0924 was found on chromosome 2 of the J2315 genome and appeared to 
be part of an operon that was homologous to the Mex AB-OprM efflux pump found 
in P. aeruginosa. Other genes, which could be part of the efflux operon were also 
up- regulated, such as BCAM 0925, an outer membrane protein (OprM precursor) 
and BCAM 0927, a secretion protein (HlyD family). MexAB-OprM is a well 
characterised efflux pump in P. aeruginosa that is constitutively expressed 
(Piddock, 2006a). Although not up-regulated in this experiment, BCAM 0926 may 
also be part of this operon and contains 12 transmembrane helices which is 
characteristic of RND efflux pumps (Borges-Walmsley and Walmsley, 2001) (Table 
6 .1).
The MexAB-OprM pump was first described by Poole et al. who found a 50 KDa 
outer membrane protein which had homology to previously described export 
proteins. Mutants lacking this gene were more susceptible to tetracycline, 
chloramphenicol, ciprofloxacin streptonigrin and dipyridyl (Poole et al., 1993). The 
expression of the outer membrane protein led to resistance to a number of 
unrelated compounds indicating that this protein was part of an efflux operon (Poole 
et al., 1993). The MexAB-OprM efflux protein is involved with the efflux of multiple 
antibiotics, but may also efflux other compounds such as ethidium bromide, 
acriflavine, SDS, triclosan and organic solvents (Piddock, 2006a). The ability to 
efflux a range of substrates raised concerns that the widespread use of 
disinfectants may induce a number of efflux pumps that can also efflux antibiotics, 
leading to the emergence of strains with multi drug resistance.
In B. cenocepacia J2315, three genes possibly involved with RND efflux were 
identified with altered expression in response to chlorhexidine (Table 5.4). One of 
these genes (BCAM 0925) was homologous to OprM, an outer membrane channel 
found in P. aeruginosa. This channel is essential for the efflux of toxic compounds
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although some Mex pumps are able to work without it (Chuanchuen et al., 2002). 
The efflux protein seen in B. cenocepacia J2315 may be regulated by a response 
regulator (BCAM0924) and this could be part of a two component regulator system 
as BCAM 0923, has homology to a sensor kinase. This suggests that the efflux 
operon may be induced by sub inhibitory levels of chlorhexidine by interacting with 
the response regulator and thus allowing chlorhexidine to be removed from the cell. 
This observation is the first time the MexAB-OprM efflux pump has been associated 
with resistance to chlorhexidine. J2315 also has resistance to a number of 
antibiotics including (3 lactams such as imipenem and piperacillin, as well as 
tobramycin and trimethoprim / sulfamethoxazole. The induction of this efflux pump 
by chlorhexidine may also increase resistance to some of these antibiotics, if they 
are substrates for the pump.
Other Mex efflux systems have now been described in P. aeruginosa, such as 
MexCD-OprJ (Poole et al., 1996), MexEF-OprN (Kohler et al., 1997) and MexXY- 
OprM (Chuanchuen et al., 2002). P. aeruginosa, PA01 induced expression of the 
MexCD-OprJ multidrug efflux pump in the presence of clinically important 
disinfectants, such as benzalkonium chloride, chlorhexidine gluconate and other 
cytotoxic agents like ethidium bromide (Morita et al., 2003). When the efflux pump 
was induced by these compounds the strain exhibited increased resistance to 
norfloxacin. The MexCD-OprJ efflux pump, can also efflux tetracycline, 
chloramphenicol, streptomycin, erythromycin and carbenicillin (Morita et al., 2003). 
Clearly, this resistance to a number of substrates in this strain are induced by 
clinically relevant disinfectants, which may be problematic in a clinical situation.
The MexXY-OprM efflux pump can also efflux triclosan, a well used disinfectant. 
This efflux pump is regulated by the repressor mexL. After exposure to triclosan, 
mutants containing a single nucleotide change in the repressor were selected. 
These mutants were able to efflux triclosan without the requirement of the OprM 
membrane channel, but could only efflux tetracycline and erythromycin if this 
channel was present (Chuanchuen et al., 2002). This study provided evidence that 
the efflux operon was regulated by a two component system that was induced by
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the presence of the disinfectant triclosan, although for efflux of other compounds, 
the tripartite structure, including the OprM channel was required.
BCAL 2353 was homologous to a transport related protein and was found on 
chromosome 1. There were 10 predicted transmembrane helices (Table 6.2), 
indicating that this gene could be involved in transport of organic substances and 
cytotoxic products out of the cell (Borges-Walmsley and Walmsley, 2001). There 
were 2 other genes that may be part of an operon. BCAL 2351 had no homology to 
known proteins and was unclassified; where as BCAL 2352 was homologous to a 
carbonic anhydrase and inorganic ion transport. The transport of inorganic ions, 
such as sulphur across the bacterial membrane is important for many processes. 
The Bcc produce many virulence factors, such as intrinsic resistance, production of 
catalase and superoxide dimutase, unusual lipopolysaccharide structure, quorum 
sensing, flagella, biofilm formation and production of siderophores. Production of 
several of these virulence factors are associated with anabolic pathways such as 
sulphur assimilation (Iwanicka-Nowicka et al., 2007). B. cenocepacia produces a 
yellow green fluorescent siderophore, pyochelin. The production of this 
siderophore is dependent on sulphur availability and will not be produced if there is 
limited sulphur (Farmer and Thomas, 2004). This signifies that the transport of 
inorganic ions such as sulphur may be essential for the production of virulence 
factors and bacterial survival. The role of the transport related gene BCAL 2353 
has not been defined in B. cenocepacia J2315 as of yet. The altered expression in 
response to chlorhexidine may suggest that this gene plays a role in transporting 
this substance out of the cell or it may promote transport of inorganic ions that are 
important for the bacterium’s survival in the presence of this biocide. To further 
elucidate the role of these two genes in chlorhexidine, it was attempted to delete 
the genes by mutagenesis.
6.32 Mutagenesis of genes BCAM 0924 and BCAL 2353
Deletion of the genes was first attempted using a plasmid insertion method by 
Flannagan et al. (Flannagan et al., 2007). They constructed a suicide vector that 
contained a resistance gene (Tp), flanked by omega fragments. The plasmid was
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inserted into the target genes and polar mutations would be observed due to the 
presence of omega fragments (terminates RNA and protein synthesis prematurely). 
However, in this investigation no mutants could be isolated. Tri-parental mating 
was carried out, but isolates selected did not contain the trimethoprim cassette and 
the gene product was still present, suggesting that the plasmid had not inserted 
correctly. Therefore a second strategy of allelic exchange was tried. This method 
used a suicide vector as described by Quandt et al (Quandt and Hynes, 1993). 
Construction of this suicide vector containing the target gene with a trimethoprim 
resistance cassette was carried out and mated into B. cenocepacia K56-2. Mutants 
were selected and RAPD profiling carried out to check that the mutants were K56-2, 
not contaminants (Figure 6.5) and characterisation carried out.
To determine if the mutants of BCAM 0924 and BCAL 2353 were more susceptible 
to chlorhexidine MIC experiments were carried out using a Bioscreen rapid growth 
analyser. The Bioscreen C took an OD reading every 5 minutes for 48 hours and 
growth curves were calculated (Figure 6.8). The wildtype K56-2 was capable of 
growing at 100 pg/ml (Figure 6.8, a) although this was at a much lower rate than 
with no biocide present. The mutants for both genes were capable of growing up to 
40 pg/ml of chlorhexidine. After this point no growth was observed (Figure 6.8, b 
and c), signifying that the mutants were 2.5 times more susceptible to chlorhexidine 
than the wildtype strain. Therefore, it appears the BCAM 0924 and BCAL 2353 do 
have a role in chlorhexidine resistance and that the ability to survive in higher 
concentrations was attenuated when these genes were not present. However, the 
two genes, especially BCAM 0924 may only be a small part of an operon that is 
involved in resistance to chlorhexidine. A greater increase in susceptibility may be 
observed if other genes in the operon are also deleted, for example the sensor 
kinase domain that is involved in the regulation of the RND efflux pump with BCAM 
0924.
The ability to form biofilms was also screened to establish if these two genes played 
a role in other antimicrobial resistance mechanisms. The mutants for both genes 
had attenuated biofilm production when compared to the wildtype strain, with the 
wildtype producing 2 — 4 fold more biofilm than the mutants (Figure 6.9). This
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suggests that the two genes may play a role in other mechanisms that allow 
bacterial survival in chlorhexidine such as the ability to form biofilms. In Candida 
albicans, efflux pumps were up-regulated when in biofilms promoting a multi drug 
resistant, protected life style (Ramage et al., 2002). Consequently, a similar 
mechanism may be at work in the mutants, with the response regulator BCAM 0924 
and transport gene BCAL 2353 playing a role in biofilm formation and efflux up 
regulation.
The mutants isolated were subjected to molecular analysis to establish that the Tp 
cassette had inserted correctly in the gene. The first check carried out was a PCR 
screen specific for the Tp cassette. This PCR screen was positive for all the 
mutants checked (Figure 6.4), producing a band of approximately 500 bp. 
However, when internal primers were designed that flanked the restriction cloning 
site for the Tp cassette, the results were less conclusive. A wildtype band (300 bp) 
was present from the screen for the control K56-2, but also for the mutants where a 
larger band of approximately 800 bp should be visible. This indicated that a double 
crossover had not occurred or that the Tp cassette had not inserted in the correct 
place. Therefore, although an increase in chlorhexidine susceptibility was observed 
in these mutants, the results are questionable due to the inability to obtain the 
correct size band for the genes with the inserted Tp cassette.
6.33 Does the presence of sub inhibitory levels of chlorhexidine induce 
biofilm formation and inhibition of swarming?
The observation that sub inhibitory levels of chlorhexidine caused a global down 
regulation of motility and chemotaxis genes raised a number of questions. Flagella 
are important for many processes and are a key virulence factor. For a host -  
pathogen interaction to occur the pathogen must first attach to epithelial cells. 
Pathogens use motility combined with chemotaxis to attach and colonise cells 
(Ramos et al., 2004). Invasion of host cells is important for the establishment of the 
infection and attachment to surfaces may increase the chances of biofilms forming. 
In flagella mutants, virulence is severely attenuated, for example a non motile B. 
cepacia strain generated by random transposon mutagenesis had reduced
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invasiveness of respiratory epithelial cells (Tomich et al., 2002). As well as having 
a role in initial attachment and invasion, the flagellum machinery are similar to type 
three secretion systems, indicating the flagella may actually play a role in secreting 
virulence factors into the cytosol of host cells (Ramos et al., 2004).
Although flagella are important virulence factors for pathogenic bacteria, they are 
also a significant stimulator of the host’s immune system. To avoid this pro- 
inflammatory response and resist phagocytes, some pathogens can regulate their 
flagellar and become non motile. P. aeruginosa is the most common CF infection 
and is often carried chronically by the patient. These chronic isolates are non 
motile and are difficult to eradicate. Notably, the lack of motility in these chronic CF 
isolates are very different to environmental isolates, where only motile isolates are 
found (Mahenthiralingam et al., 1994). These non flagellated isolates were 
resistant to phagocytosis by macrophages and therefore could persist in the lungs 
of CF patients (Mahenthiralingam et al., 1994). It was suggested that flagella 
expression was regulated by a sigma factor (RpoN) and that the repression of 
flagella may be due to harsh environmental conditions (Mahenthiralingam et al., 
1994). This has been seen in E. coli, where isolates became non flagellated due to 
high temperatures, high concentrations of inorganic salts, high concentrations of 
carbohydrates, high concentrations of low molecular weight alcohols and presence 
of gyrase inhibitors (Shi et al., 1993). The adaptation to become non flagellated 
and therefore non motile may have a number of advantages for the bacteria, such 
as evasion of the hosts immune system, biofilm production and loss of other 
virulence genes, aiding survival in harsh environments. Consequently, similar 
mechanisms may be occurring in B. cenocepacia J2315 in the presence of 
chlorhexidine.
The question “does sub inhibitory levels of chlorhexidine induce biofilm formation” 
was addressed in this investigation. Biofilms contribute to antimicrobial resistance 
as cells grown within a biofilm have an altered growth rate, making the uptake of 
antimicrobials difficult and penetration of the biofilm may be prevented by the 
accompanying production of an exopolysaccharide (Stickler, 1999). In Burkholderia 
strains biofilm production has also been linked to intracellular survival and the
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invasion of host cells, via the destruction of the glycocalyx layer produced by 
epithelial cells (Savoia and Zucca, 2007).
The contribution of biofilms to antimicrobial resistance is well documented; however 
the efficacy of biocides against biofilms has also become a concern. Miyano et al. 
found that 0.1% and 0.2% chlorhexidine gluconate and 0.1% benzalkonium chloride 
had no effect on B. cepacia strains in biofilms compared to planktonic growth and 
that 0.5% chlorhexidine gluconate, 0.5% benzalkonium chloride and 0.1% 
alkyldiainoethyl glycine were barely effective against biofilms even after 60 minutes 
of exposure (Miyano et al., 2003). This was corroborated by an investigation of 
common hospital biocides against biofilms of MRSA and P. aeruginosa. The 
biocides contained benzalkonium chloride (1%), chlorhexidine gluconate (4%) and 
triclosan (1%) (Smith and Hunter, 2008). The biocides killed 99.9% of these 
bacteria when grown planktonically, but when applied to P. aeruginosa and MRSA 
bioflms, viable cells were isolated after 24 hours of growth (up to 80% and 0 -11% 
respectively) and no biocide was 100% effective against the bioflms (Smith and 
Hunter, 2008). Therefore biofilms pose a real problem for hospitals and clinicians 
and can render some disinfection procedures useless.
A worrying observation is the possibility of induction of biofilm formation in the 
presence of sub-inhibitory levels of the biocide. This phenomenon has been seen 
in P. aeruginosa strains in response to the aminoglycoside tobramycin (Hoffman et 
al., 2005). This study found that concentrations of tobramycin below the MIC 
caused a maximum of 3.4 fold increase in biofilm production and that this induction 
was regulated by a response regulator named as the aminoglycoside response 
regulator (arr) (Hoffman et al., 2005). This regulator encoded a phosphodiesterase 
whose substrate was cyclic di guanosine monophosphate (ci- di -  GMP), a bacterial 
second messenger that regulates cell adhesiveness (Hoffman et al., 2005). 
Bioinformatic analysis did not demonstrate the presence of a significant arr gene 
homolog in the Bcc.
In this investigation a biofilm assay was used to determine if sub-inhibitory levels of 
chlorhexidine induced biofilm formation. The assay used a rapid 96 well plate
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assay and a crystal violet stain. The wells of the plates were first coated with 
mucin, a protein component of mucus that is abundant in CF airways and aids 
attachment of cells to the surface of the plate, thus producing more biomass and 
making biofilms easier to visualise (Landry et al., 2006). The plate assay revealed 
that 58.3% and 83% of strains had induction of biofilm production in the presence of 
chlorhexidine and CPC respectively. This induction did not appear to correlate with 
resistance as some of the more resistant strains did not show this effect, for 
example B. cenocepacia LMG 18832, chlorhexidine MIC >100 pg/ml and B. 
multivorans LMG 16660, chlorhexidine MIC -  90 -  100pg/ml, both had no induction 
of biofilms in chlorhexidine (Figure 6.10). Thus the induction of biofilms by biocides 
appears to be strain specific and is not conserved across the complex.
It also appeared that strains associated with epidemic outbreaks were not more 
likely to induce biofilms than those strains associated with sporadic infection. 
Nonetheless, a larger panel of strains that includes all members of the Bcc should 
be screened so a definite conclusion can be made. The biofilm induction appeared 
to be most effective in CPC and chlorhexidine, with other biocides not exhibiting this 
effect (e.g. triclosan and benzalkonium chloride), suggesting that the induction is 
also dependent on the type of biocide applied as well as the strain. However, in 
tobramycin, the same induction was seen in all 4 strains screened with a maximum 
increase of 20.5% in B. cenocepacia C4455 (Figure 6.12). This supports the study 
by Hoffman et al (2005), which found an induction by tobramycin in P. aeruginosa 
and therefore a similar regulatory mechanism may be at work in the Bcc.
Although the biofilm assays provided information on the ability to form biofilms, 
there were some issues with the reproducibility of the assay. Often repeats would 
give widely different results. This was combated by the use of mucin to coat the 
plates and aid adhesion, which did result in better reproducibility. However, there 
were still differences between the repeats, resulting in large standard errors (Figure
6.10 and Figure 6.11). To decrease fluctuations in the results a modified method 
could be used, where cells are left to adhere for approximately 4 hours. The plates 
are then washed and fresh media applied and biofilms then left to develop (Peeters 
et al., 2008). However, the results indicate that in some strains of the Bcc including
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the epidemic ET-12 lineage B. cenocepacia J2315, biofilms can be induced by sub 
inhibitory levels of biocide, which could be problematic in hospital settings, where a 
bacterium may be in contact with low levels of biocide frequently.
As well as the ability to form biofilms in the presence of biocides, the repression of 
flagella genes suggests that swarming motility may also be inhibited. Swarming is 
needed for a number of applications such as allowing the bacterium to reach a 
surface, used for chemotaxis so the bacterium can reach nutrients and for the 
spreading of biofilms across a surface (Pratt and Kolter, 1998). In this investigation 
it was seen that all species of the Bcc had strains that were capable of swarming 
motility, but this was not universal with some strains exhibiting no swarming or very 
poor swarming. Interestingly, B. cenocepacia strains were among the worst 
swarmers (Table 6.3). In chlorhexidine 67% of strains screened showed inhibition 
of swarming, indicating that chlorhexidine does repress flagella and inhibit motility. 
Nonetheless, as with biofilm induction, this inhibition was not seen in all strains, 
again suggesting that it may be strain dependent, although it does not appear to 
correlate with chlorhexidine resistance (Table 6.4). The inhibition of swarming may 
be part of a survival pathway, where chlorhexidine is sensed by the cell and 
swarming is inhibited. This may prevent contact with the biocide and biofilm 
production is induced to increase resistance to the compound.
There was a tentative correlation between biofilm induction and swarming inhibition 
in response to chlorhexidine. Out of 10 strains, 6 demonstrated both swarming 
reduction and biofilm induction in chlorhexidine (Table 6.5), suggesting that 
chlorhexidine is responsible for this behaviour and that the two processes may be 
linked to aid the bacterium’s survival in chlorhexidine. It may also induce a lifestyle 
that is not only more resistant to biocides, but also to other antimicrobial agents. 
However, a larger panel of strains should be screened before a conclusion can be 
confirmed. In contrast, other studies have indicated that swarming is necessary for 
biofilm production as it allows the attachment of the bacteria to a surface and then 
disperses the biofilm across the surface (Daniels et al., 2004, Pratt and Kolter, 
1998). Other studies have also suggested that biofilm formation and swarming are 
independent of one another (Huber et al., 2001), which may explain why in two
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cases swarming inhibition was seen but initiation of biofilm production was not seen 
(Table 6.5).
6.34 Is there a coordinated regulatory pathway for this phenotype?
The investigation by Hoffman et al. found that the aminoglycoside antibiotic, 
tobramycin induced biofilm formation due to an aminoglycoside response regulator, 
which contained an EAL type domain (Hoffman et al., 2005). This as well as 
GGDEF domains are linked to two component regulatory systems that regulate a 
number of process in the cell. It has been previously shown that the GGDEF and 
EAL domains are second messenger signal molecules that either produce or inhibit 
cyclic di-guanosine monophosphate (ci di -  GMP). This signalling molecule is 
produced by the phosphorylation of a response regulator by a sensor kinase in 
response to a stimuli and is know to regulate cellulose biosynthesis, cell 
differentiation and motility and biofilm production (Paul et al., 2004, Jenal, 2004). 
The involvement in motility and biofilm is particularly interesting as it may have 
some relevance to this investigation, where flagella were repressed in response to 
chlorhexidine and biofilm production enhanced and motility inhibited.
The apparent sensing of chlorhexidine and coordinated down regulation of flagella 
in B. cenocepacia, indicated that a two component system regulator may be 
involved. Further evidence to support this theory comes from searching for 
conserved sequences in upstream regions of repressed genes by MEME (Bailey et 
al., 2006). The analysis of 9 upstream gene sequences 150 -  200 bp revealed 
some areas of conservation, that all had similar positions pointing to the possibility 
of a conserved regulatory binding motif (Figure 6.13.a and b), adding further weight 
to the two component regulator theory. In addition, an investigation by Simm et al. 
found that GGDEF domains produced ci di-GMP, which led to a sessile, non motile, 
biofilm lifestyle and that EAL domains may encode a phosphodiesterase that 
degrades ci di-GMP. These domains were involved with enhancement of swarming 
and swimming motility and the degradation of ci di-GMP (Simm et al., 2004). The 
genes encoding the response regulator containing the GGDEF and EAL domain
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Figure 6.17 Effect of ci di-GMP on motility and biofilm production.
An increase in c di-GMP levels encoded by GGDEF domains causes a transition to a sessile 
lifestyle, with an increase in biofilm production and aggregation of cells onto surface. Other 
processes such as cellulose biosynthesis are also regulated by ci di-GMP. In contrast, the EAL 
domain acts as a phosphatase, degrading levels of ci di -  GMP and causes a switch to a motile 
lifestyle, by increasing swarming, swimming and twitching motility. Figure adapted from (Simm et 
al., 2004)
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were cloned into E. coli and P. aeruginosa and the same phenotypes were 
observed, indicating that ci di-GMP does act as signal molecule that regulates the 
transition from a motile lifestyle to a sessile lifestyle (Figure 6.17). Therefore 
chlorhexidine sensing and the regulation of biofilm formation and motility may be 
controlled by a two component system encoding a GGDEF domain and the release 
of ci di-GMP.
To attempt to elucidate the regulatory genes that are involved with chlorhexidine 
sensing, a random transposon mutagenesis screen was carried out to uncouple the 
swarming regulation, so that mutants would still swarm in the presence of 
chlorhexidine. B. cenocepacia J2315, did show the swarming effect (Figure 6.15), 
however, it also did not swarm particularly well and other strains were selected for 
the screen on this basis. B. multivorans ATCC 17616 was initially chosen, but 
preliminary experiments found that this strain had an insertion “hotspot” and the 
mutagenesis was not random. Therefore 8. cenocepacia AU1054 was used as an 
alternative model strain. Potential AU1054 mutants were selected on swarming 
agar containing chlorhexidine at 5 pg/ml and bioinformatics analysis carried out to 
determine function (Table 6.6). It was hoped that the mutagenesis would reveal a 
particular regulatory gene that was involved with the regulation of this phenotype. 
However, hits in many genes were observed suggesting that there may be a 
number of pathways involved. The genes involved included membrane protease 
subunits, transcriptional regulators and glycosyl transferases. Two genes were 
selected for further analysis, the cheY receiver as this is involved with chemotaxis 
and the glycosyl transferase as this had multiple hits. Bioinformatic analysis was 
carried out on these genes and their surrounding genes to determine the role they 
may play in swarming inhibition.
6.35 CheY  receiver protein
One of the mutants was homologous to a CheY receiver. This receiver is part of a 
response regulator and is involved in the chemosensory system. This system is 
linked with the regulation of flagella, so was selected for further analysis as the
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motility phenotype was being investigated. The surrounding genes of the CheY 
receiver were all involved with pilus assembly and motility related genes (Table 
6.9), making this a very likely regulatory target for inhibition of motility in the 
presence of chlorhexidine. The CheY two component system has already been 
linked to biofilm production by a number of studies. Hickman et al. found a CheY 
homolog in P. aeruginosa (wspR), which contained a GGDEF domain and therefore 
catalysed the production of the signal molecule ci di-GMP. They observed that 
increased levels of ci di -  GMP enhanced biofilm formation and aggregation of cells 
to surfaces (Hickman et al., 2005). Another investigation found that P. aeruginosa 
cheY mutant strains (inactivated in the chemotaxis system) were deficient at cap 
formation and formed attenuated biofilms. Based on this evidence there is a strong 
indication that the cheY response regulator may be a key part in regulation of 
biofilm production and motility in response to a environmental stimuli.
6.36 Glycosyl transferase
An interesting observation from the mutagenesis screen was the multiple hits in a 
glycosyl transferase gene (Table 6 10.). The surrounding genes were also involved 
with glycosylation and were also homologous to ABC type transporters, indicating 
that secretion of glycogen may also be involved. Glycosyl transferases are 
enzymes that catalyse post translational modification of proteins by adding sugar 
moieties. Flagella are known to be glycosylated. Glycosylation can be involved in 
flagellar assembly and biological function (Logan, 2006). The glycosylation of the 
structural protein flagellin may also be involved in virulence of pathogenic bacteria. 
Mutants of P. aeruginosa in flagellar glycosylation, but still with active flagella were 
created and tested in burn wound infection models (Arora et al., 2005). This 
investigation found that the lethal dose of the glycosylation mutants, to kill the 
mouse model increased 35 -  10, 000 fold, indicating that glycosylation is important 
for virulence (Arora et al., 2005). Another study found that temperature dependent 
expression of flagella in Listeria monocytogenes was regulated by a glycosyl 
transferase, which acts as a repressor by inhibiting a response regulator MogR
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(Shen et al., 2006). Therefore the glycosylation of flagellar may be involved in the 
regulation of motility and may also be important in virulence.
Both the cheY operon and the glycosyl transferase operon contain genes that 
contain a tetratricopeptide repeat motif (Bcen_1046 and Bcen_2091). These 
repeats are important for the functioning of cell chaperone, cell cycle, transcription 
and protein transport complexes (Blatch and Lassie, 1999). The TPR may be 
involved in transcription and protein interactions, including mediating interactions 
between kinases (Blatch and Lassie, 1999). Broms et al. found that TPR repeats 
were essential for chaperone activity for the activity of translocator proteins PopB 
and PopD, involved with the secretion of virulence factors in type three secretion 
systems (Broms et al., 2006). These tetratricopeptide repeats may be an essential 
component of two component regulator systems that controls the expression of the 
flagella operon leading to the phenotypes observed in this investigation. 
Subsequently the TPRs may be an interesting area for further investigation and a 
potential target for novel therapeutics.
6.37 Correlation of swarming genes to the J2315 genome
The microarray experiment was carried out on the model strain B. cenocepacia 
J2315, however due to constraints of using this strain for mutagenesis, a different 
strain, B. cenocepacia AU1054 was used for the transposon mutagenesis screen. 
To correlate these results to the microarray data, the genes highlighted in the 
mutagenesis screen were BLAST searched in the J2315 genome and then 
compared to the gene list obtained from GeneSpring. Unfortunately, there was very 
little correlation between genes found from the microarray and genes from the 
mutagenesis screen. The only gene that had a correlation was Bcen_1095, 
chromosome 1, hypothetical protein, which was homologous to J2315 gene BCAM 
2418 (putative membrane bound repetitive protein gene), which was significantly 
up-regulated in the microarray by 1.5 fold change (Table 5.1 and 6.5). Thus this 
indicates that the regulatory mechanisms controlling the regulation may differ in the 
two organisms or that the screen was not sufficient to target the correct regulatory
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genes. This theory is supported by the amount of genes recovered from the 
mutagenesis screen, where only a few genes would be expected to be involved if it 
was a coordinated phenotype regulated by a single system.
6.38 Two component regulatory systems may be involved in 
chlorhexidine sensing
The evidence presented in this chapter, suggests that a coordinated regulatory 
pathway is involved in the sensing of chlorhexidine. This regulation is likely to be 
controlled by a two component regulatory system, which sense chlorhexidine at the 
cell membrane level. This may then cause the autophosphorylation of a sensor 
kinase, which is then transferred to the response regulator (possibly CheY, from the 
mutagenesis screen), which cause the release of a sensor molecule. From the 
literature a good candidate for this sensor molecule is ci di-GMP, which has already 
been shown to be involved with the switching between a motile lifestyle and a 
sessile lifestyle (Simm et al., 2004). The release of ci di-GMP may bind a 
regulatory binding motif, such as the conserved motif found by MEME analysis 
which in turn leads to the repression of the flagella operon. The switching off of 
these genes, promotes a switch to a non motile, sessile lifestyle, with the increase 
of biofilm and exopolysaccharide production. Thus the Bcc strain can then survive 
at higher concentrations of the biocide as biofilms exhibit increased resistance to a 
number of antimicrobials and are also involved with persistence in the CF lung and 
chronic inflammation (Aubert et al., 2008) (Figure 6.18).
This proposed pathway has not yet been fully elucidated and additional work would 
be required to determine all the genes involved and confirm that ci di-GMP was the 
sensing molecule. In addition, not all strains exhibit this effect with some strains 
only showing biofilm induction and others only showing swarming inhibition. 
Therefore it appears this sensing pathway may not be ubiquitous within the Bcc and 
further investigations should be carried out to determine if this correlates with 
resistance and virulence (discussed in section 6.5).
Two component systems are abundant in bacterial species and the Bcc are no 
exception. A novel sensor kinase response regulator hybrid, AtsR was described in
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increase in biofilm production and thus a more resistant phenotype.
Figure 6.18 Possible mechanism of chlorhexidine sensing in the Bcc
Chlorhexidine is sensed by the cell membrane leading to the autophosphorylation of a sensor kinase. This phosphate group is transferred to the response regulator and the release of a sensor 
molecule occurs (ci -d  -  GMP). This binds to a conserved regulatory motif that causes the repression of the flagella operon, leading to increased biofilm production and decreased motility and 
hence a more resistant phenotype.
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B. cenocepacia K56-2 (Aubert et al., 2008). Inactivation of atsR led to a 
hyperadherent strain and increased biofilm production, indicating that this sensor 
kinase response regulator hybrid was important for regulating biofilm production. 
This gene was involved with the regulation of a type 6 secretion system. 
Consequently it appears that atsR is involved with the regulation of virulence factors 
in the Bcc. Therein, a number of regulatory systems may be involved in the 
coordination of virulence and resistant mechanisms in the Bcc and these regulatory 
systems may be good targets for the development of novel therapeutics. Inhibiting 
the ability of the Bcc to adapt to environmental stimuli such as antimicrobials would 
leave them more vulnerable to treatment and may prevent the acquisition of strains 
that are difficult to eradicate.
6.4 Conclusions
To conclude, this chapter aimed to investigate the role of genes identified from the 
microarray experiment described in Chapter 5. Two up-regulated genes, a 
response regulator and a transport related gene were deleted and the effects on 
chlorhexidine susceptibility examined. Although the mutants obtained from these 
experiments did show an increased susceptibility to chlorhexidine, the results were 
not conclusive as there were difficulties in confirming the phenotype of the mutants. 
Therefore, it cannot be certain that the mutants obtained were true mutants for the 
two target genes. Nonetheless, a knockdown effect was observed, indicating that 
these genes might be important. Further mutagenesis studies should be carried out 
to create true mutants. One gene could also be part of a two component regulator 
system (BCAM 0924, response regulator), subsequently both components may 
need to be deleted before a significant effect can be seen.
As well as looking at up-regulated genes, repressed genes were also investigated. 
All the down-regulated genes were involved with motility, raising the question of 
whether chlorhexidine inhibits swarming motility and induces biofilm formation. 
Biofilm assays on chlorhexidine and CPC and swarming assays with chlorhexidine 
confirmed that this hypothesis was true for the majority of strains screened (Table 
6.4). However, not all strains were capable of showing these phenotypes in the 
presence of chlorhexidine and biofilm formation and swarming inhibition did not
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always correlate (Table 6.5). Thus, chlorhexidine sensing may only be present in 
specific strains. Multiple EM for motif elicitation was also carried out to look for 
conserved regions, up stream of down-regulated genes. There was evidence for a 
conserved region supporting the evidence that the biofilm induction, swarming 
inhibition pathway may be co-ordinately regulated.
To determine genes involved in this regulation, a mutagenesis screen was 
performed. Unfortunately, the screen did not reveal a particular regulatory gene 
that could potentially be involved with the regulation of the swarming and biofilm 
production. A number of regulatory genes appeared to be involved, including CheY 
receivers and glycosyl transferases. Therefore further investigation could be 
carried out on these elements to determine their exact role in regulating motility and 
biofilm production.
Finally, the evidence obtained in this investigation point to a coordinated phenotype 
of the switch from a motile lifestyle to a sessile, biofilm lifestyle, regulated via a two 
component regulatory systems. These systems are well known to aid bacterial 
adaptation to environmental stimuli and may allow survival in harsh environments. 
In this case, it appears that sub inhibitory levels of chlorhexidine are inducing a two 
component system to repress flagella, leading to swarming inhibition and biofilm 
induction, thus allowing some strains of the Bcc complex to survive in the presence 
of chlorhexidine. The two component system and the efflux pumps and transport 
genes may be good candidates for novel therapeutics as inhibiting these 
mechanisms may significantly increase susceptibility not only to chlorhexidine but 
other antimicrobials as well.
6.5 Future work
6.51 Mutagenesis of up-regulated efflux and transport genes
Due to the inclusive results from the mutagenesis carried out in this study, further 
mutagenesis should be carried out to fully determine the importance of the efflux 
response regulator and the transport related gene for chlorhexidine susceptibility. A
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new mutagenesis strategy has been devised by Flannagan et al. which creates 
targeted gene deletions specifically for Burkholderia (Flannagan et al., 2008). This 
strategy is based on the homing endonuclease 1-Scel. It involves cloning the 
sequences flanking the chromosomal region marked for deletion into a suicide 
plasmid that carries the 1-Scel recognition site. This plasmid also contains a 
trimethoprim resistance cassette. The plasmid is transferred into Burkholderia by tri 
parental mating, resulting in a targeted insertion. A second plasmid is then 
introduced, which constitutively expresses the 1-Scel endonuclease, which causes 
a double strand break in the inserted plasmid sequence. This stimulates 
recombination between mutant and parent alleles. This leads to either the 
restoration of the wild type phenotype or deletion of the gene and the loss of the 
integrated plasmid and the trimethoprim resistance. To isolate the correct 
recombinants, PCR and southern hybridisation can be carried out on Tp sensitive 
mutants (Flannagan etal., 2008).
6.52 Biofilm and swarming screens
To improve the biofilm and swarming screens a larger panel of strains, that 
encompasses all the Bcc species should be tested for swarming inhibition and 
biofilm induction. This would allow the correlation of the two phenotypes to be more 
reliable and conclusive and may aid the determination of whether biofilm formation 
and swarming regulation are coupled or independent of one another.
Swarming inhibition could also be observed visually by using confocal microscopy. 
A bacterial suspension in increasing concentrations of the biocide can be placed 
under the microscope and the inhibition of swarming observed. It would be 
expected that in higher concentrations, the bacteria would no longer be seen to be 
moving. It would also be interesting to see if they still produce flagella at higher 
concentrations or whether they are just paralyzed.
Problems with reproducibility in the biofilm screen could be overcome by using the 
slightly modified assay as described by Peeters et al. In this method, a 4 hour 
adhesion step was included. After this adhesion step, the supernatant was
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removed and fresh medium added. Biofilms are then left to develop for 24 hours 
and then plates washed and stained (Peeters et al., 2008). The investigators found 
that this method produced reliable and reproducible results, thus the extra adhesion 
step may be useful to improve the assay used in this study.
The effect of sub inhibitory levels of chlorhexidine on biofilm formation could also be 
investigated using a lab model. Biofilms are often associated with implants and 
foreign devices, including urinary catheters. A bladder model has been developed 
that allows the formation of biofilms on catheters to be observed. The catheter is 
inserted into the model and inflated with a buffer, which can include the biocide to 
be tested. Artificial urine can be inoculated with the bacterial suspension and 
pumped through the model and urinary catheter. This can be run up to 7 days or 
until the catheter is blocked (Williams and Stickler, 2008). Comparisons can be 
made between a control with no biocide and the model with biocide, on time for 
blockage, how quick biofilm production occurs and thickness of biofilm. Catheter 
sections could be observed using a scanning electron microscope to look for 
differences as well. Flow cells can also be used to investigate the development of 
biofilms on silicone plates. This method has the added advantage of allowing 
biofilm production to be recorded visually at specific time points, so that 
comparisons can easily be made (Jones et al., 2005) This may add to the 
understanding of biofilm production in the presence of biocides.
In addition, an increase in biofilm production should correlate with an increase in 
exopolysaccharide production. Experiments could be performed using a Congo red 
dye which binds to exopolysaccharides to check the correlation between biofilm 
production and exopolysaccharide production (Harrison-Balestra et al., 2003).
6.53 Two component systems
This investigation indicated that a two component regulator system may be involved 
in the regulation of swarming and biofilm production. However, this has not been 
fully elucidated. To determine the exact nature of the regulation, further studies can 
be carried out. The potential of a GGDEF domain and ci di-GMP involvement is
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high. BLAST searches for this domain could be carried out and correlated to the 
regulatory genes determined by the mutagenesis screen carried out in this 
investigation. This search may also highlight potential regulatory genes that were 
previously missed. In the investigation by Hoffman et al. the presence of ci di-GMP 
was confirmed by the addition of GTP, a ci di -GMP inhibitor. This abolished the 
biofilm induction seen with tobramycin (Hoffman et al., 2005). Thus, GTP addition 
would be a appropriate test to see if biofilm induction is abolished in chlorhexidine 
and to confirm if ci di-GMP plays a role.
From the mutagenesis screen a number of genes were highlighted as being 
involved in the regulation of swarming and biofilm induction. To further elucidate 
their roles, targeted deletion of these genes should be performed and the effect on 
swarming and biofilm induction in the presence of chlorhexidine investigated. 
Furthermore, as flagella are an important virulence factor, mutants unable to 
regulate motility in response to antimicrobials may have attenuated virulence. To 
screen for this infection models could be used, such as the agar bead rat model of 
infection (Sokol etal., 1999).
As this swarming inhibition and biofilm induction is not universal among Bcc species 
a correlation between regulatory genes, the ability to stop swarming and induce 
biofilms and resistance could be carried out. PCR primers specific for important 
two component regulatory genes could be designed and amplification in a number 
of strains could be carried out. Southern hybridisation would allow the 
determination of the presence of these genes in a panel of resistant and sensitive 
strains rapidly, by creating nylon membranes spotted with the genomic DNA of 
these strains. Hybridisation with Dig labelled probes would then be performed and 
chemiluminescent detection carried out to look for the presence of the genes 
(Baldwin et al., 2004). This can then be correlated to biofilm induction and 
swarming inhibition.
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7.1 Introduction
Using transposon mutagenesis, a previous investigation identified two B. 
cenocepacia genes that may be involved in resistance to triclosan, BCAL 2166, 
tmpA and BCAL 3474, fadD (Rees, 2004). Three other genes were implicated in 
resistance to chlorhexidine, BCAL 2716, lytB, BCAL 0500, hsIU and BCAL 3128, 
gltA (Rees, 2004). These five genes were all found on the first chromosome of B. 
cenocepacia and possibly represent intrinsic mechanisms of resistance to these 
two biocides.
7.11 tmpA
The tmpA gene had homology to a putative outer membrane lipoprotein, however, 
this protein was poorly characterised and was of unknown function. Mutants of this 
gene had a 100 fold reduction in triclosan susceptibility compared to wildtype B. 
cenocepacia K56-2 (Rees, 2004). Investigation of the genes surrounding tmpA 
revealed homology to genes involved with transport of metal ions. Hence, this gene 
may be part of a metal transport efflux system. The tmpA gene may also encode 
the outer membrane component of an RND efflux pump, although this particular 
gene deviated from some of the characteristics typically associated with RND efflux. 
RND efflux pumps are approximately 1000 amino acid proteins in size, containing 
12 to 14 transmembrane helices (Borges-Walmsley and Walmsley, 2001), however, 
tmpA and its surrounding genes encode a smaller amino acid product (220 amino 
acids), with only 6 predicted transmembrane helices (Rees, 2004).
The tmpA gene was also associated with cross resistance to a number of unrelated 
compounds, including chlorhexidine, CPC, 5 -  phenyl-1-pentanol, cetrimide and 
benzalkonium chloride, as well as the antibiotics ciprofloxacin, nalidixic acid, 
novobiocin, trimethoprim, chloramphenicol, erythromycin, polymyxin B and 
amikacin. Most of these agents have been previously documented as substrates 
for efflux pumps (Nikaido, 1998, Schweizer, 2003), adding to evidence that this
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gene may be an efflux pump. However, the tmpA gene had no homology to 
previously described efflux pumps in the Burkholderia genome, therefore it may 
represent a novel efflux pump that has of yet not been characterised (Rees, 2004). 
Consequently, tmpA was an interesting target for further analysis as it may 
contribute significantly to the resistance of B. cenocepacia and potentially be a 
target for novel therapeutics.
7.12 fadD
The fadD gene was also associated with resistance to triclosan. This gene 
encodes a long chain fatty acid coA-ligase (acetyl- coA synthase). It is associated 
with the uptake of exogenous long chain fatty acids into the cell, which are then 
converted into acyl Co A derivatives which are utilised as a source of energy 
through the p oxidation pathway or incorporated into phospholipids via a glycerol 
phosphate acyltransferase system (Jackowski et al., 1994). It is perhaps not 
surprising that a gene involved with fatty acid synthesis was involved in resistance 
to triclosan as it is known that this pathway is a specific target of triclosan (McMurry 
et al., 1998b). The proposed hypothesis of the interaction of fadD and triclosan 
resistance suggests that an inactivation of fadD leads to increased permeability of 
the outer membrane due to the lack of conversion of acyl Co A derivatives into 
phospholipids (Figure 7.1). In addition, fadD has been shown to be involved with 
the degradation of fatty acids (Olivera et al., 2001) and therefore this gene may also 
be involved with the degradation of triclosan through the p oxidation pathway 
(Rees, 2004).
7.13 lytB
Three genes were associated with chlorhexidine susceptibility. The lytB gene is 
well characterised and involved in a number of cellular processes including 
biosynthesis of isoprenoids (Cunningham et al., 2000), penicillin tolerance 
(Gustafson et al., 1993), polymyxin B resistance (Burtnick and Woods, 1999), bile 
resistance (Begley et al., 2002) and phospholipids and peptidoglycan synthesis
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Figure 7.1 The fatty acid uptake pathway and the role of fadD
The fatty acid pathway and the possible role of fadD, determined by inactivation of the gene. 
Exogenous fatty acids are transported across the outer membrane via the transporter protein fadL 
and then diffuse into the cytoplasm. The fatty acid is then used as a substrate for acyl coA synthase 
(product of fadD) which converts the fatty acid to acyl co-A via the (3 oxidation pathway. The 
products are then incorporated into phospholipids which make up the membrane. Inactivating the 
fadD gene prevents the p oxidation pathway and causes an increase in membrane permeability and 
thus an increase in susceptibility. Adapted from (Jackowski etal., 1994) and (Rees, 2004).
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(Rodionov and Ishiguro, 1996). The most likely basis of chlorhexidine resistance 
that can be attributed to this gene may be its involvement in peptidoglycan and 
phospholipid synthesis. A possible mechanism for the increased susceptibility of 
the lytB mutant to chlorhexidine may be due to reduced membrane integrity as a 
result of mutations in the lytB gene. This may leave the membrane more 
permeable to agents like chlorhexidine and would also explain the cross resistance 
exhibited to cetrimide, meropenem, piperacillin, gentamicin, ampicillin and ticarcillin 
(Rees, 2004).
7.14 gltA
The gltA gene encoded a glycosyltransferase, associated with the biosynthesis of 
the LPS O antigen (Schnaitman and Klena, 1993, DeShazer et al., 1998). 
Mutations in this gene also resulted in changes in other cellular processes such as 
reduced growth rates, reduced viability, reduced motility and changes in the LPS 
profile (Rees, 2004). The LPS is well known as a virulence factor and is 
responsible for resistance to many antimicrobials, especially cationic antibiotics 
(Mahenthiralingam et al., 2005). Therefore if mutations in the gltA gene are 
involved in LPS formation and membrane integrity it follows that susceptibility to 
cationic agents such as chlorhexidine should increase. Swarming motility was also 
seen to decrease in the gltA mutant (Rees, 2004). This may be explained by the 
structure of the flagellum. In Gram negative bacteria the flagellum is attached to 
the cell wall via an outer L ring which is anchored to the LPS layer (Madigan et al., 
2001b). Consequently, changes to the structure of the LPS may also lead to 
changes in flagella and hence motility.
7.15 hsIU
The third gene found to be involved with chlorhexidine susceptibility was the hsIU, 
heat shock gene. This gene is part of the stress response system which is up- 
regulated in response to an environmental stress such as pH, temperature, 
osmolarity, UV irradiation and the presence of toxic compounds such as antibiotics 
(Ramos et al., 2001). Different heat shock proteins are activated depending on the 
stress and their function is to repair and degrade misfolded proteins, to allow the
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bacteria to survive (Ramos et al., 2001). The presence of an agent such as 
biocides may induce the stress response and therefore the heat shock type proteins 
aiding resistance to the antimicrobial, thus inactivation of these genes could 
potentially increase susceptibility.
7.16 Aims
The aim of this chapter was to explore the roles of these genes further. The 
triclosan susceptible mutant with an inactivated tmpA was of particular interest as it 
may represent a novel efflux pump which has yet to be described in the Bcc. 
Whole cell and outer membrane proteins were extracted to look for profile 
differences and an efflux inhibitor assay carried out to determine if any of the 
mutants are efflux related.
7.2 Results
7.21 MIC determination of mutants
The MIC value for all the mutants were carried out as described in Chapter 2.0 
section 2.241. MICs were carried out on four biocides in total including 
chlorhexidine, CPC, triclosan and benzalkonium chloride. The wildtype B. 
cenocepacia K56-2 had high MIC values to all the biocides screened (Table 7.1). 
For example K56-2 could survive in the maximum concentration tested for 
chlorhexidine, CPC and benzalkonium chloride. The mutants were attenuated in 
their ability to survive in the biocides compared to the wildtype. All the mutants 
were capable of surviving in the maximum CPC concentration tested of 500 pg/ml 
(Table 7.1). The triclosan sensitive mutants had an MIC value of 50 pg/ml 
compared to >500 pg/ml for the wildtype. They also had an increased sensitivity to 
chlorhexidine and to benzalkonium chloride (Table 7.1). The chlorhexidine 
sensitive mutants had MICs of < 10 pg/ml, lytB, and 50 pg/ml gltA and hsIU 
compared to >100 pg/ml for the wild type (Table 7.1). However, the chlorhexidine 
sensitive mutants did not exhibit increased susceptibility to triclosan or CPC and the 
heat shock gene did not have increased susceptibility to benzalkonium chloride
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Table 7.1 MIC values for triclosan and chlorhexidine sensitive mutants
Biocide MIC (M g/m l)
Wild type
Triclosan sensitive  
mutants
Chlorhexidine sensitive mutants
Biocide K56-2 tmpA fadD lytB gltA hsIU
Chlorhexidine >100 50 50 <10 50 50
T riclosan >500 50 50 >300 >500 300
CPC >500 500 500 500 >500 >500
BZK >300 50 -100 50-100 50-100 50-100 300
Grey shaded areas indicate mutants with a knock down in MIC value from the wild type 6. 
cenocepacia K56-2.
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either. These results corroborated those obtained by the previous investigation and 
thus the next stages could be performed.
7.22 Whole cell protein lysis
To determine if any differences were present in the protein profile of the mutants 
that may be attributed to their increased susceptibility, whole cell protein extraction 
was carried out (Chapter 2, section 2.81). To determine protein concentration so a 
suitable amount could be run on the gel, a calibration curve using bovine serum 
albumin standards was produced (Figure 7.2). Protein concentrations obtained 
from the mutants could then be determined as described in Chapter 2, section 2.82. 
Approximately 20 pg of protein was required to give clear results on gel separation. 
The protein were run on a 4 -  20% Tris-HCI gradient gel (Bio-Rad). This gradient 
allows a range of protein sizes to be separated and viewed. The whole cell protein 
extraction produced a large number of bands which made detecting differences 
difficult. The Coomassie blue stain was also quite faint, meaning that once 
photographed some bands were difficult to visualise. However, from this analysis 
there appeared to be no differences in the protein profile between the wildtype and 
the mutants (Figure 7.3). All bands appeared to be the same size and no 
discernible differences were seen. This may have been due to the sheer number of 
bands present in a whole cell extract, therefore outer membrane extraction was 
performed to look for differences at particular band sizes.
7.23 Outer membrane protein extraction
Outer membrane protein extraction was carried out using a Bio-Rad Ready Prep 
protein kit (Chapter 2, section 2.83). This kit produced three fractions, a 
hydrophobic fraction, a hydrophilic section and an insoluble pellet. All three 
fractions were included in the analysis. Again protein quantification was carried out 
(Chapter 2, section 2.83) by creating a standard curve using pre determined bovine 
gamma globulin concentrations. Once protein concentration was determined, 1 -  
500 pg was added to the Readyprep 2D clean up. Using the bioinformatics 
software programme Artemis, features of each gene were investigated. The
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Figure 7.2 Calibration curve of bovine serum albumin standards (mg/ml)
Protein concentration was determined using a Bio-Rad Quick start Bradford assay. Standard bovine 
serum albumin solutions were provided ranging from 0 .1 2 5 -2  mg/ml. The standards and proteins 
to be tested were incubated with Coomassie blue stain and absorbance read at 595 nm. A standard 
curve was produced and linear regression analysis used to determine the exact protein 
concentrations (Chapter 2, section 2.82).
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Figure 7.3 SDS PAGE of wild type B. cenocepacia K56-2 and mutants
Protein products were ran on a 4 -  12% Tris HCI gel at 80 volts. 20 pg of protein were run on the gel and gels were stained with Coomassie Blue. Protein 
marker showing the relevant protein sizes are shown in KDa on the right handside of the figure.
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size of these genes ranged from 35 KDa to 60.8 KDa (Table 7.2). To enhance the 
resolution of the SDS-PAGE gels, a 12.5% gel was chosen as this separated bands 
in the region of 21.5 - 66 KDa. The gels were silver stained to increase the intensity 
of the bands and to make visualisation easier (Figure 7.4). As seen with the whole 
cell protein extraction, no differences in the band patterns were observed in any of 
the fractions for the tmpA mutant and the lytB mutant (Figure 7.4, pellet fraction not 
shown). Silver staining was more efficient, however this process may need 
optimising as three of the mutants in the hydrophilic fraction had a smeared profile, 
making it difficult to determine any differences. Nonetheless, some band pattern 
differences were visible, but the extent of these could not be clearly elucidated 
(Figure 7.4). None of the band differences correlated clearly to the expected sizes 
of the proteins encoded by each mutated gene (Table 7.2). The hydrophobic band 
pattern was also difficult to visualise due to the low yield of protein from the 
extraction.
7.24 Efflux inhibitor assays
The possibility that tmpA may be part of a novel efflux was tested using an efflux 
inhibitor assay (Chapter 2, section 2.29). The efflux inhibitor carbonyl cyanide 3- 
chlorophenylhydrazone (CCCP) was added to a mixture of the bacterial suspension 
and ethidium bromide and fluorescence measured. CCCP is an energy uncoupler 
that disrupts the proton motive force in efflux pumps preventing them from acting. 
The hypothesis that the tmpA gene was involved with efflux was tested using this 
inhibitor. The tmpA mutant should show reduced efflux of the fluorescent 
compound ethidium bromide compared to the wild type K56-2. Once CCCP has 
been added, the accumulation of ethidium bromide should increase in K56-2 due to 
the inhibition of efflux pumps. This should then be comparable to the tmpA mutant.
The experiment was repeated twice so standard errors of the mean could be 
determined. The results from this experiment were inconclusive as to whether 
tmpA was involved with efflux. The two site directed knock outs of tmpA had 
accumulation levels of ethidium bromide similar to those of K56-2 before the 
addition of CCCP. Once CCCP had been added, accumulation in all three strains
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Table 7.2 Protein size data for mutants
Mutant Gene Number Size (KDa) Amino acids
tmpA BCAL2166 41.4 381
fadD BCAL 3474 60.8 557
lytB BCAL 2710 35 326
hsIU BCAL 0500 49 447
gltA BCAL3128 49 434
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B = tmpA D = lytB F = gltA 2 = hydrophobic fraction
Figure 7.4 SDS PAGE of outer membrane proteins for K56-2 and mutants
Outer membranes were run on a 12.5% Tris HCI gel at 80 volts. Approximately 3 pi of protein product were run on the gel and then silver stained.
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Figure 7.5 Efflux inhibitor assays on wild type K56-2 and tmpA mutants (± SE)
tmpA mutants created by site directed mutagenesis. Suspensions were exposed to ethidium 
bromide and fluorescence measured for 10 minutes. CCCP was then added and fluorescence 
recorded for a further 16 minutes.
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increased, however there was no dramatic increase in accumulation in K56-2 
(Figure 7.5).
7.3 Discussion
7.31 Correlation of triclosan and chlorhexidine transposon mutants to 
microarray data
Genes associated with susceptibility to triclosan and chlorhexidine were determined 
in a previous study. The five genes were correlated to the microarray experiment 
performed in this investigation. Only the heat shock protein BCAL 0500 passed the 
statistical significant filter of P < 0.05, with an up-regulated fold change in response 
to chlorhexidine of 1.9. BCAL 2166 (tmpA) and BCAL 3128 (gltA), although not 
statistically significant were very slightly up-regulated with a 1.2 and 1.1 fold change 
respectively. Although this is very low, efflux pumps may only require a small fold 
change to make a large difference. BCAL 3474 (fadD) and BCAL 2716 (lytB) did 
not pass normalisation and therefore could not be analysed. The chlorhexidine 
microarray experiment correlates to the heat shock protein mutant which was 
implicated in chlorhexidine susceptibility, indicating that this gene may be of 
importance for chlorhexidine resistance. The other genes did not correlate well, 
although the triclosan associated outer membrane protein (tmpA) could possibly 
have a role in both triclosan and chlorhexidine resistance, although further 
investigation is required to confirm this.
7.32 Is triclosan and chlorhexidine resistance associated with 
membrane changes?
The transposon mutants were found to have roles in phospholipid and 
peptidoglycan synthesis, stress response, glycosyl transferases and fatty acid 
synthesis. Interestingly the tmpA gene was homologous to a poorly characterised 
outer membrane protein that may be involved in efflux. All of these genes could 
contribute to resistance to triclosan and chlorhexidine via modifications of the LPS 
and outer membrane leaving the bacterium less permeable to the substances 
(Rees, 2004). This chapter aimed to examine if membrane protein changes and 
alterations in efflux was associated with the tmpA gene.
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Changes to the outer membrane and LPS profile have been well documented in the 
literature as corresponding with changes to resistance. A study in ciprofloxacin 
resistant P. aeruginosa isolated from patients undergoing treatment lost a 31 -  32 
KDa outer membrane protein (Daikos et al., 1988). Rajyaguru and Muszynski 
(Rajyaguru and Muszynski, 1997) found that stepwise exposure to trimethoprim / 
sulfamethoxazole resulted in a deficiency of a major outer membrane protein at 
approximately 47 KDa. In addition these mutants expressed outer membrane 
proteins that were not found in the wildtype strain. LPS differences were also 
observed in the trimethoprim / sulfamethoxazole and chloramphenicol resistant 
mutants with the appearance of new high and low molecular weight LPS bands 
(Rajyaguru and Muszynski, 1997). Tattawasart et al (Tattawasart et al., 2000) 
provided evidence of outer membrane changes in response to biocides. 
Chlorhexidine and CPC resistant strains of P. stutzeri strains had alterations in their 
outer membranes with the appearance of two new bands. LPS changes were also 
observed with the loss of the fastest migrating band in chlorhexidine resistant 
strains (Tattawasart et al., 2000). Many of these strains were also associated with 
cross resistance to other antimicrobials such ceftazidime and piperacillin 
(Rajyaguru and Muszynski, 1997).
The B. cenocepacia mutants isolated in the study by Rees et al. (Rees, 2004) found 
cross susceptibility to a number of antibiotics such as trimethoprim, 
chloramphenicol, ciprofloxacin, meropenem, piperacillin and gentamicin which may 
be due to changes in the outer membrane. It was hypothesised that the triclosan 
and chlorhexidine sensitive mutants would perhaps show a loss of some major 
protein bands. Whole cell protein extraction was performed however clear results 
were not obtained and no differences could be observed between the mutants and 
the wild type (Figure 7.3). Therefore outer membrane protein extraction was 
attempted and a silver staining method carried out to clarify results. Nonetheless, a 
very poor yield of protein was obtained from the kit used to extract membranes, 
particularly for the hydrophobic fraction. Consequently when ran on a gel, 
visualisation was very poor (Figure 7.4). No discernible differences could be 
isolated from the gel obtained, although three mutants appeared to produce a 
smeared pattern making visualisation more difficult (Figure 7.4). The results of 
protein analysis were inconclusive as to whether outer membrane changes had
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occurred in the mutants as absences of bands were not seen. However, to improve 
the possibility of seeing outer membrane changes a different extraction approach 
could be taken. In this investigation an extraction kit was used that did not involve 
the use of ultra centrifugation. To obtain better yields of protein a method described 
in Tattawasart et al. (Tattawasart et al., 2000) could be used which incorporates 
ultra centrifugation. To improve the resolution and separation of proteins a 2 -  
dimensional (2D) protein analysis could be used. 2D analysis could improve the 
chances of changes in the membrane being seen. Changes in the membrane may 
not have been seen due to low expression of proteins, as a small change in 
expression may still have a functional effect.
7.33 Is the tmpA gene a triclosan efflux pump?
The poorly characterised tmpA gene showed homology to an RND efflux pump and 
thus may be a previously unknown triclosan efflux pump. Subsequently, this finding 
could potentially be important as it may explain the high resistance exhibited by this 
strain and could be a novel target for new therapeutics. Recently, a triclosan 
specific RND efflux pump has been determined in P. aeruginosa, another bacterial 
species that exhibits high intrinsic resistance to triclosan. This mechanism of 
resistance was isolated when mutants deficient in five efflux pumps were exposed 
to triclosan. Resistant mutants were readily obtained and it was found that a 
triclosan specific efflux pump was being over expressed to compensate for the loss 
of other pumps (Mima et al., 2007). Similarly, in this investigation the tmpA gene 
could be a RND efflux pump that is specific for triclosan. However, this mutant did 
exhibit cross susceptibility to other antimicrobials, thus it may be capable of 
removing other compounds as well as triclosan.
To assess the possibility of tmpA being involved in efflux an assay was set up using 
the efflux inhibitor CCCP. In the tmpA mutant CCCP should not increase the 
accumulation of the effluxes substrate, although a small increase may be seen as 
this inhibitor will prevent all efflux pumps from working. K56-2 should see an 
increase in fluorescence when in the presence of CCCP (fluorescence was directly 
related to accumulation in the cell), due to the inhibition of efflux (Guglierame et al., 
2006). However, in this investigation the results were inconclusive. K56-2 did not
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exhibit a sharp rise in fluorescence once CCCP was added and was not 
comparable to the mutants (Figure 7.5). There were some issues that arose during 
this experiment that may be attributed to discrepancies in results. The substrate 
used for the assay was ethidium bromide so that fluorescence could easily be 
monitored. However, this efflux pump could potentially be specific for triclosan or 
may not transport ethidium bromide as a substrate.
More detailed results may be obtained by growing the wild type in the presence of 
triclosan to over express the efflux pump. It may also be possible to radiolabel the 
triclosan and look for biocide accumulation using spectrometry (Nair et al., 2004). 
The triclosan efflux pump identified in P. aeruginosa was over expressed in mutants 
deficient in other efflux pumps (Mima et al., 2007). To see if the tmpA gene was 
over expressed in K56-2, quantitative real time PCR could be performed. This 
could be compared to triclosan resistant and sensitive strains to see if it is an 
important factor. Alternatively a microarray experiment could be performed to look 
for up regulation of transcription of genes in the whole genome in response to 
triclosan. This approach would provide a large reservoir of data and would 
hopefully corroborate with the results obtained in this investigation.
7.4 Conclusions
Triclosan and chlorhexidine susceptible mutants were isolated and characterised 
previously. To further elucidate the roles these genes play in resistance to these 
biocides protein extractions were performed to look for alterations in the 
membranes. No obvious changes were observed, indicating that other factors such 
as efflux may be more important or that the methods employed were not sufficient 
to clearly identify changes. Similarly, no differences were observed when outer 
membrane proteins were extracted. The possibility that tmpA was involved in efflux 
was assessed using efflux inhibitor assays. These results did not indicate that 
tmpA was part of an efflux pump, although problems with reproducibility and issues 
with the optimisation of the experiment may skew the results. Therefore, to fully 
elucidate the mechanisms of triclosan resistance in this strain further experiments 
are required.
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8.1 Biocide and antibiotic susceptib ility  o f the Bcc
An up to date survey of the biocide and antibiotic susceptibility of all current 
members of the Bcc was performed. This provided information on biocide 
susceptibility in relation to their taxonomy and epidemiology. A panel of P. 
aeruginosa strains was also screened for biocide susceptibility and its relation to CF 
epidemiology of these bacteria. From this work the following conclusions can be 
made:
Epidemic strains in CF infections demonstrate elevated biocide resistance
1) Epidemic strains, such as B. cenocepacia ET-12 strain J2315 (Govan et al., 
1993), the B. multivorans Glasgow outbreak strain LMG 16660 (Whiteford et 
al., 1995) and the P. aeruginosa Liverpool epidemic strains (Cheng et al., 
1996) were less susceptible to biocides and antibiotics than other non 
epidemic strains. The Liverpool epidemic strains had a MIC value four times 
higher than other strains to chlorhexidine. This biocide appears to be 
effective against other strains of P. aeruginosa, thus the lower susceptibility 
may contribute to these strains persistence in clinical settings and CF 
patients. There was also evidence that these epidemic strains are less 
susceptible to a range of unrelated biocides. For example B. cenocepacia 
J2315 was less susceptible to chlorhexidine, CPC, triclosan and povidone 
compared to other strains, such as B. anthina.
Evidence of biocide -  antibiotic cross resistance was inconclusive
2) There was conflicting evidence of cross resistance between biocide and 
antibiotic mechanisms of resistance. Strains such as B. cenocepacia J2315 
were capable of surviving in a number of unrelated biocides and were 
classed as resistant using Etest® strips to a number of antibiotics. This 
indicates there may be some overlaps in mechanisms of resistance.
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However, a B. dolosa strain was resistant to all 10 antibiotics but sensitive to 
chlorhexidine and CPC. Further work should be carried out to fully 
determine the contribution of cross resistance to multi drug resistant 
organisms
Commercial biocide formulations may be ineffective on Bcc bacteria
3) Two commercial biocides were screened to look for bactericidal effects. 
Although they were successful at killing the majority of strains tested, 
including the epidemic B. multivorans LMG 16660, two strains a B. cepacia 
and B. cenocepacia strain were capable of surviving, in certain strains after 
an hour exposure to the biocide. This may be a cause for concern and 
suggests that some of the more resistant strains of the Bcc will not be 
effectively killed by commercial disinfectants. Therefore, clinics disinfection 
procedures should be monitored carefully and adjusted to efficiently kill all 
the Bcc.
Several biocide classes are ineffective against Bcc bacteria
4) From this investigation it can be concluded that QAC biocides such as CPC 
and benzalkonium chloride, triclosan and povidone are ineffective against 
the Bcc and therefore should be avoided in situations where these biocides 
are abundant, such as CF clinics. Although chlorhexidine is more effective 
against both the Bcc and P. aeruginosa it should be noted that some strains, 
particularly problematic epidemic strains were highly resistant to this biocide, 
thus caution should be exercised when using this biocide.
Proposal of new biocide challenge testing Bcc reference strains
5) Standard susceptibility tests for biocides currently include B. cepacia strain 
ATCC 25416, they type strain for the Bcc species. However, this strain was 
one of the more sensitive strains found in this, investigation. Three Bcc 
biocide resistant strains from this study were proposed as potential reference 
strains for biocide efficacy testing; B. cenocepacia J2315, B. multivorans
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LMG 16660 and B. cenocepacia LMG 18832. This would allow a more 
accurate decision to be made on the suitability of that biocide for use in 
clinical situations (Rose etai ,  2009).
8.2 M olecular basis of chlorhexidine resistance
To further characterise the molecular basis of chlorhexidine resistance a whole 
genome expression approach using a microarray of B. cenocepacia J2315 was 
performed. The microarray allowed altered gene expression in response to 
exposure to chlorhexidine to be examined and highlighted genes that may be of 
importance for survival in chlorhexidine. Genome expression of P. aeruginosa in 
response to triclosan has been researched (Mima et al., 2007), however as far as 
we are aware this study is the first to examine the transcriptomic response of a 
bacterium to chlorhexidine. The following conclusions were made:
Novel chlorhexidine up-regulated genes
1) Genes up-regulated in response to chlorhexidine included efflux pumps 
homologous to the mexAB-OprM efflux pump found in P. aeruginosa, outer 
membrane proteins and transport related proteins such as an ABC 
transporter. These genes may all be involved in resistance to chlorhexidine 
as these components have all been described as potential resistant 
mechanisms and may be potential targets for novel therapeutics.
Knock-out of chlorhexidine up-regulated genes
2) Site directed mutagenesis of two genes, BCAM 0924, a response regulator 
and BCAL 2353 a transport related gene was carried out. A phenotypic 
knock down in the MIC was observed with the mutants, compared to the 
wildtype (40 pg/ml compared to 100 pg/ml). However these mutants could 
not be confirmed as “true” genetic mutants, since it appears that a single 
cross over had occurred during the mutation strategy. Thus before the role
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of these two genes can be fully established, further mutagenesis should be 
performed to obtain clean mutations.
B. cenocepacia motility is down-regulated in response to chlorhexidine
3) Genes repressed in response to chlorhexidine were observed. The majority 
were involved with motility and chemotaxis and raised the question of 
whether swarming and biofilm induction was effected by chlorhexidine.
The swarming phenotype is highly variable across the Bcc
4) Swarming was screened for 251 strains of the Bcc. Not all strains were 
capable of swarming with B. cenocepacia strains being among the worst 
swarmers. Sub inhibitory levels of chlorhexidine caused an inhibitory 
swarming effect in 67% of strains screened, with no differences observed 
between chlorhexidine resistant or sensitive strains. When other biocides 
such as CPC and triclosan were screened, the inhibition was not seen, 
indicating that this swarming down-regulation response may be specific for 
chlorhexidine.
Sub-inhibitory concentrations of biocides induce biofilm formation
5) Biofilm induction in response to sub inhibitory concentrations of chlorhexidine 
and CPC was screened. A total of 58.3% and 83% of Bcc strains had an 
induction of biofilm production in chlorhexidine and CPC. Thus, it appears 
that sub inhibitory levels of chlorhexidine may induce a biofilm lifestyle in Bcc 
bacteria leading to increased resistance to antimicrobial agents. This may 
be a major factor contributing to the ability of Bcc bacteria to contaminate 
pharmaceuticals and other commercial products (Jimenez, 2007).
Searching for regulation of chlorhexidine dependent swarming down-
regulation
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6) The inhibition of swarming and induction of biofilms in response to 
chlorhexidine could be regulated by a two component system regulator. 
MEME analysis found a potential conserved regulatory binding region up­
stream of all gene sets down-regulated by chlorhexidine exposure in B. 
cenocepacia. Transposon mutagenesis was performed to try and uncouple 
the swarming regulation and determine the regulatory genes involved. This 
screen found potential interesting genes such as a cheY like receiver, which 
is a response regulator involved in chemotaxis. Several other genes of 
interest including other regulation and envelope genes were identified. 
Further work should be carried out to determine the regulatory mechanism of 
this phenomenon which may be a significant factor in this organism’s ability 
to survive in chlorhexidine. Once identified this regulatory response sensor 
could provide a potentially useful therapeutic target.
The Bcc are a diverse and versatile group of bacteria that cause many problems. 
In addition to their antibiotic resistance this study has shown the Bcc posses very 
high biocide resistance mediated by a number of mechanisms. Health care 
workers and clinicians should take particular care to ensure that disinfection 
practices are adequate to kill all members of the Bcc to prevent the acquisition of 
these infections in CF and vulnerable patients via routine susceptibility testing.
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10.1 Appendix 1: Biocide susceptibility of the Burkholderia 
cepacia complex
Paper published in the Journal of antimicrobial chemotherapy (In press). This 
paper is based on the work carried out in Chapter 3.0.
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Objectives: The Burkholderia cepacia complex (Bcc) species are important opportunistic pathogens 
with intrinsic antibiotic resistance. They are also well known as contaminants of disinfectants, yet their 
biocide susceptibility has not been studied in detail. We investigated Bcc biocide susceptibility and 
correlated it to their taxonomy, antibiotic susceptibility and ability to form biofilms.
Methods: Genetically distinct Bcc strains belonging to 12 of the defined species were examined. 
Biocide susceptibility was assessed by (i) broth dilution MIC assays, (ii) agar growth-based MBC 
screens and (iii) suspension tests. Antibiotic MIC was determined by Etest* strips, and the ability to 
form biofilms was examined in a 96-well plate assay.
Results: Biocide susceptibility varied across the Bcc complex with high MIC recorded for chlorhexi­
dine (>100 mg/L), cetylpyridinium chloride (>200 mg/L), triclosan (>500 mg/L), benzalkonium chloride 
(>400 mg/L) and povidone (>50000 mg/L). Species-dependent differences were apparent only for cetyl­
pyridinium chloride. There was no correlation between biocide susceptibility and (i) antibiotic suscepti­
bility or (ii) the ability to form biofilms. Biocide MBC was considerably higher than the MIC 
(chlorhexidine, 6-fold greater; cetylpyridinium chloride, 20-fold greater). Cystic fibrosis outbreak 
strains (Burkholderia multivorans Glasgow strain and Burkholderia cenocepacla ET12) possessed elev­
ated chlorhexidine resistance, and Bcc bacteria were also shown to remain viable in current commer­
cial biocide formulations.
Conclusions: Bcc bacteria are resistant to a wide range of biocides and further representatives of this 
group should be included as reference strains in the development of new anti-infectives and commer­
cial formulations.
Keywords: antibiotics, resistance and susceptibility, minimal inhibitory concentration
Introduction
The Burkholderia cepacia complex (Bcc) species are proble­
matic Gram-negative opportunistic pathogens, and people with 
cystic fibrosis (CF) are particularly prone to chronic Bcc lung 
infection.1 The Bcc consists of multiple closely related species, 
all of which have been isolated from clinical infections.1- Until 
very recently, the following 10 species had been formally desig­
nated as members of the complex:3 B. cepacia, Burkholderia 
multivorans, Burkholderia cenocepacia, Burkholderia stabilis, 
Burkholderia vietnamiensis, Burkholderia dolosa, Burkholderia 
ambifaria, Burkholderia anthina, Burkholderia pyrrocinia and 
Burkholderia ubonensis. Two recent studies have extended the 
complex to 17 species by the addition of Burkholderia latens sp. 
nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. 
nov., Burkholderia seminalis sp. nov., Burkholderia metallica
sp. nov.,4 Burkholderia lata and Burkholderia contaminans.5 O f 
these 17 species, B. cenocepacia and B. multivorans are most 
associated with CF infection, which together account for ~85%  
to 95% of all Bcc infections in this disease.1 The epidemiology 
of Bcc infection outside CF has not been extensively 
studied; however, the recent studies of Reik et al.6 have shown 
B. cenocepacia (25.6%), B. cepacia (18.9%) and B. multivorans 
(15.6%) to be the most common non-CF infections seen in the 
USA.
An important feature of Bcc bacteria is their very high innate 
antimicrobial resistance to both antibiotics and biocides.1,2 Bcc 
species are intrinsically resistant to many antibiotics such as 
aminoglycosides and polymyxin B and often require combi­
nation therapy to suppress infection in CF.7 The antibiotics 
polymyxin, gentamicin and vancomycin are used at high con­
centrations in B. cepacia Selective Agar, a highly effective
•Corresponding author. Tel: +44-29-20875875; Fax: +44-29-20874305; E-mail: mahenthiralingame@cardiff.ac.uk
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B. cepacia complex biocide susceptibility
medium for their isolation from CF sputum.8 Nzula et al.9 com­
pared the antibiotic susceptibility o f six Bcc species and con­
cluded that it was highly variable except for innate polymyxin 
resistance and not linked to the taxonomic status o f the isolates 
examined. Efflux, the secretion o f chromosomal (3-lactamases 
and the impermeability o f the outer envelope o f Bcc bacteria 
have been implicated in antibiotic resistance.1
In contrast, the molecular basis for biocide resistance in Bcc 
bacteria has been poorly studied despite these organisms being 
linked w ith many instances o f contamination in disinfectants 
and other anti-infective solutions.10 Pharmaceutical formulations 
containing benzalkonium chloride,11 cetylpyridinium chloride12 
and chlorhexidine1314 have become contaminated w ith Bcc bac­
teria and led to large outbreaks o f infection. Even during com­
mercial manufacture, disinfectants such as povidone-iodine may 
become contaminated w ith  Bcc bacteria.15 A  review o f commer­
cial recalls in the USA from 1998 to 2006 demonstrated that 
Bcc bacteria were the most commonly isolated Gram-negative 
bacteria in both sterile and non-sterile products.10 M ultip le 
instances o f a single Bcc strain causing either contamination or 
clin ical infection at geographically distinct sites have been ident­
ified using multilocus sequence typing (M LST);16-18 these data 
suggest that in our burgeoning world economy, the potential for 
global distribution o f contaminating bacteria in anti-infective 
agents may exist.
The aim o f this study was to provide an up-to-date survey o f 
the biocide susceptibility profiles o f a representative panel o f 
Bcc species that accounts for taxonomy and genetic diversity. 
To ensure that a wide genetic diversity o f Bcc bacteria were 
sampled, isolates were also selected on the basis o f their M LST
type.19 Biocide susceptibility was investigated using a standar­
dized broth dilution method to determine MICs; this was also 
correlated to the M BC for resistant and susceptible strains. 
A  possible link  between biocide resistance and multidrug resist­
ance has been proposed,20 and this hypothesis was also explored 
by correlating biocide and antibiotic resistance profiles o f the 
Bcc isolates tested.
Material and methods
Bacterial collection
A panel o f 101 genetically distinct Bcc strains were selected from 
the Cardiff University collection3 and the Belgium Coordinated 
Collection of Microorganisms (BCCM; http://bccm.belspo.be/about/ 
lmg.php). The selected strains encompassed reference strains from 
the defined Bcc strain panels.21,22 Additional B. multivorans strains 
from the Glasgow outbreak23 were kindly provided by Dr Alan 
Brown and Prof. John R.W. Govan (Edinburgh University, UK). 
MLST was used to type and select strains spanning the genetic 
diversity o f the Bcc.19 The strains spanned 11 of the most prevalent 
Bcc species (Table 1) and also two strains from the Bcc novel 
Group K  (a distinct MLST cluster from the former Group K  isolates 
re-named as the new species B. lata and B. contaminans); the 
source o f the strains varied and included clinical (56), non-clinical 
(9) and environmental strains (36). Initia lly all strains were screened 
against chlorhexidine (ICN Biomedicals) and cetylpyridinium chlor­
ide (ICN Biomedicals) as representatives o f agents that could be 
easily screened in a broth dilution assay. From this screen, a subcol­
lection of 38 strains was selected that spanned the range of
Table 1. Susceptibility of Bcc and other species to chlorhexidine and cetylpyridinium chloride
Chlorhexidine MIC (mg/L) Cetylpyridinium chloride M IC (mg/L)
Species (number of strains tested) mean minimum mean maximum mean minimum mean maximum
B. cepacia (10) 57 65 170* 175b
B. multivorans (30) 36.6 46 77.7 101.3
B. cenocepacia (31) 47.4 54.8 175.5C 184.5'
B. stabilis (3) 40 46.7 146.7 166.7
B. vietnamiensis (5) 52 58 90 106
B. dolosa (3) 26.7 36.7 66.7 86.7
B. ambifaria (6) 33.3 41.7 98.3 116.7
B. anthina (2) 10 20 95 125
B. pyrrocinia (2) 15 25 50 70
B. lata (4) 15 25 183.3d 200d
B. contaminans (3) 13.3 23.3 200e 200f
Novel Bcc Group K (2) 50 60 200s 2008
Mean Bcc (101) 33.03 41.9 129.4 144.3
aAt the mean minimum cetylpyridinium chloride MIC, B. cepacia was significantly more resistant than B. multivorans. B. dolosa, B. ambifaria and B. 
pyrrocinia (P <  0.05).
At the mean maximum cetylpyridinium chloride MIC, B. cepacia was significantly more resistant than B. multivorans. B. dolosa and B. pyrrocinia 
(P <  0.05).
cAt the mean minimum and mean maximum cetylpyridinium chloride MICs, B. cenocepacia was significantly more resistant than B. multivorans, 
B. vietnamensis, B. dolosa, B. ambifaria, B. anthina and B. pyrrocinia (PC 0.05).
dAt the mean minimum and mean maximum cetylpyridinium chloride MICs, B. lata was significantly more resistant than B. multivorans (P <  0.05). 
eAt the mean minimum cetylpyridinium chloride MIC, B. contaminans was significantly more resistant than B. multivorans and B. atnbifaria {P <  0.05). 
fAt the mean maximum cetylpyridinium chloride MIC, B. contaminans was significantly more resistant than B. multivorans (P <  0.05).
gAt the mean minimum and mean maximum cetylpyridinium chloride MICs, Bcc novel Group K was significantly more resistant than B. multivorans 
(P <0.05).
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chlorhexidine and cetylpyridinium chloride susceptibility observed: 
22 strains with low MICs and 16 with high MICs were selected to 
provide a spectrum of Bcc biocide resistance.
The subcollection was then used (i) to examine the susceptibility 
to three additional biocides povidone (Sigma Aldrich), benzalko- 
nium chloride (Sigma Aldrich) and triclosan (5-chlon>2-(2.4 
dichlorophenoxy)phenol; Fluka, Biochemika) and (ii) to determine 
the MBC values of chlorhexidine and cetylpyridinium chloride. In 
addition, 10 non-Bcc species were also screened for chlorhexidine 
and cetylpyridinium chloride susceptibility as control species 
(which, except for Escherichia coli, can infect the CF lung): 
Staphylococcus aureus [both methicillin-resistant (MRSA, two iso­
lates) and -sensitive (MSSA, four isolates)] and Pseudomonas aeru­
ginosa (24 isolates), as well as one control isolate for Burkholderia 
gladioli, Stenotrvphomonas maltophilia, Ralstonia mannitolytica. 
Pseudomonas stutzeri, Ralstonia picketti. Pseudomonas putida, 
Achromobacter xylosoxidans and E. coli. All strains were grown in 
Tryptone soya broth (TSB) or agar (TSA; Oxoid) and incubated for 
24-72 h at 37 C.
Broth dilution M IC  method
A broth dilution assay adapted to examine biocide susceptibility of 
Bcc bacteria was carried out as follows. Aqueous solutions (steri­
lized by filtration) of chlorhexidine (10 mg/mL) and cetylpyridinium 
chloride (S mg/mL) were used to make up stock concentrations of 
100 and 1000 mg/L biocides. These solutions were then added to 
TSB to make up biocide concentrations ranging from 0 to 100 mg/L 
for chlorhexidine and 0 to 200 mg/L for cetylpyridinium chloride. 
We found that growth of bacteria in a liquid medium when com­
pared with that on slopes of solid agar produced consistent numbers 
of viable cells for the Bcc strains studied. Therefore, each Bcc strain 
was grown overnight (18 h) in 3 mL of TSB at 37°C (in a 14 mL 
tube, shaken horizontally at 200 rpm); the culture was diluted to an 
optical density (OD) of I (630 nm) corresponding to a viable count 
of -~1 x 10* cfu/mL. Approximately I x 105 cfu of each test Bcc 
strain were then added to 1 mL of each biocide concentration, and 
200 p.L of this was added to three replicate wells within a 96-well 
plate. The microplates were incubated with shaking (200 rpm) at 
37'C for 24 h and the OD was read using a Dynex Technologies 
MRX® microplate absorbance reader with Revelation application. 
An endpoint reading at 630 nm was taken with 10 s of shaking 
beforehand.
B. multivorans LMG 13010 was included in all assays as a control 
strain as preliminary experiments with this strain exhibited a reprodu­
cible effect. Addition of biocides to the growth media resulted in 
changes in OD. Therefore, the MIC value was designated as the 
concentration of biocides that resulted in an 80% knockdown of 
culture OD in comparison with the control wild-type growth with no 
added biocide. Viable counts performed on the control strain after 
running the broth dilution MIC assay demonstrated the presence of 
9.7 x 105 cfu/mL at a chlorhexidine concentration of 20 mg/L, while 
no viable cells were detected above this concentration. Using the 
80% knockdown in culture OD, the MIC for the control strain was 
found to be 30-40 mg/L. which corresponded well to the absence of 
viable cells in concentrations of chlorhexidine above 20 mg/L. The 
results were subjected to statistical analysis in order to determine 
levels of susceptibility.
A gar dilution M IC  method
To screen the subset of 38 strains against the three additional 
biocides povidone, benzalkonium chloride and triclosan, an agar
dilution method was used. The method allowed for higher concen­
trations of biocides to be examined when the broth dilution assay 
was prevented due to the biocides altering the OD reading. Stock 
solutions of the three biocides were made up as follows: 
10000 mg/L of triclosan in DMSO (this solvent did not inhibit the 
growth of Bcc bacteria at the concentrations used); 200000 mg/L 
of povidone in water and 10000 mg/L of benzalkonium chloride in 
water. After autoclaving, TSA was cooled to 50°C and the appro­
priate amount of each biocide was added to 40 mL of agar for 
concentration ranges of 0-500 mg/L for triclosan, 0-400 mg/L 
for benzalkonium chloride and 0-50000 mg/L for povidone. The 
bacterial strains were cultured and diluted to 1x10* cfu/mL as 
described above and 200 p.L of this suspension was then added to 
a 96-well plate in order to create a master plate containing eight 
replicates of each test strain. The strain suspensions from the 
master plate were then replicated onto the biocide-containing agar 
plates using a 96-well replicator and left to grow for 48 h at 37°C. 
The MIC was designated as the concentration of biocides of which 
no visible growth was apparent.
M B C
Bacteria] cultures were grown as described above and diluted to 
~  106 cfu/mL. Chlorhexidine or cetylpyridinium chloride was added 
to diluted bacteria up to a maximum of 5000 mg/L; 200 p,L of this 
suspension was placed into 96-well plates and incubated at 37°C 
with shaking for 24 h. After incubation, 20 p.L of the bacterial 
suspension was placed into 100 p.L of neutralizer solution (0.75% 
azolectin and 5% Tween)24 and left in contact for 5 min. The neu­
tralizer solution was previously screened for efficiency of biocide 
termination and lack of toxicity towards the test bacteria (data not 
shown). After neutralization, the culture was replicated onto TSA 
and incubated for 24-48 h at 37°C; the MBC value was observed as 
the concentration at which growth ceased. Given the known starting 
viable count of bacteria, the dilution made in the neutralizer and the 
volume transferred by the replica plater (1.5 p.L), in the absence of 
bacterial growth, the MBC assay was capable of detecting a 
99.995% rate of bacterial kill.
Antibiotic M IC  testing: Etest® strips
The susceptibility of Bcc strains to 10 antibiotics was determined 
using Antibiotic Etest® strips as described by the manufacturer (AB 
Biodisk). The strains (60 tested) were selected on the basis of their 
resistance to chlorhexidine and cetylpyridinium chloride. The 10 
antibiotics examined were amikacin, azithromycin, ciprofloxacin, 
ceftazidime, chloramphenicol, imipenem, meropenem, piperacillin, 
tobramycin and trimethoprim/sulfamethoxazole; all these antibiotics 
may be used to treat microbial infection in individuals with CF. The 
selection of antibiotics used to treat Bcc infection in CF is depen­
dent on multiple factors including strain antibiogram, patient toler­
ance and clinic practice. Double or triple antibiotic combination 
therapy is recommended with meropenem/high-dose tobramycin 
combined with ceftazidime, trimethoprim/sulfamethoxazole, chlor­
amphenicol or amikacin.7 The bacterial strains tested were revived 
on agar plates, and fresh colony growth resuspended in Iso-Sensitest 
broth (Oxoid) to an OD of 0.5 at 630 nm. This culture was then 
swabbed onto Iso-Sensitest agar plates and left to dry for 15 min. 
Etest® strips were then placed on top of the lawn of bacteria and 
left at 37 'C overnight. The MIC was read from the strips and the 
resistance/susceptibility determined using the manufacturer’s guide­
lines. Spontaneous resistance of each Bcc strain was measured by 
counting the number of colonies that grew within the initial zone of
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clearing after 48 h of incubation; spontaneous resistance was defined 
by the appearance of one or more colonies after 48 h of growth.
Suspension Tests
Two commercial skin cleanser biocide formulations were assessed 
in a standardized suspension test assay:25 HibiSCRUB™ (contain­
ing an alcoholic solution of 4% chlorhexidine gluconate; Regent 
Medical Ltd) and Cuticura™ Waterless Hand Sanitizer (containing 
an unspecified amount of triclosan; Cuticura Labs Corp., NY, USA). 
Bacterial cultures were grown as described above and diluted to 
~ I0 *  cfu/mL. and I mL of this suspension was added to 9mL of 
commercial biocide. After exposure for S, 10, 20 and 60 min, 
100 p.L of this suspension was removed and placed into 900 pL of a 
neutralizer solution (0.75% azolectin and 5% Tween 80) for 5 min. 
A control experiment containing water instead of biocides was also 
carried out at the same time. To enumerate viable bacteria, serial 
dilutions and viable counts were conducted.
Biofilm assays
An adapted biofilm assay was used to determine the biofilm pro­
duction for Bcc strains.26 Plates (96-well) were coated with 1 mg/well 
of porcine mucin (Sigma Aldrich, M1778; 200 pL of a 5000 mg/L 
solution was placed in each well) and left at 37°C overnight. 
Porcine mucin was used to aid the adherence of bacterial cells to the 
wells of the plate as mucin is a protein commonly found in the 
lungs. Plates were washed three times with PBS and 0.1% Tween 20 
and then stored at 4 C until use. Bacterial cultures were grown in 
nutrient broth as described above and diluted to ~ I0 6 cfu/mL; 
200 |lL of each strain was then placed into 96-well plates. Eight 
replicates of each strain were assessed with the control row contain­
ing only broth. The plates were incubated at 37'C statically for 72 h. 
After incubation, the plates were washed three times with PBS to 
remove planktonic growth. The remaining biofilm was fixed with 
methanol for 15 min. Once methanol was removed and plates were 
dried, biofilms were stained with 1% Crystal Violet for 5 min. The 
stain was removed by washing with water and plates were dried. 
Biofilm thickness was measured by adding 33% glacial acetic acid 
and taking an OD reading at 570 nm using an automated plate 
reader (see above).
Statistical analysis
Due to the multifactorial mechanisms of biocide action, the MIC 
values obtained in replicate experiments spanned a range; therefore 
the results were split into a mean minimum value and a mean 
maximum value. All the results were analysed using the statistical 
software Minitab V.14. Kruskal-Wallis and Mann-Whitney statisti­
cal tests were carried out on the datasets and significant differences 
were determined {P <  0.05 for Kruskal-Wallis and P<0.05 for 
Mann-Whitney). An antibiotic profile score was also calculated as 
a measure of overall antibiotic resistance within a Bcc species as 
follows: (i) for a given antibiotic, the mean MIC for all the strains 
in the species tested was calculated and (ii) the mean for all 10 of 
the antibiotics tested was then calculated to produce an overall score 
value for the Bcc species. Mann-Whitney tests were applied to 
determine the significance of the species’ mean antibiotic profile 
score (P<0.05); however, the significance of the score was not 
determined for Bcc species represented by less than two strains. The 
antibiotic profile score did not correlate to clinically defined break 
points for resistance; it just served as a measure of the overall 
multiple drug resistance observed in each Bcc species.
Results
Chlorhexidine and cetylpyridinium chloride susceptibility
MICs of chlorhexidine and cetylpyridinium chloride were 
initially determined for 101 strains of the Bcc; after replicate 
analysis, the mean minimum and mean maximum MIC values 
for each species were calculated (Table 1). For chlorhexidine, a 
variable range of growth inhibition was observed around the 
Bcc species mean (33-42  mg/L), from 10 mg/L (B. lata) to 
65 mg/L (B. cepacia; Table 1). Although there were no 
significant differences observed between species, strains of 
B. cepacia, B. vietnamiensis and B. cenocepacia possessed the 
highest chlorhexidine M IC  values observed (Table 1). 
Approximately 3-fold larger amounts of cetylpyridinium chlor­
ide were required to inhibit the growth of Bcc compared with 
chlorhexidine (mean M IC range, 129-144 mg/L; Table 1). In 
addition, species differences were apparent, with B. cepacia, 
B. cenocepacia, B. lata, B. contaminans and novel Bcc Group K 
strains being significantly less susceptible to cetylpyridinium 
chloride than other members of the Bcc (Table 1; P <  0.05%).
The collection of isolates examined contained nine examples 
of Bcc strains that were involved in outbreaks involving multiple 
CF patients; interestingly, two of these epidemic strains demon­
strated very high levels of chlorhexidine resistance. The B. ceno­
cepacia ET12 epidemic strain J2315 and two additional strains 
that were single-locus variants ( part of the same epidemic cable 
pilus and B. cepacia Epidemic Strain Marker-positive lineage) 
of J2315 had high MIC values for chlorhexidine that were 
>100 mg/L (one of these, LMG 18827, is shown in Table 2). 
Of the remaining 28 B. cenocepacia strains tested, only one 
other recA Group III-A  outbreak strain (MU1; Table 2) and 
one non-epidemic III-B group strain (LMG 18832; Table 2) 
possessed a chlorhexidine MIC in excess of 100 mg/L. Other 
epidemic strains within B. cenocepacia III-B  such as the 
Philadelphia-District Columbia27 and Mid-Western strains28 
were prevented from growing by <60  mg/L chlorhexidine.
The B. multivorans isolate LMG 16660, a strain that caused a 
major outbreak among CF patients in Glasgow,23 possessed a 
very high chlorhexidine M IC  value (90-100 mg/L; Table 2) 
compared with the other B. multivorans strains. To determine 
whether this was a feature of the outbreak isolates, 19 additional 
Glasgow strains (from 17 CF patients involved in the outbreak) 
were examined and their chlorhexidine MICs were found to 
range from 44 to 100 mg/L. These minimum and maximum 
chlorhexidine MICs were significantly higher than the respective 
mean levels observed for all the other B. multivorans strains 
examined (22-33 mg/L; P<0.05). However, in contrast to the 
elevated chlorhexidine MIC, the Glasgow outbreak strains 
were significantly more susceptible to cetylpyridinium chloride 
(76.5-89.5 mg/L; /*<0.05) than the other B. multivorans strains 
(105-127 mg/L; P<0.05).
The Bcc strains were also compared with a control group of 
non-Bcc species commonly encountered in CF infection. With 
chlorhexidine, there were no significant differences between 
the MIC values for Bcc compared with non-Bcc species, 
although 6 of 10 species tested were prevented from growth 
by <20  mg/L chlorhexidine. R. pickettii, R. mannitolytica,
S. aureus and P. aeruginosa required more than 20 mg/L chlor­
hexidine to inhibit growth. Cetylpyridinium chloride resistance 
was significantly elevated in several Bcc species compared with
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Table 2. Biocide susceptibility and MBCs for selected Bcc strains
Species and strain name
Chlorhexidine Cetylpyridinium chloride
Triclosan MIC" (mg/L)
Benzalkonium chloride 
MIC8 (mg/L)MIC (mg/L) MBC (mg/L) MIC (mg/L) MBC (mg/L)
B. cepacia (7)
LMG 17997 100 100 70-100 2000 400 200
ATCC 49709 100 100 >200 500 300 50
IST43I 90-100 — >200 3000 400-450 200
LMG 18821 90-100 300 >200 2000 >500 100
AVCI7I7 70-80 300 >200 >5000 500 200
ATCC 17759 20-30 100 >200 3000 >500 100
BccOI76 10-20 50 30-40 50 500 100
B. multivorans (5)
LMG 16660 90-100 300 >200 >5000 >500 200-250
ATCC 17616 10-20 300 50-150 1000 50 150
Cl 582 100 300 >200 1000 450-500 150
Cl 607 100 500 200 >5000 500 250
LMG 18825 20-30 100 50-100 50 50 100
B. cenocepacia (12)
J2315b >100 100 >200 >5000 >500 350
X I00 90-100 500 70-100 >5000 >500 350
LMG 18827b >100 — >200 — 500 150
MUI >100 1000 >200 >5000 10 350
WH1 10-20 100 150-180 4000 450-500 200
LMG 16654 80-90 300 >200 >5000 >500 50
DN 100 500 >200 2000 450-500 50
K56-2b 90-100 300 >200 >5000 >500 150
PC002 100 300 >200 >5000 >500 >400
ATCC 25609 50-60 300 >200 >5000 400 350
LMG 18832 >100 1000 >200 >5000 >500 350
PC523 10-20 100 150-190 3000 500 200
B. stabilis (2)
ATCC 35254 10-20 100 200 >5000 500 200
LMG 14294 100 100 180-200 >5000 400 200
B. vietnamiensis (4)
LMG 16232 100 100 180-200 4000 450-500 100
G4 10-20 300 30-50 500 50 50
JI738 20-30 100 10-30 50 50 50
LMG 10929 100 100 30-50 300 100 50
B. dolosa (2)
LMG 18943 20-30 300 50-70 2000 450-500 200
AU0090 40-50 100 100-120 5000 450-500 100
B. ambifaria (3)
MC40-6 20-30 50 100-120 2000 50 50
ATCC 53267 100 — 180-200 5000 >500 50
LMG 19467 20-30 50 70-100 1000 >500 150
B. anthina (2)
LMG 16670 10-20 50 70-100 500 150-200 50
LMG 20980 10-20 50 120-150 2000 150 50-100
B. pyrrocinia ( 1)
LMG 14191 10-20 50 50-70 2000 50 50
Mean maximum value (mg/L) 74 229 155 2998 374 164
“The MIC of triclosan and benzalkonium chloride was determined on agar media. 
I^solates representative of the B. cenocepacia ET12 epidemic CF strain.
506
B. cepacia complex biocide susceptibility
other CF colonizers, with B. cepacia, B. cenocepacia and Bcc 
novel Group K being significantly less susceptible (F<0.05). 
Overall, P. aeruginosa was the only CF pathogen that demon­
strated chlorhexidine MICs (33-42 mg/L) and cetylpyridinium 
chloride MICs (200 mg/L) equivalent to those found in Bcc 
bacteria.
M B C
After screening 101 strains from the Bcc for growth inhibition, 
38 strains spanning the observed MIC ranges for chlorhexidine 
and cetylpyridinium chloride were selected for MBC analysis 
(Table 2). The mean Bcc chlorhexidine MBC was 229 mg/L 
(Table 2). ~6-fold greater than the mean MIC for this biocide. 
The endpoint difference between the MIC and MBC assays 
demonstrated that the M IC  concentration should not be taken as 
a measure of biocide efficacy, since for all but two of the 
strains examined it was below the bactericidal concentration. 
The majority of strains tested (35 out of 38) required no more 
than 300 mg/L for a bactericidal outcome. One B. multivorans 
and two B. cenocepacia strains had MBCs of 500 mg/L; two 
B. cenocepacia strains needed 1000 mg/L of chlorhexidine to 
achieve killing, 10-fold above their respective MIC concen­
tration (Table 2). In contrast, 27 of the 38 Bcc strains required 
over 20-fold more cetylpyridinium chloride than the M IC for 
a bactericidal outcome, with a mean cetylpyridinium chloride 
MBC of 2998 mg/L (Table 2). In addition, 13 Bcc strains (eight 
of which were B. cenocepacia) were still viable after a 24 h 
exposure to 5000 mg/L of cetylpyridinium chloride.
Triclosan, povidone and benzalkonium chloride susceptibility
The same subgroup of Bcc strains selected for MBC analysis 
was tested for their growth susceptibility to triclosan, povidone 
and benzalkonium chloride (Table 2). All Bcc strains tested 
possessed povidone MICs in excess of 50000 mg/L, except for
one B. pyrrocinia strain (M IC 2000 mg/L). The mean maximum 
M IC  observed for triclosan was 374 mg/L with 11 Bcc strains 
having MICs >500 mg/L. The mean maximum MIC of 
benzalkonium chloride was 164 mg/L, similar to that of the 
other quaternary ammonium compound tested, cetylpyridinium 
chloride (155 mg/L for the subgroup of strains tested). Both 
B. cenocepacia J2315 and K56-2 from the ET12 epidemic 
lineage (which possessed high chlorhexidine and cetylpyridi­
nium chloride MICs; Table 1) had high MICs of triclosan 
(>500 mg/L), povidone [>50000 mg/L (5%)] and benzalko­
nium chloride (350 mg/L).
Antibiotic susceptibilities
Antibiotic susceptibility to 10 antibiotics commonly used in CF 
was determined for 60 Bcc strains (Table 3). Clinically defined 
resistance or susceptibility to individual antibiotics varied widely 
for the Bcc strains tested. However, when the total antibiotic M IC  
score was examined, B. cepacia, B. multivorans, B. cenocepacia 
and B. dolosa possessed the greatest levels of multiple drug resist­
ance (Table 3). B. dolosa, in particular, possessed very high levels 
of antibiotic resistance (Table 3); however, this did not correlate to 
elevated biocide resistance. For example, the B. dolosa strain 
LMG 18943, a strain associated with an outbreak in a hospital in 
Boston,29 had a chlorhexidine M IC  value of 20 -30  mg/L and a 
cetylpyridinium chloride M IC value of 50 -70  mg/L, but was 
resistant to all 10 antibiotics tested.
Overall, the Bcc strains examined were most susceptible 
to meropenem, imipenem, piperacillin and trimethoprim/ 
sulfamethoxazole; B. cenocepacia strains such as J2315 were, 
however, innately resistant to this antibiotic combination. 
Spontaneous resistant colonies appearing within the zones of 
clearing on the Etest* strips occurred most frequently with the 
[5-lactam antibiotics (meropenem, imipenem and piperacillin). 
In addition, B. multivorans and B. cenocepacia strains (41% and 
33%, respectively, of the strains tested) produced the most
Table 3. Mean MIC (mg/L) values for Bcc species to 10 antibiotics
Organism (number of strains Antibiotic profile
tested) AMK AZM CAZ CHL CIP IPM MEM PIP TOB SXT score
B. cepacia (5) 109.6 125.3 5.98 13.3 5.2 17.6 0.9 13.1 88.23 0.5 37.9“
B. multivorans (24) 81.6 110.4 52.9 101.6 1.976 25.8 2.2 21.4 30 0.4 42.8b
B. cenocepacia (14) 111.5 81.2 2.6 12.2 1 35.6 3.1 23.4 37.5 9.1 31.7C
B. stabilis (2) 8 32.7 1.6 22 16.3 3 1.5 3 4.5 2 9.5d
B. vietnamiensis (4) 6.3 13.5 2.5 8 0.2 0.4 0.5 1.25 4.6 0.3 3.8
B. dolosa (4) 224 256 66.7 192.7 10.3 26.2 17.5 82.3 118 12 100.6°
B. ambifaria (4) 9.8 23.6 1.2 3.25 0.1 1.1 0.2 1.1 6.6 0.1 4.7
B. anthina ( 1) 16 32 1.5 4 0.19 2 0.38 1 8 0.19 6.5d
B. pyrrtK'inia ( 1) 0.094 24 0.75 1.5 0.003 0.19 0.002 0.25 2 0.002 2.9d
B. contaminans ( 1) 1 16 1.5 8 0.25 24 0.75 1 0.38 0.125 5.3d
AMK, amikacin; AZM, azithromycin; CIP, ciprofloxacin; CAZ. ceftazidime; CHL, chloramphenicol; IPM, imipenem; MEM. meropenem; PIP, piperacillin; 
TOB, tobramycin; SXT, trimethoprim/sulfamethoxazole.
mB. cepacia was significantly more resistant than B. vietnamensis and B. ambifaria (PC 0.05).
bB. multivorans was significantly more resistant than B. ambifaria (P <  0.05).
eB. cenocepacia was significantly more resistant than B. vietnamensis and B. ambifaria (PC 0.05).
dB. stabilis. B. anthina, B. pyrrocinia and B. contaminans were not statistically significant owing to small sample size.
eB. dolosa was significantly more resistant than B. stabilis, B. vietnamensis and B. ambifaria (PC 0.05).
507
Rose et al.
spontaneous resistance to the P-lactams. All other Bcc species 
tested demonstrated low rates of this phenomenon with 
B. vietnamiensis (at 11 % of strains tested) being the next 
highest observed.
Susceptibility to commercial biocide formulations
To determine whether commercial biocide formulation was bac­
tericidal for Bcc strains that possessed high MIC and MBC to 
specific disinfectants, suspension tests were performed. Two bio­
cides were evaluated: Hibiscrub, a chlorhexidine-based disinfec­
tant used in clinical settings for pre-operative hand disinfection 
and skin antiseptisis, and Cuticura, a hand gel sold for both 
home and clinical use. Four Bcc strains with high resistance to 
chlorhexidine (9 0 -100 mg/L) were tested: B. cepacia LMG  
18821, B. multivorans LMG 16660, B. cenocepacia J2315 and 
Bcc novel Group K strain 24. B. multivomns ATCC 17616 was 
used as a susceptible control isolate. Five minutes of exposure to 
the commercial biocide formulation was sufficient to achieve 
killing of three Bcc strains (strain LMG 16660, Group K strain 24 
and ATCC 17616). However, B. cepacia LMG 18821 remained 
viable after 1 h of exposure to Cuticura (only a 1 log reduction in 
viable count was observed); the strain was killed within 5 min in 
Hibiscrub. B. cenocepacia J2315 remained viable in Hibiscrub 
after 1 h of exposure; however, it was more susceptible to 
Cuticura with complete killing observed after 20 min.
Biofilm production
Bacteria within biofilms are less susceptible to killing by anti­
microbial agents than planktonic cells. To determine whether 
there was a correlation between biofilm formation and biocide 
resistance in a planktonic state, 11 Bcc strains were screened 
for biofilm production. Six strains were selected with high 
0 8 0  mg/L) and five with low (<30  mg/L) resistance to 
chlorhexidine (Figure 1). No correlation between chlorhexidine 
MIC and the ability to form a biofilm was observed. For 
example, B. multivorans strain ATCC 17616, which possessed a
High MIC Low MIC0.5
0.45
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Figure 1. Biofilm production by selected Bcc strains. Six strains with high 
(black bars) and five with low (open bars) chlorhexidine MICs were tested 
for biofilm formation. The biofilm biomass readout is shown on the vertical 
axis. Strains are as follows: I. B. cepacia LMG 18821; 2, B. multivorans 
LMG 16660; 3, B. cenocepacia LMG 18832; 4, B. cenocepacia J2315; 
5. B. cenocepacia C4455; 6, B. cepacia novel Group K 24; 7, B. multivorans 
LMG 13010; 8, B. multivorans ATCC 17616; 9, B. dolosa LMG 18943; 
10, B. ambifaria AMMO; 11, Burkholderia vietnamensis G4.
low chlorhexidine M IC  (10-20 mg/L) and low MICs to the 
other biocide screens (Table 1), produced the most biofilms. 
In contrast, B. cenocepacia J2315, which was representative of 
a highly transmissible lineage associated with major clinical 
infections and possessed high biocide (Table 2) and antibiotic 
resistance (see above), was a poor biofilm former.
Discussion
Bcc bacteria are known to possess high levels of antimicrobial 
resistance; however, a survey of their biocide resistance that 
accounts for the recent changes in their taxonomy has not been 
performed. Our analysis of the biocides chlorhexidine, cetylpyri­
dinium chloride, triclosan and benzalkonium chloride has 
demonstrated that susceptibility to these agents varies consider­
ably across a panel of genetically distinct Bcc strains. Species- 
dependent differences were apparent only for cetylpyridinium 
chloride. No specific correlations between biocide susceptibility, 
antibiotic susceptibility and the ability to form biofilms were 
seen; however, certain CF outbreak strains possessed very high 
chlorhexidine resistance. The ability of biocide-resistant Bcc 
strains to survive exposure to two widely used commercial skin 
washing biocides was also demonstrated, suggesting that there is 
still room to improve disinfectant formulations to ensure they 
kill this group of bacteria.
While the correlation of antibiotic susceptibility to six geno- 
movars has been reported,9 the influence of Bcc taxonomy on 
biocide susceptibility has not been examined. The M IC  for Bcc 
strains was investigated in great depth for chlorhexidine and 
cetylpyridinium chloride, with B. cepacia, B. cenocepacia, 
B. lata, B. contaminans and Bcc novel Group K being signifi­
cantly less sensitive to cetylpyridinium chloride than other 
species. Previous work correlating clinical antibiotic resistance 
to Bcc taxonomy did not find any significant trends,9 however, 
we found that if an overall antibiotic resistance score was calcu­
lated based on the MIC value, then B. cepacia, B. multivorans, 
B. cenocepacia and B. dolosa were significantly more resistant. 
Interestingly, B. cenocepacia, which overall possessed both high 
biocide (Tables 1 and 2) and antibiotic resistance (Table 3), was 
also the most prevalent Bcc species encountered in a recent 
survey of both CF and other clinical infections.6
Correlations between antibiotic resistance and biocide resist­
ance were not obvious among the Bcc bacteria. Certain epidemic 
Bcc strains such as those of the ET12 group (e.g. J2315, Table 2) 
possessed the highest levels of resistance to both classes of anti­
microbial agents. The Glasgow outbreak B. multivorans strain23 
possessed chlorhexidine MICs that were nearly double that of 
other B. multivorans strains (Table 2), yet had similar levels of 
antibiotic resistance within this species group. Other strains, 
such as the epidemic B. dolosa LMG 18943,-9 possessed low 
chlorhexidine and cetylpyridinium chloride MICs (Table 2) but 
were resistant to all 10 antibiotics tested. There was also a lack 
of correlation between planktonic biocide resistance and the 
ability to form biofilms (Figure 1) for Bcc bacteria. This suggests 
that despite the advantages biofilm growth confers in terms of 
survival under antimicrobial stress, not all Bcc bacteria have 
adopted this phenotype, but instead have other enhanced resist­
ance mechanisms that function during planktonic growth. 
However, strains such as B. cenocepacia C4455 and Bcc novel 
Group K 24 (Figure 1), which have both high intrinsic biocide
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and a good ability to form biofilms, have the potential to be par­
ticularly problematic in contamination or outbreak scenarios. 
The lipopolysaccharide (UPS) structure of Bcc bacteria is very 
unusual and also varies between species.31 Given the important 
role this part of the Bcc cell envelope plays in its resistance to 
cationic antimicrobial agents, it would be interesting in future 
studies to compare the LPS structures of strains that are resistant 
or susceptible to membrane-active biocides such as chlorhexidine.
Maintaining product sterility is a problem faced by many 
manufacturing industries and a recent survey of the pharma­
ceutical industry has shown that Bcc bacteria are one of the 
leading causes of pharmaceutical product recalls.10 Our analysis 
of MBC data showed that Bcc bacteria may need more than 25 
times more biocides over the M IC value to achieve killing. The 
concentrations of biocides used in commercial products are 
dependent on the biocide and type of product application. 
Chlorhexidine, cetylpyridinium chloride and triclosan are used 
in a variety of commercial products in concentrations ranging 
from 0.1% to 4% (1000-40000 mg/L).32 At the lowest level, 
this is insufficient to kill Bcc bacteria. For example, two 
B. cenocepacia strains had chlorhexidine MBCs of 1000 mg/L 
and 31 Bcc strains had cetylpyridinium chloride MBCs in 
excess of 1000 mg/L (Table 2). Dilute solutions of chlorhexidine 
appear particularly prone to contamination with Bcc bacteria, 
and outbreaks associated with mouthwash (0.2%)33 or blood- 
product disinfectant solutions (0.5% and lower concentrations)13 
have been reported. The M IC  of five disinfectants used for 
organ irrigation in CF lung-transplant procedures was evaluated 
by Ferry et al.u  Tauroiin and Noxyflex were found to be more 
inhibitory towards the 19 Bcc isolates tested than chlorhexidine, 
triclosan and povidone, and were specifically recommended for 
use where these bacteria may be present.34
The efficacy of skin disinfection products and procedures 
may be tested according to standard European guidelines using 
bacterial species such as E. coli, P. aeruginosa, S. aureus and 
Enterococcus hirae.2*  Preservative challenge test guidelines 
include the B. cepacia Type strain ATCC 25416, among the 
recommended test strains. However, although this strain pos­
sessed the maximal cetylpyridinium chloride MIC (>200 mg/L), 
its chlorhexidine M IC was 20-30 mg/L and was not among the 
most resistant encountered in our survey. Three well-defined 
strains stand out in our analysis as being resistant to multiple 
biocides (Table 2): (i) B. cenocepacia LMG 18832 (ATCC 
17765), a urinary tract infection isolate;22 (ii) B. cenocepacia 
J2315 (LMG 16656), an epidemic CF isolate,22 and (iii) B. mul­
tivorans LMG 16660 (C l576), a CF isolate from the Glasgow 
outbreak.23 All the latter strains were included in a historical 
reference panel of Bcc strains22 and are available from recog­
nized strain collections. Given the major role Bcc organisms 
may play in the contamination of such products,10 future testing 
should also include these bacteria.
In summary, the characterization of Bcc as a group of proble­
matic opportunistic pathogens has advanced considerably in 
the last decade.3 The ability to genetically define strains17,1 and 
systematically identify new species within the group4,5 has 
improved considerably. We have shown that as a closely related 
group of Gram-negative pathogens, Bcc bacteria possess very 
high resistance to biocides and commercial formulations of 
these agents. This understanding, together with the potential use 
of the biocide-resistant reference strains we have defined, can be 
used to develop new anti-infectives capable of killing Bcc
bacteria and preventing their occurrence in disease2 and con­
tamination of commercial products.10
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Chapter 10 Appendices
10.2 Appendix 2: raw microarrav and sequence data
CD-ROM of raw microarray data, including quality control reports and raw 
microarray imagines produced by the Agilent feature extractor software. Raw 
sequences generated from the transposon mutagenesis screen are included on the 
CD-ROM.
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